PDC_ID	PDC_Name	Peptide_ID	Peptide_Name	receptor_id	Receptor_name	Linker_ID	Linker_Name	payload_ID	Therapeutic_target_ID	therapeutic_target_name	Payload_Name	PDC_Status	Puchem_CID	drugmap_id	ttd_id	INTEDE_ID	DRESIS_ID
PDC_00001	"([&alpha;,&beta;-<sup>3</sup>H]Nal)Lu-PSMA-617"	PEP00030	PSMA-617	REC00042	Glutamate carboxypeptidase 2 (FOLH1)	LIN00073	(S)-2-(4-(aminomethyl)cyclohexane-1-carboxamido)-3-(naphthalen-2-yl)propanoic acid	DRG00047	TAR10052	Human Deoxyribonucleic acid (hDNA)	Lutetium-175	Investigative	.	.	.	.	.
PDC_00002	(123B9)<sub>2</sub>L2PTX	PEP00160	123B9	REC00028	Ephrin type-A receptor 2 (EPHA2)	LIN00049	Antitriazole	DRG00012	TAR10017	Microtubule (MT)	Paclitaxel	Investigative	.	.	.	.	.
PDC_00003	(DOX-S)<sub>2</sub>-S-Pep	PEP00008	CCKIGLFRWR	REC00017	72 kDa type IV collagenase (MMP2)	LIN00009	"2,2-Dipyridyl disulfide"	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00004	[<sub>18</sub>F]AlF-NOTA-octreotide	PEP00105	Octreotide	REC00031	Somatostatin receptor type 1 (SSTR1)	LIN00087	Amide bond	DRG00048	TAR10052	Human Deoxyribonucleic acid (hDNA)	Fluorine-18	Investigative	.	.	.	.	.
PDC_00005	[<sup>177</sup>Lu]Lu-4	PEP00030	PSMA-617	REC00042	Glutamate carboxypeptidase 2 (FOLH1)	LIN00042	rac-(R)-2-(2-aminoacetamido)-3-(4-(2-(((R)-1-carboxy-2-phenylethyl)amino)-2-oxoethoxy)phenyl)propanoic acid	DRG00049	TAR10052	Human Deoxyribonucleic acid (hDNA)	Lutetium-177	Investigative	.	.	.	.	.
PDC_00006	[<sup>177</sup>Lu]Lu-7	PEP00030	PSMA-617	REC00042	Glutamate carboxypeptidase 2 (FOLH1)	LIN00042	rac-(R)-2-(2-aminoacetamido)-3-(4-(2-(((R)-1-carboxy-2-phenylethyl)amino)-2-oxoethoxy)phenyl)propanoic acid	DRG00049	TAR10052	Human Deoxyribonucleic acid (hDNA)	Lutetium-177	Investigative	.	.	.	.	.
PDC_00007	[<sup>177</sup>Lu]Lu-P17-079	PEP00030	PSMA-617	REC00042	Glutamate carboxypeptidase 2 (FOLH1)	LIN00071	Phosphonic Acid Linker	DRG00049	TAR10052	Human Deoxyribonucleic acid (hDNA)	Lutetium-177	Investigative	.	.	.	.	.
PDC_00008	[<sup>177</sup>Lu]Lu-P17-081	PEP00030	PSMA-617	REC00042	Glutamate carboxypeptidase 2 (FOLH1)	LIN00042	rac-(R)-2-(2-aminoacetamido)-3-(4-(2-(((R)-1-carboxy-2-phenylethyl)amino)-2-oxoethoxy)phenyl)propanoic acid	DRG00049	TAR10052	Human Deoxyribonucleic acid (hDNA)	Lutetium-177	Investigative	.	.	.	.	.
PDC_00009	[<sup>64</sup>Cu]PDC-1	PEP00098	&alpha;v&beta;6-BP	REC00014	Integrin alpha-V; Integrin beta-6 (ITGAV; ITGB6)	LIN00064	Mc-PEG2-Val-Cit-PABC	DRG00038	TAR10017	Microtubule (MT)	Monomethyl auristatin E	Investigative	.	.	.	.	.
PDC_00011	"[4Lys(Ac),8Lys(Dau=Aoa)]-GnRH-III"	PEP00168	GnRH-III	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00019	Aminooxyacetic acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00013	"[4Lys(Dau=Aoa),8Lys(Dau=Aoa)]-GnRH-III"	PEP00168	GnRH-III	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00019	Aminooxyacetic acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00015	[8Lys(Dau=Aoa-GFLG)]-GnRH-III	PEP00168	GnRH-III	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00019	Aminooxyacetic acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00016	[8Lys(Dau=Aoa-K(Dau=Aoa))]GnRH-III	PEP00168	GnRH-III	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00019	Aminooxyacetic acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00017	[8Lys(Dau=Aoa-LRRY)]-GnRH-III	PEP00168	GnRH-III	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00019	Aminooxyacetic acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00018	[8Lys(Dox-O-glut)]-GnRH-III	PEP00168	GnRH-III	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00033	Glutaric acid	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00019	[d-Cys<sup>6</sup>-des-Gly<sup>10</sup>-Pro<sup>9</sup>-&alpha;-azaGly-NH<sub>2</sub>]-GnRH-Dox	PEP00027	GnRH analogs 3	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00066	N-succinimidyl-3-maleimidopropionate	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00020	[d-Cys<sup>6</sup>-des-Gly<sup>10</sup>-Pro<sup>9</sup>-NH<sub>2</sub>]-GnRH-Dox	PEP00028	GnRH analogs 1	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00066	N-succinimidyl-3-maleimidopropionate	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00021	[d-Cys<sup>6</sup>-des-Gly<sup>10</sup>-Pro<sup>9</sup>-NHEt]-GnRH-Dox	PEP00029	GnRH analogs 2	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00066	N-succinimidyl-3-maleimidopropionate	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00022	[GG]PDIP-alk-PQ	PEP00004	[GG]PDIP	REC00057	Phosphatidylserine lipid headgroups	LIN00023	Alkyne-Triazole	DRG00005	TAR10015	Plasmodium Deoxyribonucleic acid (Malaria DNA)	Primaquine	Investigative	.	.	.	.	.
PDC_00023	<sup>111</sup>In-DTPA-octreotide	PEP00105	Octreotide	REC00031	Somatostatin receptor type 1 (SSTR1)	LIN00087	Amide bond	DRG00027	TAR10052	Human Deoxyribonucleic acid (hDNA)	Indium-111	Approved	49800006	.	.		.
PDC_00024	<sup>159</sup>Tb-PSMA-617	PEP00030	PSMA-617	REC00042	Glutamate carboxypeptidase 2 (FOLH1)	LIN00073	(S)-2-(4-(aminomethyl)cyclohexane-1-carboxamido)-3-(naphthalen-2-yl)propanoic acid	DRG00050	.	.	Terbium-159	Investigative	.	.	.	.	.
PDC_00025	<sup>161</sup>Tb-PSMA-617	PEP00030	PSMA-617	REC00042	Glutamate carboxypeptidase 2 (FOLH1)	LIN00073	(S)-2-(4-(aminomethyl)cyclohexane-1-carboxamido)-3-(naphthalen-2-yl)propanoic acid	DRG00051	TAR10052	Human Deoxyribonucleic acid (hDNA)	Terbium-161	Investigative	.	.	.	.	.
PDC_00026	<sup>175</sup>Lu-PSMA-617	PEP00030	PSMA-617	REC00042	Glutamate carboxypeptidase 2 (FOLH1)	LIN00073	(S)-2-(4-(aminomethyl)cyclohexane-1-carboxamido)-3-(naphthalen-2-yl)propanoic acid	DRG00047	TAR10052	Human Deoxyribonucleic acid (hDNA)	Lutetium-175	Investigative	.	.	.	.	.
PDC_00027	<sup>177</sup>Lu-DOTATATE	PEP00109	3-Tyr-Octreotate	REC00031	Somatostatin receptor type 1 (SSTR1)	LIN00087	Amide bond	DRG00049	TAR10052	Human Deoxyribonucleic acid (hDNA)	Lutetium-177	Approved	76966897	DMT8GVU	D0M5VV	.	.
PDC_00028	<sup>177</sup>Lu-PSMA I&T	PEP00111	PSMA I&T	REC00042	Glutamate carboxypeptidase 2 (FOLH1)	LIN00011	PSMA-I&T Linker	DRG00049	TAR10052	Human Deoxyribonucleic acid (hDNA)	Lutetium-177	Phase 2	.	.	.	.	.
PDC_00029	<sup>177</sup>Lu-PSMA-617	PEP00030	PSMA-617	REC00042	Glutamate carboxypeptidase 2 (FOLH1)	LIN00073	(S)-2-(4-(aminomethyl)cyclohexane-1-carboxamido)-3-(naphthalen-2-yl)propanoic acid	DRG00049	TAR10052	Human Deoxyribonucleic acid (hDNA)	Lutetium-177	Approved	122706785	.	.		.
PDC_00031	<sup>18</sup>F-fallypride	PEP00169	Fallypride	REC00021	D(2) dopamine receptor; D(3) dopamine receptor (DRD2; DRD3)	LIN00086	Alkane	DRG00048	TAR10052	Human Deoxyribonucleic acid (hDNA)	Fluorine-18	Investigative	449762	.	.		.
PDC_00032	<sup>18</sup>F-PSMA-1007	PEP00030	PSMA-617	REC00042	Glutamate carboxypeptidase 2 (FOLH1)	LIN00044	2-(4-(aminomethyl)benzamido)-3-(naphthalen-2-yl)propanoic acid	DRG00048	TAR10052	Human Deoxyribonucleic acid (hDNA)	Fluorine-18	Investigative	134159760	.	.		.
PDC_00033	<sup>225</sup>Ac-DOTATOC	PEP00031	Edotreotide	REC00031	Somatostatin receptor type 1 (SSTR1)	LIN00087	Amide bond	DRG00053	TAR10052	Human Deoxyribonucleic acid (hDNA)	Actinium-225	Investigative	.	.	.	.	.
PDC_00034	<sup>225</sup>Ac-PSMA-617	PEP00030	PSMA-617	REC00042	Glutamate carboxypeptidase 2 (FOLH1)	LIN00073	(S)-2-(4-(aminomethyl)cyclohexane-1-carboxamido)-3-(naphthalen-2-yl)propanoic acid	DRG00053	TAR10052	Human Deoxyribonucleic acid (hDNA)	Actinium-225	Phase 1	154731605	.	.		.
PDC_00035	<sup>64</sup>Cu-NODAGA-E[c(RGDyK)]2	PEP00124	c(RGDyK)	REC00013	Integrin alpha-V; Integrin beta-3 (ITGAV; ITGB3)	LIN00025	NODAGA	DRG00052	TAR10052	Human Deoxyribonucleic acid (hDNA)	Copper-64	Investigative	.	.	.	.	.
PDC_00036	<sup>67</sup>Ga-MMC(TMZ)-TOC	PEP00108	3-Tyr-Octreotide	REC00031	Somatostatin receptor type 1 (SSTR1)	LIN00087	Amide bond	DRG00007	TAR10016	Human Deoxyribonucleic acid (hDNA)	Temozolomide	Investigative	.	.	.	.	.
PDC_00037	<sup>68</sup>Ga-DOTA-GIP1234	PEP00154	GIP1234	REC99999	Undisclosed	LIN00043	2-((2-aminoethyl)sulfonyl)ethane-1-thiol	DRG00028	TAR10052	Human Deoxyribonucleic acid (hDNA)	Gallium-68	Investigative	.	.	.	.	.
PDC_00038	<sup>68</sup>Ga-DOTANOC	PEP00106	3-Nal-Octreotide	REC00031	Somatostatin receptor type 1 (SSTR1)	LIN00087	Amide bond	DRG00028	TAR10052	Human Deoxyribonucleic acid (hDNA)	Gallium-68	Phase 1	135391021	.	.		.
PDC_00039	<sup>68</sup>Ga-DOTATATE	PEP00109	3-Tyr-Octreotate	REC00031	Somatostatin receptor type 1 (SSTR1)	LIN00087	Amide bond	DRG00028	TAR10052	Human Deoxyribonucleic acid (hDNA)	Gallium-68	Approved	131634491	.	.		.
PDC_00041	<sup>68</sup>Ga-NODAGA-E[c(RGDyK)]2	PEP00124	c(RGDyK)	REC00013	Integrin alpha-V; Integrin beta-3 (ITGAV; ITGB3)	LIN00025	NODAGA	DRG00028	TAR10052	Human Deoxyribonucleic acid (hDNA)	Gallium-68	Phase 3	.	.	.	.	.
PDC_00042	<sup>68</sup>Ga-PSMA HBED-CC	PEP00030	PSMA-617	REC00042	Glutamate carboxypeptidase 2 (FOLH1)	LIN00026	Aminocaproic acid	DRG00028	TAR10052	Human Deoxyribonucleic acid (hDNA)	Gallium-68	Investigative	.	.	.	.	.
PDC_00043	<sup>68</sup>Ga-PSMA-11	PEP00030	PSMA-617	REC00042	Glutamate carboxypeptidase 2 (FOLH1)	LIN00026	Aminocaproic acid	DRG00028	TAR10052	Human Deoxyribonucleic acid (hDNA)	Gallium-68	Approved	154572876	DMWLTU2	DBG46D	.	.
PDC_00044	<sup>68</sup>Ga-PSMA-617	PEP00030	PSMA-617	REC00042	Glutamate carboxypeptidase 2 (FOLH1)	LIN00073	(S)-2-(4-(aminomethyl)cyclohexane-1-carboxamido)-3-(naphthalen-2-yl)propanoic acid	DRG00028	TAR10052	Human Deoxyribonucleic acid (hDNA)	Gallium-68	Phase 2/3	135390844	.	.		.
PDC_00045	<sup>90</sup>Y-DOTATOC	PEP00031	Edotreotide	REC00031	Somatostatin receptor type 1 (SSTR1)	LIN00087	Amide bond	DRG00054	TAR10052	Human Deoxyribonucleic acid (hDNA)	Yttrium-90	Phase 2	15605154	.	.		.
PDC_00046	<sup>99m</sup>Tc-3PRGD2	PEP00122	c(RGDfK)	REC00013	Integrin alpha-V; Integrin beta-3 (ITGAV; ITGB3)	LIN00017	PEG<sub>2</sub>	DRG00055	TAR10052	Human Deoxyribonucleic acid (hDNA)	Technetium-99m	Phase 3	.	.	.	.	.
PDC_00047	<sup>99m</sup>Tc-HYNIC-CLB-c(NGR)	PEP00018	Cyclic NGR	REC99999	Undisclosed	LIN00087	Amide bond	DRG00002	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Chlorambucil	Investigative	.	.	.	.	.
PDC_00048	<sup>99m</sup>Tc-octreotide	PEP00105	Octreotide	REC00031	Somatostatin receptor type 1 (SSTR1)	LIN00087	Amide bond	DRG00055	TAR10052	Human Deoxyribonucleic acid (hDNA)	Technetium-99m	Investigative	.	.	.	.	.
PDC_00049	<sup>D</sup>T7-SS-DOX	PEP00167	DT7	REC00008	Transferrin receptor protein 1 (TFRC)	LIN00022	SPDP	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00050	<sup>L</sup>T7-SS-DOX	PEP00167	DT7	REC00008	Transferrin receptor protein 1 (TFRC)	LIN00022	SPDP	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00051	1131-MMAE	PEP00017	Peptide 1131	REC00046	Kita-kyushu lung cancer antigen 1 (CT83)	LIN00008	Mc-Vc-PABC	DRG00038	TAR10017	Microtubule (MT)	Monomethyl auristatin E	Investigative	.	.	.	.	.
PDC_00052	5-Fu-FF	PEP00032	Dipeptide	REC99999	Undisclosed	LIN00032	4-Methyl-3-nitrobenzoic acid	DRG00003	TAR10006	Thymidylate synthase (TYMS)	Fluorouracil	Investigative	.	.	.	.	.
PDC_00053	ABD-RGDK-DOXO	PEP00094	ABD-RGDK	REC99999	Undisclosed	LIN00041	(6-maleimidocaproyl) hydrazone derivative	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00054	ABD-RPARPAR-DOXO	PEP00095	ABD-RPARPAR	REC99999	Undisclosed	LIN00041	(6-maleimidocaproyl) hydrazone derivative	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00055	Ac-NleEHfRWGK(Dau=Aoa)-NH<sub>2</sub>	PEP00113	Ac-NleEHfRWGK-NH<sub>2</sub>	REC00041	Melanocyte-stimulating hormone receptor (MC1R)	LIN00019	Aminooxyacetic acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00056	Ac-SYSNleEHFRWGK(Dau=Aoa)PV-NH<sub>2</sub>	PEP00138	Ac-SYSNleEHFRWGKPV-NH<sub>2</sub>	REC00041	Melanocyte-stimulating hormone receptor (MC1R)	LIN00019	Aminooxyacetic acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00057	AEZS-108	PEP00152	[D-Lys6]-LH-RH	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00033	Glutaric acid	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Terminated in Phase 3	16134409	DMAYO46	D02HBB	.	.
PDC_00059	ALOS4-CPT	PEP00104	ALOS4	REC00013	Integrin alpha-V; Integrin beta-3 (ITGAV; ITGB3)	LIN00014	GABA	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_00060	An2-M6G	PEP00162	Angiopep-2	REC00045	Prolow-density lipoprotein receptor-related protein 1; Low-density lipoprotein receptor-related protein 2 (LRP1; LRP2)	LIN00022	SPDP	DRG00039	TAR10010	Mu-type opioid receptor (OPRM1)	Morphine-6-glucuronide	Preclinical	.	.	.	.	.
PDC_00061	An2-morphine	PEP00162	Angiopep-2	REC00045	Prolow-density lipoprotein receptor-related protein 1; Low-density lipoprotein receptor-related protein 2 (LRP1; LRP2)	LIN00034	"3,6,9-Trioxaundecanedioic acid"	DRG00029	TAR10010	Mu-type opioid receptor (OPRM1)	Morphine	Investigative	.	.	.	.	.
PDC_00062	ANG1005	PEP00162	Angiopep-2	REC00045	Prolow-density lipoprotein receptor-related protein 1; Low-density lipoprotein receptor-related protein 2 (LRP1; LRP2)	LIN00003	Succinic Acid	DRG00012	TAR10017	Microtubule (MT)	Paclitaxel	Phase 3	46884921	.	.		.
PDC_00063	ANG-PTX	PEP00162	Angiopep-2	REC00045	Prolow-density lipoprotein receptor-related protein 1; Low-density lipoprotein receptor-related protein 2 (LRP1; LRP2)	LIN00096	Ester bond	DRG00012	TAR10017	Microtubule (MT)	Paclitaxel	Investigative	.	.	.	.	.
PDC_00064	ANG-TAT-PTX	PEP00139	Angiopep-2/TAT	REC00044	Prolow-density lipoprotein receptor-related protein 1 (LRP1)	LIN00096	Ester bond	DRG00012	TAR10017	Microtubule (MT)	Paclitaxel	Investigative	.	.	.	.	.
PDC_00065	BA-NFs	PEP00034	FFYEEG-ARVYIHPF	REC00030	Type-1 angiotensin II receptor (AGTR1)	LIN00087	Amide bond	DRG00014	.	.	Baicalin	Investigative	.	.	.	.	.
PDC_00066	BP9a-DOX	PEP00007	BP9a	REC00008	Transferrin receptor protein 1 (TFRC)	LIN00066	N-succinimidyl-3-maleimidopropionate	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00067	BP9a-SS-DOX	PEP00007	BP9a	REC00008	Transferrin receptor protein 1 (TFRC)	LIN00091	Disulfide bond	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00068	BT5528	PEP00170	BCY6099	REC00028	Ephrin type-A receptor 2 (EPHA2)	LIN00005	Val-Cit	DRG00038	TAR10017	Microtubule (MT)	Monomethyl auristatin E	Phase 1/2	166177190	.	.		.
PDC_00069	BT8009	PEP00171	Bicycle toxin conjugate precursor	REC00048	Nectin-4 (NECTIN4)	LIN00005	Val-Cit	DRG00038	TAR10017	Microtubule (MT)	Monomethyl auristatin E	Phase 2/3	.	.	.	.	.
PDC_00070	c[DKP-RGD]-PEG4-Aoa=dau	PEP00163	c[DKP-RGD]	REC00022	"Indoleamine 2,3-dioxygenase 1 (IDO1)"	LIN00019	Aminooxyacetic acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00071	c[DKP-RGD]-PEG4-sC18(dau=Aoa-GFLG-Lys8)	PEP00164	c[DKP-RGD]-PEG<sub>4</sub>-sC18	REC99999	Undisclosed	LIN00002	GFLG	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00072	c[DKP-RGD]-PEG4-sC18(dau=Aoa-Lys8)	PEP00164	c[DKP-RGD]-PEG<sub>4</sub>-sC18	REC99999	Undisclosed	LIN00019	Aminooxyacetic acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00073	Conjugates 1a	PEP00122	c(RGDfK)	REC00013	Integrin alpha-V; Integrin beta-3 (ITGAV; ITGB3)	LIN00087	Amide bond	DRG00002	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Chlorambucil	Investigative	.	.	.	.	.
PDC_00074	Conjugates 1b	PEP00122	c(RGDfK)	REC00013	Integrin alpha-V; Integrin beta-3 (ITGAV; ITGB3)	LIN00018	Carbamic acid	DRG00056	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_00075	Conjugates 1c	PEP00122	c(RGDfK)	REC00013	Integrin alpha-V; Integrin beta-3 (ITGAV; ITGB3)	LIN00089	Amide; Ester	DRG00002	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Chlorambucil	Investigative	.	.	.	.	.
PDC_00076	Conjugates 1d	PEP00122	c(RGDfK)	REC00013	Integrin alpha-V; Integrin beta-3 (ITGAV; ITGB3)	LIN00088	Amide; Carbamate	DRG00057	TAR10019	DNA topoisomerase 1 (TOP1); Human Deoxyribonucleic acid (hDNA)	Chlorambucils; Camptothecins	Investigative	.	.	.	.	.
PDC_00077	Conjugates 8a	PEP00122	c(RGDfK)	REC00013	Integrin alpha-V; Integrin beta-3 (ITGAV; ITGB3)	LIN00087	Amide bond	DRG00002	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Chlorambucil	Investigative	.	.	.	.	.
PDC_00078	Conjugates 8b	PEP00122	c(RGDfK)	REC00013	Integrin alpha-V; Integrin beta-3 (ITGAV; ITGB3)	LIN00096	Ester bond	DRG00002	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Chlorambucil	Investigative	.	.	.	.	.
PDC_00079	Conjugates 8c	PEP00122	c(RGDfK)	REC00013	Integrin alpha-V; Integrin beta-3 (ITGAV; ITGB3)	LIN00018	Carbamic acid	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_00080	Cot-APTEDB-SN38	PEP00172	Cot-APT<sub>EDB</sub>	REC00050	Vesicle-associated membrane protein 8 (VAMP8)	LIN00096	Ester bond	DRG00018	TAR10008	DNA topoisomerase 1 (TOP1)	7-Ethyl-10-hydroxycamptothecin	Investigative	.	.	.	.	.
PDC_00081	CPP-SA-PTX	PEP00123	RGDKLAK	REC00013	Integrin alpha-V; Integrin beta-3 (ITGAV; ITGB3)	LIN00003	Succinic Acid	DRG00012	TAR10017	Microtubule (MT)	Paclitaxel	Investigative	171378447	.	.		.
PDC_00082	CPT-AAM-1	PEP00047	AAM-1	REC00055	Cell membrane	LIN00039	2-(Disulfanyl)ethyl hydrogen carbonate	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_00083	CPT-AAM-2	PEP00015	AAM-2	REC00055	Cell membrane	LIN00039	2-(Disulfanyl)ethyl hydrogen carbonate	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_00084	Cq-C10-TP10	PEP00002	TP10	REC99999	Undisclosed	LIN00021	GSHG	DRG00032	.	.	"N1-(7-chloroquinolin-4-yl)butane-1,4-diamine"	Investigative	.	.	.	.	.
PDC_00085	Cq-C4-DPT-sh1	PEP00144	DPT-sh1	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00032	.	.	"N1-(7-chloroquinolin-4-yl)butane-1,4-diamine"	Investigative	.	.	.	.	.
PDC_00086	Cq-C4-DPT-sh2	PEP00129	DPT-sh2	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00032	.	.	"N1-(7-chloroquinolin-4-yl)butane-1,4-diamine"	Investigative	.	.	.	.	.
PDC_00087	Cq-C4-IDR-1018	PEP00147	IDR-1018	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00032	.	.	"N1-(7-chloroquinolin-4-yl)butane-1,4-diamine"	Investigative	.	.	.	.	.
PDC_00088	Cq-C4-PasTAT	PEP00033	PasTAT	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00032	.	.	"N1-(7-chloroquinolin-4-yl)butane-1,4-diamine"	Investigative	.	.	.	.	.
PDC_00089	Cq-C4-Penetratin	PEP00128	Penetratin	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00032	.	.	"N1-(7-chloroquinolin-4-yl)butane-1,4-diamine"	Investigative	.	.	.	.	.
PDC_00090	Cq-C4-R9	PEP00132	R9	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00032	.	.	"N1-(7-chloroquinolin-4-yl)butane-1,4-diamine"	Investigative	.	.	.	.	.
PDC_00091	Cq-C4-TAT	PEP00051	TAT	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00032	.	.	"N1-(7-chloroquinolin-4-yl)butane-1,4-diamine"	Investigative	.	.	.	.	.
PDC_00092	Cq-C4-TP10	PEP00002	TP10	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00032	.	.	"N1-(7-chloroquinolin-4-yl)butane-1,4-diamine"	Investigative	.	.	.	.	.
PDC_00093	Cq-C4-Transportan	PEP00053	Transportan	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00032	.	.	"N1-(7-chloroquinolin-4-yl)butane-1,4-diamine"	Investigative	.	.	.	.	.
PDC_00094	Cq-S-S-TP10	PEP00002	TP10	REC99999	Undisclosed	LIN00029	Cystine	DRG00032	.	.	"N1-(7-chloroquinolin-4-yl)butane-1,4-diamine"	Investigative	.	.	.	.	.
PDC_00095	Cq-TR-TP10	PEP00002	TP10	REC99999	Undisclosed	LIN00057	"6-(4-(amino(carboxy)methyl)-1H-1,2,3-triazol-1-yl)hexanoic acid"	DRG00032	.	.	"N1-(7-chloroquinolin-4-yl)butane-1,4-diamine"	Investigative	.	.	.	.	.
PDC_00096	CRB-FFE-YSV	PEP00173	YSV	REC99999	Undisclosed	LIN00001	FFE	DRG00002	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Chlorambucil	Investigative	.	.	.	.	.
PDC_00097	cRGD-SMCC-DM1	PEP00122	c(RGDfK)	REC00013	Integrin alpha-V; Integrin beta-3 (ITGAV; ITGB3)	LIN00040	Sulfo-SMCC	DRG00031	TAR10017	Microtubule (MT)	Mertansine DM1	Investigative	.	.	.	.	.
PDC_00099	cRGD-SS-DM1	PEP00122	c(RGDfK)	REC00013	Integrin alpha-V; Integrin beta-3 (ITGAV; ITGB3)	LIN00091	Disulfide bond	DRG00031	TAR10017	Microtubule (MT)	Mertansine DM1	Investigative	.	.	.	.	.
PDC_00100	cRPQ-SMCC-DM1	PEP00127	c(RPQfK)	REC00013	Integrin alpha-V; Integrin beta-3 (ITGAV; ITGB3)	LIN00040	Sulfo-SMCC	DRG00031	TAR10017	Microtubule (MT)	Mertansine DM1	Investigative	.	.	.	.	.
PDC_00101	cRPQ-SS-DM1	PEP00127	c(RPQfK)	REC00013	Integrin alpha-V; Integrin beta-3 (ITGAV; ITGB3)	LIN00091	Disulfide bond	DRG00031	TAR10017	Microtubule (MT)	Mertansine DM1	Investigative	.	.	.	.	.
PDC_00102	CTCE-DTX	PEP00065	CTCE	REC00039	C-X-C chemokine receptor type 4 (CXCR4)	LIN00078	Thiol group (SH) and maleimide	DRG00020	TAR10017	Microtubule (MT)	Docetaxel	Investigative	.	.	.	.	.
PDC_00103	SC-CTCE-DTX	PEP00092	Scrambled -CTCE	REC99999	Undisclosed	LIN00078	Thiol group (SH) and maleimide	DRG00020	TAR10017	Microtubule (MT)	Docetaxel	Investigative	.	.	.	.	.
PDC_00104	Cyclic NGR peptidedaunomycin conjugates 1	PEP00100	Cyclic NGR	REC00023	Aminopeptidase N (ANPEP)	LIN00002	GFLG	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00105	"Cytolysin[F7,P34]-NPY bioconjugate"	PEP00158	"[K4,F7,K22,P34]-NPY"	REC00027	Neuropeptide Y receptor type 1 (NPY1R)	LIN00091	Disulfide bond	DRG00036	.	.	Cytolysin-dithiopyridine	Investigative	.	.	.	.	.
PDC_00106	Dau=Aoa-GFLG-c[DKP-RGD]	PEP00163	c[DKP-RGD]	REC00022	"Indoleamine 2,3-dioxygenase 1 (IDO1)"	LIN00019	Aminooxyacetic acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00107	Dau=Aoa-LRRYfQWAV&beta;AlaHStaNle-NH<sub>2</sub>	PEP00089	LRRYfQWAV&beta;AlaHStaNle-NH<sub>2</sub>	REC00054	Bombesin receptor	LIN00019	Aminooxyacetic acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00108	Dau=Aoa-LRRYfQWAVGHStaL-NH<sub>2</sub>	PEP00088	LRRYfQWAVGHStaL-NH<sub>2</sub>	REC00054	Bombesin receptor	LIN00019	Aminooxyacetic acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00109	Dau=Aoa-LRRYQWAVGHLNle-NH<sub>2</sub>	PEP00091	LRRYQWAVGHLNle-NH<sub>2</sub>	REC00054	Bombesin receptor	LIN00019	Aminooxyacetic acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00110	Dau=Aoa-SYSNleEHFRWGK(Dau=Aoa)PV-NH<sub>2</sub>	PEP00138	Ac-SYSNleEHFRWGKPV-NH<sub>2</sub>	REC00041	Melanocyte-stimulating hormone receptor (MC1R)	LIN00019	Aminooxyacetic acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00111	Dau=Aoa-SYSNleEHFRWGKPV-NH<sub>2</sub>	PEP00138	Ac-SYSNleEHFRWGKPV-NH<sub>2</sub>	REC00041	Melanocyte-stimulating hormone receptor (MC1R)	LIN00019	Aminooxyacetic acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00112	Dau=Aoa-TFFYGGSRGK(Dau=Aoa)RNNFK(Dau=Aoa)TEEY-OH	PEP00162	Angiopep-2	REC00045	Prolow-density lipoprotein receptor-related protein 1; Low-density lipoprotein receptor-related protein 2 (LRP1; LRP2)	LIN00019	Aminooxyacetic acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00113	Dau=Aoa-TFFYGGSRGK(Dau=Aoa)RNNFKTEEY-OH	PEP00162	Angiopep-2	REC00045	Prolow-density lipoprotein receptor-related protein 1; Low-density lipoprotein receptor-related protein 2 (LRP1; LRP2)	LIN00019	Aminooxyacetic acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00114	Dau=Aoa-TFFYGGSRGKRNNFK(Dau=Aoa)TEEY-OH	PEP00162	Angiopep-2	REC00045	Prolow-density lipoprotein receptor-related protein 1; Low-density lipoprotein receptor-related protein 2 (LRP1; LRP2)	LIN00019	Aminooxyacetic acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00115	Dau=Aoa-TFFYGGSRGKRNNFKTEEY-OH	PEP00162	Angiopep-2	REC00045	Prolow-density lipoprotein receptor-related protein 1; Low-density lipoprotein receptor-related protein 2 (LRP1; LRP2)	LIN00019	Aminooxyacetic acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00116	DauQ=AoaGFLGD4G5HbPG	PEP00080	D4	REC00005	Pro-epidermal growth factor (EGF)	LIN00002	GFLG	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00117	DauQ=AoaGFLGD4G5PEG	PEP00080	D4	REC00005	Pro-epidermal growth factor (EGF)	LIN00002	GFLG	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00118	DauQ=AoaGFLGD4HbPG	PEP00080	D4	REC00005	Pro-epidermal growth factor (EGF)	LIN00002	GFLG	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00119	DauQ=AoaGFLGD4PEG	PEP00080	D4	REC00005	Pro-epidermal growth factor (EGF)	LIN00002	GFLG	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00120	DauQ=AoaGFLGGE11G5HbPG	PEP00157	GE11	REC00005	Pro-epidermal growth factor (EGF)	LIN00002	GFLG	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00121	DauQ=AoaGFLGGE11G5PEG	PEP00157	GE11	REC00005	Pro-epidermal growth factor (EGF)	LIN00002	GFLG	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00122	DauQ=AoaGFLGGE11HbPG	PEP00157	GE11	REC00005	Pro-epidermal growth factor (EGF)	LIN00002	GFLG	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00123	DauQ=AoaGFLGGE11PEG	PEP00157	GE11	REC00005	Pro-epidermal growth factor (EGF)	LIN00002	GFLG	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00124	D-Cys6-LHRH vedotin	PEP00151	LHRH	REC00006	Progonadoliberin-1 (GNRH1)	LIN00063	Maleimidocaproyl (MC) moiety-valine-citrulline (VC) dipeptide-para-aminobenzyloxycarbamoyl (PABC) spacer (MC-VC-PABC)	DRG00038	TAR10017	Microtubule (MT)	Monomethyl auristatin E	Investigative	.	.	.	.	.
PDC_00125	De Novo Cyclic Peptide (DNCP)-&beta;-naloxamine (NalA) conjugates 1	PEP00155	YAyITCTF	REC00034	Kappa-type opioid receptor (OPRK1)	LIN00087	Amide bond	DRG00035	TAR10027	Kappa-type opioid receptor (OPRK1)	&beta;-Naloxamine	Investigative	.	.	.	.	.
PDC_00126	De Novo Cyclic Peptide (DNCP)-&beta;-naloxamine (NalA) conjugates 2	PEP00142	tNeslCSf	REC00034	Kappa-type opioid receptor (OPRK1)	LIN00087	Amide bond	DRG00035	TAR10027	Kappa-type opioid receptor (OPRK1)	&beta;-Naloxamine	Investigative	.	.	.	.	.
PDC_00127	De Novo Cyclic Peptide (DNCP)-&beta;-naloxamine (NalA) conjugates 3	PEP00023	DAyaVCTf	REC00034	Kappa-type opioid receptor (OPRK1)	LIN00087	Amide bond	DRG00035	TAR10027	Kappa-type opioid receptor (OPRK1)	&beta;-Naloxamine	Investigative	.	.	.	.	.
PDC_00128	De Novo Cyclic Peptide (DNCP)-&beta;-naloxamine (NalA) conjugates 4	PEP00134	sdhAACSf	REC00034	Kappa-type opioid receptor (OPRK1)	LIN00087	Amide bond	DRG00035	TAR10027	Kappa-type opioid receptor (OPRK1)	&beta;-Naloxamine	Investigative	.	.	.	.	.
PDC_00129	D-Lys6-GnRH-gemcitabine(2G1)	PEP00152	[D-Lys6]-LH-RH	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00018	Carbamic acid	DRG00013	TAR10009	Ribonucleoside-diphosphate reductase subunit M2 (RRM2)	Gemcitabine	Investigative	.	.	.	.	.
PDC_00130	D-Lys6-GnRH-gemcitabine(2G2)	PEP00152	[D-Lys6]-LH-RH	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00018	Carbamic acid	DRG00013	TAR10009	Ribonucleoside-diphosphate reductase subunit M2 (RRM2)	Gemcitabine	Investigative	.	.	.	.	.
PDC_00131	D-Lys6-GnRH-gemcitabine(GSHG)	PEP00152	[D-Lys6]-LH-RH	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00021	GSHG	DRG00013	TAR10009	Ribonucleoside-diphosphate reductase subunit M2 (RRM2)	Gemcitabine	Investigative	.	.	.	.	.
PDC_00132	Doce-&beta;A-thioether-CGFLG-C6-[KTVRTSADE]	PEP00077	KTVRTSADE	REC00007	Fibronectin (FN1)	LIN00082	A-thioether-CGFLG-C6	DRG00020	TAR10017	Microtubule (MT)	Docetaxel	Investigative	.	.	.	.	.
PDC_00133	DOX-ApoA-1 mimic peptide	PEP00009	ApoA-1 mimic peptide	REC99999	Undisclosed	LIN00012	3-Disulfanylpropanoic Acid	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00134	DOX-EMCH-fMLFC	PEP00036	DEF	REC00026	fMet-Leu-Phe receptor (FPR1)	LIN00067	N-&epsilon;-maleimidocaproic acid hydrazide	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00135	Dox-GLRKRLRKFRNK	PEP00048	GLRKRLRKFRNK	REC00055	Cell membrane	LIN00060	"S-(1-(2-carboxyethyl)-2,5-dioxopyrrolidin-3-yl)cysteine"	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00136	Dox-GLRKRLRKFRNKIKEK	PEP00049	GLRKRLRKFRNKIKEK	REC00055	Cell membrane	LIN00060	"S-(1-(2-carboxyethyl)-2,5-dioxopyrrolidin-3-yl)cysteine"	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00137	Dox-GLRKRLRKFRNKIKK	PEP00050	GLRKRLRKFRNKIKK	REC00055	Cell membrane	LIN00060	"S-(1-(2-carboxyethyl)-2,5-dioxopyrrolidin-3-yl)cysteine"	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00138	DOXKGFRWR	PEP00064	KGFRWR	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00139	DOXO-EMCH-(RNWELRLK-PEG4)2	PEP00126	RNWELRLK	REC00010	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	LIN00053	EMCH	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00140	DOXoxmCPP	PEP00021	oxmCPP	REC99999	Undisclosed	LIN00091	Disulfide bond	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00141	DOXoxmCPPamph	PEP00012	oxmCPPamph	REC99999	Undisclosed	LIN00091	Disulfide bond	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00142	Dox-S-S-GFLG-C6-[KTVRTSADE]	PEP00077	KTVRTSADE	REC00007	Fibronectin (FN1)	LIN00076	S-S-GFLG-C6	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00143	DTX-P7	PEP00081	Heptapeptide	REC00016	Heat shock protein HSP 90-alpha (HSP90AA1)	LIN00003	Succinic Acid	DRG00020	TAR10017	Microtubule (MT)	Docetaxel	Preclinical	.	.	.	.	.
PDC_00144	E1-3 doxorubicin	PEP00038	E1-3	REC99999	Undisclosed	LIN00033	Glutaric acid	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00145	E1-7 doxorubicin	PEP00143	E1-7	REC99999	Undisclosed	LIN00033	Glutaric acid	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00146	EETI-2.5Z-amide -gemcitabine	PEP00040	EETI-2.5Z	REC00059	Integrin	LIN00023	Alkyne-Triazole	DRG00013	TAR10009	Ribonucleoside-diphosphate reductase subunit M2 (RRM2)	Gemcitabine	Investigative	.	.	.	.	.
PDC_00147	EETI-2.5Z-carbamate -gemcitabine	PEP00040	EETI-2.5Z	REC00059	Integrin	LIN00058	"(3-(1H-1,2,3-triazol-4-yl)propyl)carbamic acid"	DRG00013	TAR10009	Ribonucleoside-diphosphate reductase subunit M2 (RRM2)	Gemcitabine	Investigative	.	.	.	.	.
PDC_00148	EETI-2.5Z-ester-gemcitabine	PEP00040	EETI-2.5Z	REC00059	Integrin	LIN00024	"3-(1H-1,2,3-Triazol-4-yl)propanoic acid"	DRG00013	TAR10009	Ribonucleoside-diphosphate reductase subunit M2 (RRM2)	Gemcitabine	Investigative	.	.	.	.	.
PDC_00149	EETI-2.5Z-Val-Ala-PAB-gemcitabine	PEP00040	EETI-2.5Z	REC00059	Integrin	LIN00059	"rac-4-((R)-2-((R)-2-(3-(1H-1,2,3-triazol-4-yl)propanamido)-3-methylbutanamido)propanamido)benzyl hydrogen carbonate"	DRG00013	TAR10009	Ribonucleoside-diphosphate reductase subunit M2 (RRM2)	Gemcitabine	Investigative	.	.	.	.	.
PDC_00150	ER-472	PEP00093	Chlorotoxin	REC00001	Neuropilin-1 (NRP1)	LIN00020	Dimethyl disulfide	DRG00058	TAR10017	Microtubule (MT)	Cryptophycin analog	Investigative	.	.	.	.	.
PDC_00151	FAP-TG prodrug	PEP00137	FAP substrate	REC99999	Undisclosed	LIN00030	12-Aminododecanoic acid	DRG00024	TAR10021	Calcium-transporting ATPase type 2C member 1 (ATP2C1)	Thapsigargin	Investigative	.	.	.	.	.
PDC_00152	FU-NHOHAS1411	PEP00133	RRWWRRWRR	REC99999	Undisclosed	LIN00106	No Linker	DRG00044	.	.	AGRO100	Investigative	.	.	.	.	.
PDC_00153	GA-TAT	PEP00022	TAT (trans-activator of transcription) 	REC99999	Undisclosed	LIN00026	Aminocaproic acid	DRG00030	.	.	Gambogic acid	Investigative	.	.	.	.	.
PDC_00154	GE11-DOX conjugate	PEP00112	GE11 peptide	REC00004	Epidermal growth factor receptor (EGFR)	LIN00091	Disulfide bond	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00155	Geo75	PEP00124	c(RGDyK)	REC00013	Integrin alpha-V; Integrin beta-3 (ITGAV; ITGB3)	LIN00015	"(Ethane-1,2-diylbis(oxy))bis(ethane-2,1-diyl) bis(4-nitrophenyl) dicarbonate"	DRG00043	TAR10024	SRSF protein kinase 1 (SRPK1)	JH-VII-139-1	Investigative	.	.	.	.	.
PDC_00156	Geo77	PEP00124	c(RGDyK)	REC00013	Integrin alpha-V; Integrin beta-3 (ITGAV; ITGB3)	LIN00033	Glutaric acid	DRG00043	TAR10024	SRSF protein kinase 1 (SRPK1)	JH-VII-139-1	Investigative	.	.	.	.	.
PDC_00157	Geo85	PEP00124	c(RGDyK)	REC00013	Integrin alpha-V; Integrin beta-3 (ITGAV; ITGB3)	LIN00038	2-[2-[2-(Carboxyamino)ethoxy]ethoxy]ethylcarbamic acid	DRG00043	TAR10024	SRSF protein kinase 1 (SRPK1)	JH-VII-139-1	Investigative	.	.	.	.	.
PDC_00158	"GFZ-xGLP-1 (1a, Lys20-derived conjugates)"	PEP00055	Xenopus glucagon-like peptide-1 (xGLP-1)	REC00036	Glucagon-like peptide 1 receptor (GLP1R)	LIN00037	Fmoc-Glu-OtBu	DRG00004	TAR10007	Lipoprotein lipase (LPL)	Gemfibrozil	Investigative	.	.	.	.	.
PDC_00159	"GFZ-xGLP-1 (1b, Lys20-derived conjugates)"	PEP00055	Xenopus glucagon-like peptide-1 (xGLP-1)	REC00036	Glucagon-like peptide 1 receptor (GLP1R)	LIN00055	Fmoc-6-aminohexanol	DRG00004	TAR10007	Lipoprotein lipase (LPL)	Gemfibrozil	Investigative	.	.	.	.	.
PDC_00160	"GFZ-xGLP-1 (1c, Lys20-derived conjugates)"	PEP00055	Xenopus glucagon-like peptide-1 (xGLP-1)	REC00036	Glucagon-like peptide 1 receptor (GLP1R)	LIN00054	Fmoc-12-Ado-OH	DRG00004	TAR10007	Lipoprotein lipase (LPL)	Gemfibrozil	Investigative	.	.	.	.	.
PDC_00161	"GFZ-xGLP-1 (1d, Lys20-derived conjugates)"	PEP00055	Xenopus glucagon-like peptide-1 (xGLP-1)	REC00036	Glucagon-like peptide 1 receptor (GLP1R)	LIN00037	Fmoc-Glu-OtBu	DRG00004	TAR10007	Lipoprotein lipase (LPL)	Gemfibrozil	Investigative	.	.	.	.	.
PDC_00162	"GFZ-xGLP-1 (1e, Lys20-derived conjugates)"	PEP00055	Xenopus glucagon-like peptide-1 (xGLP-1)	REC00036	Glucagon-like peptide 1 receptor (GLP1R)	LIN00055	Fmoc-6-aminohexanol	DRG00004	TAR10007	Lipoprotein lipase (LPL)	Gemfibrozil	Investigative	.	.	.	.	.
PDC_00163	"GFZ-xGLP-1 (1f, Lys20-derived conjugates)"	PEP00055	Xenopus glucagon-like peptide-1 (xGLP-1)	REC00036	Glucagon-like peptide 1 receptor (GLP1R)	LIN00054	Fmoc-12-Ado-OH	DRG00004	TAR10007	Lipoprotein lipase (LPL)	Gemfibrozil	Investigative	.	.	.	.	.
PDC_00164	"GFZ-xGLP-1 (1g, Lys20-derived conjugates)"	PEP00055	Xenopus glucagon-like peptide-1 (xGLP-1)	REC00036	Glucagon-like peptide 1 receptor (GLP1R)	LIN00037	Fmoc-Glu-OtBu	DRG00004	TAR10007	Lipoprotein lipase (LPL)	Gemfibrozil	Investigative	.	.	.	.	.
PDC_00165	"GFZ-xGLP-1 (1h, Lys20-derived conjugates)"	PEP00055	Xenopus glucagon-like peptide-1 (xGLP-1)	REC00036	Glucagon-like peptide 1 receptor (GLP1R)	LIN00055	Fmoc-6-aminohexanol	DRG00004	TAR10007	Lipoprotein lipase (LPL)	Gemfibrozil	Investigative	.	.	.	.	.
PDC_00166	"GFZ-xGLP-1 (1i, Lys20-derived conjugates)"	PEP00055	Xenopus glucagon-like peptide-1 (xGLP-1)	REC00036	Glucagon-like peptide 1 receptor (GLP1R)	LIN00054	Fmoc-12-Ado-OH	DRG00004	TAR10007	Lipoprotein lipase (LPL)	Gemfibrozil	Investigative	.	.	.	.	.
PDC_00167	"GFZ-xGLP-1 (2a, Lys20-derived conjugates)"	PEP00056	Exendin-4 xGLP-1 fusion peptide (xGLP-Ex)	REC00036	Glucagon-like peptide 1 receptor (GLP1R)	LIN00055	Fmoc-6-aminohexanol	DRG00004	TAR10007	Lipoprotein lipase (LPL)	Gemfibrozil	Investigative	.	.	.	.	.
PDC_00168	"GFZ-xGLP-1 (2b, Lys20-derived conjugates)"	PEP00056	Exendin-4 xGLP-1 fusion peptide (xGLP-Ex)	REC00036	Glucagon-like peptide 1 receptor (GLP1R)	LIN00054	Fmoc-12-Ado-OH	DRG00004	TAR10007	Lipoprotein lipase (LPL)	Gemfibrozil	Investigative	.	.	.	.	.
PDC_00169	"GFZ-xGLP-1 (2c, Lys20-derived conjugates)"	PEP00057	Lixisenatide xGLP-1 fusion peptide (xGLP-Sen)	REC00036	Glucagon-like peptide 1 receptor (GLP1R)	LIN00055	Fmoc-6-aminohexanol	DRG00004	TAR10007	Lipoprotein lipase (LPL)	Gemfibrozil	Investigative	.	.	.	.	.
PDC_00170	"GFZ-xGLP-1 (2d, Lys20-derived conjugates)"	PEP00057	Lixisenatide xGLP-1 fusion peptide (xGLP-Sen)	REC00036	Glucagon-like peptide 1 receptor (GLP1R)	LIN00054	Fmoc-12-Ado-OH	DRG00004	TAR10007	Lipoprotein lipase (LPL)	Gemfibrozil	Investigative	.	.	.	.	.
PDC_00171	"GFZ-xGLP-1 (3a, Lys20-derived conjugates)"	PEP00056	Exendin-4 xGLP-1 fusion peptide (xGLP-Ex)	REC00036	Glucagon-like peptide 1 receptor (GLP1R)	LIN00052	Dual headed Fmoc-6-aminohexanol	DRG00004	TAR10007	Lipoprotein lipase (LPL)	Gemfibrozil	Investigative	.	.	.	.	.
PDC_00172	"GFZ-xGLP-1 (3b, Lys20-derived conjugates)"	PEP00056	Exendin-4 xGLP-1 fusion peptide (xGLP-Ex)	REC00036	Glucagon-like peptide 1 receptor (GLP1R)	LIN00051	Dual headed Fmoc-12-Ado-OH	DRG00004	TAR10007	Lipoprotein lipase (LPL)	Gemfibrozil	Investigative	.	.	.	.	.
PDC_00173	"GFZ-xGLP-1 (3c, Lys20-derived conjugates)"	PEP00057	Lixisenatide xGLP-1 fusion peptide (xGLP-Sen)	REC00036	Glucagon-like peptide 1 receptor (GLP1R)	LIN00052	Dual headed Fmoc-6-aminohexanol	DRG00004	TAR10007	Lipoprotein lipase (LPL)	Gemfibrozil	Investigative	.	.	.	.	.
PDC_00174	"GFZ-xGLP-1 (3d, Lys20-derived conjugates)"	PEP00057	Lixisenatide xGLP-1 fusion peptide (xGLP-Sen)	REC00036	Glucagon-like peptide 1 receptor (GLP1R)	LIN00051	Dual headed Fmoc-12-Ado-OH	DRG00004	TAR10007	Lipoprotein lipase (LPL)	Gemfibrozil	Investigative	.	.	.	.	.
PDC_00175	Glypican-3-targeting peptide-chlorin e6 conjugates 8a 	PEP00026	DYEMHLWWGTEL	REC00038	Glypican-3 (GPC3)	LIN00006	Gamma-Aminobutyric Acid	DRG00034	.	.	Chlorin e6	Investigative	.	.	.	.	.
PDC_00176	Glypican-3-targeting peptide-chlorin e6 conjugates 8b	PEP00025	DHLASLWWGTEL	REC00038	Glypican-3 (GPC3)	LIN00006	Gamma-Aminobutyric Acid	DRG00034	.	.	Chlorin e6	Investigative	.	.	.	.	.
PDC_00177	Glypican-3-targeting peptide-chlorin e6 conjugates 8c	PEP00125	RLNVGGTYFLTTRQ	REC00038	Glypican-3 (GPC3)	LIN00006	Gamma-Aminobutyric Acid	DRG00034	.	.	Chlorin e6	Investigative	.	.	.	.	.
PDC_00178	Glypican-3-targeting peptide-chlorin e6 conjugates 8d	PEP00066	KKKRLNVGGTYFLTTRQ	REC00038	Glypican-3 (GPC3)	LIN00006	Gamma-Aminobutyric Acid	DRG00034	.	.	Chlorin e6	Investigative	.	.	.	.	.
PDC_00179	"GnRH-III-[2&Delta;His, 3D-Tic, 4Lys(Bu), 7D-Trp 8Lys(Dau=Aoa)]"	PEP00168	GnRH-III	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00019	Aminooxyacetic acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00180	"GnRH-III-[2&Delta;His, 3D-Tic, 4Lys(Bu), 8Lys(Dau=Aoa)]"	PEP00168	GnRH-III	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00019	Aminooxyacetic acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00181	"GnRH-III-[2&Delta;His, 3D-Tic, 7D-Trp 8Lys(Dau=Aoa)]"	PEP00168	GnRH-III	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00019	Aminooxyacetic acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00182	"GnRH-III-[2&Delta;His, 3D-Tic, 8Lys(Dau=Aoa)]"	PEP00168	GnRH-III	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00019	Aminooxyacetic acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00184	"GnRH-III-[2&Delta;His-3D-Tic, 8Lys(glutaryl-diamine-PTX)] conjugate "	PEP00168	GnRH-III	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00033	Glutaric acid	DRG00012	TAR10017	Microtubule (MT)	Paclitaxel	Investigative	.	.	.	.	.
PDC_00185	"GnRH-III-[2&Delta;His-3D-Tic, 8Lys(glutaryl-Val-Ala-PABC-Dau conjugate "	PEP00168	GnRH-III	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00028	Val-Ala	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00186	"GnRH-III-[2&Delta;His-3D-Tic, 8Lys(glutaryl-Val-Ala-PABC-diamine-PTX)] conjugate "	PEP00168	GnRH-III	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00005	Val-Cit	DRG00012	TAR10017	Microtubule (MT)	Paclitaxel	Investigative	.	.	.	.	.
PDC_00188	"GnRH-III-[2&Delta;His-3D-Tic,8Lys(glutaryl-Dau)] conjugate "	PEP00168	GnRH-III	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00028	Val-Ala	DRG00012	TAR10017	Microtubule (MT)	Paclitaxel	Investigative	.	.	.	.	.
PDC_00189	"GnRH-III-[2&Delta;His-3D-Tic,8Lys(glutaryl-Val-Cit-PABC-Dau)] conjugate "	PEP00168	GnRH-III	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00005	Val-Cit	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00190	"GnRH-III-[2&Delta;His-3D-Tic,8Lys(glutaryl-Val-Cit-PABC-diamine-PTX)] conjugate "	PEP00168	GnRH-III	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00033	Glutaric acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00191	"GnRH-III-[2His-3Trp,8Lys(glutaryl-Dau)] conjugate "	PEP00168	GnRH-III	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00028	Val-Ala	DRG00012	TAR10017	Microtubule (MT)	Paclitaxel	Investigative	.	.	.	.	.
PDC_00192	"GnRH-III-[2His-3Trp,8Lys(glutaryl-diamine-PTX)] conjugate "	PEP00168	GnRH-III	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00033	Glutaric acid	DRG00012	TAR10017	Microtubule (MT)	Paclitaxel	Investigative	.	.	.	.	.
PDC_00193	"GnRH-III-[2His-3Trp,8Lys(glutaryl-Val-Ala-PABC-Dau)] conjugate "	PEP00168	GnRH-III	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00028	Val-Ala	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00194	"GnRH-III-[2His-3Trp,8Lys(glutaryl-Val-Cit-PABC-Dau)] "	PEP00168	GnRH-III	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00005	Val-Cit	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00195	"GnRH-III-[2His-3Trp,8Lys(glutaryl-Val-Cit-PABC-diamine-PTX)] conjugate "	PEP00168	GnRH-III	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00033	Glutaric acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00196	"GnRH-III-[3D-Tic, 4Lys(Bu), 7D-Trp 8Lys(Dau=Aoa)]"	PEP00168	GnRH-III	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00019	Aminooxyacetic acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00197	"GnRH-III-[3D-Tic, 4Lys(Bu), 8Lys(Dau=Aoa)]"	PEP00168	GnRH-III	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00019	Aminooxyacetic acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00198	"GnRH-III-[3D-Tic, 7D-Trp 8Lys(Dau=Aoa)]"	PEP00168	GnRH-III	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00019	Aminooxyacetic acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00199	"GnRH-III-[3D-Tic, 8Lys(Dau=Aoa)]"	PEP00168	GnRH-III	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00019	Aminooxyacetic acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00200	"GnRH-III-[3D-Trp, 4Lys(Bu), 8Lys(Dau=Aoa)]"	PEP00168	GnRH-III	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00019	Aminooxyacetic acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00201	"GnRH-III-[3D-Trp, 8Lys(Dau=Aoa)]"	PEP00168	GnRH-III	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00019	Aminooxyacetic acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00202	"GnRH-III-[4Lys(Bu), 6Asp(OMe), 8Lys(Dau=Aoa)]"	PEP00168	GnRH-III	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00019	Aminooxyacetic acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00203	"GnRH-III-[4Lys(Bu), 8Lys(Dau=Aoa), 10&Delta;Gly-NH-Et]"	PEP00168	GnRH-III	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00019	Aminooxyacetic acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00205	"GnRH-III-[4Lys(Bu), 8Lys(Dau=Aoa)]"	PEP00168	GnRH-III	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00019	Aminooxyacetic acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00206	"GnRH-III-[6Asp(OMe), 8Lys(Dau=Aoa)]"	PEP00168	GnRH-III	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00019	Aminooxyacetic acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00207	"GnRH-III-[8Lys(Dau=Aoa), 10&Delta;Gly-NH-Et]"	PEP00168	GnRH-III	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00019	Aminooxyacetic acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00208	GnRH-III-[8Lys(Dau=Aoa)]	PEP00168	GnRH-III	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00019	Aminooxyacetic acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00209	HCPTMDP26-PEG	PEP00067	MDP26	REC99999	Undisclosed	LIN00004	Glycylglycylglycine	DRG00046	TAR10008	DNA topoisomerase 1 (TOP1)	Hydroxycamptothecin	Investigative	.	.	.	.	.
PDC_00210	HK2-TG prodrug	PEP00082	HK2 substrate	REC99999	Undisclosed	LIN00030	12-Aminododecanoic acid	DRG00024	TAR10021	Calcium-transporting ATPase type 2C member 1 (ATP2C1)	Thapsigargin	Investigative	.	.	.	.	.
PDC_00211	HR97-brimonidine	PEP00037	HR97	REC00055	Cell membrane	LIN00065	Mc-Val-Cit-PAB-OH	DRG00001	TAR10001	Alpha-2A adrenergic receptor (ADRA2A)	Brimonidine	Investigative	.	.	.	.	.
PDC_00212	HR97-SunitiGel	PEP00037	HR97	REC00055	Cell membrane	LIN00065	Mc-Val-Cit-PAB-OH	DRG00059	TAR10011	Vascular endothelial growth factor receptor 2 (KDR)	Sunitinib	Investigative	.	.	.	.	.
PDC_00213	H-TFFYGGSRGK(Dau=Aoa)RNNFK(Dau=Aoa)TEEY-OH	PEP00162	Angiopep-2	REC00045	Prolow-density lipoprotein receptor-related protein 1; Low-density lipoprotein receptor-related protein 2 (LRP1; LRP2)	LIN00019	Aminooxyacetic acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00214	H-TFFYGGSRGK(Dau=Aoa)RNNFKTEEY-OH	PEP00162	Angiopep-2	REC00045	Prolow-density lipoprotein receptor-related protein 1; Low-density lipoprotein receptor-related protein 2 (LRP1; LRP2)	LIN00019	Aminooxyacetic acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00215	H-TFFYGGSRGK(Dau=Aoa-GFLG)RNNFKTEEY-OH	PEP00162	Angiopep-2	REC00045	Prolow-density lipoprotein receptor-related protein 1; Low-density lipoprotein receptor-related protein 2 (LRP1; LRP2)	LIN00002	GFLG	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00216	H-TFFYGGSRGK(Dau=Aoa-VA)RNNFKTEEY-OH	PEP00162	Angiopep-2	REC00045	Prolow-density lipoprotein receptor-related protein 1; Low-density lipoprotein receptor-related protein 2 (LRP1; LRP2)	LIN00080	2-(aminooxy)acetic acid-VA	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00217	H-TFFYGGSRGK(Dau=Aoa-VAGG)RNNFKTEEY-OH	PEP00162	Angiopep-2	REC00045	Prolow-density lipoprotein receptor-related protein 1; Low-density lipoprotein receptor-related protein 2 (LRP1; LRP2)	LIN00081	2-(aminooxy)acetic acid-VAGG	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00218	H-TFFYGGSRGKRNNFK(Dau=Aoa)TEEY-OH	PEP00162	Angiopep-2	REC00045	Prolow-density lipoprotein receptor-related protein 1; Low-density lipoprotein receptor-related protein 2 (LRP1; LRP2)	LIN00019	Aminooxyacetic acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00219	I-1 (NPNWGRSWYNQRFKGC=(-SS-O-COO-CPT)GRIKPRKGYTR)	PEP00115	P1GCGT1	REC00010	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	LIN00039	2-(Disulfanyl)ethyl hydrogen carbonate	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_00220	I-2 (NPNWGRSWYNQRFKGC=(-SS-COO-CPT)GRIKPRKGYTR)	PEP00115	P1GCGT1	REC00010	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	LIN00012	3-Disulfanylpropanoic Acid	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_00221	I-3 (NPNWGRSWYNQRFKGC=(-S-Maleimide-CPT)GRIKPRKGYTR)	PEP00115	P1GCGT1	REC00010	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	LIN00031	"4-yl 6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanoate"	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_00222	I-4 (NPNWGRSWYNQRFKGC=(-SS-O-COO-CPT)GC=(-SS-O-COO-CPT)GRIKPRKGYTR)	PEP00114	P1GCGCGT1	REC00010	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	LIN00039	2-(Disulfanyl)ethyl hydrogen carbonate	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_00223	I-5 (NPNWGRSWYNQRFKGC=(-SS-COO-CPT)GC=(-SS-COO-CPT)GRIKPRKGYTR)	PEP00114	P1GCGCGT1	REC00010	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	LIN00012	3-Disulfanylpropanoic Acid	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_00224	I-6 (NPNWGRSWYNQRFKGC=(-S-Maleimide-CPT)GC=(-S-Maleimide-CPT)GRIKPRKGYTR)	PEP00114	P1GCGCGT1	REC00010	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	LIN00031	"4-yl 6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanoate"	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_00225	Kb-CC01	PEP00016	Kb-C01	REC00055	Cell membrane	LIN00036	Py-SS	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_00226	Kb-CC02	PEP00013	Kb-C02	REC00055	Cell membrane	LIN00036	Py-SS	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_00227	Kb-CC03	PEP00011	Kb-C03	REC00055	Cell membrane	LIN00036	Py-SS	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_00228	Kb-CC04	PEP00010	Kb-C04	REC00055	Cell membrane	LIN00036	Py-SS	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_00229	Kb-CC05	PEP00068	Kb-C05	REC00055	Cell membrane	LIN00036	Py-SS	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_00230	Kb-CC06	PEP00069	Kb-C06	REC00055	Cell membrane	LIN00036	Py-SS	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_00231	Kb-CC07	PEP00070	Kb-C07	REC00055	Cell membrane	LIN00036	Py-SS	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_00232	Kb-CC08	PEP00071	Kb-C08	REC00055	Cell membrane	LIN00036	Py-SS	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_00233	KYL-TGX	PEP00079	LNCaP-specific peptide	REC00010	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	LIN00072	PSA-cleavable linker (SSKYQSL)	DRG00037	TAR10022	Phosphatidylinositol 3-kinase catalytic subunit type 3 (PIK3C3)	TGX-D1	Investigative	.	.	.	.	.
PDC_00234	L-Leu-12ADT	PEP00059	HSSKLQ	REC99999	Undisclosed	LIN00084	8-O-(12-aminododecanyl)-8-O-debutanoyl	DRG00024	TAR10021	Calcium-transporting ATPase type 2C member 1 (ATP2C1)	Thapsigargin	Investigative	.	.	.	.	.
PDC_00235	LWJ-M30	PEP00110	B6	REC00008	Transferrin receptor protein 1 (TFRC)	LIN00091	Disulfide bond	DRG00026	TAR10017	Microtubule (MT)	Maytansine	Investigative	.	.	.	.	.
PDC_00236	M1-PTX	PEP00140	M1	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00012	TAR10017	Microtubule (MT)	Paclitaxel	Investigative	.	.	.	.	.
PDC_00237	M1-RGD-PTX	PEP00141	M1-RGD	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00012	TAR10017	Microtubule (MT)	Paclitaxel	Investigative	.	.	.	.	.
PDC_00238	M-DM1	PEP00003	M	REC00056	M2-like tumor-associated macrophages	LIN00066	N-succinimidyl-3-maleimidopropionate	DRG00031	TAR10017	Microtubule (MT)	Mertansine DM1	Investigative	.	.	.	.	.
PDC_00239	Melflufen	PEP00150	p-Fluorophenylalanine	REC00053	Aminopeptidases	LIN00085	Acetic acid	DRG00025	TAR10016	Human Deoxyribonucleic acid (hDNA)	Melphalan	Approved	.	.	.	.	.
PDC_00241	Mipsagargin	PEP00153	PSMA-specific peptide	REC00042	Glutamate carboxypeptidase 2 (FOLH1)	LIN00087	Amide bond	DRG00041	TAR10021	Calcium-transporting ATPase type 2C member 1 (ATP2C1)	12Adt-asp	Discontinued	.	.	.	.	.
PDC_00243	MMC(TMZ)-TOC	PEP00108	3-Tyr-Octreotide	REC00031	Somatostatin receptor type 1 (SSTR1)	LIN00087	Amide bond	DRG00007	TAR10016	Human Deoxyribonucleic acid (hDNA)	Temozolomide	Investigative	.	.	.	.	.
PDC_00244	MPD3	PEP00063	DEVD	REC00035	Caspase-3 (CASP3)	LIN00027	(4-Aminophenyl)methyl hydrogen carbonate	DRG00020	TAR10017	Microtubule (MT)	Docetaxel	Investigative	.	.	.	.	.
PDC_00245	mPEG-AAN-PTP-7-CDM-PTX	PEP00006	CAAN-PTP-7	REC00055	Cell membrane	LIN00010	CDM	DRG00012	TAR10017	Microtubule (MT)	Paclitaxel	Investigative	.	.	.	.	.
PDC_00246	MP-P1	PEP00145	P1	REC99999	Undisclosed	LIN00087	Amide bond	DRG00016	TAR10016	Human Deoxyribonucleic acid (hDNA)	Mesoporphyrin IX	Investigative	.	.	.	.	.
PDC_00247	MP-P2	PEP00146	P2	REC99999	Undisclosed	LIN00087	Amide bond	DRG00016	TAR10016	Human Deoxyribonucleic acid (hDNA)	Mesoporphyrin IX	Investigative	.	.	.	.	.
PDC_00248	MP-P5	PEP00135	P5	REC99999	Undisclosed	LIN00087	Amide bond	DRG00016	TAR10016	Human Deoxyribonucleic acid (hDNA)	Mesoporphyrin IX	Investigative	.	.	.	.	.
PDC_00249	MP-P6	PEP00136	P6	REC99999	Undisclosed	LIN00087	Amide bond	DRG00016	TAR10016	Human Deoxyribonucleic acid (hDNA)	Mesoporphyrin IX	Investigative	.	.	.	.	.
PDC_00250	MTX-cLABL	PEP00119	cLABL	REC00011	Intercellular adhesion molecule 1 (ICAM1)	LIN00097	Glu -carboxylic acid	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_00251	MTX-cLBEL	PEP00118	cLBEL	REC00011	Intercellular adhesion molecule 1 (ICAM1)	LIN00097	Glu -carboxylic acid	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_00252	NLG-RGD	PEP00163	c[DKP-RGD]	REC00022	"Indoleamine 2,3-dioxygenase 1 (IDO1)"	LIN00003	Succinic Acid	DRG00040	TAR10023	"Indoleamine 2,3-dioxygenase 1 (IDO1)"	NLG919	Investigative	.	.	.	.	.
PDC_00253	OGF-Gem	PEP00156	OGF	REC00052	Opioid growth factor receptor (OGFR)	LIN00003	Succinic Acid	DRG00013	TAR10009	Ribonucleoside-diphosphate reductase subunit M2 (RRM2)	Gemcitabine	Investigative	.	.	.	.	.
PDC_00254	Omi-hyd-Dex	PEP00062	Omiganan-NH-NH<sub>2</sub>	REC99999	Undisclosed	LIN00100	Hydrazone bond	DRG00008	TAR10005	Glucocorticoid receptor (NR3C1)	Dexamethasone	Investigative	.	.	.	.	.
PDC_00255	Oxali-PtY1	PEP00005	C(StBu)GASGGKK	REC00013	Integrin alpha-V; Integrin beta-3 (ITGAV; ITGB3)	LIN00101	"(2-(3-mercapto-2,5-dioxopyrrolidin-1-yl)ethyl)carbamic acid"	DRG00060	.	.	Platinum(IV)	Investigative	.	.	.	.	.
PDC_00256	P-(A5G27)-PTX	PEP00076	P-(A5G27)-FITC	REC00024	CD44 antigen (CD44)	LIN00062	4-(2-(glycylglycyl)hydrazineylidene)pentanoic acid	DRG00012	TAR10017	Microtubule (MT)	Paclitaxel	Investigative	.	.	.	.	.
PDC_00257	P-(A5G27scrm)-PTX	PEP00078	P-(A5G27scrm)-FITC	REC00024	CD44 antigen (CD44)	LIN00062	4-(2-(glycylglycyl)hydrazineylidene)pentanoic acid	DRG00012	TAR10017	Microtubule (MT)	Paclitaxel	Investigative	.	.	.	.	.
PDC_00258	P4-bendamustine	PEP00060	p4	REC99999	Undisclosed	LIN00006	Gamma-Aminobutyric Acid	DRG00015	TAR10016	Human Deoxyribonucleic acid (hDNA)	Bendamustine	Investigative	.	.	.	.	.
PDC_00259	P4-Bend-PEG-AuNP	PEP00060	p4	REC99999	Undisclosed	LIN00006	Gamma-Aminobutyric Acid	DRG00015	TAR10016	Human Deoxyribonucleic acid (hDNA)	Bendamustine	Investigative	.	.	.	.	.
PDC_00260	P4-chlorambucil	PEP00060	p4	REC99999	Undisclosed	LIN00006	Gamma-Aminobutyric Acid	DRG00002	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Chlorambucil	Investigative	.	.	.	.	.
PDC_00261	P4-Chlor-PEG-AuNP	PEP00060	p4	REC99999	Undisclosed	LIN00006	Gamma-Aminobutyric Acid	DRG00002	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Chlorambucil	Investigative	.	.	.	.	.
PDC_00262	P4-melphalan	PEP00060	p4	REC99999	Undisclosed	LIN00087	Amide bond	DRG00025	TAR10016	Human Deoxyribonucleic acid (hDNA)	Melphalan	Investigative	.	.	.	.	.
PDC_00263	P4-Melph-PEG-AuNP	PEP00060	p4	REC99999	Undisclosed	LIN00087	Amide bond	DRG00025	TAR10016	Human Deoxyribonucleic acid (hDNA)	Melphalan	Investigative	.	.	.	.	.
PDC_00264	P6-bendamustine	PEP00099	p6	REC99999	Undisclosed	LIN00006	Gamma-Aminobutyric Acid	DRG00015	TAR10016	Human Deoxyribonucleic acid (hDNA)	Bendamustine	Investigative	.	.	.	.	.
PDC_00265	P6-chlorambucil	PEP00099	p6	REC99999	Undisclosed	LIN00006	Gamma-Aminobutyric Acid	DRG00002	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Chlorambucil	Investigative	.	.	.	.	.
PDC_00266	P6-melphalan	PEP00099	p6	REC99999	Undisclosed	LIN00087	Amide bond	DRG00025	TAR10016	Human Deoxyribonucleic acid (hDNA)	Melphalan	Investigative	.	.	.	.	.
PDC_00267	PDC-5a	PEP00158	"[K4,F7,K22,P34]-NPY"	REC00027	Neuropeptide Y receptor type 1 (NPY1R)	LIN00087	Amide bond	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_00268	PDC-5b	PEP00158	"[K4,F7,K22,P34]-NPY"	REC00027	Neuropeptide Y receptor type 1 (NPY1R)	LIN00002	GFLG	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_00269	PDC-5c	PEP00158	"[K4,F7,K22,P34]-NPY"	REC00027	Neuropeptide Y receptor type 1 (NPY1R)	LIN00087	Amide bond	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_00270	PDC-5d	PEP00158	"[K4,F7,K22,P34]-NPY"	REC00027	Neuropeptide Y receptor type 1 (NPY1R)	LIN00002	GFLG	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_00271	PDC-CPT1	PEP00149	Cyclic peptide [W(WR)4K(&beta;Ala)] 	REC99999	Undisclosed	LIN00087	Amide bond	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_00272	PDC-CPT2	PEP00149	Cyclic peptide [W(WR)4K(&beta;Ala)] 	REC99999	Undisclosed	LIN00046	3-(3-((2-(carboxyamino)ethyl)disulfaneyl)propanamido)propanoic acid	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_00273	PDC-G1	PEP00046	GFLG-QWAVGHL-Nle	REC00029	Gastrin-releasing peptide receptor (GRPR)	LIN00002	GFLG	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00274	PDC-G2	PEP00044	GFLG-fQWAVGHL-Nle	REC00029	Gastrin-releasing peptide receptor (GRPR)	LIN00002	GFLG	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00275	PDC-G3	PEP00042	GFLG-fQWAV-&beta;-Ala-H-Aib-Nle	REC00029	Gastrin-releasing peptide receptor (GRPR)	LIN00002	GFLG	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00276	PDC-G4	PEP00043	GFLG-fQWAV-&beta;-Ala-H-N-Me-Ala-Nle	REC00029	Gastrin-releasing peptide receptor (GRPR)	LIN00002	GFLG	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00277	PDC-G5	PEP00045	GFLG-fQWAVGH-Sta-L	REC00029	Gastrin-releasing peptide receptor (GRPR)	LIN00002	GFLG	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00278	PDC-L1	PEP00090	LRRY-QWAVGHL-Nle	REC00029	Gastrin-releasing peptide receptor (GRPR)	LIN00016	LRRY	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00279	PDC-L2	PEP00086	LRRY-fQWAVGHL-Nle	REC00029	Gastrin-releasing peptide receptor (GRPR)	LIN00016	LRRY	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00280	PDC-L3	PEP00083	LRRY-fQWAV-&beta;-Ala-H-Aib-Nle	REC00029	Gastrin-releasing peptide receptor (GRPR)	LIN00016	LRRY	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00281	PDC-L4	PEP00084	LRRY-fQWAV-&beta;-Ala-H-N-Me-Ala-Nle	REC00029	Gastrin-releasing peptide receptor (GRPR)	LIN00016	LRRY	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00282	PDC-L5	PEP00087	LRRY-fQWAVGH-Sta-L	REC00029	Gastrin-releasing peptide receptor (GRPR)	LIN00016	LRRY	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00283	PDC-L6	PEP00085	LRRYFQWAVAH-Sta-Nle	REC00029	Gastrin-releasing peptide receptor (GRPR)	LIN00016	LRRY	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00284	PDC-PTX1	PEP00149	Cyclic peptide [W(WR)4K(&beta;Ala)] 	REC99999	Undisclosed	LIN00033	Glutaric acid	DRG00012	TAR10017	Microtubule (MT)	Paclitaxel	Investigative	.	.	.	.	.
PDC_00285	PDC-Z1	PEP00116	HER2-targeting peptide P1	REC00010	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	LIN00026	Aminocaproic acid	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_00286	PDC-Z10	PEP00116	HER2-targeting peptide P1	REC00010	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	LIN00013	b-Thiosuccinimide	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_00287	PDC-Z11	PEP00116	HER2-targeting peptide P1	REC00010	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	LIN00091	Disulfide bond	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_00288	PDC-Z12	PEP00116	HER2-targeting peptide P1	REC00010	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	LIN00091	Disulfide bond	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_00289	PDC-Z2	PEP00116	HER2-targeting peptide P1	REC00010	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	LIN00091	Disulfide bond	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_00290	PDC-Z3	PEP00116	HER2-targeting peptide P1	REC00010	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	LIN00002	GFLG	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_00291	PDC-Z4	PEP00116	HER2-targeting peptide P1	REC00010	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	LIN00091	Disulfide bond	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_00292	PDC-Z5	PEP00116	HER2-targeting peptide P1	REC00010	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	LIN00091	Disulfide bond	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_00293	PDC-Z6	PEP00116	HER2-targeting peptide P1	REC00010	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	LIN00013	b-Thiosuccinimide	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_00294	PDC-Z7	PEP00116	HER2-targeting peptide P1	REC00010	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	LIN00091	Disulfide bond	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_00295	PDC-Z8	PEP00116	HER2-targeting peptide P1	REC00010	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	LIN00091	Disulfide bond	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_00296	PDC-Z9	PEP00116	HER2-targeting peptide P1	REC00010	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	LIN00013	b-Thiosuccinimide	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_00297	PDIP-alk-PQ	PEP00039	PDIP	REC00057	Phosphatidylserine lipid headgroups	LIN00023	Alkyne-Triazole	DRG00005	TAR10015	Plasmodium Deoxyribonucleic acid (Malaria DNA)	Primaquine	Investigative	.	.	.	.	.
PDC_00298	PDIP-DBCO-SS-PQ	PEP00039	PDIP	REC00057	Phosphatidylserine lipid headgroups	LIN00075	SS-DSCO-Azide	DRG00005	TAR10015	Plasmodium Deoxyribonucleic acid (Malaria DNA)	Primaquine	Investigative	.	.	.	.	.
PDC_00299	PDIP-DBCO-triox-PQ	PEP00039	PDIP	REC00057	Phosphatidylserine lipid headgroups	LIN00079	Triox-DSCO-Azide	DRG00005	TAR10015	Plasmodium Deoxyribonucleic acid (Malaria DNA)	Primaquine	Investigative	.	.	.	.	.
PDC_00300	PDIP-PEG1-PQ	PEP00039	PDIP	REC00057	Phosphatidylserine lipid headgroups	LIN00070	PEG-Triazole	DRG00005	TAR10015	Plasmodium Deoxyribonucleic acid (Malaria DNA)	Primaquine	Investigative	.	.	.	.	.
PDC_00301	PDIP-PEG3-PQ	PEP00039	PDIP	REC00057	Phosphatidylserine lipid headgroups	LIN00069	PEG<sub>3</sub>-Triazole	DRG00005	TAR10015	Plasmodium Deoxyribonucleic acid (Malaria DNA)	Primaquine	Investigative	.	.	.	.	.
PDC_00302	PEN-221	PEP00107	"[Tyr3,Cys8] Octreotate amide"	REC00032	Somatostatin receptor type 2 (SSTR2)	LIN00091	Disulfide bond	DRG00031	TAR10017	Microtubule (MT)	Mertansine DM1	Phase 2	.	.	.	.	.
PDC_00303	Peptide 18-4-doxorubicin	PEP00161	Peptide 18-4	REC00009	"Keratin, type II cytoskeletal 1 (KRT1)"	LIN00040	Sulfo-SMCC	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00304	Peptide-Dox hydrazone	PEP00161	Peptide 18-4	REC00009	"Keratin, type II cytoskeletal 1 (KRT1)"	LIN00061	"(Z)-N'-(2-hydroxyethylidene)-6-(3-mercapto-2,5-dioxopyrrolidin-1-yl)hexanehydrazide"	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00306	Peptide-drug conjugate 10	PEP00021	oxmCPP	REC99999	Undisclosed	LIN00091	Disulfide bond	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00307	pHA-AHX-VAP-DOX	PEP00117	<sup>D</sup>VAP	REC00018	Endoplasmic reticulum chaperone BiP; D(2) dopamine receptor (HSPA5; DRD2)	LIN00047	AHX	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00308	pHA-AOHX-VAP-DOX	PEP00117	<sup>D</sup>VAP	REC00018	Endoplasmic reticulum chaperone BiP; D(2) dopamine receptor (HSPA5; DRD2)	LIN00050	AOHX	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00309	pHLIP-M-DOX 	PEP00054	pHLIP (GGEQ)	REC99999	Undisclosed	LIN00040	Sulfo-SMCC	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00310	pHLIP-PAMAM-DOX	PEP00054	pHLIP (GGEQ)	REC99999	Undisclosed	LIN00068	PAMAM linker	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00311	pHLIP-SS-DOX	PEP00001	pHLIP (AEQ)	REC00020	DNA topoisomerase 2-alpha (TOP2A)	LIN00091	Disulfide bond	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00312	pHLIP-S-S-DOX	PEP00054	pHLIP (GGEQ)	REC99999	Undisclosed	LIN00091	Disulfide bond	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00313	PNS-SS-DOX	PEP00035	Fmoc-FKKGSHC	REC99999	Undisclosed	LIN00045	2-Aminothiolane	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00314	PP-P1	PEP00145	P1	REC99999	Undisclosed	LIN00087	Amide bond	DRG00006	TAR10003	Hematopoietic prostaglandin D synthase (HPGDS)	Protoporphyrin IX	Investigative	.	.	.	.	.
PDC_00315	PP-P2	PEP00146	P2	REC99999	Undisclosed	LIN00087	Amide bond	DRG00006	TAR10003	Hematopoietic prostaglandin D synthase (HPGDS)	Protoporphyrin IX	Investigative	.	.	.	.	.
PDC_00316	PP-P5	PEP00135	P5	REC99999	Undisclosed	LIN00087	Amide bond	DRG00006	TAR10003	Hematopoietic prostaglandin D synthase (HPGDS)	Protoporphyrin IX	Investigative	.	.	.	.	.
PDC_00317	PP-P6	PEP00136	P6	REC99999	Undisclosed	LIN00087	Amide bond	DRG00006	TAR10003	Hematopoietic prostaglandin D synthase (HPGDS)	Protoporphyrin IX	Investigative	.	.	.	.	.
PDC_00318	PSMA-TG prodrug	PEP00024	Tumor homing peptide H-Asp-isoGlu-isoGlu-isoGlu-isoGlu-OH	REC99999	Undisclosed	LIN00030	12-Aminododecanoic acid	DRG00024	TAR10021	Calcium-transporting ATPase type 2C member 1 (ATP2C1)	Thapsigargin	Investigative	.	.	.	.	.
PDC_00319	PTX-SM-TAR	PEP00020	TAR	REC00001	Neuropilin-1 (NRP1)	LIN00074	SA-MAL	DRG00012	TAR10017	Microtubule (MT)	Paclitaxel	Investigative	.	.	.	.	.
PDC_00320	PVGLIG-paclitaxel	PEP00120	Hexapeptide	REC00017	72 kDa type IV collagenase (MMP2)	LIN00096	Ester bond	DRG00012	TAR10017	Microtubule (MT)	Paclitaxel	Investigative	.	.	.	.	.
PDC_00321	QR-KLU	PEP00121	QR	REC00025	Vascular endothelial growth factor receptor 1 (FLT1)	LIN00026	Aminocaproic acid	DRG00061	.	.	KLUKLUKKLUKLUK	Investigative	.	.	.	.	.
PDC_00322	RGD-GFLG-DOX	PEP00041	GFLG	REC00013	Integrin alpha-V; Integrin beta-3 (ITGAV; ITGB3)	LIN00002	GFLG	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00323	rL-A9-DOX	PEP00148	rL-A9	REC00010	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	LIN00040	Sulfo-SMCC	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00324	RR-BA	PEP00130	RR	REC00015	Cathepsin B (CTSB)	LIN00087	Amide bond	DRG00033	TAR10013	Biliverdin reductase A (BLVRA)	Ursodeoxycholic acid	Investigative	.	.	.	.	.
PDC_00326	sC18(dau-Aoa-Lys8)	PEP00164	c[DKP-RGD]-PEG<sub>4</sub>-sC18	REC99999	Undisclosed	LIN00019	Aminooxyacetic acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00327	SG3299	PEP00097	A20FMDV2	REC00014	Integrin alpha-V; Integrin beta-6 (ITGAV; ITGB6)	LIN00028	Val-Ala	DRG00063	TAR10016	Human Deoxyribonucleic acid (hDNA)	Pyrrolobenzodiazepine (PBD) dimer	Investigative	.	.	.	.	.
PDC_00329	SG3511	PEP00096	NALRDQTGLKNPVQLARAVC	REC00014	Integrin alpha-V; Integrin beta-6 (ITGAV; ITGB6)	LIN00028	Val-Ala	DRG00063	TAR10016	Human Deoxyribonucleic acid (hDNA)	Pyrrolobenzodiazepine (PBD) dimer	Investigative	.	.	.	.	.
PDC_00331	SMAC-P1 CPT conjugates 1	PEP00102	SMAC-P1 S1	REC00010	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	LIN00039	2-(Disulfanyl)ethyl hydrogen carbonate	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_00332	SMAC-P1 CPT conjugates 2	PEP00102	SMAC-P1 S1	REC00010	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	LIN00012	3-Disulfanylpropanoic Acid	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_00333	SMAC-P1 CPT conjugates 3	PEP00102	SMAC-P1 S1	REC00010	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	LIN00031	"4-yl 6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanoate"	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_00334	SMAC-P1 CPT conjugates 4	PEP00101	SMAC-P1 S2	REC00010	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	LIN00039	2-(Disulfanyl)ethyl hydrogen carbonate	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_00335	SMAC-P1 CPT conjugates 5	PEP00101	SMAC-P1 S2	REC00010	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	LIN00012	3-Disulfanylpropanoic Acid	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_00336	SMAC-P1 CPT conjugates 6	PEP00101	SMAC-P1 S2	REC00010	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	LIN00031	"4-yl 6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanoate"	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_00337	SMAC-P1 CPT conjugates 7	PEP00103	SMAC-P1 S3	REC00010	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	LIN00039	2-(Disulfanyl)ethyl hydrogen carbonate	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_00338	SMAC-P1 CPT conjugates 8	PEP00103	SMAC-P1 S3	REC00010	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	LIN00012	3-Disulfanylpropanoic Acid	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_00339	SMAC-P1 CPT conjugates 9	PEP00103	SMAC-P1 S3	REC00010	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	LIN00031	"4-yl 6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanoate"	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_00340	SN38-HKD	PEP00014	CGVVQQ	REC00012	Integrin alpha-V (ITGAV)	LIN00035	4-(Disulfanyl)butanoic acid	DRG00018	TAR10008	DNA topoisomerase 1 (TOP1)	7-Ethyl-10-hydroxycamptothecin	Investigative	.	.	.	.	.
PDC_00341	SN38-HKD/RGDR	PEP00014	CGVVQQ	REC00012	Integrin alpha-V (ITGAV)	LIN00035	4-(Disulfanyl)butanoic acid	DRG00018	TAR10008	DNA topoisomerase 1 (TOP1)	7-Ethyl-10-hydroxycamptothecin	Investigative	.	.	.	.	.
PDC_00342	STRAP-1-MTX	PEP00165	STRAP-1	REC00055	Cell membrane	LIN00087	Amide bond	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_00343	STRAP-2-MTX	PEP00165	STRAP-1	REC00055	Cell membrane	LIN00087	Amide bond	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_00344	STRAP-3-MTX	PEP00166	STRAP-3	REC00055	Cell membrane	LIN00087	Amide bond	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_00345	STRAP-4-MTX	PEP00166	STRAP-3	REC00055	Cell membrane	LIN00087	Amide bond	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_00346	T7-SN-38	PEP00167	DT7	REC00008	Transferrin receptor protein 1 (TFRC)	LIN00048	Ahx-Val	DRG00018	TAR10008	DNA topoisomerase 1 (TOP1)	7-Ethyl-10-hydroxycamptothecin	Investigative	.	.	.	.	.
PDC_00347	"Tesaglitazar-[F<sup>7</sup>, P<sup>34</sup>]-NPY"	PEP00159	"[K4(C-&beta;A-),F7,L17,P34]-hNPY"	REC00027	Neuropeptide Y receptor type 1 (NPY1R)	LIN00002	GFLG	DRG00023	TAR10014	Peroxisome proliferator-activated receptor alpha (PPARA)	Tesaglitazar	Investigative	.	.	.	.	.
PDC_00348	TF&alpha;-peptide-duocarmycin conjugate	PEP00058	TF&alpha;-peptide	REC00060	Thomsen-Friedenreich antigen (TFa)	LIN00005	Val-Cit	DRG00045	TAR10016	Human Deoxyribonucleic acid (hDNA)	Duocarmycin Sa	Investigative	.	.	.	.	.
PDC_00349	TH1902	PEP00052	TH19P01	REC00049	Sortilin (SORT1)	LIN00003	Succinic Acid	DRG00020	TAR10017	Microtubule (MT)	Docetaxel	Phase 3	.	.	.	.	.
PDC_00350	TM5	PEP00131	SDT7	REC00055	Cell membrane	LIN00056	Fmoc-azido-L-alanine	DRG00017	TAR10020	Prostaglandin G/H synthase 2 (PTGS2)	Paradol	Investigative	.	.	.	.	.
PDC_00351	TPP-DOX-AP2H	PEP00061	AP2H	REC00047	Mitochondria-eating protein (SPATA18)	LIN00100	Hydrazone bond	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00352	Tubugi-1-NPY	PEP00159	"[K4(C-&beta;A-),F7,L17,P34]-hNPY"	REC00027	Neuropeptide Y receptor type 1 (NPY1R)	LIN00091	Disulfide bond	DRG00042	TAR10017	Microtubule (MT)	Tubugis	Investigative	.	.	.	.	.
PDC_00353	Cyclic NGR peptidedaunomycin conjugates 2	PEP00019	Cyclic NGR 2	REC00023	Aminopeptidase N (ANPEP)	LIN00002	GFLG	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00354	Cyclic NGR peptidedaunomycin conjugates 3	PEP00073	Cyclic NGR 3	REC00023	Aminopeptidase N (ANPEP)	LIN00002	GFLG	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00355	Cyclic NGR peptidedaunomycin conjugates 4	PEP00072	Cyclic NGR 4	REC00023	Aminopeptidase N (ANPEP)	LIN00002	GFLG	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00356	Cyclic NGR peptidedaunomycin conjugates 5	PEP00075	Cyclic NGR 5	REC00023	Aminopeptidase N (ANPEP)	LIN00002	GFLG	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00357	Cyclic NGR peptidedaunomycin conjugates 6	PEP00074	Cyclic NGR 6	REC00023	Aminopeptidase N (ANPEP)	LIN00002	GFLG	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_00358	GLP-1-MK-801	PEP00176	GLP-1 analogue	REC00043	"Glutamate receptor ionotropic, NMDA 1 (GRIN1)"	LIN00091	Disulfide bond	DRG00022	TAR10026	"Glutamate receptor ionotropic, NMDA 3A (GRIN3A)"	Dizocilpine	Preclinical	.	.	.	.	.
PDC_00359	TH1904	PEP00052	TH19P01	REC00049	Sortilin (SORT1)	LIN00117	"3,3-Dimethylglutaric acid"	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Preclinical	.	.	.	.	.
PDC_00360	BT1718	PEP00174	BT1718 Bicycle peptide	REC00037	Matrix metalloproteinase-14 (MMP14)	LIN00091	Disulfide bond	DRG00026	TAR10017	Microtubule (MT)	Maytansine	Phase 2	.	.	.	.	.
PDC_00361	CBX-12	PEP00175	Unique variant of pHLIP	REC00019	DNA topoisomerase 1 (TOP1)	LIN00091	Disulfide bond	DRG00021	TAR10018	DNA topoisomerase 1 (TOP1)	Exatecan	Phase 2	.	.	.	.	.
PDC_00362	SBI1301	PEP00177	SOR-C27	REC00051	Transient receptor potential cation channel subfamily V member 6 (TRPV6)	LIN00116	Thioglycolic acid	DRG00012	TAR10017	Microtubule (MT)	Paclitaxel	Preclinical	.	.	.	.	.
PDC_00363	Dazdotuftide	PEP00178	TKPR	REC99999	Undisclosed	LIN00118	Diazo bond	DRG00064	.	.	Choline phosphate	Phase 3	.	.	.	.	.
PDC_00364	[<sup>177</sup>Lu]Lu-DPI-4452	PEP00179	DPI-4452	REC99999	Undisclosed	LIN00119	Ethyl 2-(piperazin-1-yl)acetate	DRG00049	TAR10052	Human Deoxyribonucleic acid (hDNA)	Lutetium-177	Phase 1/2	.	.	.	.	.
PDC_00365	Debio-0328	PEP00179	DPI-4452	REC99999	Undisclosed	LIN00119	Ethyl 2-(piperazin-1-yl)acetate	DRG00028	TAR10052	Human Deoxyribonucleic acid (hDNA)	Gallium-68	Phase 1	.	.	.	.	.
PDC_00366	CBP-1008	PEP00180	SOR-C13	REC00051	Transient receptor potential cation channel subfamily V member 6 (TRPV6)	LIN00065	Mc-Val-Cit-PAB-OH	DRG00038	TAR10017	Microtubule (MT)	Monomethyl auristatin E	Phase 2/3	.	.	.	.	.
PDC_00367	CBP-1018	PEP00181	LDC10B	REC00042	Glutamate carboxypeptidase 2 (FOLH1)	LIN00065	Mc-Val-Cit-PAB-OH	DRG00038	TAR10017	Microtubule (MT)	Monomethyl auristatin E	Phase 1	.	.	.	.	.
PDC_00368	BGC-0222	PEP00122	c(RGDfK)	REC00013	Integrin alpha-V; Integrin beta-3 (ITGAV; ITGB3)	LIN00120	PEG<sub>114</sub>	DRG00065	TAR10008	DNA topoisomerase 1 (TOP1)	Irinotecan	Phase 1	.	.	.	.	.
PDC_00369	Bevonescein	PEP00182	ALM-488 Peptide	REC99999	Undisclosed	LIN00087	Amide bond	DRG00066	TAR10028	"Alkaline phosphatase, tissue-nonspecific isozyme (ALPL)"	5-Carboxyfluorescein	Phase 3	.	.	.	.	.
PDC_00370	18F vipivotide traxetan	PEP00030	PSMA-617	REC00042	Glutamate carboxypeptidase 2 (FOLH1)	LIN00073	(S)-2-(4-(aminomethyl)cyclohexane-1-carboxamido)-3-(naphthalen-2-yl)propanoic acid	DRG00048	TAR10052	Human Deoxyribonucleic acid (hDNA)	Fluorine-18	Phase 3	.	.	.	.	.
PDC_00371	Copper dotatate Cu-64	PEP00109	3-Tyr-Octreotate	REC00031	Somatostatin receptor type 1 (SSTR1)	LIN00087	Amide bond	DRG00052	TAR10052	Human Deoxyribonucleic acid (hDNA)	Copper-64	Approved	.	.	.	.	.
PDC_00372	RWRWRWRW - Doxorubicin conjugate	PEP00183	RWRWRWRW	REC99999	Undisclosed	LIN00033	Glutaric acid	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00373	WRWRWRWRWK - Doxorubicin conjugate	PEP00184	WRWRWRWRWK	REC99999	Undisclosed	LIN00033	Glutaric acid	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00374	GFLG - Doxorubicin conjugate	PEP00041	GFLG	REC00013	Integrin alpha-V; Integrin beta-3 (ITGAV; ITGB3)	LIN00146	Undisclosed	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00375	CGRKKRRQRRRPPQ - Doxorubicin conjugate	PEP00185	CGRKKRRQRRRPPQ	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00376	CGRKKRRQRRPPQ - Doxorubicin conjugate	PEP00186	CGRKKRRQRRPPQ	REC99999	Undisclosed	LIN00121	Succinimide	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00377	AKKRRQRRRAKKRRQRRR - Natamycin conjugate	PEP00187	AKKRRQRRRAKKRRQRRR	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00163	TAR10033	Fungal Cell membrane (Fung CM)	Natamycin	Investigative	.	.	.	.	.
PDC_00378	CRRRRRRRRGGGPKKKKKK - Doxorubicin conjugate	PEP00188	CRRRRRRRRGGGPKKKKKK	REC99999	Undisclosed	LIN00121	Succinimide	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00379	HAIYPRHGGCGMPKKKPTPIQLNP - Doxorubicin conjugate	PEP00189	HAIYPRHGGCGMPKKKPTPIQLNP	REC99999	Undisclosed	LIN00121	Succinimide	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00380	Bim-BH3 domain core region - Palmitic acid conjugate	PEP00466	Bim-BH3 domain core region	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00069	TAR10045	Fatty acid-binding protein 5 (FABP5)	Palmitic acid	Investigative	.	.	.	.	.
PDC_00381	CPP2 - 5-Bromo-2-thiazolecarboxylic acid (BTZCA) conjugate	PEP00492	CPP2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00192	.	.	5-Bromo-2-thiazolecarboxylic acid (BTZCA)	Investigative	.	.	.	.	.
PDC_00382	CPP2 - 4-(2-Benzothiazolylamino)-4-oxobutanoic acid (BenzoTZ-C2) conjugate	PEP00492	CPP2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00132	.	.	4-(2-Benzothiazolylamino)-4-oxobutanoic acid (BenzoTZ-C2)	Investigative	.	.	.	.	.
PDC_00383	CPP2 - 5-Bromothiazole (BTZ-C2) conjugate	PEP00492	CPP2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00127	.	.	5-Bromothiazole (BTZ-C2)	Investigative	.	.	.	.	.
PDC_00384	CPP2 - 2-Amino-5-methylthiazole (MTZ-C2) conjugate	PEP00492	CPP2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00125	.	.	2-Amino-5-methylthiazole (MTZ-C2)	Investigative	.	.	.	.	.
PDC_00385	CPP2 - 2-Amino-5-nitrothiazole (NTZ-C2) conjugate	PEP00492	CPP2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00092	.	.	2-Amino-5-nitrothiazole (NTZ-C2)	Investigative	.	.	.	.	.
PDC_00386	Neuropeptide Y (NPY) - Maleimide derivative of daunorubicin conjugate	PEP00643	Neuropeptide Y (NPY)	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00169	.	.	Maleimide derivative of daunorubicin	Investigative	.	.	.	.	.
PDC_00387	Neuropeptide Y (NPY) - Maleimide derivative of doxorubicin conjugate	PEP00643	Neuropeptide Y (NPY)	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00326	.	.	Maleimide derivative of doxorubicin	Investigative	.	.	.	.	.
PDC_00388	Galectin-3 targeting peptide (G3-C12) - Captopril conjugate	PEP00566	Galectin-3 targeting peptide (G3-C12)	REC99999	Undisclosed	LIN00122	Mercaptoacetic acid	DRG00106	TAR10036	HUMAN angiotensin-converting enzyme (ACE)	Captopril	Investigative	.	.	.	.	.
PDC_00389	Galectin-3 targeting peptide (G3-C12) - Fluorescein isothiocyanate conjugate	PEP00566	Galectin-3 targeting peptide (G3-C12)	REC99999	Undisclosed	LIN00122	Mercaptoacetic acid	DRG00100	.	.	Fluorescein isothiocyanate	Investigative	.	.	.	.	.
PDC_00390	[D-Lys6]-LH-RH - Doxorubicin conjugate	PEP00152	[D-Lys6]-LH-RH	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00033	Glutaric acid	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00391	Linear arginineglycineaspartic acid (RGD) - Naproxen conjugate 3	PEP01018	RGD	REC00059	Integrin	LIN00087	Amide bond	DRG00121	TAR10032	Prostaglandin G/H synthase 1 (COX-1)	Naproxen	Investigative	.	.	.	.	.
PDC_00392	XNRG - Ibuprofen conjugate	PEP01019	NGR	REC00062	Aminopeptidase N (ANPEP)	LIN00026	Aminocaproic acid	DRG00075	TAR10020	Prostaglandin G/H synthase 2 (PTGS2)	Ibuprofen	Investigative	.	.	.	.	.
PDC_00393	Linear arginineglycineaspartic acid (RGD) - Ibuprofen conjugate 1	PEP01018	RGD	REC00059	Integrin	LIN00087	Amide bond	DRG00075	TAR10020	Prostaglandin G/H synthase 2 (PTGS2)	Ibuprofen	Investigative	.	.	.	.	.
PDC_00394	Linear asparagineglycinearginine (NGR) 1 - Naproxen conjugate 1	PEP01019	NGR	REC00062	Aminopeptidase N (ANPEP)	LIN00087	Amide bond	DRG00121	TAR10032	Prostaglandin G/H synthase 1 (COX-1)	Naproxen	Investigative	.	.	.	.	.
PDC_00395	Linear asparagineglycinearginine (NGR) 2 - Ibuprofen conjugate	PEP01019	NGR	REC00062	Aminopeptidase N (ANPEP)	LIN00087	Amide bond	DRG00075	TAR10020	Prostaglandin G/H synthase 2 (PTGS2)	Ibuprofen	Investigative	.	.	.	.	.
PDC_00396	Linear arginineglycineaspartic acid (RGD) - Naproxen conjugate 4	PEP01018	RGD	REC00059	Integrin	LIN00026	Aminocaproic acid	DRG00121	TAR10032	Prostaglandin G/H synthase 1 (COX-1)	Naproxen	Investigative	.	.	.	.	.
PDC_00397	Linear arginineglycineaspartic acid (RGD) - Ibuprofen conjugate 2	PEP01018	RGD	REC00059	Integrin	LIN00026	Aminocaproic acid	DRG00075	TAR10020	Prostaglandin G/H synthase 2 (PTGS2)	Ibuprofen	Investigative	.	.	.	.	.
PDC_00398	Linear asparagineglycinearginine (NGR) 1 - Naproxen conjugate 2	PEP01019	NGR	REC00062	Aminopeptidase N (ANPEP)	LIN00026	Aminocaproic acid	DRG00121	TAR10032	Prostaglandin G/H synthase 1 (COX-1)	Naproxen	Investigative	.	.	.	.	.
PDC_00399	Lytic peptides 1 - Pteroic acid conjugate	PEP00620	Lytic peptides 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00222	TAR10031	Bacterial Dihydropteroate synthetase (Bact folP)	Pteroic acid	Investigative	.	.	.	.	.
PDC_00400	Lytic peptides 2 - Pteroic acid conjugate	PEP00621	Lytic peptides 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00222	TAR10031	Bacterial Dihydropteroate synthetase (Bact folP)	Pteroic acid	Investigative	.	.	.	.	.
PDC_00401	Lytic peptides 3 - Pteroic acid conjugate	PEP00622	Lytic peptides 3	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00222	TAR10031	Bacterial Dihydropteroate synthetase (Bact folP)	Pteroic acid	Investigative	.	.	.	.	.
PDC_00402	Lytic peptides 4 - Pteroic acid conjugate	PEP00623	Lytic peptides 4	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00222	TAR10031	Bacterial Dihydropteroate synthetase (Bact folP)	Pteroic acid	Investigative	.	.	.	.	.
PDC_00403	Lytic peptides 5 - Fluorescein conjugate	PEP00624	Lytic peptides 5	REC99999	Undisclosed	LIN00123	3-Aminopropionic acid	DRG00285	.	.	Fluorescein	Investigative	.	.	.	.	.
PDC_00404	Lytic peptides 6 - Paclitaxel conjugate	PEP00625	Lytic peptides 6	REC99999	Undisclosed	LIN00031	"4-yl 6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanoate"	DRG00012	TAR10017	Microtubule (MT)	Paclitaxel	Investigative	.	.	.	.	.
PDC_00405	Lytic peptides 5 - Paclitaxel conjugate	PEP00624	Lytic peptides 5	REC99999	Undisclosed	LIN00031	"4-yl 6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanoate"	DRG00012	TAR10017	Microtubule (MT)	Paclitaxel	Investigative	.	.	.	.	.
PDC_00406	Dipeptide 1 - Curcumin conjugate 1	PEP00497	VI	REC00067	Solute carrier family 15 member 1 (SLC15A1)	LIN00150	2-Hydroxyacetic acid	DRG00162	TAR10029	Tissue transglutaminase (TG2)	Curcumin	Investigative	.	.	.	.	.
PDC_00408	Dipeptide 3 - Curcumin conjugate 1	PEP00499	AA	REC00067	Solute carrier family 15 member 1 (SLC15A1)	LIN00150	2-Hydroxyacetic acid	DRG00162	TAR10029	Tissue transglutaminase (TG2)	Curcumin	Investigative	.	.	.	.	.
PDC_00409	Dipeptide 4 - Curcumin conjugate 1	PEP00500	VA	REC00067	Solute carrier family 15 member 1 (SLC15A1)	LIN00150	2-Hydroxyacetic acid	DRG00162	TAR10029	Tissue transglutaminase (TG2)	Curcumin	Investigative	.	.	.	.	.
PDC_00410	Dipeptide 5 - Curcumin conjugate 1	PEP00501	VG	REC00067	Solute carrier family 15 member 1 (SLC15A1)	LIN00150	2-Hydroxyacetic acid	DRG00162	TAR10029	Tissue transglutaminase (TG2)	Curcumin	Investigative	.	.	.	.	.
PDC_00411	Dipeptide 6 - Curcumin conjugate 1	PEP00502	IV	REC00067	Solute carrier family 15 member 1 (SLC15A1)	LIN00150	2-Hydroxyacetic acid	DRG00162	TAR10029	Tissue transglutaminase (TG2)	Curcumin	Investigative	.	.	.	.	.
PDC_00412	Dipeptide 7 - Curcumin conjugate 1	PEP00503	FV	REC00067	Solute carrier family 15 member 1 (SLC15A1)	LIN00150	2-Hydroxyacetic acid	DRG00162	TAR10029	Tissue transglutaminase (TG2)	Curcumin	Investigative	.	.	.	.	.
PDC_00413	Dipeptide 8 - Curcumin conjugate 1	PEP00504	GV	REC00067	Solute carrier family 15 member 1 (SLC15A1)	LIN00150	2-Hydroxyacetic acid	DRG00162	TAR10029	Tissue transglutaminase (TG2)	Curcumin	Investigative	.	.	.	.	.
PDC_00414	Dipeptide 9 - Curcumin conjugate 1	PEP00505	AV	REC00067	Solute carrier family 15 member 1 (SLC15A1)	LIN00150	2-Hydroxyacetic acid	DRG00162	TAR10029	Tissue transglutaminase (TG2)	Curcumin	Investigative	.	.	.	.	.
PDC_00415	Dipeptide 10 - Curcumin conjugate 1	PEP00506	VV	REC00067	Solute carrier family 15 member 1 (SLC15A1)	LIN00150	2-Hydroxyacetic acid	DRG00162	TAR10029	Tissue transglutaminase (TG2)	Curcumin	Investigative	.	.	.	.	.
PDC_00416	Dipeptide 1 - Curcumin conjugate 2	PEP00497	VI	REC00067	Solute carrier family 15 member 1 (SLC15A1)	LIN00125	Glycol acid	DRG00162	TAR10029	Tissue transglutaminase (TG2)	Curcumin	Investigative	.	.	.	.	.
PDC_00417	Dipeptide 2 - Curcumin conjugate	PEP00498	VF	REC99999	Undisclosed	LIN00125	Glycol acid	DRG00162	TAR10029	Tissue transglutaminase (TG2)	Curcumin	Investigative	.	.	.	.	.
PDC_00418	Dipeptide 3 - Curcumin conjugate 2	PEP00499	AA	REC00067	Solute carrier family 15 member 1 (SLC15A1)	LIN00125	Glycol acid	DRG00162	TAR10029	Tissue transglutaminase (TG2)	Curcumin	Investigative	.	.	.	.	.
PDC_00419	Dipeptide 4 - Curcumin conjugate 2	PEP00500	VA	REC00067	Solute carrier family 15 member 1 (SLC15A1)	LIN00125	Glycol acid	DRG00162	TAR10029	Tissue transglutaminase (TG2)	Curcumin	Investigative	.	.	.	.	.
PDC_00420	Dipeptide 5 - Curcumin conjugate 2	PEP00501	VG	REC00067	Solute carrier family 15 member 1 (SLC15A1)	LIN00125	Glycol acid	DRG00162	TAR10029	Tissue transglutaminase (TG2)	Curcumin	Investigative	.	.	.	.	.
PDC_00421	Dipeptide 6 - Curcumin conjugate 2	PEP00502	IV	REC00067	Solute carrier family 15 member 1 (SLC15A1)	LIN00125	Glycol acid	DRG00162	TAR10029	Tissue transglutaminase (TG2)	Curcumin	Investigative	.	.	.	.	.
PDC_00422	Dipeptide 7 - Curcumin conjugate	PEP00503	FV	REC00067	Solute carrier family 15 member 1 (SLC15A1)	LIN00125	Glycol acid	DRG00162	TAR10029	Tissue transglutaminase (TG2)	Curcumin	Investigative	.	.	.	.	.
PDC_00423	Dipeptide 8 - Curcumin conjugate 2	PEP00504	GV	REC00067	Solute carrier family 15 member 1 (SLC15A1)	LIN00125	Glycol acid	DRG00162	TAR10029	Tissue transglutaminase (TG2)	Curcumin	Investigative	.	.	.	.	.
PDC_00424	Dipeptide 9 - Curcumin conjugate	PEP00505	AV	REC00067	Solute carrier family 15 member 1 (SLC15A1)	LIN00125	Glycol acid	DRG00162	TAR10029	Tissue transglutaminase (TG2)	Curcumin	Investigative	.	.	.	.	.
PDC_00425	Dipeptide 10 - Curcumin conjugate 2	PEP00506	VV	REC00067	Solute carrier family 15 member 1 (SLC15A1)	LIN00125	Glycol acid	DRG00162	TAR10029	Tissue transglutaminase (TG2)	Curcumin	Investigative	.	.	.	.	.
PDC_00426	Tripeptide 1 - N-(4-Hydroxyphenyl)-N-methylethenesulfonamide conjugate 1	PEP00861	Tripeptide 1	REC99999	Undisclosed	LIN00126	PEG	DRG00227	.	.	N-(4-Hydroxyphenyl)-N-methylethenesulfonamide	Investigative	.	.	.	.	.
PDC_00427	Tripeptide 1 - N-(4-Hydroxyphenyl)-N-methylethenesulfonamide conjugate 2	PEP00861	Tripeptide 1	REC99999	Undisclosed	LIN00126	PEG	DRG00227	.	.	N-(4-Hydroxyphenyl)-N-methylethenesulfonamide	Investigative	.	.	.	.	.
PDC_00428	Model peptide 1 - N-(4-Hydroxyphenyl)-N-methylethenesulfonamide conjugate	PEP00636	Model peptide 1	REC99999	Undisclosed	LIN00126	PEG	DRG00227	.	.	N-(4-Hydroxyphenyl)-N-methylethenesulfonamide	Investigative	.	.	.	.	.
PDC_00429	Tripeptide 1 - 2-[2-(2-Azidoethoxy)ethoxy]acetic acid conjugate 1	PEP00861	Tripeptide 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00186	.	.	2-[2-(2-Azidoethoxy)ethoxy]acetic acid	Investigative	.	.	.	.	.
PDC_00430	Tripeptide 1 - 2-[2-(2-Azidoethoxy)ethoxy]acetic acid conjugate 2	PEP00861	Tripeptide 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00186	.	.	2-[2-(2-Azidoethoxy)ethoxy]acetic acid	Investigative	.	.	.	.	.
PDC_00431	Model peptide 1 - Camptothecin conjugate	PEP00636	Model peptide 1	REC99999	Undisclosed	LIN00127	Triazole	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_00432	Model peptide 1 - Fluorescein conjugate	PEP00636	Model peptide 1	REC99999	Undisclosed	LIN00127	Triazole	DRG00285	.	.	Fluorescein	Investigative	.	.	.	.	.
PDC_00433	Model peptide 1 - N-methyl-4-(2-propyn-1-yloxy)-benzenamine conjugate	PEP00636	Model peptide 1	REC99999	Undisclosed	LIN00127	Triazole	DRG00198	.	.	N-methyl-4-(2-propyn-1-yloxy)-benzenamine	Investigative	.	.	.	.	.
PDC_00434	Model peptide 1 - N-Methyl-N-phenylethenesulfonamide conjugate	PEP00636	Model peptide 1	REC99999	Undisclosed	LIN00127	Triazole	DRG00173	.	.	N-Methyl-N-phenylethenesulfonamide	Investigative	.	.	.	.	.
PDC_00435	Tripeptide 1 - 4-[(Ethenylsulfonyl)methylamino]-N-2-propyn-1-ylbenzamide conjugate 1	PEP00861	Tripeptide 1	REC99999	Undisclosed	LIN00127	Triazole	DRG00244	.	.	4-[(Ethenylsulfonyl)methylamino]-N-2-propyn-1-ylbenzamide	Investigative	.	.	.	.	.
PDC_00436	Tripeptide 1 - 4-[(Ethenylsulfonyl)methylamino]-N-2-propyn-1-ylbenzamide conjugate 2	PEP00861	Tripeptide 1	REC99999	Undisclosed	LIN00127	Triazole	DRG00244	.	.	4-[(Ethenylsulfonyl)methylamino]-N-2-propyn-1-ylbenzamide	Investigative	.	.	.	.	.
PDC_00437	"Tripeptide, linear - Methylenenorcamphor conjugate"	PEP00992	"Tripeptide, linear"	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00116	.	.	Methylenenorcamphor	Investigative	.	.	.	.	.
PDC_00438	"Hexapeptide, cyclic 1 - Methyl acrylate conjugate 1"	PEP00592	"Hexapeptide, cyclic 1"	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00087	.	.	Methyl acrylate	Investigative	.	.	.	.	.
PDC_00440	"Pentapeptide, linear 1 - Methyl acrylate conjugate"	PEP00746	"Pentapeptide, linear 1"	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00087	.	.	Methyl acrylate	Investigative	.	.	.	.	.
PDC_00441	"Pentapeptide, linear 2 - (R)-5-oxo-2-pyrrolidinecarboxamide conjugate 1"	PEP00747	"Pentapeptide, linear 2"	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00181	.	.	(R)-5-oxo-2-pyrrolidinecarboxamide	Investigative	.	.	.	.	.
PDC_00442	"Pentapeptide, linear 2 - (R)-5-oxo-2-pyrrolidinecarboxamide conjugate 2"	PEP00747	"Pentapeptide, linear 2"	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00181	.	.	(R)-5-oxo-2-pyrrolidinecarboxamide	Investigative	.	.	.	.	.
PDC_00445	"Hexapeptide, cyclic 1 - Methyl acrylate conjugate"	PEP00592	"Hexapeptide, cyclic 1"	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00087	.	.	Methyl acrylate	Investigative	.	.	.	.	.
PDC_00446	"Hexapeptide, cyclic 2 - Methyl acrylate conjugate"	PEP00593	"Hexapeptide, cyclic 2"	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00087	.	.	Methyl acrylate	Investigative	.	.	.	.	.
PDC_00447	"Hexapeptide, cyclic 3 - Methyl acrylate conjugate"	PEP00594	"Hexapeptide, cyclic 3"	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00087	.	.	Methyl acrylate	Investigative	.	.	.	.	.
PDC_00448	"Pentapeptide, linear 2 - (R)-5-oxo-2-pyrrolidinecarboxamide conjugate 3"	PEP00747	"Pentapeptide, linear 2"	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00181	.	.	(R)-5-oxo-2-pyrrolidinecarboxamide	Investigative	.	.	.	.	.
PDC_00449	"Tripeptide, linear - (R)-5-oxo-2-pyrrolidinecarboxamide conjugate 1"	PEP00992	"Tripeptide, linear"	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00181	.	.	(R)-5-oxo-2-pyrrolidinecarboxamide	Investigative	.	.	.	.	.
PDC_00450	"Tripeptide, linear - (R)-5-oxo-2-pyrrolidinecarboxamide conjugate 2"	PEP00992	"Tripeptide, linear"	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00181	.	.	(R)-5-oxo-2-pyrrolidinecarboxamide	Investigative	.	.	.	.	.
PDC_00451	"Tripeptide, linear - (R)-5-oxo-2-pyrrolidinecarboxamide conjugate 3"	PEP00992	"Tripeptide, linear"	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00181	.	.	(R)-5-oxo-2-pyrrolidinecarboxamide	Investigative	.	.	.	.	.
PDC_00452	"Tripeptide, linear - (R)-5-oxo-2-pyrrolidinecarboxamide conjugate 4"	PEP00992	"Tripeptide, linear"	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00181	.	.	(R)-5-oxo-2-pyrrolidinecarboxamide	Investigative	.	.	.	.	.
PDC_00453	"Tripeptide, linear - (R)-5-oxo-2-pyrrolidinecarboxamide conjugate 5"	PEP00992	"Tripeptide, linear"	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00181	.	.	(R)-5-oxo-2-pyrrolidinecarboxamide	Investigative	.	.	.	.	.
PDC_00454	"Tripeptide, linear - (R)-5-oxo-2-pyrrolidinecarboxamide conjugate 6"	PEP00992	"Tripeptide, linear"	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00181	.	.	(R)-5-oxo-2-pyrrolidinecarboxamide	Investigative	.	.	.	.	.
PDC_00455	"Tripeptide, linear - (R)-5-oxo-2-pyrrolidinecarboxamide conjugate 7"	PEP00992	"Tripeptide, linear"	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00181	.	.	(R)-5-oxo-2-pyrrolidinecarboxamide	Investigative	.	.	.	.	.
PDC_00456	"Tripeptide, linear - (R)-5-oxo-2-pyrrolidinecarboxamide conjugate 8"	PEP00992	"Tripeptide, linear"	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00181	.	.	(R)-5-oxo-2-pyrrolidinecarboxamide	Investigative	.	.	.	.	.
PDC_00457	"GTGVP - 3,4-Dihydro-4-oxo-2-quinazolinebutanoic acid conjugate 1"	PEP00191	GTGVP	REC99999	Undisclosed	LIN00087	Amide bond	DRG00223	.	.	"3,4-Dihydro-4-oxo-2-quinazolinebutanoic acid"	Investigative	.	.	.	.	.
PDC_00458	"GDGVP - 3,4-Dihydro-4-oxo-2-quinazolinebutanoic acid conjugate 1"	PEP00192	GDGVP	REC99999	Undisclosed	LIN00087	Amide bond	DRG00223	.	.	"3,4-Dihydro-4-oxo-2-quinazolinebutanoic acid"	Investigative	.	.	.	.	.
PDC_00459	"GDGVP - 3,4-Dihydro-4-oxo-2-quinazolinebutanoic acid conjugate 5"	PEP00193	GFGVP	REC99999	Undisclosed	LIN00087	Amide bond	DRG00223	.	.	"3,4-Dihydro-4-oxo-2-quinazolinebutanoic acid"	Investigative	.	.	.	.	.
PDC_00460	"GYGVP - 3,4-Dihydro-4-oxo-2-quinazolinebutanoic acid conjugate 1"	PEP00194	GYGVP	REC99999	Undisclosed	LIN00087	Amide bond	DRG00223	.	.	"3,4-Dihydro-4-oxo-2-quinazolinebutanoic acid"	Investigative	.	.	.	.	.
PDC_00461	"GWGVP - 3,4-Dihydro-4-oxo-2-quinazolinebutanoic acid conjugate 1"	PEP00195	GWGVP	REC99999	Undisclosed	LIN00087	Amide bond	DRG00223	.	.	"3,4-Dihydro-4-oxo-2-quinazolinebutanoic acid"	Investigative	.	.	.	.	.
PDC_00462	"GTGVP - 3,4-Dihydro-4-oxo-2-quinazolinebutanoic acid conjugate 2"	PEP00191	GTGVP	REC99999	Undisclosed	LIN00087	Amide bond	DRG00399	.	.	"3-(4-Oxo-3,4-dihydroquinazolin-2-yl)propanoic acid"	Investigative	.	.	.	.	.
PDC_00463	"GDGVP - 3,4-Dihydro-4-oxo-2-quinazolinebutanoic acid conjugate 2"	PEP00192	GDGVP	REC99999	Undisclosed	LIN00087	Amide bond	DRG00399	.	.	"3-(4-Oxo-3,4-dihydroquinazolin-2-yl)propanoic acid"	Investigative	.	.	.	.	.
PDC_00464	"GDGVP - 3,4-Dihydro-4-oxo-2-quinazolinebutanoic acid conjugate 6"	PEP00193	GFGVP	REC99999	Undisclosed	LIN00087	Amide bond	DRG00399	.	.	"3-(4-Oxo-3,4-dihydroquinazolin-2-yl)propanoic acid"	Investigative	.	.	.	.	.
PDC_00465	"GYGVP - 3,4-Dihydro-4-oxo-2-quinazolinebutanoic acid conjugate 2"	PEP00194	GYGVP	REC99999	Undisclosed	LIN00087	Amide bond	DRG00399	.	.	"3-(4-Oxo-3,4-dihydroquinazolin-2-yl)propanoic acid"	Investigative	.	.	.	.	.
PDC_00466	"GWGVP - 3,4-Dihydro-4-oxo-2-quinazolinebutanoic acid conjugate 2"	PEP00195	GWGVP	REC99999	Undisclosed	LIN00087	Amide bond	DRG00399	.	.	"3-(4-Oxo-3,4-dihydroquinazolin-2-yl)propanoic acid"	Investigative	.	.	.	.	.
PDC_00467	"GTGVP - 3,4-Dihydro-4-oxo-2-quinazolinebutanoic acid conjugate 3"	PEP00191	GTGVP	REC99999	Undisclosed	LIN00087	Amide bond	DRG00223	.	.	"3,4-Dihydro-4-oxo-2-quinazolinebutanoic acid"	Investigative	.	.	.	.	.
PDC_00468	"GDGVP - 3,4-Dihydro-4-oxo-2-quinazolinebutanoic acid conjugate 3"	PEP00192	GDGVP	REC99999	Undisclosed	LIN00087	Amide bond	DRG00223	.	.	"3,4-Dihydro-4-oxo-2-quinazolinebutanoic acid"	Investigative	.	.	.	.	.
PDC_00469	"GDGVP - 3,4-Dihydro-4-oxo-2-quinazolinebutanoic acid conjugate 7"	PEP00193	GFGVP	REC99999	Undisclosed	LIN00087	Amide bond	DRG00223	.	.	"3,4-Dihydro-4-oxo-2-quinazolinebutanoic acid"	Investigative	.	.	.	.	.
PDC_00470	"GYGVP - 3,4-Dihydro-4-oxo-2-quinazolinebutanoic acid conjugate 3"	PEP00194	GYGVP	REC99999	Undisclosed	LIN00087	Amide bond	DRG00223	.	.	"3,4-Dihydro-4-oxo-2-quinazolinebutanoic acid"	Investigative	.	.	.	.	.
PDC_00471	"GWGVP - 3,4-Dihydro-4-oxo-2-quinazolinebutanoic acid conjugate 3"	PEP00195	GWGVP	REC99999	Undisclosed	LIN00087	Amide bond	DRG00223	.	.	"3,4-Dihydro-4-oxo-2-quinazolinebutanoic acid"	Investigative	.	.	.	.	.
PDC_00472	"GTGVP - 3,4-Dihydro-4-oxo-2-quinazolinebutanoic acid conjugate 4"	PEP00191	GTGVP	REC99999	Undisclosed	LIN00087	Amide bond	DRG00399	.	.	"3-(4-Oxo-3,4-dihydroquinazolin-2-yl)propanoic acid"	Investigative	.	.	.	.	.
PDC_00473	"GDGVP - 3,4-Dihydro-4-oxo-2-quinazolinebutanoic acid conjugate 4"	PEP00192	GDGVP	REC99999	Undisclosed	LIN00087	Amide bond	DRG00399	.	.	"3-(4-Oxo-3,4-dihydroquinazolin-2-yl)propanoic acid"	Investigative	.	.	.	.	.
PDC_00474	"GDGVP - 3,4-Dihydro-4-oxo-2-quinazolinebutanoic acid conjugate 8"	PEP00193	GFGVP	REC99999	Undisclosed	LIN00087	Amide bond	DRG00399	.	.	"3-(4-Oxo-3,4-dihydroquinazolin-2-yl)propanoic acid"	Investigative	.	.	.	.	.
PDC_00475	"GYGVP - 3,4-Dihydro-4-oxo-2-quinazolinebutanoic acid conjugate 4"	PEP00194	GYGVP	REC99999	Undisclosed	LIN00087	Amide bond	DRG00399	.	.	"3-(4-Oxo-3,4-dihydroquinazolin-2-yl)propanoic acid"	Investigative	.	.	.	.	.
PDC_00476	"GWGVP - 3,4-Dihydro-4-oxo-2-quinazolinebutanoic acid conjugate 4"	PEP00195	GWGVP	REC99999	Undisclosed	LIN00087	Amide bond	DRG00399	.	.	"3-(4-Oxo-3,4-dihydroquinazolin-2-yl)propanoic acid"	Investigative	.	.	.	.	.
PDC_00477	GFLGTKPPR - N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide conjugate	PEP00196	GFLGTKPPR	REC99999	Undisclosed	LIN00019	Aminooxyacetic acid	DRG00189	.	.	N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide	Investigative	.	.	.	.	.
PDC_00478	TKPPR - N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide conjugate	PEP00197	TKPPR	REC99999	Undisclosed	LIN00019	Aminooxyacetic acid	DRG00189	.	.	N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide	Investigative	.	.	.	.	.
PDC_00479	GFLGTKPR - N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide conjugate	PEP00198	GFLGTKPR	REC99999	Undisclosed	LIN00019	Aminooxyacetic acid	DRG00189	.	.	N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide	Investigative	.	.	.	.	.
PDC_00480	TKPR - N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide conjugate	PEP00178	TKPR	REC99999	Undisclosed	LIN00019	Aminooxyacetic acid	DRG00189	.	.	N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide	Investigative	.	.	.	.	.
PDC_00481	GFLGTKPKG - N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide conjugate 1	PEP00199	GFLGTKPKG	REC99999	Undisclosed	LIN00019	Aminooxyacetic acid	DRG00189	.	.	N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide	Investigative	.	.	.	.	.
PDC_00482	TKPKG - N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide conjugate 1	PEP00200	TKPKG	REC99999	Undisclosed	LIN00019	Aminooxyacetic acid	DRG00189	.	.	N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide	Investigative	.	.	.	.	.
PDC_00483	TKPKG - N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide conjugate 2	PEP00200	TKPKG	REC99999	Undisclosed	LIN00019	Aminooxyacetic acid	DRG00189	.	.	N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide	Investigative	.	.	.	.	.
PDC_00484	TKPKG - N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide conjugate 3	PEP00200	TKPKG	REC99999	Undisclosed	LIN00019	Aminooxyacetic acid	DRG00189	.	.	N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide	Investigative	.	.	.	.	.
PDC_00485	GFLGTKPKG - N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide conjugate	PEP00199	GFLGTKPKG	REC99999	Undisclosed	LIN00019	Aminooxyacetic acid	DRG00189	.	.	N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide	Investigative	.	.	.	.	.
PDC_00486	TKPKG - N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide conjugate 4	PEP00200	TKPKG	REC99999	Undisclosed	LIN00019	Aminooxyacetic acid	DRG00189	.	.	N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide	Investigative	.	.	.	.	.
PDC_00487	TKPRTKPKGTKPKG - N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide conjugate	PEP00201	TKPRTKPKGTKPKG	REC99999	Undisclosed	LIN00019	Aminooxyacetic acid	DRG00189	.	.	N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide	Investigative	.	.	.	.	.
PDC_00488	TKPKGTKPKG - N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide conjugate	PEP00202	TKPKGTKPKG	REC99999	Undisclosed	LIN00019	Aminooxyacetic acid	DRG00189	.	.	N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide	Investigative	.	.	.	.	.
PDC_00489	TKPKGTKPKGTKPKGTKPKG - N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide conjugate 1	PEP00203	TKPKGTKPKGTKPKGTKPKG	REC99999	Undisclosed	LIN00019	Aminooxyacetic acid	DRG00189	.	.	N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide	Investigative	.	.	.	.	.
PDC_00490	TKPKGTKPKGTKPKGTKPKG - N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide conjugate 2	PEP00203	TKPKGTKPKGTKPKGTKPKG	REC99999	Undisclosed	LIN00019	Aminooxyacetic acid	DRG00189	.	.	N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide	Investigative	.	.	.	.	.
PDC_00491	TKPKGTKPKGTKPKGTKPKG - N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide conjugate 3	PEP00203	TKPKGTKPKGTKPKGTKPKG	REC99999	Undisclosed	LIN00019	Aminooxyacetic acid	DRG00189	.	.	N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide	Investigative	.	.	.	.	.
PDC_00492	TKPKGTKPKGTKPKGTKPKG - N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide conjugate 4	PEP00203	TKPKGTKPKGTKPKGTKPKG	REC99999	Undisclosed	LIN00019	Aminooxyacetic acid	DRG00400	.	.	N-(4-acetylphenyl)-5-chloro-2-hydroxybenzamide	Investigative	.	.	.	.	.
PDC_00493	TKPKGTKPKGTKPKGTKPKG - N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide conjugate 5	PEP00203	TKPKGTKPKGTKPKGTKPKG	REC99999	Undisclosed	LIN00019	Aminooxyacetic acid	DRG00189	.	.	N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide	Investigative	.	.	.	.	.
PDC_00494	TKPKGTKPKGTKPKGTKPKG - N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide conjugate 6	PEP00203	TKPKGTKPKGTKPKGTKPKG	REC99999	Undisclosed	LIN00019	Aminooxyacetic acid	DRG00189	.	.	N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide	Investigative	.	.	.	.	.
PDC_00495	GFLGTKPKGTKPKGTKPKGTKPKG - N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide conjugate	PEP00204	GFLGTKPKGTKPKGTKPKGTKPKG	REC99999	Undisclosed	LIN00019	Aminooxyacetic acid	DRG00189	.	.	N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide	Investigative	.	.	.	.	.
PDC_00496	TKPKGTKPKGTKPKGTKPKG - N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide conjugate 7	PEP00203	TKPKGTKPKGTKPKGTKPKG	REC99999	Undisclosed	LIN00019	Aminooxyacetic acid	DRG00401	.	.	5-formyl-2-hydroxy-N-[4-(trifluoromethyl)phenyl]benzamide	Investigative	.	.	.	.	.
PDC_00497	TKPKGTKPKGTKPKGTKPKG - N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide conjugate 8	PEP00203	TKPKGTKPKGTKPKGTKPKG	REC99999	Undisclosed	LIN00019	Aminooxyacetic acid	DRG00189	.	.	N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide	Investigative	.	.	.	.	.
PDC_00498	TKPKGTKPKGTKPKGTKPKG - N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide conjugate 9	PEP00203	TKPKGTKPKGTKPKGTKPKG	REC99999	Undisclosed	LIN00019	Aminooxyacetic acid	DRG00400	.	.	N-(4-acetylphenyl)-5-chloro-2-hydroxybenzamide	Investigative	.	.	.	.	.
PDC_00499	FRARXRARXRAR - Nalidixic acid conjugate	PEP00205	FRARXRARXRAR	REC00063	DNA gyrase subunit B (gyrB)	LIN00087	Amide bond	DRG00300	.	.	Nalidixic Acid	Investigative	.	.	.	.	.
PDC_00500	RXRXRX - Nalidixic acid conjugate	PEP00206	RXRXRX	REC00063	DNA gyrase subunit B (gyrB)	LIN00087	Amide bond	DRG00300	.	.	Nalidixic Acid	Investigative	.	.	.	.	.
PDC_00501	XRXRXRX - Nalidixic acid conjugate	PEP00207	XRXRXRX	REC00063	DNA gyrase subunit B (gyrB)	LIN00087	Amide bond	DRG00300	.	.	Nalidixic Acid	Investigative	.	.	.	.	.
PDC_00502	RXRX - Nalidixic acid conjugate	PEP00208	RXRX	REC00063	DNA gyrase subunit B (gyrB)	LIN00087	Amide bond	DRG00300	.	.	Nalidixic Acid	Investigative	.	.	.	.	.
PDC_00503	XRRR - Nalidixic acid conjugate	PEP00209	XRRR	REC00063	DNA gyrase subunit B (gyrB)	LIN00087	Amide bond	DRG00300	.	.	Nalidixic Acid	Investigative	.	.	.	.	.
PDC_00504	"XGLRKRLRKFRNKIKEK - 1,4,7-Triazacyclononane-1-glutaric acid-4,7-acetic acid conjugate 2"	PEP00210	XGLRKRLRKFRNKIKEK	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00205	.	.	"1,4,7-Triazacyclononane-1-glutaric acid-4,7-acetic acid"	Investigative	.	.	.	.	.
PDC_00505	"XGLRKRLRKFRNKIKEK - 1,4,7-Triazacyclononane-1-glutaric acid-4,7-acetic acid conjugate 1"	PEP00210	XGLRKRLRKFRNKIKEK	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00205	.	.	"1,4,7-Triazacyclononane-1-glutaric acid-4,7-acetic acid"	Investigative	.	.	.	.	.
PDC_00506	XGLRKRLRKFRNKIKEK - 2-Nitro-1H-imidazole-1-acetic acid conjugate 2	PEP00210	XGLRKRLRKFRNKIKEK	REC99999	Undisclosed	LIN00130	Propanamide	DRG00123	.	.	2-Nitro-1H-imidazole-1-acetic acid	Investigative	.	.	.	.	.
PDC_00507	XGLRKRLRKFRNKIKEK - 2-Nitro-1H-imidazole-1-acetic acid conjugate 1	PEP00210	XGLRKRLRKFRNKIKEK	REC99999	Undisclosed	LIN00130	Propanamide	DRG00123	.	.	2-Nitro-1H-imidazole-1-acetic acid	Investigative	.	.	.	.	.
PDC_00508	Amyloid disrupting peptide - &Alpha;-Cyano-4-hydroxycinnamic acid conjugate 1	PEP00423	Amyloid disrupting peptide	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00071	.	.	&Alpha;-Cyano-4-hydroxycinnamic acid	Investigative	.	.	.	.	.
PDC_00509	Amyloid disrupting peptide - &Alpha;-Cyano-4-hydroxycinnamic acid conjugate 2	PEP00423	Amyloid disrupting peptide	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00071	.	.	&Alpha;-Cyano-4-hydroxycinnamic acid	Investigative	.	.	.	.	.
PDC_00510	Amyloid disrupting peptide - Sulfosalicylic acid conjugate	PEP00423	Amyloid disrupting peptide	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00088	.	.	Sulfosalicylic acid	Investigative	.	.	.	.	.
PDC_00511	Amyloid disrupting peptide - Mellitic acid conjugate	PEP00423	Amyloid disrupting peptide	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00072	.	.	Mellitic acid	Investigative	.	.	.	.	.
PDC_00512	Amyloid disrupting peptide - Pyromellitic acid conjugate	PEP00423	Amyloid disrupting peptide	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00086	.	.	Pyromellitic acid	Investigative	.	.	.	.	.
PDC_00514	"Amyloid disrupting peptide - 4-(Chlorocarbonyl)-1,2-benzenedicarboxylic acid conjugate"	PEP00423	Amyloid disrupting peptide	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00182	.	.	"4-(Chlorocarbonyl)-1,2-benzenedicarboxylic acid"	Investigative	.	.	.	.	.
PDC_00515	"Amyloid disrupting peptide - 1,3,5-Benzenetricarboxylic acid conjugate"	PEP00423	Amyloid disrupting peptide	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00095	TAR10048	Hemoglobin (HB)	"1,3,5-Benzenetricarboxylic acid"	Investigative	.	.	.	.	.
PDC_00516	Amyloid disrupting peptide - Terephthalic acid conjugate	PEP00423	Amyloid disrupting peptide	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00091	.	.	Terephthalic acid	Investigative	.	.	.	.	.
PDC_00518	"Autoinducing peptide (AIP) 1 - (T-4)-[2-[4-azido-1-(4-iodo-3,5-dimethyl-2H-pyrrol-2-ylidene-&kappa;N)butyl]-4-iodo-3,5-dimethyl-1H-pyrrolato-&kappa;N]difluoro-boron conjugate"	PEP00446	Autoinducing peptide (AIP) 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00327	.	.	"(T-4)-[2-[4-azido-1-(4-iodo-3,5-dimethyl-2H-pyrrol-2-ylidene-&kappa;N)butyl]-4-iodo-3,5-dimethyl-1H-pyrrolato-&kappa;N]difluoro-boron"	Investigative	.	.	.	.	.
PDC_00519	Autoinducing peptide (AIP) 1 - 4-Pentynoic acid conjugate 1	PEP00446	Autoinducing peptide (AIP) 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00289	.	.	4-Pentynoic acid	Investigative	.	.	.	.	.
PDC_00520	Autoinducing peptide (AIP) 1 - 4-Pentynoic acid conjugate 2	PEP00446	Autoinducing peptide (AIP) 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00289	.	.	4-Pentynoic acid	Investigative	.	.	.	.	.
PDC_00521	Autoinducing peptide (AIP) 1 - 4-Pentynoic acid conjugate 3	PEP00446	Autoinducing peptide (AIP) 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00289	.	.	4-Pentynoic acid	Investigative	.	.	.	.	.
PDC_00522	Autoinducing peptide (AIP) 1 - 4-Pentynoic acid conjugate 4	PEP00446	Autoinducing peptide (AIP) 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00289	.	.	4-Pentynoic acid	Investigative	.	.	.	.	.
PDC_00523	Autoinducing peptide (AIP) 2 - 4-Pentynoic acid conjugate	PEP00447	Autoinducing peptide (AIP) 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00289	.	.	4-Pentynoic acid	Investigative	.	.	.	.	.
PDC_00524	"Autoinducing peptide (AIP) 2 - (T-4)-[2-[4-azido-1-(4-iodo-3,5-dimethyl-2H-pyrrol-2-ylidene-&kappa;N)butyl]-4-iodo-3,5-dimethyl-1H-pyrrolato-&kappa;N]difluoro-boron conjugate"	PEP00447	Autoinducing peptide (AIP) 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00327	.	.	"(T-4)-[2-[4-azido-1-(4-iodo-3,5-dimethyl-2H-pyrrol-2-ylidene-&kappa;N)butyl]-4-iodo-3,5-dimethyl-1H-pyrrolato-&kappa;N]difluoro-boron"	Investigative	.	.	.	.	.
PDC_00525	"Autoinducing peptide (AIP) 3 - (T-4)-[2-[4-azido-1-(4-iodo-3,5-dimethyl-2H-pyrrol-2-ylidene-&kappa;N)butyl]-4-iodo-3,5-dimethyl-1H-pyrrolato-&kappa;N]difluoro-boron conjugate 1"	PEP00448	Autoinducing peptide (AIP) 3	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00327	.	.	"(T-4)-[2-[4-azido-1-(4-iodo-3,5-dimethyl-2H-pyrrol-2-ylidene-&kappa;N)butyl]-4-iodo-3,5-dimethyl-1H-pyrrolato-&kappa;N]difluoro-boron"	Investigative	.	.	.	.	.
PDC_00526	Autoinducing peptide (AIP) 1 - Fluorescent xanthylium dye conjugate	PEP00446	Autoinducing peptide (AIP) 1	REC99999	Undisclosed	LIN00126	PEG	DRG00190	.	.	Fluorescent xanthylium dye	Investigative	.	.	.	.	.
PDC_00527	Autoinducing peptide (AIP) 2 - Fluorescent xanthylium dye conjugate	PEP00447	Autoinducing peptide (AIP) 2	REC99999	Undisclosed	LIN00126	PEG	DRG00190	.	.	Fluorescent xanthylium dye	Investigative	.	.	.	.	.
PDC_00528	Autoinducing peptide (AIP) 3 - Fluorescent xanthylium dye conjugate	PEP00448	Autoinducing peptide (AIP) 3	REC99999	Undisclosed	LIN00126	PEG	DRG00190	.	.	Fluorescent xanthylium dye	Investigative	.	.	.	.	.
PDC_00529	"Autoinducing peptide (AIP) 3 - (T-4)-[2-[4-azido-1-(4-iodo-3,5-dimethyl-2H-pyrrol-2-ylidene-&kappa;N)butyl]-4-iodo-3,5-dimethyl-1H-pyrrolato-&kappa;N]difluoro-boron conjugate 2"	PEP00448	Autoinducing peptide (AIP) 3	REC99999	Undisclosed	LIN00126	PEG	DRG00327	.	.	"(T-4)-[2-[4-azido-1-(4-iodo-3,5-dimethyl-2H-pyrrol-2-ylidene-&kappa;N)butyl]-4-iodo-3,5-dimethyl-1H-pyrrolato-&kappa;N]difluoro-boron"	Investigative	.	.	.	.	.
PDC_00530	[C(WR)4K2(b-A)] - Doxorubicin & Curcumine conjugate	PEP00410	[C(WR)4K2(b-A)]	REC99999	Undisclosed	LIN00130	Propanamide	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00531	[C(WR)4K2(b-A)] - Doxorubicin conjugate	PEP00410	[C(WR)4K2(b-A)]	REC99999	Undisclosed	LIN00130	Propanamide	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00532	Antimicrobial peptides (AMP) 1 - Tobramycin conjugate	PEP00441	Antimicrobial peptides (AMP) 1	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00104	TAR10046	Bacterial 30S ribosomal RNA (Bact 30S rRNA)	Tobramycin	Investigative	.	.	.	.	.
PDC_00533	Antimicrobial peptides (AMP) 2 - Tobramycin conjugate	PEP00442	Antimicrobial peptides (AMP) 2	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00104	TAR10046	Bacterial 30S ribosomal RNA (Bact 30S rRNA)	Tobramycin	Investigative	.	.	.	.	.
PDC_00534	Antimicrobial peptides (AMP) 3 - Tobramycin conjugate	PEP00443	Antimicrobial peptides (AMP) 3	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00104	TAR10046	Bacterial 30S ribosomal RNA (Bact 30S rRNA)	Tobramycin	Investigative	.	.	.	.	.
PDC_00535	Antimicrobial peptides (AMP) 4 - Tobramycin conjugate	PEP00444	Antimicrobial peptides (AMP) 4	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00104	TAR10046	Bacterial 30S ribosomal RNA (Bact 30S rRNA)	Tobramycin	Investigative	.	.	.	.	.
PDC_00536	Antimicrobial peptides (AMP) 5 - Tobramycin conjugate	PEP00441	Antimicrobial peptides (AMP) 1	REC99999	Undisclosed	LIN00152	"2-Amino-3-(1H-1,2,3-triazol-4-yl)propanoic acid"	DRG00104	TAR10046	Bacterial 30S ribosomal RNA (Bact 30S rRNA)	Tobramycin	Investigative	.	.	.	.	.
PDC_00537	XFXGX - Aminosteroid conjugate 1	PEP00211	XFXGX	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00105	.	.	Aminosteroid	Investigative	.	.	.	.	.
PDC_00538	XFXGX - Aminosteroid conjugate 2	PEP00211	XFXGX	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00105	.	.	Aminosteroid	Investigative	.	.	.	.	.
PDC_00539	XFXGX - Aminosteroid conjugate 3	PEP00211	XFXGX	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00105	.	.	Aminosteroid	Investigative	.	.	.	.	.
PDC_00540	XFXGX - Aminosteroid conjugate 4	PEP00211	XFXGX	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00105	.	.	Aminosteroid	Investigative	.	.	.	.	.
PDC_00541	XFXGX - Aminosteroid conjugate 5	PEP00211	XFXGX	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00105	.	.	Aminosteroid	Investigative	.	.	.	.	.
PDC_00542	Poliargine (R8) 1 - Methotrexate conjugate	PEP00750	Poliargine (R8) 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_00543	Penetratine 1 - Methotrexate conjugate	PEP00721	Penetratine 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_00544	Poliargine (R8) 2 - Methotrexate conjugate	PEP00751	Poliargine (R8) 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_00545	Penetratine 2 - Methotrexate conjugate	PEP00722	Penetratine 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_00546	Poliargine (R8) 3 - Methotrexate conjugate	PEP00752	Poliargine (R8) 3	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_00547	Penetratine 3 - Methotrexate conjugate	PEP00723	Penetratine 3	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_00548	Poliargine (R8) 4 - Methotrexate conjugate	PEP00753	Poliargine (R8) 4	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_00549	Amyloid-beta C-terminal motif 1 - Trolox conjugate	PEP00424	Amyloid-beta C-terminal motif 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00299	.	.	Trolox	Investigative	.	.	.	.	.
PDC_00550	Amyloid-beta C-terminal motif 2 - Trolox conjugate	PEP00425	Amyloid-beta C-terminal motif 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00299	.	.	Trolox	Investigative	.	.	.	.	.
PDC_00551	Amyloid-beta C-terminal motif 3 - Trolox conjugate	PEP00426	Amyloid-beta C-terminal motif 3	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00299	.	.	Trolox	Investigative	.	.	.	.	.
PDC_00552	Amyloid-beta C-terminal motif 4 - Trolox conjugate	PEP00427	Amyloid-beta C-terminal motif 4	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00299	.	.	Trolox	Investigative	.	.	.	.	.
PDC_00553	Amyloid-beta C-terminal motif 5 - Trolox conjugate	PEP00428	Amyloid-beta C-terminal motif 5	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00299	.	.	Trolox	Investigative	.	.	.	.	.
PDC_00554	Amyloid-beta C-terminal motif 6 - Trolox conjugate	PEP00429	Amyloid-beta C-terminal motif 6	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00299	.	.	Trolox	Investigative	.	.	.	.	.
PDC_00555	Amyloid-beta C-terminal motif 7 - Trolox conjugate	PEP00430	Amyloid-beta C-terminal motif 7	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00299	.	.	Trolox	Investigative	.	.	.	.	.
PDC_00556	Amyloid-beta C-terminal motif 8 - Trolox conjugate	PEP00431	Amyloid-beta C-terminal motif 8	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00299	.	.	Trolox	Investigative	.	.	.	.	.
PDC_00557	Amyloid-beta C-terminal motif 9 - Trolox conjugate	PEP00432	Amyloid-beta C-terminal motif 9	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00299	.	.	Trolox	Investigative	.	.	.	.	.
PDC_00558	Amyloid-beta C-terminal motif 10 - Trolox conjugate	PEP00433	Amyloid-beta C-terminal motif 10	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00299	.	.	Trolox	Investigative	.	.	.	.	.
PDC_00559	Amyloid-beta C-terminal motif 11 - Trolox conjugate	PEP00434	Amyloid-beta C-terminal motif 11	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00299	.	.	Trolox	Investigative	.	.	.	.	.
PDC_00560	"Cell-penetrating peptide BP16 - (2S,2S)-1,1-bis(pyrid-2-ylmethyl)-2,2-bipyrrolidine ((S,S)-BPBP) conjugate"	PEP00478	Cell-penetrating peptide BP16	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00245	.	.	"(2S,2S)-1,1-bis(pyrid-2-ylmethyl)-2,2-bipyrrolidine ((S,S)-BPBP)"	Investigative	.	.	.	.	.
PDC_00561	"Cell-penetrating peptide BP17 - (2S,2S)-1,1-bis(pyrid-2-ylmethyl)-2,2-bipyrrolidine ((S,S)-BPBP) conjugate"	PEP00479	Cell-penetrating peptide BP17	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00245	.	.	"(2S,2S)-1,1-bis(pyrid-2-ylmethyl)-2,2-bipyrrolidine ((S,S)-BPBP)"	Investigative	.	.	.	.	.
PDC_00562	"Cell-penetrating peptide BP18 - (2S,2S)-1,1-bis(pyrid-2-ylmethyl)-2,2-bipyrrolidine ((S,S)-BPBP) conjugate"	PEP00480	Cell-penetrating peptide BP18	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00245	.	.	"(2S,2S)-1,1-bis(pyrid-2-ylmethyl)-2,2-bipyrrolidine ((S,S)-BPBP)"	Investigative	.	.	.	.	.
PDC_00563	"Cell-penetrating peptide BP19 - (2S,2S)-1,1-bis(pyrid-2-ylmethyl)-2,2-bipyrrolidine ((S,S)-BPBP) conjugate"	PEP00481	Cell-penetrating peptide BP19	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00245	.	.	"(2S,2S)-1,1-bis(pyrid-2-ylmethyl)-2,2-bipyrrolidine ((S,S)-BPBP)"	Investigative	.	.	.	.	.
PDC_00564	"Cell-penetrating peptide BP20 - (2S,2S)-1,1-bis(pyrid-2-ylmethyl)-2,2-bipyrrolidine ((S,S)-BPBP) conjugate"	PEP00482	Cell-penetrating peptide BP20	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00245	.	.	"(2S,2S)-1,1-bis(pyrid-2-ylmethyl)-2,2-bipyrrolidine ((S,S)-BPBP)"	Investigative	.	.	.	.	.
PDC_00565	"Cell-penetrating peptide BP21 - 1,4-dimethyl-7-(2-pyridylmethyl)-1,4,7-triazacyclononane (Me2PyTACN) conjugate"	PEP00483	Cell-penetrating peptide BP21	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00246	.	.	"1,4-dimethyl-7-(2-pyridylmethyl)-1,4,7-triazacyclononane (Me2PyTACN)"	Investigative	.	.	.	.	.
PDC_00566	"Cell-penetrating peptide BP22 - (2S,2S)-1,1-bis(pyrid-2-ylmethyl)-2,2-bipyrrolidine ((S,S)-BPBP) conjugate"	PEP00484	Cell-penetrating peptide BP22	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00245	.	.	"(2S,2S)-1,1-bis(pyrid-2-ylmethyl)-2,2-bipyrrolidine ((S,S)-BPBP)"	Investigative	.	.	.	.	.
PDC_00567	"Cell-penetrating peptide BP23 - (2S,2S)-1,1-bis(pyrid-2-ylmethyl)-2,2-bipyrrolidine ((S,S)-BPBP) conjugate"	PEP00485	Cell-penetrating peptide BP23	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00245	.	.	"(2S,2S)-1,1-bis(pyrid-2-ylmethyl)-2,2-bipyrrolidine ((S,S)-BPBP)"	Investigative	.	.	.	.	.
PDC_00568	"Cell-penetrating peptide BP24 - 1,4-dimethyl-7-(2-pyridylmethyl)-1,4,7-triazacyclononane (Me2PyTACN) conjugate"	PEP00486	Cell-penetrating peptide BP24	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00246	.	.	"1,4-dimethyl-7-(2-pyridylmethyl)-1,4,7-triazacyclononane (Me2PyTACN)"	Investigative	.	.	.	.	.
PDC_00569	"Cell-penetrating peptide BP25 - 1,4-dimethyl-7-(2-pyridylmethyl)-1,4,7-triazacyclononane (Me2PyTACN) conjugate"	PEP00487	Cell-penetrating peptide BP25	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00246	.	.	"1,4-dimethyl-7-(2-pyridylmethyl)-1,4,7-triazacyclononane (Me2PyTACN)"	Investigative	.	.	.	.	.
PDC_00570	GXXXXXXXXXXXXX - Fluorescein conjugate	PEP00212	GXXXXXXXXXXXXX	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00285	.	.	Fluorescein	Investigative	.	.	.	.	.
PDC_00571	GXXXXXXXXXXXXX - Kanamycin A conjugate	PEP00212	GXXXXXXXXXXXXX	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00080	TAR10047	Staphylococcus 30S ribosomal subunit (Stap-coc pbp2)	Kanamycin A	Investigative	.	.	.	.	.
PDC_00572	T2635-truncated peptide (HIV-1 fusion inhibitor) 1 - N-carboxyphenylpyrrole compound Gls-22 conjugate	PEP00770	T2635-truncated peptide (HIV-1 fusion inhibitor) 1	REC99999	Undisclosed	LIN00127	Triazole	DRG00247	.	.	N-carboxyphenylpyrrole compound Gls-22	Investigative	.	.	.	.	.
PDC_00573	T2635-truncated peptide (HIV-1 fusion inhibitor) 1 - Indole compound 6j conjugate	PEP00770	T2635-truncated peptide (HIV-1 fusion inhibitor) 1	REC99999	Undisclosed	LIN00127	Triazole	DRG00212	.	.	Indole compound 6j	Investigative	.	.	.	.	.
PDC_00574	T2635-truncated peptide (HIV-1 fusion inhibitor) 2 - N-carboxyphenylpyrrole compound Gls-22 conjugate	PEP00771	T2635-truncated peptide (HIV-1 fusion inhibitor) 2	REC99999	Undisclosed	LIN00127	Triazole	DRG00247	.	.	N-carboxyphenylpyrrole compound Gls-22	Investigative	.	.	.	.	.
PDC_00575	T2635-truncated peptide (HIV-1 fusion inhibitor) 2 - Indole compound 6j conjugate	PEP00771	T2635-truncated peptide (HIV-1 fusion inhibitor) 2	REC99999	Undisclosed	LIN00127	Triazole	DRG00212	.	.	Indole compound 6j	Investigative	.	.	.	.	.
PDC_00576	T2635-truncated peptide (HIV-1 fusion inhibitor) 3 - N-carboxyphenylpyrrole compound Gls-22 conjugate	PEP00772	T2635-truncated peptide (HIV-1 fusion inhibitor) 3	REC99999	Undisclosed	LIN00127	Triazole	DRG00247	.	.	N-carboxyphenylpyrrole compound Gls-22	Investigative	.	.	.	.	.
PDC_00577	Cell division cycle 6 (CDC6) - Purvalanol B (PVB) conjugate	PEP00476	Cell division cycle 6 (CDC6)	REC99999	Undisclosed	LIN00131	Hexanamide	DRG00126	TAR10042	Adrenergic receptor beta-3 (ADRB3)	Purvalanol B (PVB)	Investigative	.	.	.	.	.
PDC_00578	"&Alpha;-helical peptide - 5-(4-carboxyphenyl)-10,15,20-triphenylporphyrin conjugate"	PEP01005	&Alpha;-helical peptide	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00248	.	.	"5-(4-carboxyphenyl)-10,15,20-triphenylporphyrin"	Investigative	.	.	.	.	.
PDC_00579	"GTRSSRAGLQFPVGRVHRLLRK - 5-(4-carboxyphenyl)-10,15,20-triphenylporphyrin conjugate"	PEP00213	GTRSSRAGLQFPVGRVHRLLRK	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00248	.	.	"5-(4-carboxyphenyl)-10,15,20-triphenylporphyrin"	Investigative	.	.	.	.	.
PDC_00580	"AGIGKFLHSAKKFGKAFVGEILNS - 5-(4-carboxyphenyl)-10,15,20-triphenylporphyrin conjugate"	PEP00214	AGIGKFLHSAKKFGKAFVGEILNS	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00248	.	.	"5-(4-carboxyphenyl)-10,15,20-triphenylporphyrin"	Investigative	.	.	.	.	.
PDC_00581	"AIGKFLHSAKKFGKAFVGEILNS - 5-(4-carboxyphenyl)-10,15,20-triphenylporphyrin conjugate"	PEP00215	AIGKFLHSAKKFGKAFVGEILNS	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00248	.	.	"5-(4-carboxyphenyl)-10,15,20-triphenylporphyrin"	Investigative	.	.	.	.	.
PDC_00582	"XGIGKFLHSAKKFGKAFVGEILNS - 5-(4-carboxyphenyl)-10,15,20-triphenylporphyrin conjugate"	PEP00216	XGIGKFLHSAKKFGKAFVGEILNS	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00248	.	.	"5-(4-carboxyphenyl)-10,15,20-triphenylporphyrin"	Investigative	.	.	.	.	.
PDC_00583	"GIGKFLHSAKKF - 5-(4-carboxyphenyl)-10,15,20-triphenylporphyrin conjugate"	PEP00217	GIGKFLHSAKKF	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00248	.	.	"5-(4-carboxyphenyl)-10,15,20-triphenylporphyrin"	Investigative	.	.	.	.	.
PDC_00584	"GIGKALHSAKKFGKAFVGEILNS - 5-(4-carboxyphenyl)-10,15,20-triphenylporphyrin conjugate"	PEP00218	GIGKALHSAKKFGKAFVGEILNS	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00248	.	.	"5-(4-carboxyphenyl)-10,15,20-triphenylporphyrin"	Investigative	.	.	.	.	.
PDC_00585	"AXAXAXAXAXAXAXA - 5-(4-carboxyphenyl)-10,15,20-triphenylporphyrin conjugate 1"	PEP00219	AXAXAXAXAXAXAXA	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00248	.	.	"5-(4-carboxyphenyl)-10,15,20-triphenylporphyrin"	Investigative	.	.	.	.	.
PDC_00586	"AXAXAXAXAXAXAXA - 5-(4-carboxyphenyl)-10,15,20-triphenylporphyrin conjugate 2"	PEP00219	AXAXAXAXAXAXAXA	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00248	.	.	"5-(4-carboxyphenyl)-10,15,20-triphenylporphyrin"	Investigative	.	.	.	.	.
PDC_00587	"GIGKFLHSAKKFGKAFVGEILNS - 5-(4-carboxyphenyl)-10,15,20-triphenylporphyrin conjugate"	PEP00220	GIGKFLHSAKKFGKAFVGEILNS	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00248	.	.	"5-(4-carboxyphenyl)-10,15,20-triphenylporphyrin"	Investigative	.	.	.	.	.
PDC_00588	Tetrapeptide 1 - FMOC chloride conjugate	PEP00781	Tetrapeptide 1	REC99999	Undisclosed	LIN00131	Hexanamide	DRG00272	.	.	9-Fluorenylmethyl chloroformate	Investigative	.	.	.	.	.
PDC_00589	Pentapeptide 1 - H-glutaminyl-4-aminobenzyl phosphoramide mustard conjugate 1	PEP00724	Pentapeptide 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00249	.	.	H-glutaminyl-4-aminobenzyl phosphoramide mustard	Investigative	.	.	.	.	.
PDC_00590	Pentapeptide 1 - H-glutaminyl-4-aminobenzyl phosphoramide mustard conjugate 2	PEP00724	Pentapeptide 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00249	.	.	H-glutaminyl-4-aminobenzyl phosphoramide mustard	Investigative	.	.	.	.	.
PDC_00591	Pentapeptide 1 - H-glutaminyl-4-aminobenzyl phosphoramide mustard conjugate 3	PEP00724	Pentapeptide 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00249	.	.	H-glutaminyl-4-aminobenzyl phosphoramide mustard	Investigative	.	.	.	.	.
PDC_00593	Pentapeptide 1 - H-glutaminyl-4-aminobenzyl phosphoramide mustard conjugate 4	PEP00724	Pentapeptide 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00249	.	.	H-glutaminyl-4-aminobenzyl phosphoramide mustard	Investigative	.	.	.	.	.
PDC_00594	Pentapeptide 2 - Dansylglycine conjugate 1	PEP00725	Pentapeptide 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00273	.	.	Dansylglycine	Investigative	.	.	.	.	.
PDC_00595	Pentapeptide 2 - Dansylglycine conjugate 2	PEP00725	Pentapeptide 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00273	.	.	Dansylglycine	Investigative	.	.	.	.	.
PDC_00596	Pentapeptide 2 - Dansylglycine & Fusicoccin A (FC) conjugate	PEP00725	Pentapeptide 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00273	.	.	Dansylglycine	Investigative	.	.	.	.	.
PDC_00597	Somatostatin backbone cyclic analog - Combretastatin A4 conjugate	PEP00765	Somatostatin backbone cyclic analog	REC99999	Undisclosed	LIN00132	Butyramide	DRG00164	.	.	Combretastatin A4	Investigative	.	.	.	.	.
PDC_00598	Somatostatin backbone cyclic analog - N-[2-[(4-hydroxyphenyl)amino]-3-pyridinyl]-4-methoxy-Benzenesulfonamide conjugate	PEP00765	Somatostatin backbone cyclic analog	REC99999	Undisclosed	LIN00132	Butyramide	DRG00151	TAR10054	Tubulin beta (TUBB)	N-[2-[(4-hydroxyphenyl)amino]-3-pyridinyl]-4-methoxy-Benzenesulfonamide	Investigative	.	.	.	.	.
PDC_00599	"Somatostatin backbone cyclic analog - 5-[[2-[2-(dimethylamino)ethyl]-2,3-dihydro-1,3-dioxo-1H-benz[de]isoquinolin-5-yl]amino]-5-oxo-Pentanoic acid conjugate"	PEP00765	Somatostatin backbone cyclic analog	REC99999	Undisclosed	LIN00132	Butyramide	DRG00226	.	.	"5-[[2-[2-(dimethylamino)ethyl]-2,3-dihydro-1,3-dioxo-1H-benz[de]isoquinolin-5-yl]amino]-5-oxo-Pentanoic acid"	Investigative	.	.	.	.	.
PDC_00600	Somatostatin backbone cyclic analog - Camptothecin conjugate	PEP00765	Somatostatin backbone cyclic analog	REC99999	Undisclosed	LIN00132	Butyramide	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_00601	Somatostatin backbone cyclic analog - Chlorambucil conjugate	PEP00765	Somatostatin backbone cyclic analog	REC99999	Undisclosed	LIN00132	Butyramide	DRG00002	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Chlorambucil	Investigative	.	.	.	.	.
PDC_00602	Ubiquicidin (UBI) 31-38 - Coumarintriazole derivative 6 conjugate	PEP00998	Ubiquicidin (UBI) 31-38	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00204	.	.	Coumarintriazole derivative 6	Investigative	.	.	.	.	.
PDC_00603	Tridecaptin A1 - Rifampicin conjugate 1	PEP00860	Tridecaptin A1	REC99999	Undisclosed	LIN00126	PEG	DRG00225	.	.	Rifampicin	Investigative	.	.	.	.	.
PDC_00604	Tridecaptin A1 - Rifampicin conjugate 2	PEP00860	Tridecaptin A1	REC99999	Undisclosed	LIN00126	PEG	DRG00225	.	.	Rifampicin	Investigative	.	.	.	.	.
PDC_00605	Tridecaptin A1 - Erythromycin conjugate 1	PEP00860	Tridecaptin A1	REC99999	Undisclosed	LIN00126	PEG	DRG00280	.	.	Erythromycin	Investigative	.	.	.	.	.
PDC_00606	Tridecaptin A1 - Erythromycin conjugate 2	PEP00860	Tridecaptin A1	REC99999	Undisclosed	LIN00126	PEG	DRG00280	.	.	Erythromycin	Investigative	.	.	.	.	.
PDC_00607	Tridecaptin A1 - Vancomycin conjugate 1	PEP00860	Tridecaptin A1	REC99999	Undisclosed	LIN00126	PEG	DRG00097	.	.	Vancomycin	Investigative	.	.	.	.	.
PDC_00608	Tridecaptin A1 - Vancomycin conjugate 2	PEP00860	Tridecaptin A1	REC99999	Undisclosed	LIN00126	PEG	DRG00097	.	.	Vancomycin	Investigative	.	.	.	.	.
PDC_00609	Antimicrobial peptide Cm-p5 1 - Biotin conjugate 1	PEP00437	Antimicrobial peptide Cm-p5 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00270	.	.	Biotin	Investigative	.	.	.	.	.
PDC_00610	"Pentapeptide 3 - 3-amino-(3&beta;,5&beta;)-Cholan-24-oic aci methyl ester conjugate"	PEP00726	Pentapeptide 3	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00187	.	.	"3-amino-(3&beta;,5&beta;)-Cholan-24-oic aci methyl ester"	Investigative	.	.	.	.	.
PDC_00611	"Tetrapeptide 2 - 3-amino-(3&beta;,5&beta;)-Cholan-24-oic aci methyl ester conjugate"	PEP00782	Tetrapeptide 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00187	.	.	"3-amino-(3&beta;,5&beta;)-Cholan-24-oic aci methyl ester"	Investigative	.	.	.	.	.
PDC_00612	Antimicrobial peptide Cm-p5 2 - Biotin conjugate	PEP00438	Antimicrobial peptide Cm-p5 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00270	.	.	Biotin	Investigative	.	.	.	.	.
PDC_00613	Antimicrobial peptide Cm-p5 3 - Biotin conjugate	PEP00439	Antimicrobial peptide Cm-p5 3	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00270	.	.	Biotin	Investigative	.	.	.	.	.
PDC_00614	Pentapeptide 3 - Biotin conjugate	PEP00726	Pentapeptide 3	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00270	.	.	Biotin	Investigative	.	.	.	.	.
PDC_00615	Tetrapeptide 3 - Biotin conjugate	PEP00783	Tetrapeptide 3	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00270	.	.	Biotin	Investigative	.	.	.	.	.
PDC_00616	Pentapeptide 4 - Biotin conjugate	PEP00727	Pentapeptide 4	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00270	.	.	Biotin	Investigative	.	.	.	.	.
PDC_00617	"Antimicrobial peptide Cm-p5 1 - 3-amino-(3&beta;,5&beta;)-Cholan-24-oic aci methyl ester conjugate 1"	PEP00437	Antimicrobial peptide Cm-p5 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00187	.	.	"3-amino-(3&beta;,5&beta;)-Cholan-24-oic aci methyl ester"	Investigative	.	.	.	.	.
PDC_00618	"Antimicrobial peptide Cm-p5 1 - 3-amino-(3&beta;,5&beta;)-Cholan-24-oic aci methyl ester conjugate 2"	PEP00437	Antimicrobial peptide Cm-p5 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00187	.	.	"3-amino-(3&beta;,5&beta;)-Cholan-24-oic aci methyl ester"	Investigative	.	.	.	.	.
PDC_00619	Antimicrobial peptide Cm-p5 1 - Biotin conjugate 2	PEP00437	Antimicrobial peptide Cm-p5 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00270	.	.	Biotin	Investigative	.	.	.	.	.
PDC_00620	Antimicrobial peptide Cm-p5 1 - Palmitic acid conjugate	PEP00437	Antimicrobial peptide Cm-p5 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00069	TAR10045	Fatty acid-binding protein 5 (FABP5)	Palmitic acid	Investigative	.	.	.	.	.
PDC_00621	"Antimicrobial peptide Cm-p5 1 - 3-amino-(3&beta;,5&beta;)-Cholan-24-oic aci methyl ester conjugate 3"	PEP00437	Antimicrobial peptide Cm-p5 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00187	.	.	"3-amino-(3&beta;,5&beta;)-Cholan-24-oic aci methyl ester"	Investigative	.	.	.	.	.
PDC_00622	"Antimicrobial peptide Cm-p5 4 - 3-amino-(3&beta;,5&beta;)-Cholan-24-oic aci methyl ester conjugate"	PEP00440	Antimicrobial peptide Cm-p5 4	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00187	.	.	"3-amino-(3&beta;,5&beta;)-Cholan-24-oic aci methyl ester"	Investigative	.	.	.	.	.
PDC_00623	Model major histocompatibility complex (MHC)-binding peptide antigen 1 - 6-Deoxy-6-thio-&alpha;-GalCer conjugate	PEP00634	Model major histocompatibility complex (MHC)-binding peptide antigen 1	REC99999	Undisclosed	LIN00127	Triazole	DRG00211	.	.	6-Deoxy-6-thio-&alpha;-GalCer	Investigative	.	.	.	.	.
PDC_00624	Model major histocompatibility complex (MHC)-binding peptide antigen 2 - 6-Deoxy-6-thio-&alpha;-GalCer conjugate	PEP00635	Model major histocompatibility complex (MHC)-binding peptide antigen 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00211	.	.	6-Deoxy-6-thio-&alpha;-GalCer	Investigative	.	.	.	.	.
PDC_00625	Functionalized peptide epitope 1 - N-acylbenzimidazolinone (Nbz) conjugate	PEP00562	Functionalized peptide epitope 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00110	.	.	N-acylbenzimidazolinone (Nbz)	Investigative	.	.	.	.	.
PDC_00626	Functionalized peptide epitope 2 - Pyrrole-imidazole polyamide conjugate	PEP00563	Functionalized peptide epitope 2	REC99999	Undisclosed	LIN00126	PEG	DRG00250	.	.	Pyrrole-imidazole polyamide	Investigative	.	.	.	.	.
PDC_00627	Tetrapeptide 4 - 1-octyne conjugate	PEP00784	Tetrapeptide 4	REC99999	Undisclosed	LIN00126	PEG	DRG00096	.	.	1-octyne	Investigative	.	.	.	.	.
PDC_00628	Tetrapeptide 4 - Coumarine derivative conjugate	PEP00784	Tetrapeptide 4	REC99999	Undisclosed	LIN00127	Triazole	DRG00152	.	.	Coumarine derivative	Investigative	.	.	.	.	.
PDC_00629	GFLG - Doxorubicine conjugate	PEP00041	GFLG	REC00013	Integrin alpha-V; Integrin beta-3 (ITGAV; ITGB3)	LIN00146	Undisclosed	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00630	Tetrapeptide+dipeptide - Bisarylethyne conjugate 1	PEP00855	Tetrapeptide+dipeptide	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00251	.	.	Bisarylethyne	Investigative	.	.	.	.	.
PDC_00631	Tetrapeptide+dipeptide - Bisarylethyne conjugate 2	PEP00855	Tetrapeptide+dipeptide	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00251	.	.	Bisarylethyne	Investigative	.	.	.	.	.
PDC_00632	"c(RGDfK) - 2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide conjugate"	PEP00122	c(RGDfK)	REC00013	Integrin alpha-V; Integrin beta-3 (ITGAV; ITGB3)	LIN00146	Undisclosed	DRG00174	.	.	"2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide"	Investigative	.	.	.	.	.
PDC_00633	c(RGDfK) - Ureidopyrimidinone conjugate 1	PEP00122	c(RGDfK)	REC00013	Integrin alpha-V; Integrin beta-3 (ITGAV; ITGB3)	LIN00146	Undisclosed	DRG00252	.	.	Ureidopyrimidinone	Investigative	.	.	.	.	.
PDC_00634	c(RGDfK) - Ureidopyrimidinone conjugate 2	PEP00122	c(RGDfK)	REC00013	Integrin alpha-V; Integrin beta-3 (ITGAV; ITGB3)	LIN00146	Undisclosed	DRG00252	.	.	Ureidopyrimidinone	Investigative	.	.	.	.	.
PDC_00635	Heptapeptide 1 - Ureidopyrimidinone conjugate 3	PEP00580	Hexapeptide 1	REC99999	Undisclosed	LIN00126	PEG	DRG00252	.	.	Ureidopyrimidinone	Investigative	.	.	.	.	.
PDC_00636	Hexapeptide 2 - Ureidopyrimidinone conjugate 1	PEP00581	Hexapeptide 2	REC99999	Undisclosed	LIN00126	PEG	DRG00252	.	.	Ureidopyrimidinone	Investigative	.	.	.	.	.
PDC_00637	c(RGDfK) - Ureidopyrimidinone conjugate 3	PEP00122	c(RGDfK)	REC00013	Integrin alpha-V; Integrin beta-3 (ITGAV; ITGB3)	LIN00126	PEG	DRG00252	.	.	Ureidopyrimidinone	Investigative	.	.	.	.	.
PDC_00638	Hexapeptide 2 - Ureidopyrimidinone conjugate 2	PEP00581	Hexapeptide 2	REC99999	Undisclosed	LIN00126	PEG	DRG00252	.	.	Ureidopyrimidinone	Investigative	.	.	.	.	.
PDC_00639	Octapeptide 1 - Ureidopyrimidinone conjugate 1	PEP00657	Octapeptide 1	REC99999	Undisclosed	LIN00126	PEG	DRG00252	.	.	Ureidopyrimidinone	Investigative	.	.	.	.	.
PDC_00640	Hexapeptide 2 - Ureidopyrimidinone conjugate 3	PEP00581	Hexapeptide 2	REC99999	Undisclosed	LIN00126	PEG	DRG00252	.	.	Ureidopyrimidinone	Investigative	.	.	.	.	.
PDC_00641	Heptapeptide 1 - Ureidopyrimidinone conjugate 4	PEP00580	Hexapeptide 1	REC99999	Undisclosed	LIN00126	PEG	DRG00252	.	.	Ureidopyrimidinone	Investigative	.	.	.	.	.
PDC_00642	Hexapeptide 3 - Ureidopyrimidinone conjugate	PEP00582	Hexapeptide 3	REC99999	Undisclosed	LIN00126	PEG	DRG00252	.	.	Ureidopyrimidinone	Investigative	.	.	.	.	.
PDC_00643	Heptapeptide 1 - Ureidopyrimidinone conjugate 1	PEP00578	Heptapeptide 1	REC99999	Undisclosed	LIN00126	PEG	DRG00252	.	.	Ureidopyrimidinone	Investigative	.	.	.	.	.
PDC_00644	Hexapeptide 2 - Ureidopyrimidinone conjugate 4	PEP00581	Hexapeptide 2	REC99999	Undisclosed	LIN00126	PEG	DRG00252	.	.	Ureidopyrimidinone	Investigative	.	.	.	.	.
PDC_00645	Heptapeptide 2 - Ureidopyrimidinone conjugate	PEP00579	Heptapeptide 2	REC99999	Undisclosed	LIN00126	PEG	DRG00252	.	.	Ureidopyrimidinone	Investigative	.	.	.	.	.
PDC_00646	Octapeptide 1 - Ureidopyrimidinone conjugate 2	PEP00657	Octapeptide 1	REC99999	Undisclosed	LIN00126	PEG	DRG00252	.	.	Ureidopyrimidinone	Investigative	.	.	.	.	.
PDC_00647	Hexapeptide 4 - Ureidopyrimidinone conjugate	PEP00583	Hexapeptide 4	REC99999	Undisclosed	LIN00126	PEG	DRG00252	.	.	Ureidopyrimidinone	Investigative	.	.	.	.	.
PDC_00648	Heptapeptide 1 - Ureidopyrimidinone conjugate 2	PEP00578	Heptapeptide 1	REC99999	Undisclosed	LIN00126	PEG	DRG00252	.	.	Ureidopyrimidinone	Investigative	.	.	.	.	.
PDC_00649	Hexapeptide 5 - Ureidopyrimidinone conjugate	PEP00584	Hexapeptide 5	REC99999	Undisclosed	LIN00126	PEG	DRG00252	.	.	Ureidopyrimidinone	Investigative	.	.	.	.	.
PDC_00650	Octapeptide 2 - Ureidopyrimidinone conjugate 5	PEP00658	Octapeptide 2	REC99999	Undisclosed	LIN00126	PEG	DRG00252	.	.	Ureidopyrimidinone	Investigative	.	.	.	.	.
PDC_00651	Octapeptide 1 - Ureidopyrimidinone conjugate 3	PEP00657	Octapeptide 1	REC99999	Undisclosed	LIN00126	PEG	DRG00252	.	.	Ureidopyrimidinone	Investigative	.	.	.	.	.
PDC_00652	Octapeptide 1 - Ureidopyrimidinone conjugate 4	PEP00657	Octapeptide 1	REC99999	Undisclosed	LIN00126	PEG	DRG00252	.	.	Ureidopyrimidinone	Investigative	.	.	.	.	.
PDC_00653	Octapeptide 2 - Ureidopyrimidinone conjugate 6	PEP00658	Octapeptide 2	REC99999	Undisclosed	LIN00126	PEG	DRG00252	.	.	Ureidopyrimidinone	Investigative	.	.	.	.	.
PDC_00654	c(RGDfK) - 9-Fluorenylmethyl chloroformate conjugate	PEP00122	c(RGDfK)	REC00013	Integrin alpha-V; Integrin beta-3 (ITGAV; ITGB3)	LIN00126	PEG	DRG00272	.	.	9-Fluorenylmethyl chloroformate	Investigative	.	.	.	.	.
PDC_00655	Hexapeptide 1 - 9-Fluorenylmethyl chloroformate conjugate	PEP00580	Hexapeptide 1	REC99999	Undisclosed	LIN00126	PEG	DRG00272	.	.	9-Fluorenylmethyl chloroformate	Investigative	.	.	.	.	.
PDC_00656	Hexapeptide 3 - 9-Fluorenylmethyl chloroformate conjugate	PEP00582	Hexapeptide 3	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00272	.	.	9-Fluorenylmethyl chloroformate	Investigative	.	.	.	.	.
PDC_00657	Heptapeptide 1 - 9-Fluorenylmethyl chloroformate conjugate	PEP00578	Heptapeptide 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00272	.	.	9-Fluorenylmethyl chloroformate	Investigative	.	.	.	.	.
PDC_00658	Hexapeptide 2 - 9-Fluorenylmethyl chloroformate conjugate	PEP00581	Hexapeptide 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00272	.	.	9-Fluorenylmethyl chloroformate	Investigative	.	.	.	.	.
PDC_00659	Octapeptide 3 - 9-Fluorenylmethyl chloroformate conjugate 1	PEP00659	Octapeptide 3	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00272	.	.	9-Fluorenylmethyl chloroformate	Investigative	.	.	.	.	.
PDC_00660	"Octapeptide 3 - 2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide conjugate"	PEP00659	Octapeptide 3	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00174	.	.	"2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide"	Investigative	.	.	.	.	.
PDC_00661	"Octapeptide 4 - 2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide conjugate"	PEP00660	Octapeptide 4	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00174	.	.	"2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide"	Investigative	.	.	.	.	.
PDC_00662	Octapeptide 3 - 9-Fluorenylmethyl chloroformate conjugate 2	PEP00659	Octapeptide 3	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00272	.	.	9-Fluorenylmethyl chloroformate	Investigative	.	.	.	.	.
PDC_00663	Azidopeptides 1 - Betulinic acid conjugate 1	PEP00449	Azidopeptides 1	REC99999	Undisclosed	LIN00127	Triazole	DRG00107	TAR10039	Herpes simplex virus DNA polymerase UL30 (HSV UL30)	Betulinic acid	Investigative	.	.	.	.	.
PDC_00664	Azidopeptides 1 - Betulinic acid conjugate 2	PEP00449	Azidopeptides 1	REC99999	Undisclosed	LIN00127	Triazole	DRG00107	TAR10039	Herpes simplex virus DNA polymerase UL30 (HSV UL30)	Betulinic acid	Investigative	.	.	.	.	.
PDC_00665	Azidopeptides 1 - Betulinic acid conjugate 3	PEP00449	Azidopeptides 1	REC99999	Undisclosed	LIN00127	Triazole	DRG00107	TAR10039	Herpes simplex virus DNA polymerase UL30 (HSV UL30)	Betulinic acid	Investigative	.	.	.	.	.
PDC_00666	Azidopeptides 2 - Betulinic acid conjugate	PEP00450	Azidopeptides 2	REC99999	Undisclosed	LIN00127	Triazole	DRG00107	TAR10039	Herpes simplex virus DNA polymerase UL30 (HSV UL30)	Betulinic acid	Investigative	.	.	.	.	.
PDC_00667	Azidopeptides 3 - Betulinic acid conjugate	PEP00451	Azidopeptides 3	REC99999	Undisclosed	LIN00127	Triazole	DRG00107	TAR10039	Herpes simplex virus DNA polymerase UL30 (HSV UL30)	Betulinic acid	Investigative	.	.	.	.	.
PDC_00668	Azidopeptides 4 - Betulinic acid conjugate	PEP00452	Azidopeptides 4	REC99999	Undisclosed	LIN00127	Triazole	DRG00107	TAR10039	Herpes simplex virus DNA polymerase UL30 (HSV UL30)	Betulinic acid	Investigative	.	.	.	.	.
PDC_00669	Azidopeptides 5 - Betulinic acid conjugate	PEP00453	Azidopeptides 5	REC99999	Undisclosed	LIN00127	Triazole	DRG00107	TAR10039	Herpes simplex virus DNA polymerase UL30 (HSV UL30)	Betulinic acid	Investigative	.	.	.	.	.
PDC_00670	Alkynylptides 1 - 9-Fluorenylmethyl chloroformate conjugate	PEP00420	Alkynylptides 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00272	.	.	9-Fluorenylmethyl chloroformate	Investigative	.	.	.	.	.
PDC_00671	Alkynylptides 2 - 9-Fluorenylmethyl chloroformate conjugate	PEP00421	Alkynylptides 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00272	.	.	9-Fluorenylmethyl chloroformate	Investigative	.	.	.	.	.
PDC_00672	Azidopeptides 6 - 9-Fluorenylmethyl chloroformate conjugate	PEP00454	Azidopeptides 6	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00272	.	.	9-Fluorenylmethyl chloroformate	Investigative	.	.	.	.	.
PDC_00673	Azidopeptides 7 - 9-Fluorenylmethyl chloroformate conjugate	PEP00455	Azidopeptides 7	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00272	.	.	9-Fluorenylmethyl chloroformate	Investigative	.	.	.	.	.
PDC_00674	Azidopeptides 8 - 4-Nitrobenzyl chloroformate conjugate	PEP00456	Azidopeptides 8	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00111	.	.	4-Nitrobenzyl chloroformate	Investigative	.	.	.	.	.
PDC_00675	Azidopeptides 9 - 9-Fluorenylmethyl chloroformate conjugate	PEP00457	Azidopeptides 9	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00272	.	.	9-Fluorenylmethyl chloroformate	Investigative	.	.	.	.	.
PDC_00676	Azidopeptides 10 - 9-Fluorenylmethyl chloroformate conjugate 1	PEP00458	Azidopeptides 10	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00272	.	.	9-Fluorenylmethyl chloroformate	Investigative	.	.	.	.	.
PDC_00677	Azidopeptides 10 - 9-Fluorenylmethyl chloroformate conjugate 2	PEP00458	Azidopeptides 10	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00272	.	.	9-Fluorenylmethyl chloroformate	Investigative	.	.	.	.	.
PDC_00678	Azidopeptides 11 - 9-Fluorenylmethyl chloroformate conjugate	PEP00459	Azidopeptides 11	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00272	.	.	9-Fluorenylmethyl chloroformate	Investigative	.	.	.	.	.
PDC_00679	Azidopeptides 12 - 9-Fluorenylmethyl chloroformate conjugate	PEP00460	Azidopeptides 12	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00272	.	.	9-Fluorenylmethyl chloroformate	Investigative	.	.	.	.	.
PDC_00680	Azidopeptides 13 - 9-Fluorenylmethyl chloroformate conjugate	PEP00461	Azidopeptides 13	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00272	.	.	9-Fluorenylmethyl chloroformate	Investigative	.	.	.	.	.
PDC_00681	Azidopeptides 14 - 9-Fluorenylmethyl chloroformate conjugate	PEP00462	Azidopeptides 14	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00272	.	.	9-Fluorenylmethyl chloroformate	Investigative	.	.	.	.	.
PDC_00682	Azidopeptides 15 - 9-Fluorenylmethyl chloroformate conjugate	PEP00463	Azidopeptides 15	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00272	.	.	9-Fluorenylmethyl chloroformate	Investigative	.	.	.	.	.
PDC_00683	Azidopeptides 16 - 9-Fluorenylmethyl chloroformate conjugate	PEP00464	Azidopeptides 16	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00272	.	.	9-Fluorenylmethyl chloroformate	Investigative	.	.	.	.	.
PDC_00684	Azidopeptides 17 - 9-Fluorenylmethyl chloroformate conjugate	PEP00465	Azidopeptides 17	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00272	.	.	9-Fluorenylmethyl chloroformate	Investigative	.	.	.	.	.
PDC_00685	Glutamic acid oligopeptide 1 - Ibuprofen conjugate 1	PEP00574	Glutamic acid oligopeptide 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00075	TAR10020	Prostaglandin G/H synthase 2 (PTGS2)	Ibuprofen	Investigative	.	.	.	.	.
PDC_00686	Glutamic acid oligopeptide 2 - Ibuprofen conjugate 1	PEP00575	Glutamic acid oligopeptide 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00075	TAR10020	Prostaglandin G/H synthase 2 (PTGS2)	Ibuprofen	Investigative	.	.	.	.	.
PDC_00687	Glutamic acid oligopeptide 3 - Ibuprofen conjugate 1	PEP00576	Glutamic acid oligopeptide 3	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00075	TAR10020	Prostaglandin G/H synthase 2 (PTGS2)	Ibuprofen	Investigative	.	.	.	.	.
PDC_00688	Glutamic acid oligopeptide 1 - Ibuprofen conjugate 2	PEP00574	Glutamic acid oligopeptide 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00075	TAR10020	Prostaglandin G/H synthase 2 (PTGS2)	Ibuprofen	Investigative	.	.	.	.	.
PDC_00689	Glutamic acid oligopeptide 2 - Ibuprofen conjugate 2	PEP00575	Glutamic acid oligopeptide 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00075	TAR10020	Prostaglandin G/H synthase 2 (PTGS2)	Ibuprofen	Investigative	.	.	.	.	.
PDC_00690	Glutamic acid oligopeptide 3 - Ibuprofen conjugate 2	PEP00576	Glutamic acid oligopeptide 3	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00075	TAR10020	Prostaglandin G/H synthase 2 (PTGS2)	Ibuprofen	Investigative	.	.	.	.	.
PDC_00691	Glutamic acid oligopeptide 1 - Ibuprofen conjugate 3	PEP00574	Glutamic acid oligopeptide 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00121	TAR10032	Prostaglandin G/H synthase 1 (COX-1)	Naproxen	Investigative	.	.	.	.	.
PDC_00692	Glutamic acid oligopeptide 2 - Ibuprofen conjugate 3	PEP00575	Glutamic acid oligopeptide 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00121	TAR10032	Prostaglandin G/H synthase 1 (COX-1)	Naproxen	Investigative	.	.	.	.	.
PDC_00693	Glutamic acid oligopeptide 3 - Ibuprofen conjugate 3	PEP00576	Glutamic acid oligopeptide 3	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00121	TAR10032	Prostaglandin G/H synthase 1 (COX-1)	Naproxen	Investigative	.	.	.	.	.
PDC_00694	Glutamic acid oligopeptide 1 - Ibuprofen conjugate 4	PEP00574	Glutamic acid oligopeptide 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00121	TAR10032	Prostaglandin G/H synthase 1 (COX-1)	Naproxen	Investigative	.	.	.	.	.
PDC_00695	Glutamic acid oligopeptide 2 - Ibuprofen conjugate 4	PEP00575	Glutamic acid oligopeptide 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00121	TAR10032	Prostaglandin G/H synthase 1 (COX-1)	Naproxen	Investigative	.	.	.	.	.
PDC_00696	Glutamic acid oligopeptide 3 - Ibuprofen conjugate 4	PEP00576	Glutamic acid oligopeptide 3	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00121	TAR10032	Prostaglandin G/H synthase 1 (COX-1)	Naproxen	Investigative	.	.	.	.	.
PDC_00697	"Tripeptide 2 - 2,2,2-Cryptand conjugate"	PEP00862	Tripeptide 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00317	.	.	"4,7,13,16,21,24-Hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane"	Investigative	.	.	.	.	.
PDC_00698	"Tripeptide 2 - 2,2,1-Cryptand conjugate"	PEP00862	Tripeptide 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00119	.	.	"2,2,1-Cryptand"	Investigative	.	.	.	.	.
PDC_00699	"Tripeptide 2 - 2,1,1-Cryptand conjugate"	PEP00862	Tripeptide 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00282	.	.	[2.1.1]Cryptand siliconhexafluoride	Investigative	.	.	.	.	.
PDC_00700	Hexapeptide 6 - NSC 125620 conjugate 1	PEP00585	Hexapeptide 6	REC99999	Undisclosed	LIN00127	Triazole	DRG00177	.	.	NSC 125620	Investigative	.	.	.	.	.
PDC_00701	"Hexapeptide 7 - R,S-propargyloxyproline conjugate"	PEP00586	Hexapeptide 7	REC99999	Undisclosed	LIN00127	Triazole	DRG00229	.	.	"R,S-propargyloxyproline"	Investigative	.	.	.	.	.
PDC_00702	"Hexapeptide 6 - R,S-propargyloxyproline conjugate"	PEP00585	Hexapeptide 6	REC99999	Undisclosed	LIN00127	Triazole	DRG00229	.	.	"R,S-propargyloxyproline"	Investigative	.	.	.	.	.
PDC_00703	"Hexapeptide 8 - R,S-propargyloxyproline conjugate"	PEP00587	Hexapeptide 8	REC99999	Undisclosed	LIN00127	Triazole	DRG00229	.	.	"R,S-propargyloxyproline"	Investigative	.	.	.	.	.
PDC_00704	"Nonapeptide 1 - R,S-propargyloxyproline conjugate"	PEP00645	Nonapeptide 1	REC99999	Undisclosed	LIN00127	Triazole	DRG00229	.	.	"R,S-propargyloxyproline"	Investigative	.	.	.	.	.
PDC_00705	"Nonapeptide 2 - S,S-propargyloxyproline conjugate"	PEP00646	Nonapeptide 2	REC99999	Undisclosed	LIN00127	Triazole	DRG00203	.	.	"S,S-propargyloxyproline"	Investigative	.	.	.	.	.
PDC_00706	"Nonapeptide 3 - R,S-propargyloxyproline conjugate"	PEP00647	Nonapeptide 3	REC99999	Undisclosed	LIN00127	Triazole	DRG00229	.	.	"R,S-propargyloxyproline"	Investigative	.	.	.	.	.
PDC_00707	"Nonapeptide 2 - R,S-propargyloxyproline conjugate"	PEP00646	Nonapeptide 2	REC99999	Undisclosed	LIN00127	Triazole	DRG00229	.	.	"R,S-propargyloxyproline"	Investigative	.	.	.	.	.
PDC_00708	"Hexapeptide 7 - 1H-Thieno[3,4-d]imidazole-4-hexanamide, N-[2-[2-(azidomethoxy)ethoxy]ethyl]hexahydro-2-oxo-, (3aS,4S,6aR) conjugate"	PEP00586	Hexapeptide 7	REC99999	Undisclosed	LIN00127	Triazole	DRG00253	.	.	"1H-Thieno[3,4-d]imidazole-4-hexanamide, N-[2-[2-(azidomethoxy)ethoxy]ethyl]hexahydro-2-oxo-, (3aS,4S,6aR)"	Investigative	.	.	.	.	.
PDC_00709	Hexapeptide 6 - NSC 125620 conjugate	PEP00585	Hexapeptide 6	REC99999	Undisclosed	LIN00127	Triazole	DRG00177	.	.	NSC 125620	Investigative	.	.	.	.	.
PDC_00710	"Hexapeptide 6 - 1H-Thieno[3,4-d]imidazole-4-hexanamide, N-[2-[2-(azidomethoxy)ethoxy]ethyl]hexahydro-2-oxo-, (3aS,4S,6aR) conjugate"	PEP00585	Hexapeptide 6	REC99999	Undisclosed	LIN00127	Triazole	DRG00253	.	.	"1H-Thieno[3,4-d]imidazole-4-hexanamide, N-[2-[2-(azidomethoxy)ethoxy]ethyl]hexahydro-2-oxo-, (3aS,4S,6aR)"	Investigative	.	.	.	.	.
PDC_00711	Hexapeptide 6 - N-[4-(Azidomethyl)-2-oxo-2H-1-benzopyran-7-yl]acetamide conjugate	PEP00585	Hexapeptide 6	REC99999	Undisclosed	LIN00127	Triazole	DRG00254	.	.	N-[4-(Azidomethyl)-2-oxo-2H-1-benzopyran-7-yl]acetamide	Investigative	.	.	.	.	.
PDC_00712	"Hexapeptide 8 - 1H-Thieno[3,4-d]imidazole-4-hexanamide, N-[2-[2-(azidomethoxy)ethoxy]ethyl]hexahydro-2-oxo-, (3aS,4S,6aR) conjugate"	PEP00587	Hexapeptide 8	REC99999	Undisclosed	LIN00127	Triazole	DRG00253	.	.	"1H-Thieno[3,4-d]imidazole-4-hexanamide, N-[2-[2-(azidomethoxy)ethoxy]ethyl]hexahydro-2-oxo-, (3aS,4S,6aR)"	Investigative	.	.	.	.	.
PDC_00713	Hexapeptide 8 - N-[4-(Azidomethyl)-2-oxo-2H-1-benzopyran-7-yl]acetamide conjugate 1	PEP00587	Hexapeptide 8	REC99999	Undisclosed	LIN00127	Triazole	DRG00254	.	.	N-[4-(Azidomethyl)-2-oxo-2H-1-benzopyran-7-yl]acetamide	Investigative	.	.	.	.	.
PDC_00714	Hexapeptide 8 - N-[4-(Azidomethyl)-2-oxo-2H-1-benzopyran-7-yl]acetamide conjugate	PEP00587	Hexapeptide 8	REC99999	Undisclosed	LIN00127	Triazole	DRG00254	.	.	N-[4-(Azidomethyl)-2-oxo-2H-1-benzopyran-7-yl]acetamide	Investigative	.	.	.	.	.
PDC_00715	Nonapeptide 4 - 7-Amino-4-(azidomethyl)-2H-1-benzopyran-2-one conjugate 1	PEP00648	Nonapeptide 4	REC99999	Undisclosed	LIN00127	Triazole	DRG00220	.	.	7-Amino-4-(azidomethyl)-2H-1-benzopyran-2-one	Investigative	.	.	.	.	.
PDC_00716	Nonapeptide 4 - 7-Amino-4-(azidomethyl)-2H-1-benzopyran-2-one conjugate 2	PEP00648	Nonapeptide 4	REC99999	Undisclosed	LIN00127	Triazole	DRG00220	.	.	7-Amino-4-(azidomethyl)-2H-1-benzopyran-2-one	Investigative	.	.	.	.	.
PDC_00717	Nonapeptide 1 - 7-Amino-4-(azidomethyl)-2H-1-benzopyran-2-one conjugate	PEP00645	Nonapeptide 1	REC99999	Undisclosed	LIN00127	Triazole	DRG00220	.	.	7-Amino-4-(azidomethyl)-2H-1-benzopyran-2-one	Investigative	.	.	.	.	.
PDC_00718	Nonapeptide 2 - 7-Amino-4-(azidomethyl)-2H-1-benzopyran-2-one conjugate 1	PEP00646	Nonapeptide 2	REC99999	Undisclosed	LIN00127	Triazole	DRG00220	.	.	7-Amino-4-(azidomethyl)-2H-1-benzopyran-2-one	Investigative	.	.	.	.	.
PDC_00719	Nonapeptide 3 - 7-Amino-4-(azidomethyl)-2H-1-benzopyran-2-one conjugate	PEP00647	Nonapeptide 3	REC99999	Undisclosed	LIN00127	Triazole	DRG00220	.	.	7-Amino-4-(azidomethyl)-2H-1-benzopyran-2-one	Investigative	.	.	.	.	.
PDC_00720	Nonapeptide 2 - 7-Amino-4-(azidomethyl)-2H-1-benzopyran-2-one conjugate 2	PEP00646	Nonapeptide 2	REC99999	Undisclosed	LIN00127	Triazole	DRG00220	.	.	7-Amino-4-(azidomethyl)-2H-1-benzopyran-2-one	Investigative	.	.	.	.	.
PDC_00721	"Nonapeptide 4 - R,S-propargyloxyproline conjugate 1"	PEP00648	Nonapeptide 4	REC99999	Undisclosed	LIN00127	Triazole	DRG00229	.	.	"R,S-propargyloxyproline"	Investigative	.	.	.	.	.
PDC_00722	"Nonapeptide 4 - R,S-propargyloxyproline conjugate 2"	PEP00648	Nonapeptide 4	REC99999	Undisclosed	LIN00127	Triazole	DRG00229	.	.	"R,S-propargyloxyproline"	Investigative	.	.	.	.	.
PDC_00723	Nonapeptide 3 - Azido-functionalised rhodamine fluorophore conjugate 1	PEP00647	Nonapeptide 3	REC99999	Undisclosed	LIN00127	Triazole	DRG00255	.	.	Azido-functionalised rhodamine fluorophore	Investigative	.	.	.	.	.
PDC_00724	Nonapeptide 3 - Azido-functionalised rhodamine fluorophore conjugate 2	PEP00647	Nonapeptide 3	REC99999	Undisclosed	LIN00127	Triazole	DRG00255	.	.	Azido-functionalised rhodamine fluorophore	Investigative	.	.	.	.	.
PDC_00725	Tripeptide 3 - Propiolic acid conjugate	PEP00863	Tripeptide 3	REC99999	Undisclosed	LIN00127	Triazole	DRG00094	.	.	Propiolic acid	Investigative	.	.	.	.	.
PDC_00726	Hexapeptide 9 - Oxaliplatin conjugate	PEP00588	Hexapeptide 9	REC99999	Undisclosed	LIN00127	Triazole	DRG00256	.	.	Oxaliplatin	Investigative	.	.	.	.	.
PDC_00727	Tripeptide 4 - Propiolic acid conjugate	PEP00864	Tripeptide 4	REC99999	Undisclosed	LIN00127	Triazole	DRG00094	.	.	Propiolic acid	Investigative	.	.	.	.	.
PDC_00728	Hexapeptide 10 - Oxaliplatin conjugate	PEP00589	Hexapeptide 10	REC99999	Undisclosed	LIN00127	Triazole	DRG00256	.	.	Oxaliplatin	Investigative	.	.	.	.	.
PDC_00729	"NoxaBH3 - 6,6-Bis-bromomethyl-[3,3]bipyridine conjugate"	PEP00649	NoxaBH3	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00206	.	.	"6,6-Bis-bromomethyl-[3,3]bipyridine"	Investigative	.	.	.	.	.
PDC_00730	High-affinity DNA binding peptide HyQ10 - Chlorambucil conjugate	PEP00598	High-affinity DNA binding peptide HyQ10	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00002	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Chlorambucil	Investigative	.	.	.	.	.
PDC_00731	High-affinity DNA binding peptide HyM10 - Chlorambucil conjugate	PEP00597	High-affinity DNA binding peptide HyM10	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00002	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Chlorambucil	Investigative	.	.	.	.	.
PDC_00732	Designed oligopeptides 1 - Telithromycin (TEL) derivative conjugate 1	PEP00493	Designed oligopeptides 1	REC99999	Undisclosed	LIN00133	Butane	DRG00215	.	.	Telithromycin (TEL) derivative	Investigative	.	.	.	.	.
PDC_00733	Designed oligopeptides 1 - Telithromycin (TEL) derivative conjugate 2	PEP00493	Designed oligopeptides 1	REC99999	Undisclosed	LIN00133	Butane	DRG00215	.	.	Telithromycin (TEL) derivative	Investigative	.	.	.	.	.
PDC_00734	Designed oligopeptides 2 - Telithromycin (TEL) derivative conjugate 1	PEP00494	Designed oligopeptides 2	REC99999	Undisclosed	LIN00133	Butane	DRG00215	.	.	Telithromycin (TEL) derivative	Investigative	.	.	.	.	.
PDC_00735	Designed oligopeptides 2 - Telithromycin (TEL) derivative conjugate 2	PEP00494	Designed oligopeptides 2	REC99999	Undisclosed	LIN00133	Butane	DRG00215	.	.	Telithromycin (TEL) derivative	Investigative	.	.	.	.	.
PDC_00736	Designed oligopeptides 3 - Telithromycin (TEL) derivative conjugate 1	PEP00495	Designed oligopeptides 3	REC99999	Undisclosed	LIN00133	Butane	DRG00215	.	.	Telithromycin (TEL) derivative	Investigative	.	.	.	.	.
PDC_00737	Designed oligopeptides 3 - Telithromycin (TEL) derivative conjugate 2	PEP00495	Designed oligopeptides 3	REC99999	Undisclosed	LIN00133	Butane	DRG00215	.	.	Telithromycin (TEL) derivative	Investigative	.	.	.	.	.
PDC_00738	Designed oligopeptides 4 - Telithromycin (TEL) derivative conjugate 1	PEP00496	Designed oligopeptides 4	REC99999	Undisclosed	LIN00133	Butane	DRG00215	.	.	Telithromycin (TEL) derivative	Investigative	.	.	.	.	.
PDC_00739	Designed oligopeptides 4 - Telithromycin (TEL) derivative conjugate 2	PEP00496	Designed oligopeptides 4	REC99999	Undisclosed	LIN00133	Butane	DRG00215	.	.	Telithromycin (TEL) derivative	Investigative	.	.	.	.	.
PDC_00740	"GPLGVRGA - 3-(2H-[5,6]Fullereno-C60-Ih-[1,9-c]pyrrol-1(5H)-yl)pentanedioic acid conjugate"	PEP00221	GPLGVRGA	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00257	.	.	"3-(2H-[5,6]Fullereno-C60-Ih-[1,9-c]pyrrol-1(5H)-yl)pentanedioic acid"	Investigative	.	.	.	.	.
PDC_00741	"XGPLGVRGA - 2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide conjugate"	PEP00222	XGPLGVRGA	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00174	.	.	"2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide"	Investigative	.	.	.	.	.
PDC_00742	"XGGX - 3-(2H-[5,6]Fullereno-C60-Ih-[1,9-c]pyrrol-1(5H)-yl)pentanedioic acid conjugate"	PEP00223	XGGX	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00257	.	.	"3-(2H-[5,6]Fullereno-C60-Ih-[1,9-c]pyrrol-1(5H)-yl)pentanedioic acid"	Investigative	.	.	.	.	.
PDC_00743	22-mer peptide - 2-[2-oxo-2-[[4-[3-oxo-3-(2-oxo-1-azetidinyl)propyl]phenyl]amino]ethoxy] acetic acid conjugate	PEP00411	22-mer peptide	REC99999	Undisclosed	LIN00129	Glycolic acid	DRG00202	.	.	2-[2-oxo-2-[[4-[3-oxo-3-(2-oxo-1-azetidinyl)propyl]phenyl]amino]ethoxy] acetic acid	Investigative	.	.	.	.	.
PDC_00745	Transferrin receptor binding peptide short (TfR-Ps) - 6-Maleimidocaproic acid derivative linker conjugate 1	PEP00858	Transferrin receptor binding peptide short (TfR-Ps)	REC99999	Undisclosed	LIN00126	PEG	DRG00129	.	.	6-Maleimidocaproic acid derivative linker	Investigative	.	.	.	.	.
PDC_00746	Transferrin receptor binding peptide short (TfR-Ps) - 6-Maleimidocaproic acid derivative linker conjugate 2	PEP00858	Transferrin receptor binding peptide short (TfR-Ps)	REC99999	Undisclosed	LIN00126	PEG	DRG00129	.	.	6-Maleimidocaproic acid derivative linker	Investigative	.	.	.	.	.
PDC_00747	Transferrin receptor binding peptide short (TfR-Ps) - 6-Maleimidocaproic acid derivative linker conjugate 3	PEP00858	Transferrin receptor binding peptide short (TfR-Ps)	REC99999	Undisclosed	LIN00126	PEG	DRG00129	.	.	6-Maleimidocaproic acid derivative linker	Investigative	.	.	.	.	.
PDC_00748	Angiopep-2 - 6-Maleimidocaproic acid derivative linker conjugate 1	PEP00162	Angiopep-2	REC00045	Prolow-density lipoprotein receptor-related protein 1; Low-density lipoprotein receptor-related protein 2 (LRP1; LRP2)	LIN00126	PEG	DRG00129	.	.	6-Maleimidocaproic acid derivative linker	Investigative	.	.	.	.	.
PDC_00749	Angiopep-2 - 6-Maleimidocaproic acid derivative linker conjugate 2	PEP00162	Angiopep-2	REC00045	Prolow-density lipoprotein receptor-related protein 1; Low-density lipoprotein receptor-related protein 2 (LRP1; LRP2)	LIN00126	PEG	DRG00129	.	.	6-Maleimidocaproic acid derivative linker	Investigative	.	.	.	.	.
PDC_00750	Angiopep-2 - 6-Maleimidocaproic acid derivative linker conjugate 3	PEP00162	Angiopep-2	REC00045	Prolow-density lipoprotein receptor-related protein 1; Low-density lipoprotein receptor-related protein 2 (LRP1; LRP2)	LIN00126	PEG	DRG00129	.	.	6-Maleimidocaproic acid derivative linker	Investigative	.	.	.	.	.
PDC_00751	Angiopep-2 - 6-Maleimidocaproic acid derivative linker conjugate 4	PEP00162	Angiopep-2	REC00045	Prolow-density lipoprotein receptor-related protein 1; Low-density lipoprotein receptor-related protein 2 (LRP1; LRP2)	LIN00126	PEG	DRG00129	.	.	6-Maleimidocaproic acid derivative linker	Investigative	.	.	.	.	.
PDC_00752	T7 - 6-Maleimidocaproic acid derivative linker conjugate	PEP00167	DT7	REC00008	Transferrin receptor protein 1 (TFRC)	LIN00126	PEG	DRG00129	.	.	6-Maleimidocaproic acid derivative linker	Investigative	.	.	.	.	.
PDC_00759	Nuclear localization sequence of human NK-kappaB (NTP) - 6-Maleimidocaproic acid derivative linker conjugate	PEP00653	Nuclear localization sequence of human NK-kappaB (NTP)	REC99999	Undisclosed	LIN00126	PEG	DRG00129	.	.	6-Maleimidocaproic acid derivative linker	Investigative	.	.	.	.	.
PDC_00760	Penetratin - 6-Maleimidocaproic acid derivative linker conjugate	PEP00128	Penetratin	REC99999	Undisclosed	LIN00126	PEG	DRG00129	.	.	6-Maleimidocaproic acid derivative linker	Investigative	.	.	.	.	.
PDC_00761	Transportan - 6-Maleimidocaproic acid derivative linker conjugate	PEP00859	Transportan	REC99999	Undisclosed	LIN00126	PEG	DRG00129	.	.	6-Maleimidocaproic acid derivative linker	Investigative	.	.	.	.	.
PDC_00762	Transferrin receptor binding peptide lo (TfR-Pl)ng - 6-Maleimidocaproic acid derivative linker conjugate	PEP00857	Transferrin receptor binding peptide lo (TfR-Pl)ng	REC99999	Undisclosed	LIN00126	PEG	DRG00129	.	.	6-Maleimidocaproic acid derivative linker	Investigative	.	.	.	.	.
PDC_00764	TAT49-57 - 6-Maleimidocaproic acid derivative linker conjugate	PEP00775	TAT49-57	REC99999	Undisclosed	LIN00126	PEG	DRG00129	.	.	6-Maleimidocaproic acid derivative linker	Investigative	.	.	.	.	.
PDC_00765	TAT - 6-Maleimidocaproic acid derivative linker conjugate	PEP00773	TAT	REC99999	Undisclosed	LIN00126	PEG	DRG00129	.	.	6-Maleimidocaproic acid derivative linker	Investigative	.	.	.	.	.
PDC_00768	Transferrin receptor binding peptide short (TfR-Ps) - Fallypride derivative conjugate 1	PEP00858	Transferrin receptor binding peptide short (TfR-Ps)	REC99999	Undisclosed	LIN00126	PEG	DRG00228	.	.	Fallypride derivative	Investigative	.	.	.	.	.
PDC_00769	Transferrin receptor binding peptide short (TfR-Ps) - Fallypride derivative conjugate 2	PEP00858	Transferrin receptor binding peptide short (TfR-Ps)	REC99999	Undisclosed	LIN00126	PEG	DRG00228	.	.	Fallypride derivative	Investigative	.	.	.	.	.
PDC_00771	T7 - Fallypride derivative conjugate	PEP00167	DT7	REC00008	Transferrin receptor protein 1 (TFRC)	LIN00126	PEG	DRG00228	.	.	Fallypride derivative	Investigative	.	.	.	.	.
PDC_00779	Nuclear localization sequence of human NK-kappaB (NTP) - Fallypride derivative conjugate	PEP00653	Nuclear localization sequence of human NK-kappaB (NTP)	REC99999	Undisclosed	LIN00126	PEG	DRG00228	.	.	Fallypride derivative	Investigative	.	.	.	.	.
PDC_00780	Penetratin - Fallypride derivative conjugate	PEP00128	Penetratin	REC99999	Undisclosed	LIN00126	PEG	DRG00228	.	.	Fallypride derivative	Investigative	.	.	.	.	.
PDC_00781	Transportan - Fallypride derivative conjugate	PEP00859	Transportan	REC99999	Undisclosed	LIN00126	PEG	DRG00228	.	.	Fallypride derivative	Investigative	.	.	.	.	.
PDC_00782	Transferrin receptor binding peptide lo (TfR-Pl)ng - Fallypride derivative conjugate	PEP00857	Transferrin receptor binding peptide lo (TfR-Pl)ng	REC99999	Undisclosed	LIN00126	PEG	DRG00228	.	.	Fallypride derivative	Investigative	.	.	.	.	.
PDC_00784	TAT - Fallypride derivative conjugate	PEP00051	TAT	REC99999	Undisclosed	LIN00126	PEG	DRG00228	.	.	Fallypride derivative	Investigative	.	.	.	.	.
PDC_00787	Angiopep-2 - Fallypride derivative conjugate	PEP00162	Angiopep-2	REC00045	Prolow-density lipoprotein receptor-related protein 1; Low-density lipoprotein receptor-related protein 2 (LRP1; LRP2)	LIN00126	PEG	DRG00228	.	.	Fallypride derivative	Investigative	.	.	.	.	.
PDC_00788	Transferrin receptor binding peptide short (TfR-Ps) - Fallypride derivative conjugate 3	PEP00858	Transferrin receptor binding peptide short (TfR-Ps)	REC99999	Undisclosed	LIN00126	PEG	DRG00228	.	.	Fallypride derivative	Investigative	.	.	.	.	.
PDC_00789	Angiopep-2 - 6-Maleimidocaproic acid derivative linker conjugate 5	PEP00162	Angiopep-2	REC00045	Prolow-density lipoprotein receptor-related protein 1; Low-density lipoprotein receptor-related protein 2 (LRP1; LRP2)	LIN00126	PEG	DRG00129	.	.	6-Maleimidocaproic acid derivative linker	Investigative	.	.	.	.	.
PDC_00790	Modified ternatin 1 - 2-chloro-1-(N-methylcarbamate)-benzenemethanol conjugate 1	PEP00638	Modified ternatin 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00188	.	.	2-chloro-1-(N-methylcarbamate)-benzenemethanol	Investigative	.	.	.	.	.
PDC_00791	Modified ternatin 1 - 2-chloro-1-(N-methylcarbamate)-benzenemethanol conjugate 2	PEP00638	Modified ternatin 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00188	.	.	2-chloro-1-(N-methylcarbamate)-benzenemethanol	Investigative	.	.	.	.	.
PDC_00792	Modified ternatin 2 - 2-chloro-1-(N-methylcarbamate)-benzenemethanol conjugate	PEP00639	Modified ternatin 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00188	.	.	2-chloro-1-(N-methylcarbamate)-benzenemethanol	Investigative	.	.	.	.	.
PDC_00793	Modified ternatin 1 - 2-chloro-1-(N-methylcarbamate)-benzenemethanol conjugate 3	PEP00638	Modified ternatin 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00188	.	.	2-chloro-1-(N-methylcarbamate)-benzenemethanol	Investigative	.	.	.	.	.
PDC_00794	Modified ternatin 1 - 2-chloro-1-(N-methylcarbamate)-benzenemethanol conjugate 4	PEP00638	Modified ternatin 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00188	.	.	2-chloro-1-(N-methylcarbamate)-benzenemethanol	Investigative	.	.	.	.	.
PDC_00795	Tripeptide 5 - 2-chloro-1-(N-methylcarbamate)-benzenemethanol conjugate 1	PEP00865	Tripeptide 5	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00188	.	.	2-chloro-1-(N-methylcarbamate)-benzenemethanol	Investigative	.	.	.	.	.
PDC_00796	Tripeptide 5 - 2-chloro-1-(N-methylcarbamate)-benzenemethanol conjugate 2	PEP00865	Tripeptide 5	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00188	.	.	2-chloro-1-(N-methylcarbamate)-benzenemethanol	Investigative	.	.	.	.	.
PDC_00798	Tripeptide 6 - 2-chloro-1-(N-methylcarbamate)-benzenemethanol conjugate	PEP00866	Tripeptide 6	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00188	.	.	2-chloro-1-(N-methylcarbamate)-benzenemethanol	Investigative	.	.	.	.	.
PDC_00799	Modified ternatin 3 - 2-chloro-1-(N-methylcarbamate)-benzenemethanol conjugate	PEP00640	Modified ternatin 3	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00188	.	.	2-chloro-1-(N-methylcarbamate)-benzenemethanol	Investigative	.	.	.	.	.
PDC_00800	Modified ternatin 4 - 2-chloro-1-(N-methylcarbamate)-benzenemethanol conjugate	PEP00641	Modified ternatin 4	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00188	.	.	2-chloro-1-(N-methylcarbamate)-benzenemethanol	Investigative	.	.	.	.	.
PDC_00801	Modified ternatin 5 - 2-chloro-1-(N-methylcarbamate)-benzenemethanol conjugate	PEP00642	Modified ternatin 5	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00188	.	.	2-chloro-1-(N-methylcarbamate)-benzenemethanol	Investigative	.	.	.	.	.
PDC_00802	Tripeptide 5 - 2-chloro-1-(N-methylcarbamate)-benzenemethanol conjugate 3	PEP00865	Tripeptide 5	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00188	.	.	2-chloro-1-(N-methylcarbamate)-benzenemethanol	Investigative	.	.	.	.	.
PDC_00803	Tripeptide 7 - 2-chloro-1-(N-methylcarbamate)-benzenemethanol conjugate	PEP00867	Tripeptide 7	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00188	.	.	2-chloro-1-(N-methylcarbamate)-benzenemethanol	Investigative	.	.	.	.	.
PDC_00804	Dipeptide 11 - 2-chloro-1-(N-methylcarbamate)-benzenemethanol conjugate	PEP00507	Dipeptide 11	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00188	.	.	2-chloro-1-(N-methylcarbamate)-benzenemethanol	Investigative	.	.	.	.	.
PDC_00805	Dipeptide 12 - 2-chloro-1-(N-methylcarbamate)-benzenemethanol conjugate	PEP00508	Dipeptide 12	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00188	.	.	2-chloro-1-(N-methylcarbamate)-benzenemethanol	Investigative	.	.	.	.	.
PDC_00806	O-GlcNAc transferase fragment - linker-only uridine diphosphate (UDP) analogue conjugate 1	PEP00666	O-GlcNAc transferase fragment	REC99999	Undisclosed	LIN00133	Butane	DRG00258	.	.	linker-only uridine diphosphate (UDP) analogue	Investigative	.	.	.	.	.
PDC_00807	O-GlcNAc transferase fragment - linker-only uridine diphosphate (UDP) analogue conjugate 2	PEP00666	O-GlcNAc transferase fragment	REC99999	Undisclosed	LIN00133	Butane	DRG00258	.	.	linker-only uridine diphosphate (UDP) analogue	Investigative	.	.	.	.	.
PDC_00808	Ephrin type-A receptor 2 (EphA2) targeting peptide 1 - Paclitaxel (PTX) derivative conjugate 1	PEP00558	Ephrin type-A receptor 2 (EphA2) targeting peptide 1	REC99999	Undisclosed	LIN00127	Triazole	DRG00269	.	.	2'-O-(tert-Butyldimethylsilyl)taxol	Investigative	.	.	.	.	.
PDC_00809	Ephrin type-A receptor 2 (EphA2) targeting peptide 2 - Paclitaxel (PTX) derivative conjugate	PEP00559	Ephrin type-A receptor 2 (EphA2) targeting peptide 2	REC99999	Undisclosed	LIN00127	Triazole	DRG00269	.	.	2'-O-(tert-Butyldimethylsilyl)taxol	Investigative	.	.	.	.	.
PDC_00810	Ephrin type-A receptor 2 (EphA2) targeting peptide 3 - Paclitaxel (PTX) derivative conjugate	PEP00560	Ephrin type-A receptor 2 (EphA2) targeting peptide 3	REC99999	Undisclosed	LIN00127	Triazole	DRG00269	.	.	2'-O-(tert-Butyldimethylsilyl)taxol	Investigative	.	.	.	.	.
PDC_00811	Ephrin type-A receptor 2 (EphA2) targeting peptide 1 - Paclitaxel (PTX) derivative conjugate	PEP00558	Ephrin type-A receptor 2 (EphA2) targeting peptide 1	REC99999	Undisclosed	LIN00127	Triazole	DRG00269	.	.	2'-O-(tert-Butyldimethylsilyl)taxol	Investigative	.	.	.	.	.
PDC_00812	Cationic antimicrobial peptides (CAMP) 1 - Porphyrin derivative conjugate	PEP00472	Cationic antimicrobial peptides (CAMP) 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00170	.	.	Porphyrin derivative	Investigative	.	.	.	.	.
PDC_00813	Cationic antimicrobial peptides (CAMP) 2 - Porphyrin derivative conjugate	PEP00473	Cationic antimicrobial peptides (CAMP) 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00170	.	.	Porphyrin derivative	Investigative	.	.	.	.	.
PDC_00814	Cationic antimicrobial peptides (CAMP) 3 - Porphyrin derivative conjugate	PEP00474	Cationic antimicrobial peptides (CAMP) 3	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00170	.	.	Porphyrin derivative	Investigative	.	.	.	.	.
PDC_00815	Cationic antimicrobial peptides (CAMP) 4 - Porphyrin derivative conjugate 1	PEP00475	Cationic antimicrobial peptides (CAMP) 4	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00170	.	.	Porphyrin derivative	Investigative	.	.	.	.	.
PDC_00816	Cationic antimicrobial peptides (CAMP) 4 - Porphyrin derivative conjugate 2	PEP00475	Cationic antimicrobial peptides (CAMP) 4	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00170	.	.	Porphyrin derivative	Investigative	.	.	.	.	.
PDC_00817	"Peptide 26 - 2-(carboxymethoxy)-5-(2,5-dimethyl-1H-pyrrol-1-yl)-benzoic acid conjugate"	PEP00748	Peptide 26	REC99999	Undisclosed	LIN00123	3-Aminopropionic acid	DRG00208	.	.	"2-(carboxymethoxy)-5-(2,5-dimethyl-1H-pyrrol-1-yl)-benzoic acid"	Investigative	.	.	.	.	.
PDC_00821	XHWKHDWKPG - L-Pyroglutamic acid conjugate	PEP00224	XHWKHDWKPG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00090	TAR10049	Orexin (HCRT)	L-Pyroglutamic acid	Investigative	.	.	.	.	.
PDC_00822	XHWSHDWKPG - L-Pyroglutamic acid conjugate 2	PEP00225	XHWSHDWKPG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00090	TAR10049	Orexin (HCRT)	L-Pyroglutamic acid	Investigative	.	.	.	.	.
PDC_00823	XHWSHDWKPG - L-Pyroglutamic acid conjugate 1	PEP00225	XHWSHDWKPG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00090	TAR10049	Orexin (HCRT)	L-Pyroglutamic acid	Investigative	.	.	.	.	.
PDC_00824	XHWKHDWKPG - N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-1-(triphenylmethyl)-L-histidine conjugate	PEP00224	XHWKHDWKPG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00172	.	.	N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-1-(triphenylmethyl)-L-histidine	Investigative	.	.	.	.	.
PDC_00825	XHWSHDWKPG - N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-1-(triphenylmethyl)-L-histidine conjugate 2	PEP00225	XHWSHDWKPG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00172	.	.	N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-1-(triphenylmethyl)-L-histidine	Investigative	.	.	.	.	.
PDC_00826	XHWSHDWKPG - N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-1-(triphenylmethyl)-L-histidine conjugate 1	PEP00225	XHWSHDWKPG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00172	.	.	N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-1-(triphenylmethyl)-L-histidine	Investigative	.	.	.	.	.
PDC_00827	"XRKI - Benzoic acid, 4-[(Z)-[4-oxo-3-(2-phenylethyl)-2-thioxo-5-thiazolidinylidene]methyl] conjugate"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00217	.	.	"Benzoic acid, 4-[(Z)-[4-oxo-3-(2-phenylethyl)-2-thioxo-5-thiazolidinylidene]methyl]"	Investigative	.	.	.	.	.
PDC_00828	"XRKI - Benzoic acid, 4-[(Z)-[3-[(4-chlorophenyl)methyl]-4-oxo-2-thioxo-5-thiazolidinylidene]methyl] conjugate 5"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00259	.	.	"Benzoic acid, 4-[(Z)-[3-[(4-chlorophenyl)methyl]-4-oxo-2-thioxo-5-thiazolidinylidene]methyl]"	Investigative	.	.	.	.	.
PDC_00829	"XRKI - Benzoic acid, 4-[(Z)-[3-[(4-fluorophenyl)methyl]-4-oxo-2-thioxo-5-thiazolidinylidene]methyl] conjugate 2"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00260	.	.	"Benzoic acid, 4-[(Z)-[3-[(4-fluorophenyl)methyl]-4-oxo-2-thioxo-5-thiazolidinylidene]methyl]"	Investigative	.	.	.	.	.
PDC_00830	"XRKI - Benzoic acid, 4-[(Z)-[3-[(4-methoxyphenyl)methyl]-4-oxo-2-thioxo-5-thiazolidinylidene]methyl] conjugate 1"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00261	.	.	"Benzoic acid, 4-[(Z)-[3-[(4-methoxyphenyl)methyl]-4-oxo-2-thioxo-5-thiazolidinylidene]methyl]"	Investigative	.	.	.	.	.
PDC_00831	"XRKI - Benzoic acid, 4-[(Z)-[3-[(4-methylphenyl)methyl]-4-oxo-2-thioxo-5-thiazolidinylidene]methyl] conjugate"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00262	.	.	"Benzoic acid, 4-[(Z)-[3-[(4-methylphenyl)methyl]-4-oxo-2-thioxo-5-thiazolidinylidene]methyl]"	Investigative	.	.	.	.	.
PDC_00832	"XRKI - Benzoic acid, 4-[(Z)-[4-oxo-3-(phenylmethyl)-2-thioxo-5-thiazolidinylidene]methyl] conjugate"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00146	.	.	"Benzoic acid, 4-[(Z)-[4-oxo-3-(phenylmethyl)-2-thioxo-5-thiazolidinylidene]methyl]"	Investigative	.	.	.	.	.
PDC_00833	"XRKI - Benzoic acid, 4-[(Z)-[3-(4-methylphenyl)-4-oxo-2-thioxo-5-thiazolidinylidene]methyl] conjugate"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00148	.	.	"Benzoic acid, 4-[(Z)-[3-(4-methylphenyl)-4-oxo-2-thioxo-5-thiazolidinylidene]methyl]"	Investigative	.	.	.	.	.
PDC_00834	"XRKI - Benzoic acid, 4-[(Z)-[3-[2-(acetyloxy)ethyl]-4-oxo-2-thioxo-5-thiazolidinylidene]methyl] conjugate 1"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00263	.	.	"Benzoic acid, 4-[(Z)-[3-[2-(acetyloxy)ethyl]-4-oxo-2-thioxo-5-thiazolidinylidene]methyl]"	Investigative	.	.	.	.	.
PDC_00835	"XRKI - Benzoic acid, 4-[(Z)-[3-(2-hydroxyethyl)-2,4-dioxo-5-thiazolidinylidene]methyl] conjugate"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00264	.	.	"Benzoic acid, 4-[(Z)-[3-(2-hydroxyethyl)-2,4-dioxo-5-thiazolidinylidene]methyl]"	Investigative	.	.	.	.	.
PDC_00836	"XRKI - Benzoic acid, 4-[(Z)-[4-oxo-3-(2-propen-1-yl)-2-thioxo-5-thiazolidinylidene]methyl] conjugate"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00143	.	.	"Benzoic acid, 4-[(Z)-[4-oxo-3-(2-propen-1-yl)-2-thioxo-5-thiazolidinylidene]methyl]"	Investigative	.	.	.	.	.
PDC_00837	"XRKI - Benzoic acid, 4-[(Z)-(3-cyclohexyl-4-oxo-2-thioxo-5-thiazolidinylidene)methyl] conjugate"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00166	.	.	"Benzoic acid, 4-[(Z)-(3-cyclohexyl-4-oxo-2-thioxo-5-thiazolidinylidene)methyl]"	Investigative	.	.	.	.	.
PDC_00838	"XRKI - Benzoic acid, 4-[(Z)-(3-cyclopentyl-4-oxo-2-thioxo-5-thiazolidinylidene)methyl] conjugate"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00167	.	.	"Benzoic acid, 4-[(Z)-(3-cyclopentyl-4-oxo-2-thioxo-5-thiazolidinylidene)methyl]"	Investigative	.	.	.	.	.
PDC_00839	"XRKI - Benzoic acid, 4-[(Z)-(3-dodecyl-2,4-dioxo-5-thiazolidinylidene)methyl] conjugate"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00265	.	.	"Benzoic acid, 4-[(Z)-(3-dodecyl-2,4-dioxo-5-thiazolidinylidene)methyl]"	Investigative	.	.	.	.	.
PDC_00840	"XRKI - Benzoic acid, 4-[(Z)-(3-butyl-4-oxo-2-thioxo-5-thiazolidinylidene)methyl] conjugate 4"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00266	.	.	"Benzoic acid, 4-[(Z)-(3-butyl-4-oxo-2-thioxo-5-thiazolidinylidene)methyl]"	Investigative	.	.	.	.	.
PDC_00841	"XRKI - Benzoic acid, 4-[(Z)-[3-(1-methylethyl)-4-oxo-2-thioxo-5-thiazolidinylidene]methyl] conjugate 2"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00267	.	.	"Benzoic acid, 4-[(Z)-[3-(1-methylethyl)-4-oxo-2-thioxo-5-thiazolidinylidene]methyl]"	Investigative	.	.	.	.	.
PDC_00842	"XRKI - Benzoic acid, 4-[(Z)-(4-oxo-3-propyl-2-thioxo-5-thiazolidinylidene)methyl] conjugate 2"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00268	.	.	"Benzoic acid, 4-[(Z)-(4-oxo-3-propyl-2-thioxo-5-thiazolidinylidene)methyl]"	Investigative	.	.	.	.	.
PDC_00843	"XRKI - 4-[(Z)-(3-Ethyl-2,4-dioxo-5-thiazolidinylidene)methyl]benzoic acid conjugate"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00147	.	.	"4-[(Z)-(3-Ethyl-2,4-dioxo-5-thiazolidinylidene)methyl]benzoic acid"	Investigative	.	.	.	.	.
PDC_00844	"XRKI - Benzoic acid, 4-[(Z)-(3-methyl-2,4-dioxo-5-thiazolidinylidene)methyl] conjugate"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00219	.	.	"Benzoic acid, 4-[(Z)-(3-methyl-2,4-dioxo-5-thiazolidinylidene)methyl]"	Investigative	.	.	.	.	.
PDC_00845	"XRKI - 4-[(Z)-(2,4-Dioxo-5-thiazolidinylidene)methyl]benzoic acid conjugate"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00159	.	.	"4-[(Z)-(2,4-Dioxo-5-thiazolidinylidene)methyl]benzoic acid"	Investigative	.	.	.	.	.
PDC_00846	XRKI - 4-[(Z)-[4-Oxo-3-(phenylmethyl)-2-thioxo-5-thiazolidinylidene]methyl]benzoic acid conjugate	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00139	.	.	4-[(Z)-[4-Oxo-3-(phenylmethyl)-2-thioxo-5-thiazolidinylidene]methyl]benzoic acid	Investigative	.	.	.	.	.
PDC_00847	XRKI - 4-[(Z)-(5-Oxo-1-phenyl-2-thioxo-4-imidazolidinylidene)methyl]benzoic acid conjugate	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00207	.	.	4-[(Z)-(5-Oxo-1-phenyl-2-thioxo-4-imidazolidinylidene)methyl]benzoic acid	Investigative	.	.	.	.	.
PDC_00848	"XRKI - Benzoic acid, 4-[(Z)-[3-[(4-methoxyphenyl)methyl]-4-oxo-2-thioxo-5-thiazolidinylidene]methyl] conjugate 2"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00261	.	.	"Benzoic acid, 4-[(Z)-[3-[(4-methoxyphenyl)methyl]-4-oxo-2-thioxo-5-thiazolidinylidene]methyl]"	Investigative	.	.	.	.	.
PDC_00849	XRKI - 3-[(4-Methoxyphenyl)methyl]-4-oxo-2-thioxo-5-thiazolidineacetic acid conjugate	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00210	.	.	3-[(4-Methoxyphenyl)methyl]-4-oxo-2-thioxo-5-thiazolidineacetic acid	Investigative	.	.	.	.	.
PDC_00850	"XRKI - (5Z)-5-[(3,4-Dimethoxyphenyl)methylene]-2-thioxo-4-thiazolidinone conjugate 2"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00138	.	.	"(5Z)-5-[(3,4-Dimethoxyphenyl)methylene]-2-thioxo-4-thiazolidinone"	Investigative	.	.	.	.	.
PDC_00851	"XRKI - (5Z)-5-[(3,4-Dimethoxyphenyl)methylene]-2-thioxo-4-thiazolidinone conjugate 1"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00138	.	.	"(5Z)-5-[(3,4-Dimethoxyphenyl)methylene]-2-thioxo-4-thiazolidinone"	Investigative	.	.	.	.	.
PDC_00852	"XRKI - Benzoic acid, 3-[(Z)-(3-cyclopentyl-2,4-dioxo-5-thiazolidinylidene)methyl] conjugate"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00231	.	.	"Benzoic acid, 3-[(Z)-(3-cyclopentyl-2,4-dioxo-5-thiazolidinylidene)methyl]"	Investigative	.	.	.	.	.
PDC_00853	XRKI - 3-[(Z)-(4-Oxo-2-thioxo-5-thiazolidinylidene)methyl]benzoic acid conjugate	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00142	.	.	3-[(Z)-(4-Oxo-2-thioxo-5-thiazolidinylidene)methyl]benzoic acid	Investigative	.	.	.	.	.
PDC_00854	"XRKI - 4-[(Z)-[2,4-Dioxo-3-(phenylmethyl)-5-thiazolidinylidene]methyl]benzoic acid conjugate 10"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00196	.	.	"4-[(Z)-[2,4-Dioxo-3-(phenylmethyl)-5-thiazolidinylidene]methyl]benzoic acid"	Investigative	.	.	.	.	.
PDC_00855	"XRKI - 4-[(Z)-[2,4-Dioxo-3-(phenylmethyl)-5-thiazolidinylidene]methyl]benzoic acid conjugate 9"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00196	.	.	"4-[(Z)-[2,4-Dioxo-3-(phenylmethyl)-5-thiazolidinylidene]methyl]benzoic acid"	Investigative	.	.	.	.	.
PDC_00856	"XRKI - 4-[(Z)-[2,4-Dioxo-3-(phenylmethyl)-5-thiazolidinylidene]methyl]benzoic acid conjugate 8"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00196	.	.	"4-[(Z)-[2,4-Dioxo-3-(phenylmethyl)-5-thiazolidinylidene]methyl]benzoic acid"	Investigative	.	.	.	.	.
PDC_00857	"XRKI - 4-[(Z)-[2,4-Dioxo-3-(phenylmethyl)-5-thiazolidinylidene]methyl]benzoic acid conjugate 7"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00196	.	.	"4-[(Z)-[2,4-Dioxo-3-(phenylmethyl)-5-thiazolidinylidene]methyl]benzoic acid"	Investigative	.	.	.	.	.
PDC_00858	"XRKI - 4-[(Z)-[2,4-Dioxo-3-(phenylmethyl)-5-thiazolidinylidene]methyl]benzoic acid conjugate 6"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00196	.	.	"4-[(Z)-[2,4-Dioxo-3-(phenylmethyl)-5-thiazolidinylidene]methyl]benzoic acid"	Investigative	.	.	.	.	.
PDC_00859	"XRKI - 4-[(Z)-[2,4-Dioxo-3-(phenylmethyl)-5-thiazolidinylidene]methyl]benzoic acid conjugate 5"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00196	.	.	"4-[(Z)-[2,4-Dioxo-3-(phenylmethyl)-5-thiazolidinylidene]methyl]benzoic acid"	Investigative	.	.	.	.	.
PDC_00860	"XRKI - 4-[(Z)-[2,4-Dioxo-3-(phenylmethyl)-5-thiazolidinylidene]methyl]benzoic acid conjugate 4"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00196	.	.	"4-[(Z)-[2,4-Dioxo-3-(phenylmethyl)-5-thiazolidinylidene]methyl]benzoic acid"	Investigative	.	.	.	.	.
PDC_00861	"XRKI - 4-[(Z)-[2,4-Dioxo-3-(phenylmethyl)-5-thiazolidinylidene]methyl]benzoic acid conjugate 3"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00196	.	.	"4-[(Z)-[2,4-Dioxo-3-(phenylmethyl)-5-thiazolidinylidene]methyl]benzoic acid"	Investigative	.	.	.	.	.
PDC_00862	"XRKI - 4-[(Z)-[2,4-Dioxo-3-(phenylmethyl)-5-thiazolidinylidene]methyl]benzoic acid conjugate 2"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00196	.	.	"4-[(Z)-[2,4-Dioxo-3-(phenylmethyl)-5-thiazolidinylidene]methyl]benzoic acid"	Investigative	.	.	.	.	.
PDC_00863	"XRKI - Benzoic acid, 4-[(Z)-[3-[(4-chlorophenyl)methyl]-4-oxo-2-thioxo-5-thiazolidinylidene]methyl] conjugate 1"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00259	.	.	"Benzoic acid, 4-[(Z)-[3-[(4-chlorophenyl)methyl]-4-oxo-2-thioxo-5-thiazolidinylidene]methyl]"	Investigative	.	.	.	.	.
PDC_00864	"XRKI - Benzoic acid, 4-[(Z)-[3-[(4-fluorophenyl)methyl]-4-oxo-2-thioxo-5-thiazolidinylidene]methyl] conjugate 3"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00260	.	.	"Benzoic acid, 4-[(Z)-[3-[(4-fluorophenyl)methyl]-4-oxo-2-thioxo-5-thiazolidinylidene]methyl]"	Investigative	.	.	.	.	.
PDC_00865	"XRKI - Benzoic acid, 4-[(Z)-[3-[(4-methoxyphenyl)methyl]-4-oxo-2-thioxo-5-thiazolidinylidene]methyl] conjugate 3"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00261	.	.	"Benzoic acid, 4-[(Z)-[3-[(4-methoxyphenyl)methyl]-4-oxo-2-thioxo-5-thiazolidinylidene]methyl]"	Investigative	.	.	.	.	.
PDC_00866	"XRKI - Benzaldehyde, 4-[[4-oxo-3-(phenylmethyl)-2-thioxo-5-thiazolidinylidene]methyl] conjugate"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00137	.	.	"Benzaldehyde, 4-[[4-oxo-3-(phenylmethyl)-2-thioxo-5-thiazolidinylidene]methyl]"	Investigative	.	.	.	.	.
PDC_00867	"XRKI - Benzaldehyde, 4-[[3-(4-chlorophenyl)-4-oxo-2-thioxo-5-thiazolidinylidene]methyl] conjugate 2"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00157	.	.	"Benzaldehyde, 4-[[3-(4-chlorophenyl)-4-oxo-2-thioxo-5-thiazolidinylidene]methyl]"	Investigative	.	.	.	.	.
PDC_00868	"XRKI - Benzaldehyde, 4-[[3-(4-chlorophenyl)-4-oxo-2-thioxo-5-thiazolidinylidene]methyl] conjugate 1"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00157	.	.	"Benzaldehyde, 4-[[3-(4-chlorophenyl)-4-oxo-2-thioxo-5-thiazolidinylidene]methyl]"	Investigative	.	.	.	.	.
PDC_00869	"XRKI - Benzoic acid, 4-[(Z)-[3-[(4-fluorophenyl)methyl]-4-oxo-2-thioxo-5-thiazolidinylidene]methyl] conjugate 4"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00260	.	.	"Benzoic acid, 4-[(Z)-[3-[(4-fluorophenyl)methyl]-4-oxo-2-thioxo-5-thiazolidinylidene]methyl]"	Investigative	.	.	.	.	.
PDC_00870	"XRKI - Benzoic acid, 4-[(Z)-[3-[(4-methoxyphenyl)methyl]-4-oxo-2-thioxo-5-thiazolidinylidene]methyl] conjugate 4"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00261	.	.	"Benzoic acid, 4-[(Z)-[3-[(4-methoxyphenyl)methyl]-4-oxo-2-thioxo-5-thiazolidinylidene]methyl]"	Investigative	.	.	.	.	.
PDC_00871	"XRKI - 4-[(Z)-[2,4-Dioxo-3-(phenylmethyl)-5-thiazolidinylidene]methyl]benzoic acid conjugate 1"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00196	.	.	"4-[(Z)-[2,4-Dioxo-3-(phenylmethyl)-5-thiazolidinylidene]methyl]benzoic acid"	Investigative	.	.	.	.	.
PDC_00872	"XRKI - Benzaldehyde, 4-[(4-oxo-3-phenyl-2-thioxo-5-thiazolidinylidene)methyl] conjugate"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00140	.	.	"Benzaldehyde, 4-[(4-oxo-3-phenyl-2-thioxo-5-thiazolidinylidene)methyl]"	Investigative	.	.	.	.	.
PDC_00873	"XRKI - Benzoic acid, 4-[(Z)-[3-[2-(acetyloxy)ethyl]-4-oxo-2-thioxo-5-thiazolidinylidene]methyl] conjugate 2"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00263	.	.	"Benzoic acid, 4-[(Z)-[3-[2-(acetyloxy)ethyl]-4-oxo-2-thioxo-5-thiazolidinylidene]methyl]"	Investigative	.	.	.	.	.
PDC_00874	"XRKI - Benzoic acid, 4-[(Z)-[3-(2-hydroxyethyl)-4-oxo-2-thioxo-5-thiazolidinylidene]methyl] conjugate"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00191	.	.	"Benzoic acid, 4-[(Z)-[3-(2-hydroxyethyl)-4-oxo-2-thioxo-5-thiazolidinylidene]methyl]"	Investigative	.	.	.	.	.
PDC_00875	XRKI - 4-[[4-Oxo-3-(2-propen-1-yl)-2-thioxo-5-thiazolidinylidene]methyl]benzaldehyde conjugate	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00124	.	.	4-[[4-Oxo-3-(2-propen-1-yl)-2-thioxo-5-thiazolidinylidene]methyl]benzaldehyde	Investigative	.	.	.	.	.
PDC_00876	"XRKI - 3-Thiazolidineacetic acid, &alpha;-butyl-5-[(4-carboxyphenyl)methylene]-4-oxo-2-thioxo-, 3-methyl ester, (5Z) conjugate"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00232	.	.	"3-Thiazolidineacetic acid, &alpha;-butyl-5-[(4-carboxyphenyl)methylene]-4-oxo-2-thioxo-, 3-methyl ester, (5Z)"	Investigative	.	.	.	.	.
PDC_00877	"XRKI - Benzoic acid, 4-[(Z)-[4-oxo-3-[(tetrahydro-2-furanyl)methyl]-2-thioxo-5-thiazolidinylidene]methyl] conjugate"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00233	.	.	"Benzoic acid, 4-[(Z)-[4-oxo-3-[(tetrahydro-2-furanyl)methyl]-2-thioxo-5-thiazolidinylidene]methyl]"	Investigative	.	.	.	.	.
PDC_00878	"XRKI - Benzaldehyde, 4-[(3-cyclohexyl-4-oxo-2-thioxo-5-thiazolidinylidene)methyl] conjugate"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00156	.	.	"Benzaldehyde, 4-[(3-cyclohexyl-4-oxo-2-thioxo-5-thiazolidinylidene)methyl]"	Investigative	.	.	.	.	.
PDC_00879	"XRKI - Benzaldehyde, 4-[(3-cyclopentyl-4-oxo-2-thioxo-5-thiazolidinylidene)methyl] conjugate"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00155	.	.	"Benzaldehyde, 4-[(3-cyclopentyl-4-oxo-2-thioxo-5-thiazolidinylidene)methyl]"	Investigative	.	.	.	.	.
PDC_00880	"XRKI - Benzoic acid, 4-[(Z)-(3-butyl-4-oxo-2-thioxo-5-thiazolidinylidene)methyl] conjugate 3"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00266	.	.	"Benzoic acid, 4-[(Z)-(3-butyl-4-oxo-2-thioxo-5-thiazolidinylidene)methyl]"	Investigative	.	.	.	.	.
PDC_00881	"XRKI - Benzoic acid, 4-[(Z)-[3-(1-methylethyl)-4-oxo-2-thioxo-5-thiazolidinylidene]methyl] conjugate 1"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00267	.	.	"Benzoic acid, 4-[(Z)-[3-(1-methylethyl)-4-oxo-2-thioxo-5-thiazolidinylidene]methyl]"	Investigative	.	.	.	.	.
PDC_00882	"XRKI - Benzoic acid, 4-[(Z)-(4-oxo-3-propyl-2-thioxo-5-thiazolidinylidene)methyl] conjugate 1"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00268	.	.	"Benzoic acid, 4-[(Z)-(4-oxo-3-propyl-2-thioxo-5-thiazolidinylidene)methyl]"	Investigative	.	.	.	.	.
PDC_00883	"XRKI - Benzoic acid, 4-[(Z)-(3-cyclopropyl-4-oxo-2-thioxo-5-thiazolidinylidene)methyl] conjugate"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00230	.	.	"Benzoic acid, 4-[(Z)-(3-cyclopropyl-4-oxo-2-thioxo-5-thiazolidinylidene)methyl]"	Investigative	.	.	.	.	.
PDC_00884	"XRKI - Benzaldehyde, 4-[(Z)-(3-ethyl-4-oxo-2-thioxo-5-thiazolidinylidene)methyl] conjugate"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00144	.	.	"Benzaldehyde, 4-[(Z)-(3-ethyl-4-oxo-2-thioxo-5-thiazolidinylidene)methyl]"	Investigative	.	.	.	.	.
PDC_00885	XRKI - 4-[(3-Methyl-4-oxo-2-thioxo-5-thiazolidinylidene)methyl]benzaldehyde conjugate	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00136	.	.	4-[(3-Methyl-4-oxo-2-thioxo-5-thiazolidinylidene)methyl]benzaldehyde	Investigative	.	.	.	.	.
PDC_00886	"XRKI - Benzaldehyde, 4-[(Z)-(4-oxo-2-thioxo-5-thiazolidinylidene)methyl] conjugate"	PEP00226	XRKI	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00165	.	.	"Benzaldehyde, 4-[(Z)-(4-oxo-2-thioxo-5-thiazolidinylidene)methyl]"	Investigative	.	.	.	.	.
PDC_00887	Bombesin (BBN) fragment - 6-Heptynoic acid conjugate	PEP00468	Bombesin (BBN) fragment	REC99999	Undisclosed	LIN00126	PEG	DRG00154	.	.	6-Heptynoic acid	Investigative	.	.	.	.	.
PDC_00888	Bombesin - 6-Heptynoic acid conjugate	PEP00467	Bombesin	REC99999	Undisclosed	LIN00126	PEG	DRG00154	.	.	6-Heptynoic acid	Investigative	.	.	.	.	.
PDC_00890	YVG - 6-Heptynoic acid conjugate	PEP01004	YVG	REC99999	Undisclosed	LIN00126	PEG	DRG00154	.	.	6-Heptynoic acid	Investigative	.	.	.	.	.
PDC_00891	"XRGD - L-Ornithine, N5-[[[(2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuranyl)sulfonyl]amino]iminomethyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl] conjugate"	PEP00227	XRGD	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00171	.	.	"L-Ornithine, N5-[[[(2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuranyl)sulfonyl]amino]iminomethyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]"	Investigative	.	.	.	.	.
PDC_00893	GFLG - 3-Maleimidopropionic acid conjugate	PEP00041	GFLG	REC00013	Integrin alpha-V; Integrin beta-3 (ITGAV; ITGB3)	LIN00146	Undisclosed	DRG00128	.	.	3-Maleimidopropionic acid	Investigative	.	.	.	.	.
PDC_00894	TAT-analogue 1 - Doxorubicin conjugate	PEP00776	TAT-analogue 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00895	TAT-analogue 2 - 5-FAM (Hydroxyfluorescein) dye conjugate	PEP00777	TAT-analogue 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00328	.	.	5-FAM (Hydroxyfluorescein) dye	Investigative	.	.	.	.	.
PDC_00896	TAT-analogue 3 - Doxorubicin conjugate	PEP00778	TAT-analogue 3	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_00897	TAT-analogue 4 - 5-FAM (Hydroxyfluorescein) dye conjugate	PEP00779	TAT-analogue 4	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00328	.	.	5-FAM (Hydroxyfluorescein) dye	Investigative	.	.	.	.	.
PDC_00898	Tripeptide 8 - Quinine conjugate	PEP00868	Tripeptide 8	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00149	.	.	Quinine	Investigative	.	.	.	.	.
PDC_00899	Dipeptide 13 - Quinine conjugate	PEP00509	Dipeptide 13	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00149	.	.	Quinine	Investigative	.	.	.	.	.
PDC_00900	Dipeptide 14 - Quinine conjugate	PEP00510	Dipeptide 14	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00149	.	.	Quinine	Investigative	.	.	.	.	.
PDC_00901	Dipeptide 15 - Quinine conjugate	PEP00511	Dipeptide 15	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00149	.	.	Quinine	Investigative	.	.	.	.	.
PDC_00902	Polyarginine 1 - Cholesterol conjugate	PEP00757	Polyarginine 1	REC99999	Undisclosed	LIN00134	Sulfide	DRG00078	TAR10051	Cholinephosphate cytidylyltransferase (PCYT1B)	Cholesterol	Investigative	.	.	.	.	.
PDC_00903	Polyarginine 2 - Cholesterol conjugate	PEP00758	Polyarginine 2	REC99999	Undisclosed	LIN00134	Sulfide	DRG00078	TAR10051	Cholinephosphate cytidylyltransferase (PCYT1B)	Cholesterol	Investigative	.	.	.	.	.
PDC_00904	Polyarginine 3 - Cholesterol conjugate	PEP00759	Polyarginine 3	REC99999	Undisclosed	LIN00134	Sulfide	DRG00078	TAR10051	Cholinephosphate cytidylyltransferase (PCYT1B)	Cholesterol	Investigative	.	.	.	.	.
PDC_00905	Polyarginine 4 - Cholesterol conjugate	PEP00760	Polyarginine 4	REC99999	Undisclosed	LIN00134	Sulfide	DRG00078	TAR10051	Cholinephosphate cytidylyltransferase (PCYT1B)	Cholesterol	Investigative	.	.	.	.	.
PDC_00906	Peptide substrate - Protein kinase C inhibitor conjugate	PEP00749	Peptide substrate	REC99999	Undisclosed	LIN00127	Triazole	DRG00213	.	.	Protein kinase C inhibitor 	Investigative	.	.	.	.	.
PDC_00907	Penetratin (fragment) - Fluorene-9-methanol conjugate	PEP00719	Penetratin (fragment)	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00113	.	.	Fluorene-9-methanol	Investigative	.	.	.	.	.
PDC_00908	"TAT (trans-activator of transcription) - 2,2-Dithiobis[5-nitropyridine] conjugate"	PEP00022	TAT (trans-activator of transcription) 	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00098	.	.	"2,2-Dithiobis[5-nitropyridine]"	Investigative	.	.	.	.	.
PDC_00909	Tripeptide 9 - Betulonic acid derivative conjugate	PEP00869	Tripeptide 9	REC99999	Undisclosed	LIN00127	Triazole	DRG00234	.	.	Betulonic acid derivative	Investigative	.	.	.	.	.
PDC_00910	Tripeptide 10 - Betulonic acid derivative conjugate	PEP00870	Tripeptide 10	REC99999	Undisclosed	LIN00127	Triazole	DRG00234	.	.	Betulonic acid derivative	Investigative	.	.	.	.	.
PDC_00911	Tripeptide 11 - Betulonic acid derivative conjugate	PEP00871	Tripeptide 11	REC99999	Undisclosed	LIN00127	Triazole	DRG00234	.	.	Betulonic acid derivative	Investigative	.	.	.	.	.
PDC_00912	Tripeptide 12 - Betulonic acid derivative conjugate	PEP00872	Tripeptide 12	REC99999	Undisclosed	LIN00127	Triazole	DRG00234	.	.	Betulonic acid derivative	Investigative	.	.	.	.	.
PDC_00913	Tripeptide 13 - Betulonic acid derivative conjugate	PEP00873	Tripeptide 13	REC99999	Undisclosed	LIN00127	Triazole	DRG00234	.	.	Betulonic acid derivative	Investigative	.	.	.	.	.
PDC_00914	Tripeptide 14 - Betulonic acid derivative conjugate	PEP00874	Tripeptide 14	REC99999	Undisclosed	LIN00127	Triazole	DRG00234	.	.	Betulonic acid derivative	Investigative	.	.	.	.	.
PDC_00915	Tetrapeptide 5 - N-Hydroxysuccinimide conjugate	PEP00785	Tetrapeptide 5	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00112	.	.	N-Hydroxysuccinimide	Investigative	.	.	.	.	.
PDC_00916	Pentapeptide 5 - 4-aminocyclophosphamide prodrug conjugate	PEP00728	Pentapeptide 5	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00235	.	.	4-aminocyclophosphamide prodrug	Investigative	.	.	.	.	.
PDC_00917	Hexapeptide 11 - 4-aminocyclophosphamide prodrug conjugate 1	PEP00590	Hexapeptide 11	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00235	.	.	4-aminocyclophosphamide prodrug	Investigative	.	.	.	.	.
PDC_00918	Tetrapeptide 6 - 4-aminocyclophosphamide prodrug conjugate 1	PEP00786	Tetrapeptide 6	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00235	.	.	4-aminocyclophosphamide prodrug	Investigative	.	.	.	.	.
PDC_00919	Dipeptide 16 - 4-aminocyclophosphamide prodrug conjugate	PEP00512	Dipeptide 16	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00235	.	.	4-aminocyclophosphamide prodrug	Investigative	.	.	.	.	.
PDC_00920	Pentapeptide 6 - 4-aminocyclophosphamide prodrug conjugate	PEP00729	Pentapeptide 6	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00235	.	.	4-aminocyclophosphamide prodrug	Investigative	.	.	.	.	.
PDC_00921	Hexapeptide 11 - 4-aminocyclophosphamide prodrug conjugate 2	PEP00590	Hexapeptide 11	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00235	.	.	4-aminocyclophosphamide prodrug	Investigative	.	.	.	.	.
PDC_00922	Tetrapeptide 6 - 4-aminocyclophosphamide prodrug conjugate 2	PEP00786	Tetrapeptide 6	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00235	.	.	4-aminocyclophosphamide prodrug	Investigative	.	.	.	.	.
PDC_00923	Dipeptide 17 - Acyclovir (ACV) conjugate	PEP00513	Dipeptide 17	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00221	TAR10037	Varicella-zoster virus DNA polymerase (VZV ORF28)	Acyclovir (ACV)	Investigative	.	.	.	.	.
PDC_00924	Tetrapeptide 7 - Acyclovir (ACV) conjugate 1	PEP00787	Tetrapeptide 7	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00221	TAR10037	Varicella-zoster virus DNA polymerase (VZV ORF28)	Acyclovir (ACV)	Investigative	.	.	.	.	.
PDC_00925	Dipeptide 18 - Acyclovir (ACV) conjugate	PEP00514	Dipeptide 18	REC99999	Undisclosed	LIN00126	PEG	DRG00221	TAR10037	Varicella-zoster virus DNA polymerase (VZV ORF28)	Acyclovir (ACV)	Investigative	.	.	.	.	.
PDC_00926	Tetrapeptide 7 - Acyclovir (ACV) conjugate 2	PEP00787	Tetrapeptide 7	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00221	TAR10037	Varicella-zoster virus DNA polymerase (VZV ORF28)	Acyclovir (ACV)	Investigative	.	.	.	.	.
PDC_00927	Tetrapeptide 7 - Acyclovir (ACV) conjugate 3	PEP00787	Tetrapeptide 7	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00221	TAR10037	Varicella-zoster virus DNA polymerase (VZV ORF28)	Acyclovir (ACV)	Investigative	.	.	.	.	.
PDC_00928	Tetrapeptide 7 - Acyclovir (ACV) conjugate 4	PEP00787	Tetrapeptide 7	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00221	TAR10037	Varicella-zoster virus DNA polymerase (VZV ORF28)	Acyclovir (ACV)	Investigative	.	.	.	.	.
PDC_00929	Dipeptide 19 - Acyclovir (ACV) conjugate	PEP00515	Dipeptide 19	REC99999	Undisclosed	LIN00135	Glycole	DRG00221	TAR10037	Varicella-zoster virus DNA polymerase (VZV ORF28)	Acyclovir (ACV)	Investigative	.	.	.	.	.
PDC_00930	Tripeptide 15 - Acyclovir (ACV) conjugate	PEP00875	Tripeptide 15	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00221	TAR10037	Varicella-zoster virus DNA polymerase (VZV ORF28)	Acyclovir (ACV)	Investigative	.	.	.	.	.
PDC_00931	Tripeptide 16 - Oleanolic acid dye conjugate	PEP00876	Tripeptide 16	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00218	.	.	Oleanolic acid dye	Investigative	.	.	.	.	.
PDC_00932	Tripeptide 16 - Glycyrrhetinic acid dye conjugate	PEP00876	Tripeptide 16	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00178	.	.	Glycyrrhetinic acid dye	Investigative	.	.	.	.	.
PDC_00933	G3-C12 peptide 1 - Fluorescein conjugate	PEP00564	G3-C12 peptide 1	REC99999	Undisclosed	LIN00136	Amino-hexanoic acid	DRG00285	.	.	Fluorescein	Investigative	.	.	.	.	.
PDC_00934	G3-C12 peptide 2 - Captopril conjugate	PEP00565	G3-C12 peptide 2	REC99999	Undisclosed	LIN00136	Amino-hexanoic acid	DRG00106	TAR10036	HUMAN angiotensin-converting enzyme (ACE)	Captopril	Investigative	.	.	.	.	.
PDC_00935	Dipeptide 20 - &Beta;-D-Galactopyranoside derivative conjugate	PEP00516	Dipeptide 20	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00236	.	.	&Beta;-D-Galactopyranoside derivative	Investigative	.	.	.	.	.
PDC_00937	KKLFKKILKKL - Tosyl chloride conjugate 1	PEP00228	KKLFKKILKKL	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00089	.	.	Tosyl chloride	Investigative	.	.	.	.	.
PDC_00938	KKLFKKILKKL - Tosyl chloride conjugate 2	PEP00228	KKLFKKILKKL	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00089	.	.	Tosyl chloride	Investigative	.	.	.	.	.
PDC_00939	Ketone containing peptide 1 - Ureidopyrimidinone (UPy) conjugate 1	PEP00608	Ketone containing peptide 1	REC99999	Undisclosed	LIN00126	PEG	DRG00237	.	.	Ureidopyrimidinone (UPy)	Investigative	.	.	.	.	.
PDC_00940	N-terminal aldehyde peptide 1 - Ureidopyrimidinone (UPy) conjugate 1	PEP00650	N-terminal aldehyde peptide 1	REC99999	Undisclosed	LIN00126	PEG	DRG00237	.	.	Ureidopyrimidinone (UPy)	Investigative	.	.	.	.	.
PDC_00941	Ketone containing peptide 1 - Ureidopyrimidinone (UPy) conjugate 2	PEP00608	Ketone containing peptide 1	REC99999	Undisclosed	LIN00126	PEG	DRG00237	.	.	Ureidopyrimidinone (UPy)	Investigative	.	.	.	.	.
PDC_00942	N-terminal aldehyde peptide 2 - Ureidopyrimidinone (UPy) conjugate	PEP00651	N-terminal aldehyde peptide 2	REC99999	Undisclosed	LIN00126	PEG	DRG00237	.	.	Ureidopyrimidinone (UPy)	Investigative	.	.	.	.	.
PDC_00943	N-terminal aldehyde peptide 3 - Ureidopyrimidinone (UPy) conjugate	PEP00652	N-terminal aldehyde peptide 3	REC99999	Undisclosed	LIN00126	PEG	DRG00237	.	.	Ureidopyrimidinone (UPy)	Investigative	.	.	.	.	.
PDC_00944	Ketone containing peptide 2 - Ureidopyrimidinone (UPy) conjugate	PEP00609	Ketone containing peptide 2	REC99999	Undisclosed	LIN00126	PEG	DRG00237	.	.	Ureidopyrimidinone (UPy)	Investigative	.	.	.	.	.
PDC_00945	N-terminal aldehyde peptide 1 - Ureidopyrimidinone (UPy) conjugate 2	PEP00650	N-terminal aldehyde peptide 1	REC99999	Undisclosed	LIN00126	PEG	DRG00237	.	.	Ureidopyrimidinone (UPy)	Investigative	.	.	.	.	.
PDC_00946	Inhibitor peptide 1 - Cholestanol conjugate 1	PEP00599	Inhibitor peptide 1	REC99999	Undisclosed	LIN00126	PEG	DRG00084	.	.	Cholestanol	Investigative	.	.	.	.	.
PDC_00947	Inhibitor peptide 2 - Cholestanol conjugate	PEP00600	Inhibitor peptide 2	REC99999	Undisclosed	LIN00126	PEG	DRG00084	.	.	Cholestanol	Investigative	.	.	.	.	.
PDC_00948	Inhibitor peptide 3 - Cholestanol conjugate	PEP00601	Inhibitor peptide 3	REC99999	Undisclosed	LIN00126	PEG	DRG00084	.	.	Cholestanol	Investigative	.	.	.	.	.
PDC_00949	Inhibitor peptide 4 - Cholestanol conjugate 1	PEP00602	Inhibitor peptide 4	REC99999	Undisclosed	LIN00126	PEG	DRG00084	.	.	Cholestanol	Investigative	.	.	.	.	.
PDC_00950	Inhibitor peptide 5 - Cholestanol conjugate	PEP00603	Inhibitor peptide 5	REC99999	Undisclosed	LIN00126	PEG	DRG00084	.	.	Cholestanol	Investigative	.	.	.	.	.
PDC_00951	Inhibitor peptide 1 - Cholestanol conjugate 2	PEP00599	Inhibitor peptide 1	REC99999	Undisclosed	LIN00126	PEG	DRG00084	.	.	Cholestanol	Investigative	.	.	.	.	.
PDC_00952	Inhibitor peptide 6 - Cholestanol conjugate	PEP00604	Inhibitor peptide 6	REC99999	Undisclosed	LIN00126	PEG	DRG00084	.	.	Cholestanol	Investigative	.	.	.	.	.
PDC_00953	Inhibitor peptide 4 - Cholestanol conjugate 2	PEP00602	Inhibitor peptide 4	REC99999	Undisclosed	LIN00126	PEG	DRG00084	.	.	Cholestanol	Investigative	.	.	.	.	.
PDC_00954	Inhibitor peptide 1 - Cholestanol conjugate 3	PEP00599	Inhibitor peptide 1	REC99999	Undisclosed	LIN00126	PEG	DRG00084	.	.	Cholestanol	Investigative	.	.	.	.	.
PDC_00956	Inhibitor peptide 7 - Cholestanol conjugate	PEP00605	Inhibitor peptide 7	REC99999	Undisclosed	LIN00126	PEG	DRG00084	.	.	Cholestanol	Investigative	.	.	.	.	.
PDC_00957	Inhibitor peptide 4 - Cholestanol conjugate 3	PEP00602	Inhibitor peptide 4	REC99999	Undisclosed	LIN00126	PEG	DRG00084	.	.	Cholestanol	Investigative	.	.	.	.	.
PDC_00958	Inhibitor peptide 8 - Cholestanol conjugate	PEP00606	Inhibitor peptide 8	REC99999	Undisclosed	LIN00126	PEG	DRG00084	.	.	Cholestanol	Investigative	.	.	.	.	.
PDC_00959	Inhibitor peptide 9 - Cholestanol conjugate 1	PEP00607	Inhibitor peptide 9	REC99999	Undisclosed	LIN00126	PEG	DRG00084	.	.	Cholestanol	Investigative	.	.	.	.	.
PDC_00960	Inhibitor peptide 9 - Cholestanol conjugate 2	PEP00607	Inhibitor peptide 9	REC99999	Undisclosed	LIN00126	PEG	DRG00084	.	.	Cholestanol	Investigative	.	.	.	.	.
PDC_00961	Inhibitor peptide 9 - Cholestanol conjugate 3	PEP00607	Inhibitor peptide 9	REC99999	Undisclosed	LIN00126	PEG	DRG00084	.	.	Cholestanol	Investigative	.	.	.	.	.
PDC_00962	Inhibitor peptide 1 - Cholestanol conjugate 4	PEP00599	Inhibitor peptide 1	REC99999	Undisclosed	LIN00126	PEG	DRG00084	.	.	Cholestanol	Investigative	.	.	.	.	.
PDC_00963	c(RGDfK) - Diethyl squarate conjugate 1	PEP00122	c(RGDfK)	REC00013	Integrin alpha-V; Integrin beta-3 (ITGAV; ITGB3)	LIN00126	PEG	DRG00118	.	.	Diethyl squarate	Investigative	.	.	.	.	.
PDC_00964	c(RGDfK) - Diethyl squarate conjugate 2	PEP00122	c(RGDfK)	REC00013	Integrin alpha-V; Integrin beta-3 (ITGAV; ITGB3)	LIN00126	PEG	DRG00118	.	.	Diethyl squarate	Investigative	.	.	.	.	.
PDC_00965	Endothelial cell epitope - Diethyl squarate conjugate	PEP00557	Endothelial cell epitope	REC99999	Undisclosed	LIN00126	PEG	DRG00118	.	.	Diethyl squarate	Investigative	.	.	.	.	.
PDC_00966	"Tripeptide 17 - 1,5,9-Triazacyclododecane-1-acetic acid conjugate"	PEP00877	Tripeptide 17	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00216	.	.	"1,5,9-Triazacyclododecane-1-acetic acid"	Investigative	.	.	.	.	.
PDC_00967	"Tripeptide 18 - 1,5,9-Triazacyclododecane-1-acetic acid conjugate"	PEP00878	Tripeptide 18	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00216	.	.	"1,5,9-Triazacyclododecane-1-acetic acid"	Investigative	.	.	.	.	.
PDC_00968	"Tripeptide 19 - 1,5,9-Triazacyclododecane-1-acetic acid conjugate"	PEP00879	Tripeptide 19	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00216	.	.	"1,5,9-Triazacyclododecane-1-acetic acid"	Investigative	.	.	.	.	.
PDC_00969	"Tripeptide 20 - 1,5,9-Triazacyclododecane-1-acetic acid conjugate"	PEP00880	Tripeptide 20	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00216	.	.	"1,5,9-Triazacyclododecane-1-acetic acid"	Investigative	.	.	.	.	.
PDC_00970	"Tripeptide 21 - 1,5,9-Triazacyclododecane-1-acetic acid conjugate"	PEP00881	Tripeptide 21	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00216	.	.	"1,5,9-Triazacyclododecane-1-acetic acid"	Investigative	.	.	.	.	.
PDC_00971	"Tripeptide 22 - 1,5,9-Triazacyclododecane-1-acetic acid conjugate"	PEP00882	Tripeptide 22	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00216	.	.	"1,5,9-Triazacyclododecane-1-acetic acid"	Investigative	.	.	.	.	.
PDC_00972	"Tripeptide 23 - 1,5,9-Triazacyclododecane-1-acetic acid conjugate"	PEP00883	Tripeptide 23	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00216	.	.	"1,5,9-Triazacyclododecane-1-acetic acid"	Investigative	.	.	.	.	.
PDC_00973	"Tripeptide 24 - 1,5,9-Triazacyclododecane-1-acetic acid conjugate"	PEP00884	Tripeptide 24	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00216	.	.	"1,5,9-Triazacyclododecane-1-acetic acid"	Investigative	.	.	.	.	.
PDC_00974	Edotreotide (TOC) - DOTA tri(tert-butyl) ester conjugate	PEP00551	Edotreotide (TOC)	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00175	.	.	DOTA tri(tert-butyl) ester	Investigative	.	.	.	.	.
PDC_00975	TATE - DOTA tri(tert-butyl) ester conjugate	PEP00780	TATE	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00175	.	.	DOTA tri(tert-butyl) ester	Investigative	.	.	.	.	.
PDC_00976	Hexapeptide 12 - DOTA tri(tert-butyl) ester conjugate	PEP00591	Hexapeptide 12	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00175	.	.	DOTA tri(tert-butyl) ester	Investigative	.	.	.	.	.
PDC_00977	"Dodecapeptide - Coumarine, 7-Methoxy-2-oxo-2H-1-benzopyran-3-carboxylic acid conjugate 1"	PEP00550	Dodecapeptide	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00130	.	.	"Coumarine, 7-Methoxy-2-oxo-2H-1-benzopyran-3-carboxylic acid"	Investigative	.	.	.	.	.
PDC_00978	"Dodecapeptide - Coumarine, 7-Methoxy-2-oxo-2H-1-benzopyran-3-carboxylic acid conjugate 2"	PEP00550	Dodecapeptide	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00130	.	.	"Coumarine, 7-Methoxy-2-oxo-2H-1-benzopyran-3-carboxylic acid"	Investigative	.	.	.	.	.
PDC_00979	"Dodecapeptide - Coumarine, 7-Methoxy-2-oxo-2H-1-benzopyran-3-carboxylic acid conjugate 3"	PEP00550	Dodecapeptide	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00130	.	.	"Coumarine, 7-Methoxy-2-oxo-2H-1-benzopyran-3-carboxylic acid"	Investigative	.	.	.	.	.
PDC_00981	"Dodecapeptide - Coumarine, 7-Methoxy-2-oxo-2H-1-benzopyran-3-carboxylic acid conjugate 5"	PEP00550	Dodecapeptide	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00130	.	.	"Coumarine, 7-Methoxy-2-oxo-2H-1-benzopyran-3-carboxylic acid"	Investigative	.	.	.	.	.
PDC_00983	"Dodecapeptide - Coumarine, 7-Methoxy-2-oxo-2H-1-benzopyran-3-carboxylic acid conjugate 6"	PEP00550	Dodecapeptide	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00130	.	.	"Coumarine, 7-Methoxy-2-oxo-2H-1-benzopyran-3-carboxylic acid"	Investigative	.	.	.	.	.
PDC_00984	"Dodecapeptide - Coumarine, 7-Methoxy-2-oxo-2H-1-benzopyran-3-carboxylic acid conjugate 7"	PEP00550	Dodecapeptide	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00130	.	.	"Coumarine, 7-Methoxy-2-oxo-2H-1-benzopyran-3-carboxylic acid"	Investigative	.	.	.	.	.
PDC_00985	Melanocortin receptor 1 (MC1R) antagonist peptide 1 - P-Coumaric acid conjugate	PEP00626	Melanocortin receptor 1 (MC1R) antagonist peptide 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00067	.	.	P-Coumaric acid	Investigative	.	.	.	.	.
PDC_00986	Melanocortin receptor 1 (MC1R) antagonist peptide 2 - P-Coumaric acid conjugate	PEP00627	Melanocortin receptor 1 (MC1R) antagonist peptide 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00067	.	.	P-Coumaric acid	Investigative	.	.	.	.	.
PDC_00987	Melanocortin receptor 1 (MC1R) antagonist peptide 3 - P-Coumaric acid conjugate 1	PEP00628	Melanocortin receptor 1 (MC1R) antagonist peptide 3	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00067	.	.	P-Coumaric acid	Investigative	.	.	.	.	.
PDC_00988	Melanocortin receptor 1 (MC1R) antagonist peptide 4 - P-Coumaric acid conjugate	PEP00629	Melanocortin receptor 1 (MC1R) antagonist peptide 4	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00067	.	.	P-Coumaric acid	Investigative	.	.	.	.	.
PDC_00989	Melanocortin receptor 1 (MC1R) antagonist peptide 5 - P-Coumaric acid conjugate 1	PEP00630	Melanocortin receptor 1 (MC1R) antagonist peptide 5	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00067	.	.	P-Coumaric acid	Investigative	.	.	.	.	.
PDC_00990	Melanocortin receptor 1 (MC1R) antagonist peptide 3 - P-Coumaric acid conjugate 2	PEP00628	Melanocortin receptor 1 (MC1R) antagonist peptide 3	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00067	.	.	P-Coumaric acid	Investigative	.	.	.	.	.
PDC_00991	Melanocortin receptor 1 (MC1R) antagonist peptide 6 - P-Coumaric acid conjugate 1	PEP00631	Melanocortin receptor 1 (MC1R) antagonist peptide 6	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00067	.	.	P-Coumaric acid	Investigative	.	.	.	.	.
PDC_00992	Melanocortin receptor 1 (MC1R) antagonist peptide 5 - P-Coumaric acid conjugate 2	PEP00630	Melanocortin receptor 1 (MC1R) antagonist peptide 5	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00067	.	.	P-Coumaric acid	Investigative	.	.	.	.	.
PDC_00993	Melanocortin receptor 1 (MC1R) antagonist peptide 5 - Caffeic acid conjugate 1	PEP00630	Melanocortin receptor 1 (MC1R) antagonist peptide 5	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00073	.	.	Caffeic acid	Investigative	.	.	.	.	.
PDC_00994	Melanocortin receptor 1 (MC1R) antagonist peptide 6 - Caffeic acid conjugate	PEP00631	Melanocortin receptor 1 (MC1R) antagonist peptide 6	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00073	.	.	Caffeic acid	Investigative	.	.	.	.	.
PDC_00995	Melanocortin receptor 1 (MC1R) antagonist peptide 7 - Caffeic acid conjugate 1	PEP00632	Melanocortin receptor 1 (MC1R) antagonist peptide 7	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00073	.	.	Caffeic acid	Investigative	.	.	.	.	.
PDC_00996	Melanocortin receptor 1 (MC1R) antagonist peptide 8 - Caffeic acid conjugate 3	PEP00633	Melanocortin receptor 1 (MC1R) antagonist peptide 8	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00073	.	.	Caffeic acid	Investigative	.	.	.	.	.
PDC_00997	Melanocortin receptor 1 (MC1R) antagonist peptide 5 - Caffeic acid conjugate 2	PEP00630	Melanocortin receptor 1 (MC1R) antagonist peptide 5	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00073	.	.	Caffeic acid	Investigative	.	.	.	.	.
PDC_00998	Melanocortin receptor 1 (MC1R) antagonist peptide 7 - Caffeic acid conjugate 2	PEP00632	Melanocortin receptor 1 (MC1R) antagonist peptide 7	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00073	.	.	Caffeic acid	Investigative	.	.	.	.	.
PDC_00999	Melanocortin receptor 1 (MC1R) antagonist peptide 8 - Caffeic acid conjugate 4	PEP00633	Melanocortin receptor 1 (MC1R) antagonist peptide 8	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00073	.	.	Caffeic acid	Investigative	.	.	.	.	.
PDC_01000	Melanocortin receptor 1 (MC1R) antagonist peptide 5 - Caffeic acid conjugate 3	PEP00630	Melanocortin receptor 1 (MC1R) antagonist peptide 5	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00073	.	.	Caffeic acid	Investigative	.	.	.	.	.
PDC_01001	Melanocortin receptor 1 (MC1R) antagonist peptide 6 - P-Coumaric acid conjugate 2	PEP00631	Melanocortin receptor 1 (MC1R) antagonist peptide 6	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00067	.	.	P-Coumaric acid	Investigative	.	.	.	.	.
PDC_01002	Melanocortin receptor 1 (MC1R) antagonist peptide 8 - P-Coumaric acid conjugate	PEP00633	Melanocortin receptor 1 (MC1R) antagonist peptide 8	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00067	.	.	P-Coumaric acid	Investigative	.	.	.	.	.
PDC_01003	Activable cell-penetrating peptide (ACCP) - Doxorubicin conjugate	PEP00412	Activable cell-penetrating peptide (ACCP)	REC99999	Undisclosed	LIN00121	Succinimide	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_01004	Antibacterial peptide 1 - Cephalothin conjugate	PEP00435	Antibacterial peptide 1	REC99999	Undisclosed	LIN00018	Carbamic acid	DRG00079	TAR10041	Bacterial DD-carboxypeptidase (Bact vanYB)	Cephalothin	Investigative	.	.	.	.	.
PDC_01005	Antibacterial peptide 2 - Cephalothin conjugate 1	PEP00436	Antibacterial peptide 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00079	TAR10041	Bacterial DD-carboxypeptidase (Bact vanYB)	Cephalothin	Investigative	.	.	.	.	.
PDC_01006	Antibacterial peptide 2 - Cephalothin conjugate 2	PEP00436	Antibacterial peptide 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00079	TAR10041	Bacterial DD-carboxypeptidase (Bact vanYB)	Cephalothin	Investigative	.	.	.	.	.
PDC_01007	"GranF2 granulysin - Coumarone derivative TB5, antitubercular drug conjugate"	PEP00577	GranF2 granulysin	REC99999	Undisclosed	LIN00033	Glutaric acid	DRG00158	.	.	"Coumarone derivative TB5, antitubercular drug"	Investigative	.	.	.	.	.
PDC_01008	"OT20 tuftsin - Coumarone derivative TB5, antitubercular drug conjugate"	PEP00709	OT20 tuftsin	REC99999	Undisclosed	LIN00033	Glutaric acid	DRG00158	.	.	"Coumarone derivative TB5, antitubercular drug"	Investigative	.	.	.	.	.
PDC_01009	"CIBR peptide (Intercellular adhesion molecule-1 (ICAM-1) fragment), monomer 1 - Methotrexate conjugate 1"	PEP00489	"CIBR peptide (Intercellular adhesion molecule-1 (ICAM-1) fragment), monomer 1"	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_01010	"CIBR peptide (Intercellular adhesion molecule-1 (ICAM-1) fragment), dimer - Methotrexate conjugate 1"	PEP00488	"CIBR peptide (Intercellular adhesion molecule-1 (ICAM-1) fragment), dimer"	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_01011	"CIBR peptide (Intercellular adhesion molecule-1 (ICAM-1) fragment), dimer - Methotrexate conjugate 2"	PEP00488	"CIBR peptide (Intercellular adhesion molecule-1 (ICAM-1) fragment), dimer"	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_01012	"CIBR peptide (Intercellular adhesion molecule-1 (ICAM-1) fragment), monomer 1 - Methotrexate conjugate 2"	PEP00489	"CIBR peptide (Intercellular adhesion molecule-1 (ICAM-1) fragment), monomer 1"	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_01013	"CIBR peptide (Intercellular adhesion molecule-1 (ICAM-1) fragment), monomer 2 - Methotrexate conjugate"	PEP00490	"CIBR peptide (Intercellular adhesion molecule-1 (ICAM-1) fragment), monomer 2"	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_01014	"CIBR peptide (Intercellular adhesion molecule-1 (ICAM-1) fragment), monomer 1 - Methotrexate conjugate 3"	PEP00489	"CIBR peptide (Intercellular adhesion molecule-1 (ICAM-1) fragment), monomer 1"	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_01015	"CIBR peptide (Intercellular adhesion molecule-1 (ICAM-1) fragment), monomer 3 - Methotrexate conjugate"	PEP00491	"CIBR peptide (Intercellular adhesion molecule-1 (ICAM-1) fragment), monomer 3"	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_01016	"Elastin-base peptide 1 - 1-(2,3-Dichlorophenyl)piperazine conjugate 1"	PEP00555	Elastin-base peptide 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00135	.	.	"1-(2,3-Dichlorophenyl)piperazine"	Investigative	.	.	.	.	.
PDC_01017	"Pentapeptide 7 - 1-(2,3-Dichlorophenyl)piperazine conjugate"	PEP01022	Phenylalanine	REC99999	Undisclosed	LIN00087	Amide bond	DRG00135	.	.	"1-(2,3-Dichlorophenyl)piperazine"	Investigative	.	.	.	.	.
PDC_01018	"Pentapeptide 8 - 1-(2,3-Dichlorophenyl)piperazine conjugate"	PEP01023	Tryptophan	REC99999	Undisclosed	LIN00087	Amide bond	DRG00135	.	.	"1-(2,3-Dichlorophenyl)piperazine"	Investigative	.	.	.	.	.
PDC_01019	"Tetrapeptide 8 - 1-(2,3-Dichlorophenyl)piperazine conjugate"	PEP01024	Tyrosine	REC99999	Undisclosed	LIN00087	Amide bond	DRG00135	.	.	"1-(2,3-Dichlorophenyl)piperazine"	Investigative	.	.	.	.	.
PDC_01020	"Tetrapeptide 9 - 1-(2,3-Dichlorophenyl)piperazine conjugate"	PEP01025	GGAP	REC99999	Undisclosed	LIN00087	Amide bond	DRG00135	.	.	"1-(2,3-Dichlorophenyl)piperazine"	Investigative	.	.	.	.	.
PDC_01021	"Tetrapeptide 10 - 1-(2,3-Dichlorophenyl)piperazine conjugate"	PEP01026	GGIP	REC99999	Undisclosed	LIN00087	Amide bond	DRG00135	.	.	"1-(2,3-Dichlorophenyl)piperazine"	Investigative	.	.	.	.	.
PDC_01026	"Elastin-base peptide 1 - 1-(2,3-Dichlorophenyl)piperazine conjugate"	PEP01031	GEGFPGVGVPGVGFPGFGFPGVGVPGVGFP	REC99999	Undisclosed	LIN00087	Amide bond	DRG00135	.	.	"1-(2,3-Dichlorophenyl)piperazine"	Investigative	.	.	.	.	.
PDC_01027	"Elastin-base peptide 2 - 1-(2,3-Dichlorophenyl)piperazine conjugate 1"	PEP00556	Elastin-base peptide 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00135	.	.	"1-(2,3-Dichlorophenyl)piperazine"	Investigative	.	.	.	.	.
PDC_01029	"Elastin-base peptide 2 - 1-(2,3-Dichlorophenyl)piperazine conjugate"	PEP00556	Elastin-base peptide 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00135	.	.	"1-(2,3-Dichlorophenyl)piperazine"	Investigative	.	.	.	.	.
PDC_01030	Lipopolysaccharide (LPS) binding antimicrobial peptide YI13WF - Protoporphyrin IX derivative conjugate	PEP00614	Lipopolysaccharide (LPS) binding antimicrobial peptide YI13WF	REC99999	Undisclosed	LIN00121	Succinimide	DRG00329	.	.	Protoporphyrin IX derivative	Investigative	.	.	.	.	.
PDC_01031	Tripeptide 25 - Benztriazole conjugate	PEP00885	Tripeptide 25	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00274	.	.	1H-Benzotriazole	Investigative	.	.	.	.	.
PDC_01032	Dipeptide 21 - Vitamin D3 (calcitriol) conjugate	PEP00517	Dipeptide 21	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00160	TAR10040	Vitamin D3 receptor (VDR)	Vitamin D3 (calcitriol)	Investigative	.	.	.	.	.
PDC_01033	Dipeptide 15 - Vitamin D3 (calcitriol) conjugate	PEP00511	Dipeptide 15	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00160	TAR10040	Vitamin D3 receptor (VDR)	Vitamin D3 (calcitriol)	Investigative	.	.	.	.	.
PDC_01034	Tripeptide 26 - Vitamin E (alpha-tocopherol) conjugate	PEP00886	Tripeptide 26	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00145	.	.	Vitamin E (alpha-tocopherol)	Investigative	.	.	.	.	.
PDC_01035	Tripeptide 27 - Vitamin E (alpha-tocopherol) conjugate	PEP00887	Tripeptide 27	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00145	.	.	Vitamin E (alpha-tocopherol)	Investigative	.	.	.	.	.
PDC_01036	Dipeptide 21 - Vitamin E (alpha-tocopherol) conjugate	PEP00517	Dipeptide 21	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00145	.	.	Vitamin E (alpha-tocopherol)	Investigative	.	.	.	.	.
PDC_01037	Tripeptide 28 - Vitamin B3 (nicotinic acid) conjugate	PEP00888	Tripeptide 28	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00068	TAR10053	Nicotinic acid receptor (HCAR2)	Vitamin B3 (nicotinic acid)	Investigative	.	.	.	.	.
PDC_01038	Dipeptide 22 - Vitamin B3 (nicotinic acid) conjugate	PEP00518	Dipeptide 22	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00068	TAR10053	Nicotinic acid receptor (HCAR2)	Vitamin B3 (nicotinic acid)	Investigative	.	.	.	.	.
PDC_01039	Tripeptide 28 - Vitamin H (biotin) conjugate	PEP00888	Tripeptide 28	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00270	.	.	Biotin	Investigative	.	.	.	.	.
PDC_01040	Dipeptide 22 - Vitamin H (biotin) conjugate	PEP00518	Dipeptide 22	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00270	.	.	Biotin	Investigative	.	.	.	.	.
PDC_01041	Dipeptide 8 - Vitamin H (biotin) conjugate	PEP00504	GV	REC00067	Solute carrier family 15 member 1 (SLC15A1)	LIN00146	Undisclosed	DRG00270	.	.	Biotin	Investigative	.	.	.	.	.
PDC_01042	Oligopeptide 1 - Mestranol conjugate	PEP00677	Oligopeptide 1	REC99999	Undisclosed	LIN00127	Triazole	DRG00083	TAR10055	Estrogen receptor (ESR)	Mestranol	Investigative	.	.	.	.	.
PDC_01043	Oligopeptide 2 - Mestranol conjugate 1	PEP00678	Oligopeptide 2	REC99999	Undisclosed	LIN00127	Triazole	DRG00083	TAR10055	Estrogen receptor (ESR)	Mestranol	Investigative	.	.	.	.	.
PDC_01044	Oligopeptide 3 - Mestranol conjugate	PEP00679	Oligopeptide 3	REC99999	Undisclosed	LIN00127	Triazole	DRG00083	TAR10055	Estrogen receptor (ESR)	Mestranol	Investigative	.	.	.	.	.
PDC_01045	Oligopeptide 4 - Mestranol conjugate	PEP00680	Oligopeptide 4	REC99999	Undisclosed	LIN00127	Triazole	DRG00083	TAR10055	Estrogen receptor (ESR)	Mestranol	Investigative	.	.	.	.	.
PDC_01046	Oligopeptide 5 - Mestranol conjugate	PEP00681	Oligopeptide 5	REC99999	Undisclosed	LIN00127	Triazole	DRG00083	TAR10055	Estrogen receptor (ESR)	Mestranol	Investigative	.	.	.	.	.
PDC_01047	Oligopeptide 2 - Mestranol conjugate 2	PEP00678	Oligopeptide 2	REC99999	Undisclosed	LIN00127	Triazole	DRG00083	TAR10055	Estrogen receptor (ESR)	Mestranol	Investigative	.	.	.	.	.
PDC_01048	Oligopeptide 6 - Alpha-trifluoromethyl-alpha-hydroxy acid conjugate	PEP00682	Oligopeptide 6	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00179	.	.	Alpha-trifluoromethyl-alpha-hydroxy acid	Investigative	.	.	.	.	.
PDC_01049	Oligopeptide 2 - Alpha-trifluoromethyl-alpha-hydroxy acid conjugate 1	PEP00678	Oligopeptide 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00179	.	.	Alpha-trifluoromethyl-alpha-hydroxy acid	Investigative	.	.	.	.	.
PDC_01050	Oligopeptide 7 - Alpha-trifluoromethyl-alpha-hydroxy acid conjugate	PEP00683	Oligopeptide 7	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00179	.	.	Alpha-trifluoromethyl-alpha-hydroxy acid	Investigative	.	.	.	.	.
PDC_01051	Oligopeptide 3 - Alpha-trifluoromethyl-alpha-hydroxy acid conjugate 1	PEP00679	Oligopeptide 3	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00179	.	.	Alpha-trifluoromethyl-alpha-hydroxy acid	Investigative	.	.	.	.	.
PDC_01052	Oligopeptide 8 - Alpha-trifluoromethyl-alpha-hydroxy acid conjugate 1	PEP00684	Oligopeptide 8	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00179	.	.	Alpha-trifluoromethyl-alpha-hydroxy acid	Investigative	.	.	.	.	.
PDC_01053	Oligopeptide 4 - Alpha-trifluoromethyl-alpha-hydroxy acid conjugate 1	PEP00680	Oligopeptide 4	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00179	.	.	Alpha-trifluoromethyl-alpha-hydroxy acid	Investigative	.	.	.	.	.
PDC_01054	Oligopeptide 2 - Alpha-trifluoromethyl-alpha-hydroxy acid conjugate 2	PEP00678	Oligopeptide 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00179	.	.	Alpha-trifluoromethyl-alpha-hydroxy acid	Investigative	.	.	.	.	.
PDC_01055	Oligopeptide 9 - Alpha-trifluoromethyl-alpha-hydroxy acid conjugate	PEP00685	Oligopeptide 9	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00179	.	.	Alpha-trifluoromethyl-alpha-hydroxy acid	Investigative	.	.	.	.	.
PDC_01056	Oligopeptide 8 - Alpha-trifluoromethyl-alpha-hydroxy acid conjugate 2	PEP00684	Oligopeptide 8	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00179	.	.	Alpha-trifluoromethyl-alpha-hydroxy acid	Investigative	.	.	.	.	.
PDC_01057	Oligopeptide 2 - Alpha-trifluoromethyl-alpha-hydroxy acid conjugate 3	PEP00678	Oligopeptide 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00179	.	.	Alpha-trifluoromethyl-alpha-hydroxy acid	Investigative	.	.	.	.	.
PDC_01058	Oligopeptide 2 - Alpha-trifluoromethyl-alpha-hydroxy acid conjugate 4	PEP00678	Oligopeptide 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00179	.	.	Alpha-trifluoromethyl-alpha-hydroxy acid	Investigative	.	.	.	.	.
PDC_01059	Oligopeptide 3 - Alpha-trifluoromethyl-alpha-hydroxy acid conjugate 2	PEP00679	Oligopeptide 3	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00179	.	.	Alpha-trifluoromethyl-alpha-hydroxy acid	Investigative	.	.	.	.	.
PDC_01060	Oligopeptide 4 - Alpha-trifluoromethyl-alpha-hydroxy acid conjugate 2	PEP00680	Oligopeptide 4	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00179	.	.	Alpha-trifluoromethyl-alpha-hydroxy acid	Investigative	.	.	.	.	.
PDC_01061	Oligopeptide 8 - Alpha-trifluoromethyl-alpha-hydroxy acid conjugate 3	PEP00684	Oligopeptide 8	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00179	.	.	Alpha-trifluoromethyl-alpha-hydroxy acid	Investigative	.	.	.	.	.
PDC_01062	Tetrapeptide 11 - ()-Menthol conjugate	PEP00791	Tetrapeptide 11	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00099	.	.	()-Menthol	Investigative	.	.	.	.	.
PDC_01063	Tetrapeptide 12 - Diacetone-D-glucose conjugate	PEP00792	Tetrapeptide 12	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00168	.	.	Diacetone-D-glucose	Investigative	.	.	.	.	.
PDC_01064	Tetrapeptide 13 - Estrone conjugate	PEP00793	Tetrapeptide 13	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00077	TAR10055	Estrogen receptor (ESR)	Estrone	Investigative	.	.	.	.	.
PDC_01065	Tetrapeptide 13 - D-galactopyranose conjugate	PEP00793	Tetrapeptide 13	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00304	.	.	D-Galactose	Investigative	.	.	.	.	.
PDC_01066	Tetrapeptide 14 - Nerol conjugate	PEP00794	Tetrapeptide 14	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00131	.	.	Nerol	Investigative	.	.	.	.	.
PDC_01067	Tetrapeptide 14 - Estrone conjugate	PEP00794	Tetrapeptide 14	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00077	TAR10055	Estrogen receptor (ESR)	Estrone	Investigative	.	.	.	.	.
PDC_01068	Tetrapeptide 11 - 1H-Benzotriazole conjugate	PEP00791	Tetrapeptide 11	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00274	.	.	1H-Benzotriazole	Investigative	.	.	.	.	.
PDC_01069	Dipeptide 23 - 4-Amino-7-chloroquinoline conjugate 1	PEP01043	LFX 8k	REC00064	Falcipain-1 (FP1)	LIN00087	Amide bond	DRG00114	.	.	4-Amino-7-chloroquinoline	Investigative	.	.	.	.	.
PDC_01070	Dipeptide 23 - 4-Amino-7-chloroquinoline conjugate 2	PEP00519	Dipeptide 23	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00114	.	.	4-Amino-7-chloroquinoline	Investigative	.	.	.	.	.
PDC_01071	Dipeptide 23 - 4-Amino-7-chloroquinoline conjugate 3	PEP00519	Dipeptide 23	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00114	.	.	4-Amino-7-chloroquinoline	Investigative	.	.	.	.	.
PDC_01073	Dipeptide 23 - 4-Amino-7-chloroquinoline conjugate 4	PEP01041	LFX 8i	REC00064	Falcipain-1 (FP1)	LIN00087	Amide bond	DRG00114	.	.	4-Amino-7-chloroquinoline	Investigative	.	.	.	.	.
PDC_01074	Dipeptide 23 - 4-Amino-7-chloroquinoline conjugate 5	PEP01040	LFX 8h	REC00064	Falcipain-1 (FP1)	LIN00087	Amide bond	DRG00114	.	.	4-Amino-7-chloroquinoline	Investigative	.	.	.	.	.
PDC_01076	Dipeptide 23 - 4-Amino-7-chloroquinoline conjugate 6	PEP01038	LFX 8f	REC00064	Falcipain-1 (FP1)	LIN00087	Amide bond	DRG00114	.	.	4-Amino-7-chloroquinoline	Investigative	.	.	.	.	.
PDC_01077	Dipeptide 23 - 4-Amino-7-chloroquinoline conjugate 7	PEP01036	LFX 8d	REC00064	Falcipain-1 (FP1)	LIN00087	Amide bond	DRG00114	.	.	4-Amino-7-chloroquinoline	Investigative	.	.	.	.	.
PDC_01078	Dipeptide 23 - 4-Amino-7-chloroquinoline conjugate 8	PEP01035	LFX 8c	REC00064	Falcipain-1 (FP1)	LIN00087	Amide bond	DRG00114	.	.	4-Amino-7-chloroquinoline	Investigative	.	.	.	.	.
PDC_01079	Dipeptide 23 - 4-Amino-7-chloroquinoline conjugate 9	PEP01034	LFX 8b	REC00064	Falcipain-1 (FP1)	LIN00087	Amide bond	DRG00114	.	.	4-Amino-7-chloroquinoline	Investigative	.	.	.	.	.
PDC_01080	Dipeptide 23 - 4-Amino-7-chloroquinoline conjugate 10	PEP01032	LFX 8a	REC00064	Falcipain-1 (FP1)	LIN00087	Amide bond	DRG00114	.	.	4-Amino-7-chloroquinoline	Investigative	.	.	.	.	.
PDC_01081	Dipeptide 23 - 4-Amino-7-chloroquinoline conjugate 11	PEP00519	Dipeptide 23	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00114	.	.	4-Amino-7-chloroquinoline	Investigative	.	.	.	.	.
PDC_01083	Dipeptide 23 - 4-Amino-7-chloroquinoline conjugate 12	PEP01037	LFX 8e	REC00064	Falcipain-1 (FP1)	LIN00087	Amide bond	DRG00114	.	.	4-Amino-7-chloroquinoline	Investigative	.	.	.	.	.
PDC_01085	Dipeptide 23 - 4-Amino-7-chloroquinoline conjugate 13	PEP00519	Dipeptide 23	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00114	.	.	4-Amino-7-chloroquinoline	Investigative	.	.	.	.	.
PDC_01086	EGFR-binding peptide (EBP) - Doxorubicin conjugate	PEP00552	EGFR-binding peptide (EBP)	REC99999	Undisclosed	LIN00033	Glutaric acid	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_01087	EGFR-binding peptide (EBP) - Fmoc-protected doxorubicine conjugate	PEP00552	EGFR-binding peptide (EBP)	REC99999	Undisclosed	LIN00033	Glutaric acid	DRG00183	.	.	Fmoc-protected doxorubicine	Investigative	.	.	.	.	.
PDC_01088	ErbB-2-binding peptide - Daunorubicin conjugate	PEP00561	ErbB-2-binding peptide	REC99999	Undisclosed	LIN00033	Glutaric acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_01089	"Elastin (fragment) 1 - 3-(4-piperidyl)-6-fluoro-1,2-benzisoxazole conjugate 1"	PEP00553	Elastin (fragment) 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00134	.	.	"3-(4-piperidyl)-6-fluoro-1,2-benzisoxazole"	Investigative	.	.	.	.	.
PDC_01090	"Pentapeptide 7 - 3-(4-piperidyl)-6-fluoro-1,2-benzisoxazole conjugate"	PEP00730	Pentapeptide 7	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00134	.	.	"3-(4-piperidyl)-6-fluoro-1,2-benzisoxazole"	Investigative	.	.	.	.	.
PDC_01091	"Pentapeptide 8 - 3-(4-piperidyl)-6-fluoro-1,2-benzisoxazole conjugate"	PEP00731	Pentapeptide 8	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00134	.	.	"3-(4-piperidyl)-6-fluoro-1,2-benzisoxazole"	Investigative	.	.	.	.	.
PDC_01093	"Pentapeptide 10 - 3-(4-piperidyl)-6-fluoro-1,2-benzisoxazole conjugate"	PEP00733	Pentapeptide 10	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00134	.	.	"3-(4-piperidyl)-6-fluoro-1,2-benzisoxazole"	Investigative	.	.	.	.	.
PDC_01100	"Elastin (fragment) 1 - 3-(4-piperidyl)-6-fluoro-1,2-benzisoxazole conjugate"	PEP00553	Elastin (fragment) 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00134	.	.	"3-(4-piperidyl)-6-fluoro-1,2-benzisoxazole"	Investigative	.	.	.	.	.
PDC_01102	"Elastin (fragment) 2 - 3-(4-piperidyl)-6-fluoro-1,2-benzisoxazole conjugate"	PEP00554	Elastin (fragment) 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00134	.	.	"3-(4-piperidyl)-6-fluoro-1,2-benzisoxazole"	Investigative	.	.	.	.	.
PDC_01103	Cell-penetrating octaarginine and lung-targeting peptide - Pemetrexed conjugate 1	PEP00477	Cell-penetrating octaarginine and lung-targeting peptide	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00224	TAR10050	Candida Thymidylate synthase (Candi TMP1)	Pemetrexed	Investigative	.	.	.	.	.
PDC_01104	Octaarginine - Pemetrexed conjugate 1	PEP00656	Octaarginine	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00224	TAR10050	Candida Thymidylate synthase (Candi TMP1)	Pemetrexed	Investigative	.	.	.	.	.
PDC_01105	Lung-targeting peptide - Pemetrexed conjugate 1	PEP00615	Lung-targeting peptide	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00224	TAR10050	Candida Thymidylate synthase (Candi TMP1)	Pemetrexed	Investigative	.	.	.	.	.
PDC_01106	Cell-penetrating octaarginine and lung-targeting peptide - Pemetrexed conjugate 2	PEP00477	Cell-penetrating octaarginine and lung-targeting peptide	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00224	TAR10050	Candida Thymidylate synthase (Candi TMP1)	Pemetrexed	Investigative	.	.	.	.	.
PDC_01107	Octaarginine - Pemetrexed conjugate 2	PEP00656	Octaarginine	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00224	TAR10050	Candida Thymidylate synthase (Candi TMP1)	Pemetrexed	Investigative	.	.	.	.	.
PDC_01108	Lung-targeting peptide - Pemetrexed conjugate 2	PEP00615	Lung-targeting peptide	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00224	TAR10050	Candida Thymidylate synthase (Candi TMP1)	Pemetrexed	Investigative	.	.	.	.	.
PDC_01109	Tripeptide 29 - C-5-modified neomycin B analog conjugate	PEP00889	Tripeptide 29	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00176	.	.	C-5-modified neomycin B analog	Investigative	.	.	.	.	.
PDC_01110	QQRFEXEFEQQ - Functionalized oligo p-phenylenevinylene (OPV) conjugate	PEP00229	QQRFEXEFEQQ	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00238	.	.	Functionalized oligo p-phenylenevinylene (OPV)	Investigative	.	.	.	.	.
PDC_01111	QQXFXXXFQQQ - Functionalized oligo p-phenylenevinylene (OPV) conjugate	PEP00230	QQXFXXXFQQQ	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00238	.	.	Functionalized oligo p-phenylenevinylene (OPV)	Investigative	.	.	.	.	.
PDC_01112	Tripeptide 30 - Beta-carboline derivative conjugate 1	PEP01062	EFW	REC99999	Undisclosed	LIN00087	Amide bond	DRG00141	.	.	Beta-carboline derivative	Investigative	.	.	.	.	.
PDC_01113	Tripeptide 31 - Beta-carboline derivative conjugate 1	PEP01061	DFW	REC99999	Undisclosed	LIN00087	Amide bond	DRG00141	.	.	Beta-carboline derivative	Investigative	.	.	.	.	.
PDC_01114	Tripeptide 32 - Beta-carboline derivative conjugate	PEP01060	RFW	REC99999	Undisclosed	LIN00087	Amide bond	DRG00141	.	.	Beta-carboline derivative	Investigative	.	.	.	.	.
PDC_01115	Tripeptide 33 - Beta-carboline derivative conjugate 1	PEP01059	YFW	REC99999	Undisclosed	LIN00087	Amide bond	DRG00141	.	.	Beta-carboline derivative	Investigative	.	.	.	.	.
PDC_01116	Tripeptide 34 - Beta-carboline derivative conjugate 1	PEP01058	SFW	REC99999	Undisclosed	LIN00087	Amide bond	DRG00141	.	.	Beta-carboline derivative	Investigative	.	.	.	.	.
PDC_01117	Tripeptide 35 - Beta-carboline derivative conjugate 1	PEP01057	NFW	REC99999	Undisclosed	LIN00087	Amide bond	DRG00141	.	.	Beta-carboline derivative	Investigative	.	.	.	.	.
PDC_01118	Tripeptide 36 - Beta-carboline derivative conjugate 1	PEP01056	QFW	REC99999	Undisclosed	LIN00087	Amide bond	DRG00141	.	.	Beta-carboline derivative	Investigative	.	.	.	.	.
PDC_01119	Tripeptide 37 - Beta-carboline derivative conjugate 1	PEP01055	KFW	REC99999	Undisclosed	LIN00087	Amide bond	DRG00141	.	.	Beta-carboline derivative	Investigative	.	.	.	.	.
PDC_01120	Tripeptide 38 - Beta-carboline derivative conjugate 1	PEP01054	HFW	REC99999	Undisclosed	LIN00087	Amide bond	DRG00141	.	.	Beta-carboline derivative	Investigative	.	.	.	.	.
PDC_01121	Tripeptide 39 - Beta-carboline derivative conjugate 1	PEP01053	TFW	REC99999	Undisclosed	LIN00087	Amide bond	DRG00141	.	.	Beta-carboline derivative	Investigative	.	.	.	.	.
PDC_01122	Tripeptide 40 - Beta-carboline derivative conjugate 1	PEP01052	WFW	REC99999	Undisclosed	LIN00087	Amide bond	DRG00141	.	.	Beta-carboline derivative	Investigative	.	.	.	.	.
PDC_01123	Tripeptide 41 - Beta-carboline derivative conjugate 1	PEP01051	IFW	REC99999	Undisclosed	LIN00087	Amide bond	DRG00141	.	.	Beta-carboline derivative	Investigative	.	.	.	.	.
PDC_01124	Tripeptide 42 - Beta-carboline derivative conjugate 1	PEP01050	FFW	REC99999	Undisclosed	LIN00087	Amide bond	DRG00141	.	.	Beta-carboline derivative	Investigative	.	.	.	.	.
PDC_01125	Tripeptide 43 - Beta-carboline derivative conjugate 1	PEP01049	AFW	REC99999	Undisclosed	LIN00087	Amide bond	DRG00141	.	.	Beta-carboline derivative	Investigative	.	.	.	.	.
PDC_01126	Tripeptide 44 - Beta-carboline derivative conjugate 1	PEP01048	VFW	REC99999	Undisclosed	LIN00087	Amide bond	DRG00141	.	.	Beta-carboline derivative	Investigative	.	.	.	.	.
PDC_01127	Tripeptide 45 - Beta-carboline derivative conjugate 1	PEP01047	PFW	REC99999	Undisclosed	LIN00087	Amide bond	DRG00141	.	.	Beta-carboline derivative	Investigative	.	.	.	.	.
PDC_01128	Tripeptide 46 - Beta-carboline derivative conjugate 1	PEP01046	GFW	REC99999	Undisclosed	LIN00087	Amide bond	DRG00141	.	.	Beta-carboline derivative	Investigative	.	.	.	.	.
PDC_01129	Tripeptide 47 - Beta-carboline derivative conjugate 1	PEP01045	LFW	REC99999	Undisclosed	LIN00087	Amide bond	DRG00141	.	.	Beta-carboline derivative	Investigative	.	.	.	.	.
PDC_01130	Tripeptide 30 - Beta-carboline derivative conjugate 2	PEP00890	Tripeptide 30	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00141	.	.	Beta-carboline derivative	Investigative	.	.	.	.	.
PDC_01131	Tripeptide 31 - Beta-carboline derivative conjugate 2	PEP00891	Tripeptide 31	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00141	.	.	Beta-carboline derivative	Investigative	.	.	.	.	.
PDC_01132	Tripeptide 48 - Beta-carboline derivative conjugate	PEP00908	Tripeptide 48	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00141	.	.	Beta-carboline derivative	Investigative	.	.	.	.	.
PDC_01133	Tripeptide 33 - Beta-carboline derivative conjugate 2	PEP00893	Tripeptide 33	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00141	.	.	Beta-carboline derivative	Investigative	.	.	.	.	.
PDC_01134	Tripeptide 34 - Beta-carboline derivative conjugate 2	PEP00894	Tripeptide 34	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00141	.	.	Beta-carboline derivative	Investigative	.	.	.	.	.
PDC_01135	Tripeptide 35 - Beta-carboline derivative conjugate 2	PEP00895	Tripeptide 35	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00141	.	.	Beta-carboline derivative	Investigative	.	.	.	.	.
PDC_01136	Tripeptide 36 - Beta-carboline derivative conjugate 2	PEP00896	Tripeptide 36	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00141	.	.	Beta-carboline derivative	Investigative	.	.	.	.	.
PDC_01137	Tripeptide 37 - Beta-carboline derivative conjugate 2	PEP00897	Tripeptide 37	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00141	.	.	Beta-carboline derivative	Investigative	.	.	.	.	.
PDC_01138	Tripeptide 38 - Beta-carboline derivative conjugate 2	PEP00898	Tripeptide 38	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00141	.	.	Beta-carboline derivative	Investigative	.	.	.	.	.
PDC_01139	Tripeptide 39 - Beta-carboline derivative conjugate 2	PEP00899	Tripeptide 39	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00141	.	.	Beta-carboline derivative	Investigative	.	.	.	.	.
PDC_01140	Tripeptide 40 - Beta-carboline derivative conjugate 2	PEP00900	Tripeptide 40	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00141	.	.	Beta-carboline derivative	Investigative	.	.	.	.	.
PDC_01141	Tripeptide 41 - Beta-carboline derivative conjugate 2	PEP00901	Tripeptide 41	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00141	.	.	Beta-carboline derivative	Investigative	.	.	.	.	.
PDC_01142	Tripeptide 42 - Beta-carboline derivative conjugate 2	PEP00902	Tripeptide 42	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00141	.	.	Beta-carboline derivative	Investigative	.	.	.	.	.
PDC_01143	Tripeptide 43 - Beta-carboline derivative conjugate 2	PEP00903	Tripeptide 43	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00141	.	.	Beta-carboline derivative	Investigative	.	.	.	.	.
PDC_01144	Tripeptide 44 - Beta-carboline derivative conjugate 2	PEP00904	Tripeptide 44	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00141	.	.	Beta-carboline derivative	Investigative	.	.	.	.	.
PDC_01145	Tripeptide 45 - Beta-carboline derivative conjugate 2	PEP00905	Tripeptide 45	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00141	.	.	Beta-carboline derivative	Investigative	.	.	.	.	.
PDC_01146	Tripeptide 46 - Beta-carboline derivative conjugate 2	PEP00906	Tripeptide 46	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00141	.	.	Beta-carboline derivative	Investigative	.	.	.	.	.
PDC_01147	Tripeptide 47 - Beta-carboline derivative conjugate 2	PEP00907	Tripeptide 47	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00141	.	.	Beta-carboline derivative	Investigative	.	.	.	.	.
PDC_01148	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 1 - P-Toluenesulfonamide conjugate 1	PEP00736	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00082	TAR10030	Carbonic anhydrase IX (CA-IX)	P-Toluenesulfonamide	Investigative	.	.	.	.	.
PDC_01149	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 2 - P-Toluenesulfonamide conjugate 1	PEP00737	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00082	TAR10030	Carbonic anhydrase IX (CA-IX)	P-Toluenesulfonamide	Investigative	.	.	.	.	.
PDC_01150	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 3 - P-Toluenesulfonamide conjugate 1	PEP00738	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 3	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00082	TAR10030	Carbonic anhydrase IX (CA-IX)	P-Toluenesulfonamide	Investigative	.	.	.	.	.
PDC_01151	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 4 - P-Toluenesulfonamide conjugate 1	PEP00739	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 4	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00082	TAR10030	Carbonic anhydrase IX (CA-IX)	P-Toluenesulfonamide	Investigative	.	.	.	.	.
PDC_01152	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 5 - B-carboline alkaloid conjugate 1	PEP00740	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 5	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00133	.	.	B-carboline alkaloid	Investigative	.	.	.	.	.
PDC_01153	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 5 - B-carboline alkaloid conjugate 2	PEP00740	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 5	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00133	.	.	B-carboline alkaloid	Investigative	.	.	.	.	.
PDC_01154	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 5 - B-carboline alkaloid conjugate 3	PEP00740	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 5	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00133	.	.	B-carboline alkaloid	Investigative	.	.	.	.	.
PDC_01155	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 5 - B-carboline alkaloid conjugate 4	PEP00741	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 6	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00133	.	.	B-carboline alkaloid	Investigative	.	.	.	.	.
PDC_01156	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 5 - B-carboline alkaloid conjugate 5	PEP00741	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 6	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00133	.	.	B-carboline alkaloid	Investigative	.	.	.	.	.
PDC_01157	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 5 - B-carboline alkaloid conjugate 6	PEP00741	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 6	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00133	.	.	B-carboline alkaloid	Investigative	.	.	.	.	.
PDC_01158	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 5 - B-carboline alkaloid conjugate 7	PEP00742	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 7	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00133	.	.	B-carboline alkaloid	Investigative	.	.	.	.	.
PDC_01159	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 5 - B-carboline alkaloid conjugate 8	PEP00742	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 7	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00133	.	.	B-carboline alkaloid	Investigative	.	.	.	.	.
PDC_01160	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 5 - B-carboline alkaloid conjugate 9	PEP00742	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 7	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00133	.	.	B-carboline alkaloid	Investigative	.	.	.	.	.
PDC_01161	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 8 - B-carboline alkaloid conjugate	PEP00743	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 8	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00133	.	.	B-carboline alkaloid	Investigative	.	.	.	.	.
PDC_01162	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 8 - B-carboline alkaloid conjugate 1	PEP00743	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 8	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00133	.	.	B-carboline alkaloid	Investigative	.	.	.	.	.
PDC_01163	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 8 - B-carboline alkaloid conjugate 2	PEP00743	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 8	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00133	.	.	B-carboline alkaloid	Investigative	.	.	.	.	.
PDC_01164	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 8 - B-carboline alkaloid conjugate 3	PEP00744	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 9	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00133	.	.	B-carboline alkaloid	Investigative	.	.	.	.	.
PDC_01165	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 8 - B-carboline alkaloid conjugate 4	PEP00744	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 9	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00133	.	.	B-carboline alkaloid	Investigative	.	.	.	.	.
PDC_01166	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 8 - B-carboline alkaloid conjugate 5	PEP00744	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 9	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00133	.	.	B-carboline alkaloid	Investigative	.	.	.	.	.
PDC_01167	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 10 - B-carboline alkaloid conjugate 1	PEP00745	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 10	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00133	.	.	B-carboline alkaloid	Investigative	.	.	.	.	.
PDC_01168	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 10 - B-carboline alkaloid conjugate 2	PEP00745	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 10	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00133	.	.	B-carboline alkaloid	Investigative	.	.	.	.	.
PDC_01169	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 10 - B-carboline alkaloid conjugate 3	PEP00745	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 10	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00133	.	.	B-carboline alkaloid	Investigative	.	.	.	.	.
PDC_01170	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 4 - P-Toluenesulfonamide conjugate 2	PEP00739	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 4	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00082	TAR10030	Carbonic anhydrase IX (CA-IX)	P-Toluenesulfonamide	Investigative	.	.	.	.	.
PDC_01171	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 2 - P-Toluenesulfonamide conjugate 2	PEP00737	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00082	TAR10030	Carbonic anhydrase IX (CA-IX)	P-Toluenesulfonamide	Investigative	.	.	.	.	.
PDC_01172	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 1 - P-Toluenesulfonamide conjugate 2	PEP00736	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00082	TAR10030	Carbonic anhydrase IX (CA-IX)	P-Toluenesulfonamide	Investigative	.	.	.	.	.
PDC_01173	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 3 - P-Toluenesulfonamide conjugate 2	PEP00738	Pentapeptide generated by plasmin degradation from the fibrinogen beta chain 3	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00082	TAR10030	Carbonic anhydrase IX (CA-IX)	P-Toluenesulfonamide	Investigative	.	.	.	.	.
PDC_01174	Tripeptide 49 - Porphyrin-derivative conjugate 1	PEP00909	Tripeptide 49	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00214	.	.	Porphyrin-derivative	Investigative	.	.	.	.	.
PDC_01175	Tripeptide 49 - Porphyrin-derivative conjugate 2	PEP00909	Tripeptide 49	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00214	.	.	Porphyrin-derivative	Investigative	.	.	.	.	.
PDC_01176	"Tuftsin - 2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide conjugate"	PEP00178	TKPR	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00174	.	.	"2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide"	Investigative	.	.	.	.	.
PDC_01177	Tuftsin (liberated from the Fc domain of the heavy chain of IgG 1 - Acridone-4-carboxylic acid (4-carboxyacridone) derivative conjugate 1	PEP00994	Tuftsin (liberated from the Fc domain of the heavy chain of IgG 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00153	.	.	Acridone-4-carboxylic acid (4-carboxyacridone) derivative	Investigative	.	.	.	.	.
PDC_01178	Tuftsin (liberated from the Fc domain of the heavy chain of IgG 1 - Acridone-4-carboxylic acid (4-carboxyacridone) derivative conjugate 2	PEP00994	Tuftsin (liberated from the Fc domain of the heavy chain of IgG 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00153	.	.	Acridone-4-carboxylic acid (4-carboxyacridone) derivative	Investigative	.	.	.	.	.
PDC_01179	Tuftsin - Acridone-4-carboxylic acid (4-carboxyacridone) derivative conjugate 1	PEP00178	TKPR	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00153	.	.	Acridone-4-carboxylic acid (4-carboxyacridone) derivative	Investigative	.	.	.	.	.
PDC_01180	Tuftsin - Acridone-4-carboxylic acid (4-carboxyacridone) derivative conjugate 2	PEP00178	TKPR	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00153	.	.	Acridone-4-carboxylic acid (4-carboxyacridone) derivative	Investigative	.	.	.	.	.
PDC_01181	Tuftsin (liberated from the Fc domain of the heavy chain of IgG 1 - Acridone-4-carboxylic acid (4-carboxyacridone) derivative conjugate 3	PEP00994	Tuftsin (liberated from the Fc domain of the heavy chain of IgG 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00153	.	.	Acridone-4-carboxylic acid (4-carboxyacridone) derivative	Investigative	.	.	.	.	.
PDC_01182	Tuftsin (liberated from the Fc domain of the heavy chain of IgG 1 - Acridone-4-carboxylic acid (4-carboxyacridone) derivative conjugate 4	PEP00994	Tuftsin (liberated from the Fc domain of the heavy chain of IgG 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00153	.	.	Acridone-4-carboxylic acid (4-carboxyacridone) derivative	Investigative	.	.	.	.	.
PDC_01183	Tuftsin (liberated from the Fc domain of the heavy chain of IgG 1 - Acridone-4-carboxylic acid (4-carboxyacridone) derivative conjugate 5	PEP00994	Tuftsin (liberated from the Fc domain of the heavy chain of IgG 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00153	.	.	Acridone-4-carboxylic acid (4-carboxyacridone) derivative	Investigative	.	.	.	.	.
PDC_01184	Tuftsin - Acridone-4-carboxylic acid (4-carboxyacridone) derivative conjugate 3	PEP00178	TKPR	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00153	.	.	Acridone-4-carboxylic acid (4-carboxyacridone) derivative	Investigative	.	.	.	.	.
PDC_01185	Tuftsin - Acridone-4-carboxylic acid (4-carboxyacridone) derivative conjugate 4	PEP00178	TKPR	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00153	.	.	Acridone-4-carboxylic acid (4-carboxyacridone) derivative	Investigative	.	.	.	.	.
PDC_01186	Tuftsin (liberated from the Fc domain of the heavy chain of IgG 2 - 3-[(1-Nitroacridin-9-yl)amino]propanoic acid (nitroacrin) derivative conjugate 1	PEP00995	Tuftsin (liberated from the Fc domain of the heavy chain of IgG 2	REC99999	Undisclosed	LIN00026	Aminocaproic acid	DRG00120	.	.	3-[(1-Nitroacridin-9-yl)amino]propanoic acid (nitroacrin) derivative	Investigative	.	.	.	.	.
PDC_01187	Tuftsin (liberated from the Fc domain of the heavy chain of IgG 1 - 3-[(1-Nitroacridin-9-yl)amino]propanoic acid (nitroacrin) derivative conjugate	PEP00994	Tuftsin (liberated from the Fc domain of the heavy chain of IgG 1	REC99999	Undisclosed	LIN00026	Aminocaproic acid	DRG00120	.	.	3-[(1-Nitroacridin-9-yl)amino]propanoic acid (nitroacrin) derivative	Investigative	.	.	.	.	.
PDC_01188	Tuftsin (liberated from the Fc domain of the heavy chain of IgG 2 - 3-[(1-Nitroacridin-9-yl)amino]propanoic acid (nitroacrin) derivative conjugate 2	PEP00995	Tuftsin (liberated from the Fc domain of the heavy chain of IgG 2	REC99999	Undisclosed	LIN00026	Aminocaproic acid	DRG00120	.	.	3-[(1-Nitroacridin-9-yl)amino]propanoic acid (nitroacrin) derivative	Investigative	.	.	.	.	.
PDC_01189	Tuftsin (liberated from the Fc domain of the heavy chain of IgG 2 - 3-[(1-Nitroacridin-9-yl)amino]propanoic acid (nitroacrin) derivative conjugate 3	PEP00996	Tuftsin (liberated from the Fc domain of the heavy chain of IgG 3	REC99999	Undisclosed	LIN00026	Aminocaproic acid	DRG00120	.	.	3-[(1-Nitroacridin-9-yl)amino]propanoic acid (nitroacrin) derivative	Investigative	.	.	.	.	.
PDC_01190	Tuftsin - 3-[(1-Nitroacridin-9-yl)amino]propanoic acid (nitroacrin) derivative conjugate 1	PEP00178	TKPR	REC99999	Undisclosed	LIN00026	Aminocaproic acid	DRG00120	.	.	3-[(1-Nitroacridin-9-yl)amino]propanoic acid (nitroacrin) derivative	Investigative	.	.	.	.	.
PDC_01191	Tuftsin (liberated from the Fc domain of the heavy chain of IgG 2 - 3-[(1-Nitroacridin-9-yl)amino]propanoic acid (nitroacrin) derivative conjugate 4	PEP00996	Tuftsin (liberated from the Fc domain of the heavy chain of IgG 3	REC99999	Undisclosed	LIN00026	Aminocaproic acid	DRG00120	.	.	3-[(1-Nitroacridin-9-yl)amino]propanoic acid (nitroacrin) derivative	Investigative	.	.	.	.	.
PDC_01192	Tuftsin (liberated from the Fc domain of the heavy chain of IgG 2 - 3-[(1-Nitroacridin-9-yl)amino]propanoic acid (nitroacrin) derivative conjugate 5	PEP00996	Tuftsin (liberated from the Fc domain of the heavy chain of IgG 3	REC99999	Undisclosed	LIN00026	Aminocaproic acid	DRG00120	.	.	3-[(1-Nitroacridin-9-yl)amino]propanoic acid (nitroacrin) derivative	Investigative	.	.	.	.	.
PDC_01193	Tuftsin - 3-[(1-Nitroacridin-9-yl)amino]propanoic acid (nitroacrin) derivative conjugate 2	PEP00178	TKPR	REC99999	Undisclosed	LIN00026	Aminocaproic acid	DRG00120	.	.	3-[(1-Nitroacridin-9-yl)amino]propanoic acid (nitroacrin) derivative	Investigative	.	.	.	.	.
PDC_01194	"Tuftsin (liberated from the Fc domain of the heavy chain of IgG 1 - 1,4-dihydroxyanthraquinone (quinizarin) derivative conjugate 1"	PEP00994	Tuftsin (liberated from the Fc domain of the heavy chain of IgG 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00085	TAR10019	DNA topoisomerase 1 (TOP1); Human Deoxyribonucleic acid (hDNA)	"1,4-dihydroxyanthraquinone (quinizarin) derivative"	Investigative	.	.	.	.	.
PDC_01195	"Tuftsin (liberated from the Fc domain of the heavy chain of IgG 1 - 1,4-dihydroxyanthraquinone (quinizarin) derivative conjugate 2"	PEP00994	Tuftsin (liberated from the Fc domain of the heavy chain of IgG 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00085	TAR10019	DNA topoisomerase 1 (TOP1); Human Deoxyribonucleic acid (hDNA)	"1,4-dihydroxyanthraquinone (quinizarin) derivative"	Investigative	.	.	.	.	.
PDC_01196	"Tuftsin (liberated from the Fc domain of the heavy chain of IgG 1 - 1,4-dihydroxyanthraquinone (quinizarin) derivative conjugate 3"	PEP00994	Tuftsin (liberated from the Fc domain of the heavy chain of IgG 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00085	TAR10019	DNA topoisomerase 1 (TOP1); Human Deoxyribonucleic acid (hDNA)	"1,4-dihydroxyanthraquinone (quinizarin) derivative"	Investigative	.	.	.	.	.
PDC_01197	"Tuftsin (liberated from the Fc domain of the heavy chain of IgG 1 - 1,4-dihydroxyanthraquinone (quinizarin) derivative conjugate 4"	PEP00994	Tuftsin (liberated from the Fc domain of the heavy chain of IgG 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00085	TAR10019	DNA topoisomerase 1 (TOP1); Human Deoxyribonucleic acid (hDNA)	"1,4-dihydroxyanthraquinone (quinizarin) derivative"	Investigative	.	.	.	.	.
PDC_01198	"Tuftsin (liberated from the Fc domain of the heavy chain of IgG 1 - 1,4-dihydroxyanthraquinone (quinizarin) derivative conjugate 5"	PEP00994	Tuftsin (liberated from the Fc domain of the heavy chain of IgG 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00085	TAR10019	DNA topoisomerase 1 (TOP1); Human Deoxyribonucleic acid (hDNA)	"1,4-dihydroxyanthraquinone (quinizarin) derivative"	Investigative	.	.	.	.	.
PDC_01199	"Tuftsin (liberated from the Fc domain of the heavy chain of IgG 1 - 1,4-dihydroxyanthraquinone (quinizarin) derivative conjugate 6"	PEP00994	Tuftsin (liberated from the Fc domain of the heavy chain of IgG 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00085	TAR10019	DNA topoisomerase 1 (TOP1); Human Deoxyribonucleic acid (hDNA)	"1,4-dihydroxyanthraquinone (quinizarin) derivative"	Investigative	.	.	.	.	.
PDC_01200	"Tuftsin - 1,4-dihydroxyanthraquinone (quinizarin) derivative conjugate 1"	PEP00178	TKPR	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00085	TAR10019	DNA topoisomerase 1 (TOP1); Human Deoxyribonucleic acid (hDNA)	"1,4-dihydroxyanthraquinone (quinizarin) derivative"	Investigative	.	.	.	.	.
PDC_01201	"Tuftsin - 1,4-dihydroxyanthraquinone (quinizarin) derivative conjugate 2"	PEP00178	TKPR	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00085	TAR10019	DNA topoisomerase 1 (TOP1); Human Deoxyribonucleic acid (hDNA)	"1,4-dihydroxyanthraquinone (quinizarin) derivative"	Investigative	.	.	.	.	.
PDC_01202	"Tuftsin - 1,4-dihydroxyanthraquinone (quinizarin) derivative conjugate 3"	PEP00178	TKPR	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00085	TAR10019	DNA topoisomerase 1 (TOP1); Human Deoxyribonucleic acid (hDNA)	"1,4-dihydroxyanthraquinone (quinizarin) derivative"	Investigative	.	.	.	.	.
PDC_01203	"Tuftsin - 1,4-dihydroxyanthraquinone (quinizarin) derivative conjugate 4"	PEP00178	TKPR	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00085	TAR10019	DNA topoisomerase 1 (TOP1); Human Deoxyribonucleic acid (hDNA)	"1,4-dihydroxyanthraquinone (quinizarin) derivative"	Investigative	.	.	.	.	.
PDC_01204	"Tuftsin - 1,4-dihydroxyanthraquinone (quinizarin) derivative conjugate 5"	PEP00178	TKPR	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00085	TAR10019	DNA topoisomerase 1 (TOP1); Human Deoxyribonucleic acid (hDNA)	"1,4-dihydroxyanthraquinone (quinizarin) derivative"	Investigative	.	.	.	.	.
PDC_01205	"Tuftsin (liberated from the Fc domain of the heavy chain of IgG 4 - 2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide conjugate 1"	PEP00997	Tuftsin (liberated from the Fc domain of the heavy chain of IgG 4	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00174	.	.	"2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide"	Investigative	.	.	.	.	.
PDC_01206	"Tuftsin (liberated from the Fc domain of the heavy chain of IgG 4 - 2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide conjugate 2"	PEP00997	Tuftsin (liberated from the Fc domain of the heavy chain of IgG 4	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00174	.	.	"2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide"	Investigative	.	.	.	.	.
PDC_01207	"Tuftsin (liberated from the Fc domain of the heavy chain of IgG 4 - 2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide conjugate 3"	PEP00997	Tuftsin (liberated from the Fc domain of the heavy chain of IgG 4	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00174	.	.	"2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide"	Investigative	.	.	.	.	.
PDC_01208	"Tuftsin (liberated from the Fc domain of the heavy chain of IgG 4 - 2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide conjugate 4"	PEP00997	Tuftsin (liberated from the Fc domain of the heavy chain of IgG 4	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00174	.	.	"2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide"	Investigative	.	.	.	.	.
PDC_01209	"Tuftsin (liberated from the Fc domain of the heavy chain of IgG 4 - 2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide conjugate 5"	PEP00997	Tuftsin (liberated from the Fc domain of the heavy chain of IgG 4	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00174	.	.	"2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide"	Investigative	.	.	.	.	.
PDC_01210	Tripeptide 50 - Methotrexate conjugate 1	PEP00910	Tripeptide 50	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_01211	Tripeptide 51 - Methotrexate conjugate	PEP00911	Tripeptide 51	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_01212	Tripeptide 52 - Methotrexate conjugate	PEP00912	Tripeptide 52	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_01213	Tripeptide 53 - Methotrexate conjugate	PEP00913	Tripeptide 53	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_01214	Tripeptide 54 - Methotrexate conjugate	PEP00914	Tripeptide 54	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_01215	Tripeptide 55 - Methotrexate conjugate	PEP00915	Tripeptide 55	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_01216	Tripeptide 56 - Methotrexate conjugate 1	PEP00916	Tripeptide 56	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_01217	Tripeptide 56 - Methotrexate conjugate 2	PEP00916	Tripeptide 56	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_01218	Tripeptide 57 - Methotrexate conjugate 1	PEP00917	Tripeptide 57	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_01219	Tripeptide 50 - Methotrexate conjugate 2	PEP00910	Tripeptide 50	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_01220	Tripeptide 57 - Methotrexate conjugate 2	PEP00917	Tripeptide 57	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_01221	Tripeptide 57 - Methotrexate conjugate 3	PEP00917	Tripeptide 57	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_01222	Tripeptide 57 - Methotrexate conjugate 4	PEP00917	Tripeptide 57	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_01223	Tripeptide 57 - Methotrexate conjugate 5	PEP00917	Tripeptide 57	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_01224	Tripeptide 57 - Methotrexate conjugate 6	PEP00917	Tripeptide 57	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_01225	Tripeptide 50 - Methotrexate conjugate 3	PEP00910	Tripeptide 50	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_01226	Tripeptide 58 - Methotrexate conjugate	PEP00918	Tripeptide 58	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_01227	Tripeptide 57 - Methotrexate conjugate 7	PEP00917	Tripeptide 57	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_01228	Tripeptide 57 - Methotrexate conjugate 8	PEP00917	Tripeptide 57	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_01229	Tripeptide 59 - Methotrexate conjugate 1	PEP00919	Tripeptide 59	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_01230	Tripeptide 59 - Methotrexate conjugate 2	PEP00919	Tripeptide 59	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_01232	Tetrapeptide 15 - Methotrexate conjugate	PEP00795	Tetrapeptide 15	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_01233	Tetrapeptide 16 - Methotrexate conjugate	PEP00796	Tetrapeptide 16	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_01234	Tetrapeptide 17 - Methotrexate conjugate	PEP00797	Tetrapeptide 17	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_01235	Tetrapeptide 18 - Methotrexate conjugate	PEP00798	Tetrapeptide 18	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_01236	Pentapeptide 12 - Methotrexate conjugate	PEP00735	Pentapeptide 12	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_01237	Polyarginine 5 - Deacetylvinblastine conjugate	PEP00761	Polyarginine 5	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00184	.	.	Deacetylvinblastine	Investigative	.	.	.	.	.
PDC_01239	Polyarginine 6 - Deacetylvinblastine conjugate 1	PEP00762	Polyarginine 6	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00184	.	.	Deacetylvinblastine	Investigative	.	.	.	.	.
PDC_01240	Polyarginine 6 - Deacetylvinblastine conjugate 2	PEP00762	Polyarginine 6	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00184	.	.	Deacetylvinblastine	Investigative	.	.	.	.	.
PDC_01241	Polyarginine 7 - Deacetylvinblastine conjugate 3	PEP00763	Polyarginine 7	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00184	.	.	Deacetylvinblastine	Investigative	.	.	.	.	.
PDC_01242	Polyarginine 7 - Deacetylvinblastine conjugate 4	PEP00763	Polyarginine 7	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00184	.	.	Deacetylvinblastine	Investigative	.	.	.	.	.
PDC_01243	Tetrapeptide 19 - Doxorubicin conjugate	PEP00799	Tetrapeptide 19	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_01244	Dipeptide 24 - Doxorubicin conjugate	PEP00520	Dipeptide 24	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_01245	"Tetrapeptide 20 - 4-amino-1-[3,5-bis-O-[(1,1-dimethylethyl)dimethylsilyl]-&beta;-D-arabinofuranosyl]-2(1H)-Pyrimidinone conjugate"	PEP00800	Tetrapeptide 20	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00180	.	.	"4-amino-1-[3,5-bis-O-[(1,1-dimethylethyl)dimethylsilyl]-&beta;-D-arabinofuranosyl]-2(1H)-Pyrimidinone"	Investigative	.	.	.	.	.
PDC_01246	Tetrapeptide 20 - Cytarabine conjugate	PEP00800	Tetrapeptide 20	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00081	TAR10039	Herpes simplex virus DNA polymerase UL30 (HSV UL30)	Cytarabine	Investigative	.	.	.	.	.
PDC_01249	Dipeptide 25 - Cytarabine conjugate	PEP00521	Dipeptide 25	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00081	TAR10039	Herpes simplex virus DNA polymerase UL30 (HSV UL30)	Cytarabine	Investigative	.	.	.	.	.
PDC_01250	Tetrapeptide 20 - Vidarabine conjugate 1	PEP00800	Tetrapeptide 20	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00101	TAR10044	Adenosine A2b receptor (ADORA2B)	Vidarabine	Investigative	.	.	.	.	.
PDC_01251	Tetrapeptide 20 - Vidarabine conjugate 2	PEP00800	Tetrapeptide 20	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00101	TAR10044	Adenosine A2b receptor (ADORA2B)	Vidarabine	Investigative	.	.	.	.	.
PDC_01252	"Tetrapeptide 20 - 9-[3,5-Bis-O-[(1,1-dimethylethyl)dimethylsilyl]-&beta;-D-arabinofuranosyl]-9H-purin-6-amine conjugate"	PEP00800	Tetrapeptide 20	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00199	.	.	"9-[3,5-Bis-O-[(1,1-dimethylethyl)dimethylsilyl]-&beta;-D-arabinofuranosyl]-9H-purin-6-amine"	Investigative	.	.	.	.	.
PDC_01253	"Dipeptide 17 - 9-(2,3,5-Tri-O-acetyl-&beta;-D-arabinofuranosyl)-9H-purin-6-amine conjugate"	PEP00513	Dipeptide 17	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00117	.	.	"9-(2,3,5-Tri-O-acetyl-&beta;-D-arabinofuranosyl)-9H-purin-6-amine"	Investigative	.	.	.	.	.
PDC_01254	"Tetrapeptide 21 - 4-amino-1-[3,5-bis-O-[(1,1-dimethylethyl)dimethylsilyl]-&beta;-D-arabinofuranosyl]-2(1H)-Pyrimidinone conjugate"	PEP00801	Tetrapeptide 21	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00180	.	.	"4-amino-1-[3,5-bis-O-[(1,1-dimethylethyl)dimethylsilyl]-&beta;-D-arabinofuranosyl]-2(1H)-Pyrimidinone"	Investigative	.	.	.	.	.
PDC_01255	"Tetrapeptide 20 - 1,7-Dioxa-2-thiaspiro[4.4]nonane, 2(1H)-pyrimidinone deriv. conjugate 1"	PEP00800	Tetrapeptide 20	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00185	.	.	"1,7-Dioxa-2-thiaspiro[4.4]nonane, 2(1H)-pyrimidinone deriv."	Investigative	.	.	.	.	.
PDC_01256	"Tetrapeptide 20 - 1,7-Dioxa-2-thiaspiro[4.4]nonane, 2(1H)-pyrimidinone deriv. conjugate 2"	PEP00800	Tetrapeptide 20	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00185	.	.	"1,7-Dioxa-2-thiaspiro[4.4]nonane, 2(1H)-pyrimidinone deriv."	Investigative	.	.	.	.	.
PDC_01257	Dipeptide 26 - Cytarabine conjugate	PEP00522	Dipeptide 26	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00081	TAR10039	Herpes simplex virus DNA polymerase UL30 (HSV UL30)	Cytarabine	Investigative	.	.	.	.	.
PDC_01258	"Dipeptide 17 - 1,7-Dioxa-2-thiaspiro[4.4]nonane, 2(1H)-pyrimidinone deriv. conjugate"	PEP00513	Dipeptide 17	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00185	.	.	"1,7-Dioxa-2-thiaspiro[4.4]nonane, 2(1H)-pyrimidinone deriv."	Investigative	.	.	.	.	.
PDC_01259	Tetrapeptide 22 - Kanamycin A derivative conjugate	PEP00802	Tetrapeptide 22	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00239	.	.	Kanamycin A derivative	Investigative	.	.	.	.	.
PDC_01260	Tripeptide 60 - Kanamycin A derivative conjugate	PEP00920	Tripeptide 60	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00239	.	.	Kanamycin A derivative	Investigative	.	.	.	.	.
PDC_01261	Tripeptide 61 - Kanamycin A derivative conjugate 1	PEP00921	Tripeptide 61	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00239	.	.	Kanamycin A derivative	Investigative	.	.	.	.	.
PDC_01262	Tripeptide 62 - Neomycin B derivative conjugate	PEP00922	Tripeptide 62	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00209	.	.	Neomycin B derivative	Investigative	.	.	.	.	.
PDC_01263	Tripeptide 63 - Kanamycin A derivative conjugate	PEP00923	Tripeptide 63	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00239	.	.	Kanamycin A derivative	Investigative	.	.	.	.	.
PDC_01264	Tripeptide 64 - Kanamycin A derivative conjugate	PEP00924	Tripeptide 64	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00239	.	.	Kanamycin A derivative	Investigative	.	.	.	.	.
PDC_01265	Tripeptide 64 - Neomycin B derivative conjugate	PEP00924	Tripeptide 64	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00209	.	.	Neomycin B derivative	Investigative	.	.	.	.	.
PDC_01266	Tetrapeptide 22 - Neomycin B derivative conjugate	PEP00802	Tetrapeptide 22	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00209	.	.	Neomycin B derivative	Investigative	.	.	.	.	.
PDC_01267	Tripeptide 61 - Kanamycin A derivative conjugate 2	PEP00921	Tripeptide 61	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00239	.	.	Kanamycin A derivative	Investigative	.	.	.	.	.
PDC_01268	Dipeptide 27 - Neomycin B derivative conjugate 1	PEP00523	Dipeptide 27	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00209	.	.	Neomycin B derivative	Investigative	.	.	.	.	.
PDC_01269	Tripeptide 61 - Neomycin B derivative conjugate	PEP00921	Tripeptide 61	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00209	.	.	Neomycin B derivative	Investigative	.	.	.	.	.
PDC_01270	Dipeptide 28 - Neomycin B derivative conjugate	PEP00524	Dipeptide 28	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00209	.	.	Neomycin B derivative	Investigative	.	.	.	.	.
PDC_01271	Dipeptide 27 - Neomycin B derivative conjugate 2	PEP00523	Dipeptide 27	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00209	.	.	Neomycin B derivative	Investigative	.	.	.	.	.
PDC_01272	"Edotreotide - DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) derivative conjugate 1"	PEP00031	Edotreotide	REC00031	Somatostatin receptor type 1 (SSTR1)	LIN00127	Triazole	DRG00195	.	.	"DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) derivative"	Investigative	.	.	.	.	.
PDC_01273	"Edotreotide - 3-(2-propyn-1-yloxy)-, S-[(2,4,6-trimethoxyphenyl)methyl] benzenecarbothioic acid ester conjugate"	PEP00031	Edotreotide	REC00031	Somatostatin receptor type 1 (SSTR1)	LIN00127	Triazole	DRG00193	.	.	"3-(2-propyn-1-yloxy)-, S-[(2,4,6-trimethoxyphenyl)methyl] benzenecarbothioic acid ester"	Investigative	.	.	.	.	.
PDC_01274	"Edotreotide - DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) derivative conjugate"	PEP00031	Edotreotide	REC00031	Somatostatin receptor type 1 (SSTR1)	LIN00127	Triazole	DRG00195	.	.	"DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) derivative"	Investigative	.	.	.	.	.
PDC_01275	"Edotreotide - 3,5-bis(2-propyn-1-yloxy)-, S-[(2,4,6-trimethoxyphenyl)methyl] benzenecarbothioic acid ester conjugate"	PEP00031	Edotreotide	REC00031	Somatostatin receptor type 1 (SSTR1)	LIN00127	Triazole	DRG00194	.	.	"3,5-bis(2-propyn-1-yloxy)-, S-[(2,4,6-trimethoxyphenyl)methyl] benzenecarbothioic acid ester"	Investigative	.	.	.	.	.
PDC_01276	Oligopeptide 10 - ADP ribose conjugate	PEP00686	Oligopeptide 10	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00103	TAR10035	Long transient receptor potential channel 2 (TRPM2)	ADP ribose	Investigative	.	.	.	.	.
PDC_01277	"Oligopeptide 10 - 5-O-[(1,1-Dimethylethyl)diphenylsilyl]-&beta;-D-ribofuranosyl azide conjugate"	PEP00686	Oligopeptide 10	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00240	.	.	"5-O-[(1,1-Dimethylethyl)diphenylsilyl]-&beta;-D-ribofuranosyl azide"	Investigative	.	.	.	.	.
PDC_01278	Oligopeptide 11 - ADP ribose conjugate	PEP00687	Oligopeptide 11	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00103	TAR10035	Long transient receptor potential channel 2 (TRPM2)	ADP ribose	Investigative	.	.	.	.	.
PDC_01279	"Oligopeptide 11 - 5-O-[(1,1-Dimethylethyl)diphenylsilyl]-&beta;-D-ribofuranosyl azide conjugate"	PEP00687	Oligopeptide 11	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00240	.	.	"5-O-[(1,1-Dimethylethyl)diphenylsilyl]-&beta;-D-ribofuranosyl azide"	Investigative	.	.	.	.	.
PDC_01280	"Oligopeptide 12 - 5-O-[(1,1-Dimethylethyl)diphenylsilyl]-&beta;-D-ribofuranosyl azide conjugate"	PEP00688	Oligopeptide 12	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00240	.	.	"5-O-[(1,1-Dimethylethyl)diphenylsilyl]-&beta;-D-ribofuranosyl azide"	Investigative	.	.	.	.	.
PDC_01281	Oligopeptide 13 - Cholestanol conjugate	PEP00689	Oligopeptide 13	REC99999	Undisclosed	LIN00126	PEG	DRG00084	.	.	Cholestanol	Investigative	.	.	.	.	.
PDC_01282	Oligopeptide 14 - Cholestanol conjugate	PEP00690	Oligopeptide 14	REC99999	Undisclosed	LIN00126	PEG	DRG00084	.	.	Cholestanol	Investigative	.	.	.	.	.
PDC_01283	Oligopeptide 15 - Cholestanol conjugate	PEP00691	Oligopeptide 15	REC99999	Undisclosed	LIN00126	PEG	DRG00084	.	.	Cholestanol	Investigative	.	.	.	.	.
PDC_01284	Oligopeptide 16 - Cholestanol conjugate	PEP00692	Oligopeptide 16	REC99999	Undisclosed	LIN00126	PEG	DRG00084	.	.	Cholestanol	Investigative	.	.	.	.	.
PDC_01285	Oligopeptide 17 - Cholestanol conjugate	PEP00693	Oligopeptide 17	REC99999	Undisclosed	LIN00126	PEG	DRG00084	.	.	Cholestanol	Investigative	.	.	.	.	.
PDC_01286	Oligopeptide 18 - Cholestanol conjugate	PEP00694	Oligopeptide 18	REC99999	Undisclosed	LIN00126	PEG	DRG00084	.	.	Cholestanol	Investigative	.	.	.	.	.
PDC_01287	Oligopeptide 19 - Cholestanol conjugate	PEP00695	Oligopeptide 19	REC99999	Undisclosed	LIN00126	PEG	DRG00084	.	.	Cholestanol	Investigative	.	.	.	.	.
PDC_01288	Oligopeptide 20 - Cholestanol conjugate	PEP00696	Oligopeptide 20	REC99999	Undisclosed	LIN00126	PEG	DRG00084	.	.	Cholestanol	Investigative	.	.	.	.	.
PDC_01289	Oligopeptide 21 - Cholestanol conjugate	PEP00697	Oligopeptide 21	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00084	.	.	Cholestanol	Investigative	.	.	.	.	.
PDC_01290	Octapeptide recognized and cleaved by MMP2 - Pacitaxel derivative conjugate	PEP00661	Octapeptide recognized and cleaved by MMP2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00269	.	.	2'-O-(tert-Butyldimethylsilyl)taxol	Investigative	.	.	.	.	.
PDC_01291	Octapeptide recognized and cleaved by MMP3 - Pacitaxel derivative conjugate	PEP00662	Octapeptide recognized and cleaved by MMP3	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00269	.	.	2'-O-(tert-Butyldimethylsilyl)taxol	Investigative	.	.	.	.	.
PDC_01292	Octapeptide recognized and cleaved by MMP4 - Pacitaxel derivative conjugate	PEP00663	Octapeptide recognized and cleaved by MMP4	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00269	.	.	2'-O-(tert-Butyldimethylsilyl)taxol	Investigative	.	.	.	.	.
PDC_01293	KK (plasma membrane delivery) - Alkyne-functionalized cysteine protease inhibitor L1 conjugate	PEP00610	KK (plasma membrane delivery)	REC99999	Undisclosed	LIN00127	Triazole	DRG00197	.	.	Alkyne-functionalized cysteine protease inhibitor L1	Investigative	.	.	.	.	.
PDC_01294	SV40 (nucleus delivery) - Alkyne-functionalized cysteine protease inhibitor L1 conjugate	PEP00768	SV40 (nucleus delivery)	REC99999	Undisclosed	LIN00127	Triazole	DRG00197	.	.	Alkyne-functionalized cysteine protease inhibitor L1	Investigative	.	.	.	.	.
PDC_01295	Tat (lysosome delivery) - Alkyne-functionalized cysteine protease inhibitor L1 conjugate	PEP00774	Tat (lysosome delivery)	REC99999	Undisclosed	LIN00127	Triazole	DRG00197	.	.	Alkyne-functionalized cysteine protease inhibitor L1	Investigative	.	.	.	.	.
PDC_01296	"Neuropeptide Y derivative - 1-Fluoro-2-cyclooctyne-1-carboxylic acid + DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) derivative) conjugate 1"	PEP00644	Neuropeptide Y derivative	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00241	.	.	"1-Fluoro-2-cyclooctyne-1-carboxylic acid + DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) derivative)"	Investigative	.	.	.	.	.
PDC_01297	"Neuropeptide Y derivative - 1-Fluoro-2-cyclooctyne-1-carboxylic acid + DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) derivative) conjugate 2"	PEP00644	Neuropeptide Y derivative	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00241	.	.	"1-Fluoro-2-cyclooctyne-1-carboxylic acid + DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) derivative)"	Investigative	.	.	.	.	.
PDC_01298	Dipeptide 29 - Porphine derivative conjugate	PEP00525	Dipeptide 29	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00242	.	.	Porphine derivative	Investigative	.	.	.	.	.
PDC_01299	"Nuclear localization sequences (NLS) 1 - 2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide conjugate"	PEP00654	Nuclear localization sequences (NLS) 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00174	.	.	"2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide"	Investigative	.	.	.	.	.
PDC_01300	Nuclear localization sequences (NLS) 2 - Porphine derivative conjugate	PEP00655	Nuclear localization sequences (NLS) 2	REC99999	Undisclosed	LIN00129	Glycolic acid	DRG00242	.	.	Porphine derivative	Investigative	.	.	.	.	.
PDC_01301	Nuclear localization sequences (NLS) 1 - Porphine derivative conjugate	PEP00654	Nuclear localization sequences (NLS) 1	REC99999	Undisclosed	LIN00129	Glycolic acid	DRG00242	.	.	Porphine derivative	Investigative	.	.	.	.	.
PDC_01302	Glu-AQ 1 - 9-Acridinecarboxylic acid conjugate	PEP00567	Glu-AQ 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00115	.	.	9-Acridinecarboxylic acid	Investigative	.	.	.	.	.
PDC_01303	Glu-AQ 2 - 2-Anthraquinonecarboxylic acid conjugate 1	PEP00568	Glu-AQ 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00108	.	.	2-Anthraquinonecarboxylic acid	Investigative	.	.	.	.	.
PDC_01304	Glu-AQ 1 - 2-Anthraquinonecarboxylic acid conjugate 1	PEP00567	Glu-AQ 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00108	.	.	2-Anthraquinonecarboxylic acid	Investigative	.	.	.	.	.
PDC_01305	Glu-AQ 1 - 2-Anthraquinonecarboxylic acid conjugate	PEP00567	Glu-AQ 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00108	.	.	2-Anthraquinonecarboxylic acid	Investigative	.	.	.	.	.
PDC_01306	Glu-AQ 2 - 2-Anthraquinonecarboxylic acid conjugate	PEP00568	Glu-AQ 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00108	.	.	2-Anthraquinonecarboxylic acid	Investigative	.	.	.	.	.
PDC_01307	Glu-AQ 3 - 2-Anthraquinonecarboxylic acid conjugate	PEP00569	Glu-AQ 3	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00108	.	.	2-Anthraquinonecarboxylic acid	Investigative	.	.	.	.	.
PDC_01309	Glu-AQ 4 - 2-Anthraquinonecarboxylic acid conjugate	PEP00570	Glu-AQ 4	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00108	.	.	2-Anthraquinonecarboxylic acid	Investigative	.	.	.	.	.
PDC_01310	"Glu-AQ 2 - 2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide conjugate 1"	PEP00568	Glu-AQ 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00174	.	.	"2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide"	Investigative	.	.	.	.	.
PDC_01311	"Glu-AQ 2 - 2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide conjugate"	PEP00568	Glu-AQ 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00174	.	.	"2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide"	Investigative	.	.	.	.	.
PDC_01312	"Glu-AQ 5 - 2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide conjugate"	PEP00571	Glu-AQ 5	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00174	.	.	"2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide"	Investigative	.	.	.	.	.
PDC_01313	"Glu-AQ 3 - 2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide conjugate 1"	PEP00569	Glu-AQ 3	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00174	.	.	"2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide"	Investigative	.	.	.	.	.
PDC_01314	"Glu-AQ 3 - 2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide conjugate 2"	PEP00569	Glu-AQ 3	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00174	.	.	"2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide"	Investigative	.	.	.	.	.
PDC_01315	"Glu-AQ 3 - 2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide conjugate 3"	PEP00569	Glu-AQ 3	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00174	.	.	"2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide"	Investigative	.	.	.	.	.
PDC_01316	"Glu-AQ 6 - 2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide conjugate"	PEP00572	Glu-AQ 6	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00174	.	.	"2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide"	Investigative	.	.	.	.	.
PDC_01317	"Glu-AQ 1 - 2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide conjugate 1"	PEP00567	Glu-AQ 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00174	.	.	"2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide"	Investigative	.	.	.	.	.
PDC_01318	"Glu-AQ 1 - 2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide conjugate"	PEP00567	Glu-AQ 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00174	.	.	"2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide"	Investigative	.	.	.	.	.
PDC_01319	"Glu-AQ 7 - 2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide conjugate"	PEP00573	Glu-AQ 7	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00174	.	.	"2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide"	Investigative	.	.	.	.	.
PDC_01320	Dipeptide 30 - N-Norgalanthamine conjugate	PEP00526	Dipeptide 30	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00323	.	.	Norgalanthamine	Investigative	.	.	.	.	.
PDC_01321	Dipeptide 31 - N-Norgalanthamine conjugate	PEP00527	Dipeptide 31	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00323	.	.	Norgalanthamine	Investigative	.	.	.	.	.
PDC_01322	Tripeptide 65 - N-Norgalanthamine conjugate	PEP00925	Tripeptide 65	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00323	.	.	Norgalanthamine	Investigative	.	.	.	.	.
PDC_01323	Tripeptide 66 - N-Norgalanthamine conjugate	PEP00926	Tripeptide 66	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00323	.	.	Norgalanthamine	Investigative	.	.	.	.	.
PDC_01324	Tripeptide 67 - N-Norgalanthamine conjugate	PEP00927	Tripeptide 67	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00323	.	.	Norgalanthamine	Investigative	.	.	.	.	.
PDC_01325	Dipeptide 32 - N-Norgalanthamine conjugate	PEP00528	Dipeptide 32	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00323	.	.	Norgalanthamine	Investigative	.	.	.	.	.
PDC_01326	Dipeptide 33 - N-Norgalanthamine conjugate	PEP00529	Dipeptide 33	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00323	.	.	Norgalanthamine	Investigative	.	.	.	.	.
PDC_01327	"SFFYLRS - 1,3-Diazido-2,4,5-trifluoro-6-nitrobenzene conjugate"	PEP00231	SFFYLRS	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00243	.	.	"1,3-Diazido-2,4,5-trifluoro-6-nitrobenzene"	Investigative	.	.	.	.	.
PDC_01328	"Octarginin 1 - (8S,10S)-10-[(3-amino-2,3,6-trideoxy-&alpha;-L-lyxo-hexopyranosyl)oxy]-8-(1-hydrazonoethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-Naphthacenedione conjugate"	PEP00664	Octarginin 1	REC99999	Undisclosed	LIN00137	Glutamic acid	DRG00330	.	.	"(8S,10S)-10-[(3-amino-2,3,6-trideoxy-&alpha;-L-lyxo-hexopyranosyl)oxy]-8-(1-hydrazonoethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-Naphthacenedione"	Investigative	.	.	.	.	.
PDC_01329	"Hexarginin 1 - (8S,10S)-10-[(3-amino-2,3,6-trideoxy-&alpha;-L-lyxo-hexopyranosyl)oxy]-8-(1-hydrazonoethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-Naphthacenedione conjugate"	PEP00595	Hexarginin 1	REC99999	Undisclosed	LIN00137	Glutamic acid	DRG00330	.	.	"(8S,10S)-10-[(3-amino-2,3,6-trideoxy-&alpha;-L-lyxo-hexopyranosyl)oxy]-8-(1-hydrazonoethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-Naphthacenedione"	Investigative	.	.	.	.	.
PDC_01330	"Octarginin 2 - (8S,10S)-10-[(3-amino-2,3,6-trideoxy-&alpha;-L-lyxo-hexopyranosyl)oxy]-8-(1-hydrazonoethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-Naphthacenedione conjugate 1"	PEP00665	Octarginin 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00330	.	.	"(8S,10S)-10-[(3-amino-2,3,6-trideoxy-&alpha;-L-lyxo-hexopyranosyl)oxy]-8-(1-hydrazonoethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-Naphthacenedione"	Investigative	.	.	.	.	.
PDC_01331	"Hexarginin 2 - (8S,10S)-10-[(3-amino-2,3,6-trideoxy-&alpha;-L-lyxo-hexopyranosyl)oxy]-8-(1-hydrazonoethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-Naphthacenedione conjugate 1"	PEP00596	Hexarginin 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00330	.	.	"(8S,10S)-10-[(3-amino-2,3,6-trideoxy-&alpha;-L-lyxo-hexopyranosyl)oxy]-8-(1-hydrazonoethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-Naphthacenedione"	Investigative	.	.	.	.	.
PDC_01332	"Octarginin 2 - (8S,10S)-10-[(3-amino-2,3,6-trideoxy-&alpha;-L-lyxo-hexopyranosyl)oxy]-8-(1-hydrazonoethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-Naphthacenedione conjugate 2"	PEP00665	Octarginin 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00330	.	.	"(8S,10S)-10-[(3-amino-2,3,6-trideoxy-&alpha;-L-lyxo-hexopyranosyl)oxy]-8-(1-hydrazonoethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-Naphthacenedione"	Investigative	.	.	.	.	.
PDC_01333	"Hexarginin 2 - (8S,10S)-10-[(3-amino-2,3,6-trideoxy-&alpha;-L-lyxo-hexopyranosyl)oxy]-8-(1-hydrazonoethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-Naphthacenedione conjugate"	PEP00596	Hexarginin 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00330	.	.	"(8S,10S)-10-[(3-amino-2,3,6-trideoxy-&alpha;-L-lyxo-hexopyranosyl)oxy]-8-(1-hydrazonoethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-Naphthacenedione"	Investigative	.	.	.	.	.
PDC_01334	"GGGPKKKRKVGG - (T-4)-[4-[(3,5-dimethyl-1H-pyrrol-2-yl-&kappa;N)(3,5-dimethyl-2H-pyrrol-2-ylidene-&kappa;N)methyl]phenolato]difluoro-boron conjugate"	PEP00232	GGGPKKKRKVGG	REC99999	Undisclosed	LIN00127	Triazole	DRG00331	.	.	"(T-4)-[4-[(3,5-dimethyl-1H-pyrrol-2-yl-&kappa;N)(3,5-dimethyl-2H-pyrrol-2-ylidene-&kappa;N)methyl]phenolato]difluoro-boron"	Investigative	.	.	.	.	.
PDC_01335	"GGGPKKKXKVGG - (T-4)-[4-[(3,5-dimethyl-1H-pyrrol-2-yl-&kappa;N)(3,5-dimethyl-2H-pyrrol-2-ylidene-&kappa;N)methyl]phenolato]difluoro-boron conjugate"	PEP00233	GGGPKKKXKVGG	REC99999	Undisclosed	LIN00127	Triazole	DRG00331	.	.	"(T-4)-[4-[(3,5-dimethyl-1H-pyrrol-2-yl-&kappa;N)(3,5-dimethyl-2H-pyrrol-2-ylidene-&kappa;N)methyl]phenolato]difluoro-boron"	Investigative	.	.	.	.	.
PDC_01336	"GGGPKKKRKVGG - 2,3-Dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonic acid conjugate"	PEP00232	GGGPKKKRKVGG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00201	.	.	"2,3-Dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonic acid"	Investigative	.	.	.	.	.
PDC_01337	"GGGPKKKXKVGG - 2,3-Dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonic acid conjugate 1"	PEP00233	GGGPKKKXKVGG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00201	.	.	"2,3-Dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonic acid"	Investigative	.	.	.	.	.
PDC_01338	"GGGPKKKXKVGG - 2,3-Dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonic acid conjugate 2"	PEP00233	GGGPKKKXKVGG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00201	.	.	"2,3-Dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonic acid"	Investigative	.	.	.	.	.
PDC_01339	"GGGPKKKXKVGG - 2,3-Dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonic acid conjugate"	PEP00233	GGGPKKKXKVGG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00201	.	.	"2,3-Dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonic acid"	Investigative	.	.	.	.	.
PDC_01340	KTTKS - L-Ascorbic acid conjugate 1	PEP00234	KTTKS	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00200	.	.	L-Ascorbic acid	Investigative	.	.	.	.	.
PDC_01341	"CNGRC - Pplatinum-(SP-4-2)-(1,2-Ethanediamine-&kappa;N1,&kappa;N2)[propanedioato(2-)-&kappa;O1,&kappa;O3] conjugate"	PEP00018	Cyclic NGR	REC99999	Undisclosed	LIN00126	PEG	DRG00150	.	.	"Pplatinum-(SP-4-2)-(1,2-Ethanediamine-&kappa;N1,&kappa;N2)[propanedioato(2-)-&kappa;O1,&kappa;O3]"	Investigative	.	.	.	.	.
PDC_01342	"CNGRC - Platinum-(SP-4-2)-[2-(3-aminopropyl)propanedioato(2-)-&kappa;O1,&kappa;O3]diammine conjugate"	PEP00018	Cyclic NGR	REC99999	Undisclosed	LIN00126	PEG	DRG00332	.	.	"Platinum-(SP-4-2)-[2-(3-aminopropyl)propanedioato(2-)-&kappa;O1,&kappa;O3]diammine"	Investigative	.	.	.	.	.
PDC_01343	"QACKGKIQALCENG - Carbamic acid, N-[(3&alpha;,5&beta;,7&alpha;,12&alpha;)-7-(acetyloxy)-3,24-diamino-24-oxocholan-12-yl]-, 1,1-dimethylethyl ester conjugate 1"	PEP00235	QACKGKIQALCENG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00294	.	.	Carbamic acid	Investigative	.	.	.	.	.
PDC_01344	"QACKGKIQALCENG - Carbamic acid, N-[(3&alpha;,5&beta;,7&alpha;,12&alpha;)-7-(acetyloxy)-3,24-diamino-24-oxocholan-12-yl]-, 1,1-dimethylethyl ester conjugate 2"	PEP00235	QACKGKIQALCENG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00294	.	.	Carbamic acid	Investigative	.	.	.	.	.
PDC_01345	"QACKGKIQALCENG - Carbamic acid, N-[(3&alpha;,5&beta;,7&alpha;,12&alpha;)-7-(acetyloxy)-3,24-diamino-24-oxocholan-12-yl]-, 1,1-dimethylethyl ester conjugate 3"	PEP00235	QACKGKIQALCENG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00294	.	.	Carbamic acid	Investigative	.	.	.	.	.
PDC_01346	"QACKGKIQALCENG - Carbamic acid, N-[(3&alpha;,5&beta;,7&alpha;,12&alpha;)-7-(acetyloxy)-3,24-diamino-24-oxocholan-12-yl]-, 1,1-dimethylethyl ester conjugate 4"	PEP00235	QACKGKIQALCENG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00294	.	.	Carbamic acid	Investigative	.	.	.	.	.
PDC_01347	"QACKGKIQALCENG - Carbamic acid, N-[(3&alpha;,5&beta;,7&alpha;,12&alpha;)-7-(acetyloxy)-3,24-diamino-24-oxocholan-12-yl]-, 1,1-dimethylethyl ester conjugate 5"	PEP00235	QACKGKIQALCENG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00294	.	.	Carbamic acid	Investigative	.	.	.	.	.
PDC_01348	"QACKGKIQALCENG - Carbamic acid, N-[(3&alpha;,5&beta;,7&alpha;,12&alpha;)-7-(acetyloxy)-3,24-diamino-24-oxocholan-12-yl]-, 1,1-dimethylethyl ester conjugate 6"	PEP00235	QACKGKIQALCENG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00294	.	.	Carbamic acid	Investigative	.	.	.	.	.
PDC_01349	"QACKGKIQALCENG - Carbamic acid, N-[(3&alpha;,5&beta;,7&alpha;,12&alpha;)-7-(acetyloxy)-3,24-diamino-24-oxocholan-12-yl]-, 1,1-dimethylethyl ester conjugate 7"	PEP00235	QACKGKIQALCENG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00294	.	.	Carbamic acid	Investigative	.	.	.	.	.
PDC_01350	"QACKGKIQALCENG - Carbamic acid, N-[(3&alpha;,5&beta;,7&alpha;,12&alpha;)-7-(acetyloxy)-3,24-diamino-24-oxocholan-12-yl]-, 1,1-dimethylethyl ester conjugate 8"	PEP00235	QACKGKIQALCENG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00294	.	.	Carbamic acid	Investigative	.	.	.	.	.
PDC_01351	RIKPHQGQHIGQFPQIM - Meso-porphyrin derivative conjugate 1	PEP00236	RIKPHQGQHIGQFPQIM	REC99999	Undisclosed	LIN00126	PEG	DRG00333	.	.	Meso-porphyrin derivative	Investigative	.	.	.	.	.
PDC_01352	RIKPHQGQHIGQFPQIM - Meso-porphyrin derivative conjugate	PEP00236	RIKPHQGQHIGQFPQIM	REC99999	Undisclosed	LIN00126	PEG	DRG00333	.	.	Meso-porphyrin derivative	Investigative	.	.	.	.	.
PDC_01353	Tripeptide 68 - Naproxen conjugate 1	PEP00928	Tripeptide 68	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00121	TAR10032	Prostaglandin G/H synthase 1 (COX-1)	Naproxen	Investigative	.	.	.	.	.
PDC_01354	Tripeptide 68 - Naproxen conjugate 2	PEP00928	Tripeptide 68	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00121	TAR10032	Prostaglandin G/H synthase 1 (COX-1)	Naproxen	Investigative	.	.	.	.	.
PDC_01355	Dipeptide 34 - Naproxen conjugate 1	PEP00530	Dipeptide 34	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00121	TAR10032	Prostaglandin G/H synthase 1 (COX-1)	Naproxen	Investigative	.	.	.	.	.
PDC_01356	Tripeptide 68 - Naproxen conjugate 3	PEP00928	Tripeptide 68	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00121	TAR10032	Prostaglandin G/H synthase 1 (COX-1)	Naproxen	Investigative	.	.	.	.	.
PDC_01357	Dipeptide 34 - Naproxen conjugate 2	PEP00530	Dipeptide 34	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00121	TAR10032	Prostaglandin G/H synthase 1 (COX-1)	Naproxen	Investigative	.	.	.	.	.
PDC_01358	Tripeptide 68 - Naproxen conjugate 4	PEP00928	Tripeptide 68	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00121	TAR10032	Prostaglandin G/H synthase 1 (COX-1)	Naproxen	Investigative	.	.	.	.	.
PDC_01359	Dipeptide 34 - Naproxen conjugate 3	PEP00530	Dipeptide 34	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00121	TAR10032	Prostaglandin G/H synthase 1 (COX-1)	Naproxen	Investigative	.	.	.	.	.
PDC_01360	AAGYLLGKINLKALAALAKKIL - Firefly luciferin derivative conjugate	PEP00237	AAGYLLGKINLKALAALAKKIL	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00334	.	.	Firefly luciferin derivative	Investigative	.	.	.	.	.
PDC_01361	AMVTVLFRRLRIRRASGPPRVRV - Firefly luciferin derivative conjugate	PEP00238	AMVTVLFRRLRIRRASGPPRVRV	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00334	.	.	Firefly luciferin derivative	Investigative	.	.	.	.	.
PDC_01362	ALLIILRRRIRKQAHAHSK - Firefly luciferin derivative conjugate	PEP00239	ALLIILRRRIRKQAHAHSK	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00334	.	.	Firefly luciferin derivative	Investigative	.	.	.	.	.
PDC_01363	"GILKEPVHGA - 9,12-Octadecadienoic acid (9Z,12Z)-, hydrazide conjugate"	PEP00240	GILKEPVHGA	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00319	.	.	"cis,cis-9,12-Octadecadienoic acid, 2-benzyl-hydrazide"	Investigative	.	.	.	.	.
PDC_01364	GILKEPVHGA - (9Z)-9-Octadecenoic acid hydrazide conjugate	PEP00240	GILKEPVHGA	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00335	.	.	(9Z)-9-Octadecenoic acid hydrazide	Investigative	.	.	.	.	.
PDC_01365	"GILKEPVHGA - Cholest-5-en-3-ol (3&beta;)-, 3-(hydrazinecarboxylate) conjugate"	PEP00240	GILKEPVHGA	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00336	.	.	"Cholest-5-en-3-ol (3&beta;)-, 3-(hydrazinecarboxylate)"	Investigative	.	.	.	.	.
PDC_01366	EGFLG - Methotrexate conjugate	PEP00241	EGFLG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_01367	Tetrapeptide 23 - Methotrexate conjugate 1	PEP00803	Tetrapeptide 23	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_01368	XGFLG - Methotrexate conjugate 2	PEP00242	XGFLG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_01369	Tetrapeptide 23 - Methotrexate conjugate 2	PEP00803	Tetrapeptide 23	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_01370	"Tripeptide 69 - 3-Methoxyestra-1,3,5(10),16-tetraeno[17,16-d]pyrimidin-2-amine conjugate"	PEP00929	Tripeptide 69	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00337	.	.	"3-Methoxyestra-1,3,5(10),16-tetraeno[17,16-d]pyrimidin-2-amine"	Investigative	.	.	.	.	.
PDC_01371	"Tetrapeptide 24 - 3-Methoxyestra-1,3,5(10),16-tetraeno[17,16-d]pyrimidin-2-amine conjugate"	PEP00804	Tetrapeptide 24	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00337	.	.	"3-Methoxyestra-1,3,5(10),16-tetraeno[17,16-d]pyrimidin-2-amine"	Investigative	.	.	.	.	.
PDC_01372	"Tetrapeptide 25 - 3-Methoxyestra-1,3,5(10),16-tetraeno[17,16-d]pyrimidin-2-amine conjugate"	PEP00805	Tetrapeptide 25	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00337	.	.	"3-Methoxyestra-1,3,5(10),16-tetraeno[17,16-d]pyrimidin-2-amine"	Investigative	.	.	.	.	.
PDC_01373	"Tripeptide 70 - 3-Methoxyestra-1,3,5(10),16-tetraeno[17,16-d]pyrimidin-2-amine conjugate"	PEP00930	Tripeptide 70	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00337	.	.	"3-Methoxyestra-1,3,5(10),16-tetraeno[17,16-d]pyrimidin-2-amine"	Investigative	.	.	.	.	.
PDC_01374	"Tripeptide 71 - 3-(Phenylmethoxy)estra-1,3,5(10),16-tetraeno[17,16-d]pyrimidin-2-amine conjugate"	PEP00931	Tripeptide 71	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00338	.	.	"3-(Phenylmethoxy)estra-1,3,5(10),16-tetraeno[17,16-d]pyrimidin-2-amine"	Investigative	.	.	.	.	.
PDC_01375	"Tripeptide 72 - 3-(Phenylmethoxy)estra-1,3,5(10),16-tetraeno[17,16-d]pyrimidin-2-amine conjugate"	PEP00932	Tripeptide 72	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00338	.	.	"3-(Phenylmethoxy)estra-1,3,5(10),16-tetraeno[17,16-d]pyrimidin-2-amine"	Investigative	.	.	.	.	.
PDC_01376	"Tetrapeptide 25 - 3-(Phenylmethoxy)estra-1,3,5(10),16-tetraeno[17,16-d]pyrimidin-2-amine conjugate"	PEP00805	Tetrapeptide 25	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00338	.	.	"3-(Phenylmethoxy)estra-1,3,5(10),16-tetraeno[17,16-d]pyrimidin-2-amine"	Investigative	.	.	.	.	.
PDC_01377	EVTCVVVD - Biotin conjugate 1	PEP00243	EVTCVVVD	REC99999	Undisclosed	LIN00126	PEG	DRG00270	.	.	Biotin	Investigative	.	.	.	.	.
PDC_01378	EVTCVVVD - Biotin conjugate 2	PEP00243	EVTCVVVD	REC99999	Undisclosed	LIN00026	Aminocaproic acid	DRG00270	.	.	Biotin	Investigative	.	.	.	.	.
PDC_01379	EVTCVVVD - Biotin conjugate 3	PEP00243	EVTCVVVD	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00270	.	.	Biotin	Investigative	.	.	.	.	.
PDC_01380	AXAXQAXAX - N-[2-[2-(4-Nitrophenyl)ethynyl]-5-(2-phenylethynyl)phenyl]acetamide conjugate	PEP00244	AXAXQAXAX	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00276	.	.	N-[2-[2-(4-nitrophenyl)ethynyl]-5-(2-phenylethynyl)phenyl]acetamide	Investigative	.	.	.	.	.
PDC_01381	QAXAX - N-[2-[2-(4-Nitrophenyl)ethynyl]-5-(2-phenylethynyl)phenyl]acetamide conjugate	PEP00245	QAXAX	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00276	.	.	N-[2-[2-(4-nitrophenyl)ethynyl]-5-(2-phenylethynyl)phenyl]acetamide	Investigative	.	.	.	.	.
PDC_01382	Tetrapeptide 26 - Estradiol conjugate 1	PEP00806	Tetrapeptide 26	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00076	TAR10055	Estrogen receptor (ESR)	Estradiol	Investigative	.	.	.	.	.
PDC_01383	Tetrapeptide 27 - Estradiol conjugate 1	PEP00807	Tetrapeptide 27	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00076	TAR10055	Estrogen receptor (ESR)	Estradiol	Investigative	.	.	.	.	.
PDC_01384	Tetrapeptide 26 - Estradiol conjugate 2	PEP00806	Tetrapeptide 26	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00076	TAR10055	Estrogen receptor (ESR)	Estradiol	Investigative	.	.	.	.	.
PDC_01385	Tetrapeptide 28 - Estradiol conjugate 1	PEP00808	Tetrapeptide 28	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00076	TAR10055	Estrogen receptor (ESR)	Estradiol	Investigative	.	.	.	.	.
PDC_01386	Tetrapeptide 26 - Estradiol conjugate 3	PEP00806	Tetrapeptide 26	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00076	TAR10055	Estrogen receptor (ESR)	Estradiol	Investigative	.	.	.	.	.
PDC_01387	Tetrapeptide 27 - Estradiol conjugate 2	PEP00807	Tetrapeptide 27	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00076	TAR10055	Estrogen receptor (ESR)	Estradiol	Investigative	.	.	.	.	.
PDC_01388	RGDFRGDF - Estradiol conjugate 1	PEP00246	RGDFRGDF	REC99999	Undisclosed	LIN00129	Glycolic acid	DRG00076	TAR10055	Estrogen receptor (ESR)	Estradiol	Investigative	.	.	.	.	.
PDC_01389	RGDFRGDF - Estradiol conjugate 9	PEP00247	RGDVRGDV	REC99999	Undisclosed	LIN00129	Glycolic acid	DRG00076	TAR10055	Estrogen receptor (ESR)	Estradiol	Investigative	.	.	.	.	.
PDC_01390	RGDFRGDF - Estradiol conjugate 5	PEP00248	RGDSRGDS	REC99999	Undisclosed	LIN00129	Glycolic acid	DRG00076	TAR10055	Estrogen receptor (ESR)	Estradiol	Investigative	.	.	.	.	.
PDC_01391	Tetrapeptide 29 - Estradiol conjugate	PEP00809	Tetrapeptide 29	REC99999	Undisclosed	LIN00129	Glycolic acid	DRG00076	TAR10055	Estrogen receptor (ESR)	Estradiol	Investigative	.	.	.	.	.
PDC_01392	Tetrapeptide 27 - Estradiol conjugate 3	PEP00807	Tetrapeptide 27	REC99999	Undisclosed	LIN00129	Glycolic acid	DRG00076	TAR10055	Estrogen receptor (ESR)	Estradiol	Investigative	.	.	.	.	.
PDC_01393	Tetrapeptide 28 - Estradiol conjugate 2	PEP00808	Tetrapeptide 28	REC99999	Undisclosed	LIN00129	Glycolic acid	DRG00076	TAR10055	Estrogen receptor (ESR)	Estradiol	Investigative	.	.	.	.	.
PDC_01394	Tetrapeptide 26 - Estradiol conjugate 4	PEP00806	Tetrapeptide 26	REC99999	Undisclosed	LIN00129	Glycolic acid	DRG00076	TAR10055	Estrogen receptor (ESR)	Estradiol	Investigative	.	.	.	.	.
PDC_01395	Tetrapeptide 27 - Estradiol conjugate 4	PEP00807	Tetrapeptide 27	REC99999	Undisclosed	LIN00129	Glycolic acid	DRG00076	TAR10055	Estrogen receptor (ESR)	Estradiol	Investigative	.	.	.	.	.
PDC_01396	Tetrapeptide 28 - Estradiol conjugate 3	PEP00808	Tetrapeptide 28	REC99999	Undisclosed	LIN00129	Glycolic acid	DRG00076	TAR10055	Estrogen receptor (ESR)	Estradiol	Investigative	.	.	.	.	.
PDC_01397	Tetrapeptide 26 - Estradiol conjugate 5	PEP00806	Tetrapeptide 26	REC99999	Undisclosed	LIN00129	Glycolic acid	DRG00076	TAR10055	Estrogen receptor (ESR)	Estradiol	Investigative	.	.	.	.	.
PDC_01398	Tetrapeptide 27 - Estradiol conjugate 5	PEP00807	Tetrapeptide 27	REC99999	Undisclosed	LIN00129	Glycolic acid	DRG00076	TAR10055	Estrogen receptor (ESR)	Estradiol	Investigative	.	.	.	.	.
PDC_01399	Tetrapeptide 30 - Cyclophosphamide conjugate	PEP00810	Tetrapeptide 30	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00074	TAR10052	Human Deoxyribonucleic acid (hDNA)	Cyclophosphamide	Investigative	.	.	.	.	.
PDC_01403	RGDFRGDF - Estradiol conjugate 10	PEP00247	RGDVRGDV	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00076	TAR10055	Estrogen receptor (ESR)	Estradiol	Investigative	.	.	.	.	.
PDC_01404	RGDFRGDF - Estradiol conjugate 6	PEP00248	RGDSRGDS	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00076	TAR10055	Estrogen receptor (ESR)	Estradiol	Investigative	.	.	.	.	.
PDC_01405	RGDFRGDF - Estradiol conjugate 2	PEP00246	RGDFRGDF	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00076	TAR10055	Estrogen receptor (ESR)	Estradiol	Investigative	.	.	.	.	.
PDC_01406	RGDFRGDF - Estradiol conjugate 11	PEP00247	RGDVRGDV	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00076	TAR10055	Estrogen receptor (ESR)	Estradiol	Investigative	.	.	.	.	.
PDC_01407	RGDFRGDF - Estradiol conjugate 7	PEP00248	RGDSRGDS	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00076	TAR10055	Estrogen receptor (ESR)	Estradiol	Investigative	.	.	.	.	.
PDC_01408	RGDFRGDF - Estradiol conjugate 3	PEP00246	RGDFRGDF	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00076	TAR10055	Estrogen receptor (ESR)	Estradiol	Investigative	.	.	.	.	.
PDC_01409	RGDFRGDF - Estradiol conjugate 12	PEP00247	RGDVRGDV	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00076	TAR10055	Estrogen receptor (ESR)	Estradiol	Investigative	.	.	.	.	.
PDC_01410	RGDFRGDF - Estradiol conjugate 8	PEP00248	RGDSRGDS	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00076	TAR10055	Estrogen receptor (ESR)	Estradiol	Investigative	.	.	.	.	.
PDC_01411	RGDFRGDF - Estradiol conjugate 4	PEP00246	RGDFRGDF	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00076	TAR10055	Estrogen receptor (ESR)	Estradiol	Investigative	.	.	.	.	.
PDC_01412	Tetrapeptide 27 - Estradiol conjugate 6	PEP00807	Tetrapeptide 27	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00076	TAR10055	Estrogen receptor (ESR)	Estradiol	Investigative	.	.	.	.	.
PDC_01413	Tetrapeptide 28 - Estradiol conjugate 4	PEP00808	Tetrapeptide 28	REC99999	Undisclosed	LIN00129	Glycolic acid	DRG00076	TAR10055	Estrogen receptor (ESR)	Estradiol	Investigative	.	.	.	.	.
PDC_01414	Tetrapeptide 26 - Estradiol conjugate 6	PEP00806	Tetrapeptide 26	REC99999	Undisclosed	LIN00129	Glycolic acid	DRG00076	TAR10055	Estrogen receptor (ESR)	Estradiol	Investigative	.	.	.	.	.
PDC_01415	Tetrapeptide 27 - Estradiol conjugate 7	PEP00807	Tetrapeptide 27	REC99999	Undisclosed	LIN00129	Glycolic acid	DRG00076	TAR10055	Estrogen receptor (ESR)	Estradiol	Investigative	.	.	.	.	.
PDC_01416	Tetrapeptide 28 - Estradiol conjugate 5	PEP00808	Tetrapeptide 28	REC99999	Undisclosed	LIN00129	Glycolic acid	DRG00076	TAR10055	Estrogen receptor (ESR)	Estradiol	Investigative	.	.	.	.	.
PDC_01417	Tetrapeptide 26 - Estradiol conjugate 7	PEP00806	Tetrapeptide 26	REC99999	Undisclosed	LIN00129	Glycolic acid	DRG00076	TAR10055	Estrogen receptor (ESR)	Estradiol	Investigative	.	.	.	.	.
PDC_01418	Tetrapeptide 27 - Estradiol conjugate 8	PEP00807	Tetrapeptide 27	REC99999	Undisclosed	LIN00129	Glycolic acid	DRG00076	TAR10055	Estrogen receptor (ESR)	Estradiol	Investigative	.	.	.	.	.
PDC_01419	CPRGGSVC - Doxorubicin conjugate 1	PEP00249	CPRGGSVC	REC99999	Undisclosed	LIN00126	PEG	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_01420	CPRGGSVC - Doxorubicin conjugate 2	PEP00249	CPRGGSVC	REC99999	Undisclosed	LIN00126	PEG	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_01421	KTTKS - L-Ascorbic acid conjugate 2	PEP00234	KTTKS	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00200	.	.	L-Ascorbic acid	Investigative	.	.	.	.	.
PDC_01422	KTTKS - L-Ascorbic acid conjugate 3	PEP00234	KTTKS	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00200	.	.	L-Ascorbic acid	Investigative	.	.	.	.	.
PDC_01423	Transferrin receptor binding peptide - Artemisinin conjugate	PEP00856	Transferrin receptor binding peptide	REC99999	Undisclosed	LIN00138	Aminobenzoic acid	DRG00109	TAR10057	Plasmodium Dihydroorotate dehydrogenase (Malaria DHOdehase); Sarcoplasmic/endoplasmic reticulum calcium ATPase (ATP2A)	Artemisinin	Investigative	.	.	.	.	.
PDC_01424	T7 - Artemisinin conjugate	PEP00167	DT7	REC00008	Transferrin receptor protein 1 (TFRC)	LIN00138	Aminobenzoic acid	DRG00109	TAR10057	Plasmodium Dihydroorotate dehydrogenase (Malaria DHOdehase); Sarcoplasmic/endoplasmic reticulum calcium ATPase (ATP2A)	Artemisinin	Investigative	.	.	.	.	.
PDC_01425	Tripeptide 73 - Vinblastine conjugate 1	PEP00933	Tripeptide 73	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00122	.	.	Vinblastine	Investigative	.	.	.	.	.
PDC_01426	Tripeptide 73 - Vinblastine conjugate 2	PEP00933	Tripeptide 73	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00122	.	.	Vinblastine	Investigative	.	.	.	.	.
PDC_01427	Dipeptide 35 - Vinblastine conjugate 1	PEP00531	Dipeptide 35	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00122	.	.	Vinblastine	Investigative	.	.	.	.	.
PDC_01428	Dipeptide 35 - Vinblastine conjugate 2	PEP00531	Dipeptide 35	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00122	.	.	Vinblastine	Investigative	.	.	.	.	.
PDC_01429	Tripeptide 73 - Vinblastine conjugate 3	PEP00933	Tripeptide 73	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00122	.	.	Vinblastine	Investigative	.	.	.	.	.
PDC_01430	"RGD - (1R,3R,4aS,4bR,6aS,8S,10aS,10bS,12aS)-1-[1H]phenanthro[2,1-c]pyran]-3-carboxylic acid, octadecahydro-8-methoxy-10a,12a-dimethyl-Spiro[furan-2(3H) conjugate 1"	PEP00163	c[DKP-RGD]	REC00022	"Indoleamine 2,3-dioxygenase 1 (IDO1)"	LIN00146	Undisclosed	DRG00339	.	.	"(1R,3R,4aS,4bR,6aS,8S,10aS,10bS,12aS)-1-[1H]phenanthro[2,1-c]pyran]-3-carboxylic acid, octadecahydro-8-methoxy-10a,12a-dimethyl-Spiro[furan-2(3H)"	Investigative	.	.	.	.	.
PDC_01431	"Tripeptide 74 - (1R,3R,4aS,4bR,6aS,8S,10aS,10bS,12aS)-1-[1H]phenanthro[2,1-c]pyran]-3-carboxylic acid, octadecahydro-8-methoxy-10a,12a-dimethyl-Spiro[furan-2(3H) conjugate"	PEP00934	Tripeptide 74	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00339	.	.	"(1R,3R,4aS,4bR,6aS,8S,10aS,10bS,12aS)-1-[1H]phenanthro[2,1-c]pyran]-3-carboxylic acid, octadecahydro-8-methoxy-10a,12a-dimethyl-Spiro[furan-2(3H)"	Investigative	.	.	.	.	.
PDC_01432	"Tripeptide 75 - (1R,3R,4aS,4bR,6aS,8S,10aS,10bS,12aS)-1-[1H]phenanthro[2,1-c]pyran]-3-carboxylic acid, octadecahydro-8-methoxy-10a,12a-dimethyl-Spiro[furan-2(3H) conjugate 1"	PEP00935	Tripeptide 75	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00339	.	.	"(1R,3R,4aS,4bR,6aS,8S,10aS,10bS,12aS)-1-[1H]phenanthro[2,1-c]pyran]-3-carboxylic acid, octadecahydro-8-methoxy-10a,12a-dimethyl-Spiro[furan-2(3H)"	Investigative	.	.	.	.	.
PDC_01433	"Tripeptide 76 - (1R,3R,4aS,4bR,6aS,8S,10aS,10bS,12aS)-1-[1H]phenanthro[2,1-c]pyran]-3-carboxylic acid, octadecahydro-8-methoxy-10a,12a-dimethyl-Spiro[furan-2(3H) conjugate"	PEP00936	Tripeptide 76	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00339	.	.	"(1R,3R,4aS,4bR,6aS,8S,10aS,10bS,12aS)-1-[1H]phenanthro[2,1-c]pyran]-3-carboxylic acid, octadecahydro-8-methoxy-10a,12a-dimethyl-Spiro[furan-2(3H)"	Investigative	.	.	.	.	.
PDC_01434	"Tripeptide 75 - (1R,3R,4aS,4bR,6aS,8S,10aS,10bS,12aS)-1-[1H]phenanthro[2,1-c]pyran]-3-carboxylic acid, octadecahydro-8-methoxy-10a,12a-dimethyl-Spiro[furan-2(3H) conjugate 2"	PEP00935	Tripeptide 75	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00339	.	.	"(1R,3R,4aS,4bR,6aS,8S,10aS,10bS,12aS)-1-[1H]phenanthro[2,1-c]pyran]-3-carboxylic acid, octadecahydro-8-methoxy-10a,12a-dimethyl-Spiro[furan-2(3H)"	Investigative	.	.	.	.	.
PDC_01435	"Tripeptide 75 - (1R,3R,4aS,4bR,6aS,8S,10aS,10bS,12aS)-1-[1H]phenanthro[2,1-c]pyran]-3-carboxylic acid, octadecahydro-8-methoxy-10a,12a-dimethyl-Spiro[furan-2(3H) conjugate 3"	PEP00935	Tripeptide 75	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00339	.	.	"(1R,3R,4aS,4bR,6aS,8S,10aS,10bS,12aS)-1-[1H]phenanthro[2,1-c]pyran]-3-carboxylic acid, octadecahydro-8-methoxy-10a,12a-dimethyl-Spiro[furan-2(3H)"	Investigative	.	.	.	.	.
PDC_01436	"Tripeptide 75 - (1R,3R,4aS,4bR,6aS,8S,10aS,10bS,12aS)-1-[1H]phenanthro[2,1-c]pyran]-3-carboxylic acid, octadecahydro-8-methoxy-10a,12a-dimethyl-Spiro[furan-2(3H) conjugate 4"	PEP00937	Tripeptide 77	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00339	.	.	"(1R,3R,4aS,4bR,6aS,8S,10aS,10bS,12aS)-1-[1H]phenanthro[2,1-c]pyran]-3-carboxylic acid, octadecahydro-8-methoxy-10a,12a-dimethyl-Spiro[furan-2(3H)"	Investigative	.	.	.	.	.
PDC_01437	"Tripeptide 75 - (1R,3R,4aS,4bR,6aS,8S,10aS,10bS,12aS)-1-[1H]phenanthro[2,1-c]pyran]-3-carboxylic acid, octadecahydro-8-methoxy-10a,12a-dimethyl-Spiro[furan-2(3H) conjugate 5"	PEP00937	Tripeptide 77	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00339	.	.	"(1R,3R,4aS,4bR,6aS,8S,10aS,10bS,12aS)-1-[1H]phenanthro[2,1-c]pyran]-3-carboxylic acid, octadecahydro-8-methoxy-10a,12a-dimethyl-Spiro[furan-2(3H)"	Investigative	.	.	.	.	.
PDC_01438	"RGD - (1R,3R,4aS,4bR,6aS,8S,10aS,10bS,12aS)-1-[1H]phenanthro[2,1-c]pyran]-3-carboxylic acid, octadecahydro-8-methoxy-10a,12a-dimethyl-Spiro[furan-2(3H) conjugate 2"	PEP00163	c[DKP-RGD]	REC00022	"Indoleamine 2,3-dioxygenase 1 (IDO1)"	LIN00146	Undisclosed	DRG00339	.	.	"(1R,3R,4aS,4bR,6aS,8S,10aS,10bS,12aS)-1-[1H]phenanthro[2,1-c]pyran]-3-carboxylic acid, octadecahydro-8-methoxy-10a,12a-dimethyl-Spiro[furan-2(3H)"	Investigative	.	.	.	.	.
PDC_01439	"Tetrapeptide 31 - (1R,3R,4aS,4bR,6aS,8S,10aS,10bS,12aS)-1-[1H]phenanthro[2,1-c]pyran]-3-carboxylic acid, octadecahydro-8-methoxy-10a,12a-dimethyl-Spiro[furan-2(3H) conjugate"	PEP00811	Tetrapeptide 31	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00339	.	.	"(1R,3R,4aS,4bR,6aS,8S,10aS,10bS,12aS)-1-[1H]phenanthro[2,1-c]pyran]-3-carboxylic acid, octadecahydro-8-methoxy-10a,12a-dimethyl-Spiro[furan-2(3H)"	Investigative	.	.	.	.	.
PDC_01440	Polyarginin 1 - Daunorubicine conjugate	PEP00754	Polyarginin 1	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_01441	Polyarginin 2 - Daunorubicine conjugate	PEP00755	Polyarginin 2	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_01442	Polyarginin 3 - Daunorubicine conjugate	PEP00756	Polyarginin 3	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_01443	"GANPNAAG - 4-[(1E)-2-[2,5-dibutoxy-4-[(1E)-2-[3,4,5-tris(dodecyloxy)phenyl]ethenyl]phenyl]ethenyl]-benzoic acid conjugate"	PEP00250	GANPNAAG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00340	.	.	"4-[(1E)-2-[2,5-dibutoxy-4-[(1E)-2-[3,4,5-tris(dodecyloxy)phenyl]ethenyl]phenyl]ethenyl]-benzoic acid"	Investigative	.	.	.	.	.
PDC_01444	"NXGPKKKRKV - N-[2-[2-oxo-2-[[4-(10,15,20-triphenyl-21H,23H-porphin-5-yl)phenyl]amino]ethoxy]acetyl]-L-Aspartic acid conjugate"	PEP00251	NXGPKKKRKV	REC99999	Undisclosed	LIN00126	PEG	DRG00341	.	.	"N-[2-[2-oxo-2-[[4-(10,15,20-triphenyl-21H,23H-porphin-5-yl)phenyl]amino]ethoxy]acetyl]-L-Aspartic acid"	Investigative	.	.	.	.	.
PDC_01445	"GRKKRRQRRRPPQ - N-[2-[2-oxo-2-[[4-(10,15,20-triphenyl-21H,23H-porphin-5-yl)phenyl]amino]ethoxy]acetyl]-L-Aspartic acid conjugate"	PEP00051	TAT	REC99999	Undisclosed	LIN00126	PEG	DRG00341	.	.	"N-[2-[2-oxo-2-[[4-(10,15,20-triphenyl-21H,23H-porphin-5-yl)phenyl]amino]ethoxy]acetyl]-L-Aspartic acid"	Investigative	.	.	.	.	.
PDC_01446	GPLGIAGQ - Doxorubicin conjugate	PEP00252	GPLGIAGQ	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_01447	CTVALPGGYVRVCVXVX - Doxorubicin conjugate	PEP00253	CTVALPGGYVRVCVXVX	REC99999	Undisclosed	LIN00139	Benzyl	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_01448	CTVALPGGYVRVCVXVX - Paclitaxel conjugate	PEP00253	CTVALPGGYVRVCVXVX	REC99999	Undisclosed	LIN00139	Benzyl	DRG00012	TAR10017	Microtubule (MT)	Paclitaxel	Investigative	.	.	.	.	.
PDC_01449	"RGDFK - 3,4-dihydro-2,2,5,7,8-pentamethyl-2H-1-benzopyran-6-sulfonic acid conjugate"	PEP00122	c(RGDfK)	REC00013	Integrin alpha-V; Integrin beta-3 (ITGAV; ITGB3)	LIN00146	Undisclosed	DRG00342	.	.	"3,4-dihydro-2,2,5,7,8-pentamethyl-2H-1-benzopyran-6-sulfonic acid"	Investigative	.	.	.	.	.
PDC_01450	"DFKRG - 3,4-dihydro-2,2,5,7,8-pentamethyl-2H-1-benzopyran-6-sulfonic acid conjugate"	PEP00254	DFKRG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00342	.	.	"3,4-dihydro-2,2,5,7,8-pentamethyl-2H-1-benzopyran-6-sulfonic acid"	Investigative	.	.	.	.	.
PDC_01451	"AKPGKKKPGK - N-[(1,1-Dimethylethoxy)carbonyl]-3-[(3-nitro-2-pyridinyl)dithio]-L-alanine conjugate"	PEP00255	AKPGKKKPGK	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00343	.	.	"N-[(1,1-Dimethylethoxy)carbonyl]-3-[(3-nitro-2-pyridinyl)dithio]-L-alanine"	Investigative	.	.	.	.	.
PDC_01452	"GRKKRRQRRRPPQ - 4-(10,15,20-Tri-4-pyridinyl-21H,23H-porphin-5-yl)benzaldehyde conjugate 1"	PEP00051	TAT	REC99999	Undisclosed	LIN00126	PEG	DRG00344	.	.	"4-(10,15,20-Tri-4-pyridinyl-21H,23H-porphin-5-yl)benzaldehyde"	Investigative	.	.	.	.	.
PDC_01453	"GPKKKRKV - 4-(10,15,20-Tri-4-pyridinyl-21H,23H-porphin-5-yl)benzaldehyde conjugate 1"	PEP00256	GPKKKRKV	REC99999	Undisclosed	LIN00126	PEG	DRG00344	.	.	"4-(10,15,20-Tri-4-pyridinyl-21H,23H-porphin-5-yl)benzaldehyde"	Investigative	.	.	.	.	.
PDC_01454	"GRKKRRQRRRPPQ - 4-(10,15,20-Tri-4-pyridinyl-21H,23H-porphin-5-yl)benzaldehyde conjugate 2"	PEP00051	TAT	REC99999	Undisclosed	LIN00126	PEG	DRG00344	.	.	"4-(10,15,20-Tri-4-pyridinyl-21H,23H-porphin-5-yl)benzaldehyde"	Investigative	.	.	.	.	.
PDC_01455	"GPKKKRKV - 4-(10,15,20-Tri-4-pyridinyl-21H,23H-porphin-5-yl)benzaldehyde conjugate 2"	PEP00256	GPKKKRKV	REC99999	Undisclosed	LIN00126	PEG	DRG00344	.	.	"4-(10,15,20-Tri-4-pyridinyl-21H,23H-porphin-5-yl)benzaldehyde"	Investigative	.	.	.	.	.
PDC_01456	"GRKKRRQRRRPPQ - 4-(10,15,20-Tri-4-pyridinyl-21H,23H-porphin-5-yl)benzaldehyde conjugate 3"	PEP00051	TAT	REC99999	Undisclosed	LIN00126	PEG	DRG00344	.	.	"4-(10,15,20-Tri-4-pyridinyl-21H,23H-porphin-5-yl)benzaldehyde"	Investigative	.	.	.	.	.
PDC_01457	"GPKKKRKV - 4-(10,15,20-Tri-4-pyridinyl-21H,23H-porphin-5-yl)benzaldehyde conjugate 3"	PEP00256	GPKKKRKV	REC99999	Undisclosed	LIN00126	PEG	DRG00344	.	.	"4-(10,15,20-Tri-4-pyridinyl-21H,23H-porphin-5-yl)benzaldehyde"	Investigative	.	.	.	.	.
PDC_01458	SGRGKGGKGCGKGGAKRHRK - 7-Methoxy-4-methylcoumarin conjugate	PEP00257	SGRGKGGKGCGKGGAKRHRK	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00298	.	.	7-Methoxy-4-methylcoumarin	Investigative	.	.	.	.	.
PDC_01459	"Tetrapeptide 32 - 4-[1-[(2,2,6,6-tetraethyl-4-methoxy-1-piperidinyl)oxy]ethyl]-benzenemethanol conjugate 1"	PEP00812	Tetrapeptide 32	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00345	.	.	"4-[1-[(2,2,6,6-tetraethyl-4-methoxy-1-piperidinyl)oxy]ethyl]-benzenemethanol"	Investigative	.	.	.	.	.
PDC_01460	"Tetrapeptide 32 - 4-[1-[(2,2,6,6-tetraethyl-4-methoxy-1-piperidinyl)oxy]ethyl]-benzenemethanol conjugate 2"	PEP00812	Tetrapeptide 32	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00345	.	.	"4-[1-[(2,2,6,6-tetraethyl-4-methoxy-1-piperidinyl)oxy]ethyl]-benzenemethanol"	Investigative	.	.	.	.	.
PDC_01461	"Tetrapeptide 33 - 4-[1-[(2,2,6,6-tetraethyl-4-methoxy-1-piperidinyl)oxy]ethyl]-benzenemethanol conjugate"	PEP00813	Tetrapeptide 33	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00345	.	.	"4-[1-[(2,2,6,6-tetraethyl-4-methoxy-1-piperidinyl)oxy]ethyl]-benzenemethanol"	Investigative	.	.	.	.	.
PDC_01462	"AFGSAFG - 4-[1-[(2,2,6,6-tetraethyl-4-methoxy-1-piperidinyl)oxy]ethyl]-benzenemethanol conjugate"	PEP00258	AFGSAFG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00345	.	.	"4-[1-[(2,2,6,6-tetraethyl-4-methoxy-1-piperidinyl)oxy]ethyl]-benzenemethanol"	Investigative	.	.	.	.	.
PDC_01463	"Tetrapeptide 34 - 1-[1-[4-(Iodomethyl)phenyl]ethoxy]-2,2,6,6-tetramethylpiperidine conjugate"	PEP00814	Tetrapeptide 34	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00318	.	.	"1-[1-[4-(Iodomethyl)phenyl]ethoxy]-2,2,6,6-tetramethylpiperidine"	Investigative	.	.	.	.	.
PDC_01464	"FGSFG - 1-[1-[4-(Iodomethyl)phenyl]ethoxy]-2,2,6,6-tetramethylpiperidine conjugate"	PEP00259	FGSFG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00318	.	.	"1-[1-[4-(Iodomethyl)phenyl]ethoxy]-2,2,6,6-tetramethylpiperidine"	Investigative	.	.	.	.	.
PDC_01465	"Tripeptide 78 - 1-[1-[4-(Iodomethyl)phenyl]ethoxy]-2,2,6,6-tetramethylpiperidine conjugate"	PEP00938	Tripeptide 78	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00318	.	.	"1-[1-[4-(Iodomethyl)phenyl]ethoxy]-2,2,6,6-tetramethylpiperidine"	Investigative	.	.	.	.	.
PDC_01466	"Tetrapeptide 35 - 1-[(5R,6R,8R,9R)-4-amino-9-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-6-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-2,2-dioxido-1,7-dioxa-2-thiaspiro[4.4]non-3-en-8-yl]-3-(3-aminopropyl)-5-methyl-2,4(1H,3H)-pyrimidinedione conjugate 1"	PEP00815	Tetrapeptide 35	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00346	.	.	"1-[(5R,6R,8R,9R)-4-amino-9-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-6-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-2,2-dioxido-1,7-dioxa-2-thiaspiro[4.4]non-3-en-8-yl]-3-(3-aminopropyl)-5-methyl-2,4(1H,3H)-pyrimidinedione"	Investigative	.	.	.	.	.
PDC_01467	"Tetrapeptide 36 - 1-[(5R,6R,8R,9R)-4-amino-9-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-6-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-2,2-dioxido-1,7-dioxa-2-thiaspiro[4.4]non-3-en-8-yl]-3-(3-aminopropyl)-5-methyl-2,4(1H,3H)-pyrimidinedione conjugate 3"	PEP00816	Tetrapeptide 36	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00346	.	.	"1-[(5R,6R,8R,9R)-4-amino-9-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-6-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-2,2-dioxido-1,7-dioxa-2-thiaspiro[4.4]non-3-en-8-yl]-3-(3-aminopropyl)-5-methyl-2,4(1H,3H)-pyrimidinedione"	Investigative	.	.	.	.	.
PDC_01468	"Tetrapeptide 35 - 1-[(5R,6R,8R,9R)-4-amino-9-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-6-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-2,2-dioxido-1,7-dioxa-2-thiaspiro[4.4]non-3-en-8-yl]-3-(3-aminopropyl)-5-methyl-2,4(1H,3H)-pyrimidinedione conjugate 2"	PEP00815	Tetrapeptide 35	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00346	.	.	"1-[(5R,6R,8R,9R)-4-amino-9-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-6-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-2,2-dioxido-1,7-dioxa-2-thiaspiro[4.4]non-3-en-8-yl]-3-(3-aminopropyl)-5-methyl-2,4(1H,3H)-pyrimidinedione"	Investigative	.	.	.	.	.
PDC_01469	"Tetrapeptide 21 - 1-[(5R,6R,8R,9R)-4-amino-9-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-6-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-2,2-dioxido-1,7-dioxa-2-thiaspiro[4.4]non-3-en-8-yl]-3-(3-aminopropyl)-5-methyl-2,4(1H,3H)-pyrimidinedione conjugate 1"	PEP00801	Tetrapeptide 21	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00346	.	.	"1-[(5R,6R,8R,9R)-4-amino-9-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-6-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-2,2-dioxido-1,7-dioxa-2-thiaspiro[4.4]non-3-en-8-yl]-3-(3-aminopropyl)-5-methyl-2,4(1H,3H)-pyrimidinedione"	Investigative	.	.	.	.	.
PDC_01470	"Tetrapeptide 21 - 1-[(5R,6R,8R,9R)-4-amino-9-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-6-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-2,2-dioxido-1,7-dioxa-2-thiaspiro[4.4]non-3-en-8-yl]-3-(3-aminopropyl)-5-methyl-2,4(1H,3H)-pyrimidinedione conjugate 2"	PEP00801	Tetrapeptide 21	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00346	.	.	"1-[(5R,6R,8R,9R)-4-amino-9-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-6-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-2,2-dioxido-1,7-dioxa-2-thiaspiro[4.4]non-3-en-8-yl]-3-(3-aminopropyl)-5-methyl-2,4(1H,3H)-pyrimidinedione"	Investigative	.	.	.	.	.
PDC_01471	"Tetrapeptide 20 - 1-[(5R,6R,8R,9R)-4-amino-9-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-6-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-2,2-dioxido-1,7-dioxa-2-thiaspiro[4.4]non-3-en-8-yl]-3-(3-aminopropyl)-5-methyl-2,4(1H,3H)-pyrimidinedione conjugate 1"	PEP00800	Tetrapeptide 20	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00346	.	.	"1-[(5R,6R,8R,9R)-4-amino-9-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-6-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-2,2-dioxido-1,7-dioxa-2-thiaspiro[4.4]non-3-en-8-yl]-3-(3-aminopropyl)-5-methyl-2,4(1H,3H)-pyrimidinedione"	Investigative	.	.	.	.	.
PDC_01472	"Tetrapeptide 20 - 1-[(5R,6R,8R,9R)-4-amino-9-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-6-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-2,2-dioxido-1,7-dioxa-2-thiaspiro[4.4]non-3-en-8-yl]-3-(3-aminopropyl)-5-methyl-2,4(1H,3H)-pyrimidinedione conjugate 2"	PEP00800	Tetrapeptide 20	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00346	.	.	"1-[(5R,6R,8R,9R)-4-amino-9-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-6-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-2,2-dioxido-1,7-dioxa-2-thiaspiro[4.4]non-3-en-8-yl]-3-(3-aminopropyl)-5-methyl-2,4(1H,3H)-pyrimidinedione"	Investigative	.	.	.	.	.
PDC_01473	"Tetrapeptide 36 - 1-[(5R,6R,8R,9R)-4-amino-9-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-6-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-2,2-dioxido-1,7-dioxa-2-thiaspiro[4.4]non-3-en-8-yl]-3-(3-aminopropyl)-5-methyl-2,4(1H,3H)-pyrimidinedione conjugate 4"	PEP00816	Tetrapeptide 36	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00346	.	.	"1-[(5R,6R,8R,9R)-4-amino-9-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-6-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-2,2-dioxido-1,7-dioxa-2-thiaspiro[4.4]non-3-en-8-yl]-3-(3-aminopropyl)-5-methyl-2,4(1H,3H)-pyrimidinedione"	Investigative	.	.	.	.	.
PDC_01474	WTGWCLNPEESTWGFCTGSF - Paclitaxel succinate conjugate 1	PEP00260	WTGWCLNPEESTWGFCTGSF	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00290	.	.	Paclitaxel Succinate	Investigative	.	.	.	.	.
PDC_01475	WTGWCLNPEESTWGFCTGSF - Paclitaxel succinate conjugate 2	PEP00260	WTGWCLNPEESTWGFCTGSF	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00290	.	.	Paclitaxel Succinate	Investigative	.	.	.	.	.
PDC_01476	"ACKGGGGXQ - (3&alpha;,5&beta;,7&alpha;,12&alpha;)-7-(acetyloxy)-12-[[(1,1-dimethylethoxy)carbonyl]amino]-3-[[(2-propen-1-yloxy)carbonyl]amino]-cholan-24-oic acid conjugate 1"	PEP00261	ACKGGGGXQ	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00347	.	.	"(3&alpha;,5&beta;,7&alpha;,12&alpha;)-7-(acetyloxy)-12-[[(1,1-dimethylethoxy)carbonyl]amino]-3-[[(2-propen-1-yloxy)carbonyl]amino]-cholan-24-oic acid"	Investigative	.	.	.	.	.
PDC_01477	"ACKGGGGXQ - (3&alpha;,5&beta;,7&alpha;,12&alpha;)-7-(acetyloxy)-12-[[(1,1-dimethylethoxy)carbonyl]amino]-3-[[(2-propen-1-yloxy)carbonyl]amino]-cholan-24-oic acid conjugate 2"	PEP00261	ACKGGGGXQ	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00347	.	.	"(3&alpha;,5&beta;,7&alpha;,12&alpha;)-7-(acetyloxy)-12-[[(1,1-dimethylethoxy)carbonyl]amino]-3-[[(2-propen-1-yloxy)carbonyl]amino]-cholan-24-oic acid"	Investigative	.	.	.	.	.
PDC_01478	"ACKGGGGXQ - (3&alpha;,5&beta;,7&alpha;,12&alpha;)-7-(acetyloxy)-12-[[(1,1-dimethylethoxy)carbonyl]amino]-3-[[(2-propen-1-yloxy)carbonyl]amino]-cholan-24-oic acid conjugate 3"	PEP00261	ACKGGGGXQ	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00347	.	.	"(3&alpha;,5&beta;,7&alpha;,12&alpha;)-7-(acetyloxy)-12-[[(1,1-dimethylethoxy)carbonyl]amino]-3-[[(2-propen-1-yloxy)carbonyl]amino]-cholan-24-oic acid"	Investigative	.	.	.	.	.
PDC_01479	"GGGGXQACK - (3&alpha;,5&beta;,7&alpha;,12&alpha;)-7-(acetyloxy)-12-[[(1,1-dimethylethoxy)carbonyl]amino]-3-[[(2-propen-1-yloxy)carbonyl]amino]-cholan-24-oic acid conjugate 1"	PEP00262	GGGGXQACK	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00347	.	.	"(3&alpha;,5&beta;,7&alpha;,12&alpha;)-7-(acetyloxy)-12-[[(1,1-dimethylethoxy)carbonyl]amino]-3-[[(2-propen-1-yloxy)carbonyl]amino]-cholan-24-oic acid"	Investigative	.	.	.	.	.
PDC_01480	"GGGGXQACK - (3&alpha;,5&beta;,7&alpha;,12&alpha;)-7-(acetyloxy)-12-[[(1,1-dimethylethoxy)carbonyl]amino]-3-[[(2-propen-1-yloxy)carbonyl]amino]-cholan-24-oic acid conjugate"	PEP00262	GGGGXQACK	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00347	.	.	"(3&alpha;,5&beta;,7&alpha;,12&alpha;)-7-(acetyloxy)-12-[[(1,1-dimethylethoxy)carbonyl]amino]-3-[[(2-propen-1-yloxy)carbonyl]amino]-cholan-24-oic acid"	Investigative	.	.	.	.	.
PDC_01481	"Tetrapeptide 37 - (3&alpha;,5&beta;,7&alpha;,12&alpha;)-7-(acetyloxy)-12-[[(1,1-dimethylethoxy)carbonyl]amino]-3-[[(2-propen-1-yloxy)carbonyl]amino]-cholan-24-oic acid conjugate"	PEP00817	Tetrapeptide 37	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00347	.	.	"(3&alpha;,5&beta;,7&alpha;,12&alpha;)-7-(acetyloxy)-12-[[(1,1-dimethylethoxy)carbonyl]amino]-3-[[(2-propen-1-yloxy)carbonyl]amino]-cholan-24-oic acid"	Investigative	.	.	.	.	.
PDC_01483	"SATSSSGSGS - L-Serine-N-(2,3-dihydroxybenzoyl)-O-[N-(2,3-dihydroxybenzoyl)-O-[N-(5-&beta;-D-glucopyranosyl-2,3-dihydroxybenzoyl)-L-seryl]-L-seryl]-(313)-lactone conjugate"	PEP00263	SATSSSGSGS	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00348	.	.	"L-Serine-N-(2,3-dihydroxybenzoyl)-O-[N-(2,3-dihydroxybenzoyl)-O-[N-(5-&beta;-D-glucopyranosyl-2,3-dihydroxybenzoyl)-L-seryl]-L-seryl]-(3-13)-lactone"	Investigative	.	.	.	.	.
PDC_01484	"NSATSSSGSGS - L-Serine-N-(2,3-dihydroxybenzoyl)-O-[N-(2,3-dihydroxybenzoyl)-O-[N-(5-&beta;-D-glucopyranosyl-2,3-dihydroxybenzoyl)-L-seryl]-L-seryl]-(313)-lactone conjugate"	PEP00264	NSATSSSGSGS	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00348	.	.	"L-Serine-N-(2,3-dihydroxybenzoyl)-O-[N-(2,3-dihydroxybenzoyl)-O-[N-(5-&beta;-D-glucopyranosyl-2,3-dihydroxybenzoyl)-L-seryl]-L-seryl]-(3-13)-lactone"	Investigative	.	.	.	.	.
PDC_01485	KXCKXC - Paclitaxel derivative conjugate	PEP00265	KXCKXC	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00349	.	.	Paclitaxel derivative	Investigative	.	.	.	.	.
PDC_01486	ECRGDS - Paclitaxel derivative conjugate	PEP00266	ECRGDS	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00349	.	.	Paclitaxel derivative	Investigative	.	.	.	.	.
PDC_01487	CRGDR - Paclitaxel derivative conjugate	PEP00267	CRGDR	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00349	.	.	Paclitaxel derivative	Investigative	.	.	.	.	.
PDC_01488	XRRRRRRRR - Phenytoin conjugate	PEP00268	XRRRRRRRR	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00286	.	.	Phenytoin	Investigative	.	.	.	.	.
PDC_01489	"YIYGSFK - 4-amino-&alpha;-methyl-1H-pyrazolo[3,4-d]pyrimidine-1-acetic acid conjugate 1"	PEP00269	YIYGSFK	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00350	.	.	"4-amino-&alpha;-methyl-1H-pyrazolo[3,4-d]pyrimidine-1-acetic acid"	Investigative	.	.	.	.	.
PDC_01490	"AIYKYY - 4-amino-&alpha;-methyl-1H-pyrazolo[3,4-d]pyrimidine-1-acetic acid conjugate"	PEP00270	AIYKYY	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00350	.	.	"4-amino-&alpha;-methyl-1H-pyrazolo[3,4-d]pyrimidine-1-acetic acid"	Investigative	.	.	.	.	.
PDC_01491	"AEEEIYGEFEAKKKK - 4-amino-&alpha;-methyl-1H-pyrazolo[3,4-d]pyrimidine-1-acetic acid conjugate"	PEP00271	AEEEIYGEFEAKKKK	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00350	.	.	"4-amino-&alpha;-methyl-1H-pyrazolo[3,4-d]pyrimidine-1-acetic acid"	Investigative	.	.	.	.	.
PDC_01492	"IYGEFKKK - 4-amino-&alpha;-methyl-1H-pyrazolo[3,4-d]pyrimidine-1-acetic acid conjugate"	PEP00272	IYGEFKKK	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00350	.	.	"4-amino-&alpha;-methyl-1H-pyrazolo[3,4-d]pyrimidine-1-acetic acid"	Investigative	.	.	.	.	.
PDC_01493	"EIYGEFKK - 4-amino-&alpha;-methyl-1H-pyrazolo[3,4-d]pyrimidine-1-acetic acid conjugate"	PEP00273	EIYGEFKK	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00350	.	.	"4-amino-&alpha;-methyl-1H-pyrazolo[3,4-d]pyrimidine-1-acetic acid"	Investigative	.	.	.	.	.
PDC_01494	"EEIYGEFF - 4-amino-&alpha;-methyl-1H-pyrazolo[3,4-d]pyrimidine-1-acetic acid conjugate"	PEP00274	EEIYGEFF	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00350	.	.	"4-amino-&alpha;-methyl-1H-pyrazolo[3,4-d]pyrimidine-1-acetic acid"	Investigative	.	.	.	.	.
PDC_01495	"YIYGSFK - 4-amino-&alpha;-methyl-1H-pyrazolo[3,4-d]pyrimidine-1-acetic acid conjugate2"	PEP00269	YIYGSFK	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00350	.	.	"4-amino-&alpha;-methyl-1H-pyrazolo[3,4-d]pyrimidine-1-acetic acid"	Investigative	.	.	.	.	.
PDC_01496	"CIYKYY - 4-amino-&alpha;-methyl-1H-pyrazolo[3,4-d]pyrimidine-1-acetic acid conjugate 1"	PEP00275	CIYKYY	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00350	.	.	"4-amino-&alpha;-methyl-1H-pyrazolo[3,4-d]pyrimidine-1-acetic acid"	Investigative	.	.	.	.	.
PDC_01497	"CIYKYY - 4-amino-&alpha;-methyl-1H-pyrazolo[3,4-d]pyrimidine-1-acetic acid conjugate 2"	PEP00275	CIYKYY	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00350	.	.	"4-amino-&alpha;-methyl-1H-pyrazolo[3,4-d]pyrimidine-1-acetic acid"	Investigative	.	.	.	.	.
PDC_01498	"CYKYY - 4-amino-&alpha;-methyl-1H-pyrazolo[3,4-d]pyrimidine-1-acetic acid conjugate"	PEP00276	CYKYY	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00350	.	.	"4-amino-&alpha;-methyl-1H-pyrazolo[3,4-d]pyrimidine-1-acetic acid"	Investigative	.	.	.	.	.
PDC_01499	"IYKYY - 4-amino-&alpha;-methyl-1H-pyrazolo[3,4-d]pyrimidine-1-acetic acid conjugate"	PEP00277	IYKYY	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00350	.	.	"4-amino-&alpha;-methyl-1H-pyrazolo[3,4-d]pyrimidine-1-acetic acid"	Investigative	.	.	.	.	.
PDC_01500	"CIYKYY - 4-amino-&alpha;-methyl-1H-pyrazolo[3,4-d]pyrimidine-1-acetic acid conjugate 3"	PEP00275	CIYKYY	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00350	.	.	"4-amino-&alpha;-methyl-1H-pyrazolo[3,4-d]pyrimidine-1-acetic acid"	Investigative	.	.	.	.	.
PDC_01501	"CIYKYY - 4-amino-&alpha;-methyl-1H-pyrazolo[3,4-d]pyrimidine-1-acetic acid conjugate 4"	PEP00275	CIYKYY	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00350	.	.	"4-amino-&alpha;-methyl-1H-pyrazolo[3,4-d]pyrimidine-1-acetic acid"	Investigative	.	.	.	.	.
PDC_01502	Tetrapeptide 38 - Tert-Butyldiphenylsilyl chloride conjugate 1	PEP00818	Tetrapeptide 38	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00322	.	.	tert-Butylchlorodiphenylsilane	Investigative	.	.	.	.	.
PDC_01503	Tripeptide 79 - Tert-Butyldiphenylsilyl chloride conjugate	PEP00939	Tripeptide 79	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00322	.	.	tert-Butylchlorodiphenylsilane	Investigative	.	.	.	.	.
PDC_01504	Tetrapeptide 38 - Tert-Butyldiphenylsilyl chloride conjugate 2	PEP00818	Tetrapeptide 38	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00322	.	.	tert-Butylchlorodiphenylsilane	Investigative	.	.	.	.	.
PDC_01505	Tetrapeptide 38 - 3-O-Acetylthymidine conjugate	PEP00818	Tetrapeptide 38	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00302	.	.	3'-O-Acetylthymidine	Investigative	.	.	.	.	.
PDC_01506	Tetrapeptide 38 - Tert-Butyldiphenylsilyl chloride conjugate 3	PEP00818	Tetrapeptide 38	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00322	.	.	tert-Butylchlorodiphenylsilane	Investigative	.	.	.	.	.
PDC_01507	"Tripeptide 80 - 2,2,8-Trimethyl-4H-1,3-dioxino[4,5-c]pyridine-5-methanol conjugate"	PEP00940	Tripeptide 80	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00315	.	.	"(2,2,8-trimethyl-4H-[1,3]dioxino[4,5-c]pyridin-5-yl)methanol"	Investigative	.	.	.	.	.
PDC_01508	Tripeptide 79 - 3-O-Acetylthymidine conjugate	PEP00939	Tripeptide 79	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00302	.	.	3'-O-Acetylthymidine	Investigative	.	.	.	.	.
PDC_01509	Tetrapeptide 27 - Estradiol-3-carboxymethyl ether conjugate 1	PEP00807	Tetrapeptide 27	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00308	.	.	Edcme	Investigative	.	.	.	.	.
PDC_01510	Tetrapeptide 28 - Estradiol-3-carboxymethyl ether conjugate 1	PEP00808	Tetrapeptide 28	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00308	.	.	Edcme	Investigative	.	.	.	.	.
PDC_01511	Tetrapeptide 26 - Estradiol-3-carboxymethyl ether conjugate 1	PEP00806	Tetrapeptide 26	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00308	.	.	Edcme	Investigative	.	.	.	.	.
PDC_01512	Tetrapeptide 27 - Estradiol-3-carboxymethyl ether conjugate 2	PEP00807	Tetrapeptide 27	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00308	.	.	Edcme	Investigative	.	.	.	.	.
PDC_01513	Tetrapeptide 27 - Estradiol-3-carboxymethyl ether conjugate 3	PEP00807	Tetrapeptide 27	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00308	.	.	Edcme	Investigative	.	.	.	.	.
PDC_01514	Tetrapeptide 26 - Estradiol-3-carboxymethyl ether conjugate 2	PEP00806	Tetrapeptide 26	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00308	.	.	Edcme	Investigative	.	.	.	.	.
PDC_01515	Tetrapeptide 27 - Estradiol-3-carboxymethyl ether conjugate 4	PEP00807	Tetrapeptide 27	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00308	.	.	Edcme	Investigative	.	.	.	.	.
PDC_01516	Tetrapeptide 28 - Estradiol-3-carboxymethyl ether conjugate 2	PEP00808	Tetrapeptide 28	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00308	.	.	Edcme	Investigative	.	.	.	.	.
PDC_01517	Tetrapeptide 26 - Estradiol hemisuccinate conjugate	PEP00806	Tetrapeptide 26	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00309	.	.	17beta-Estradiol hemisuccinate	Investigative	.	.	.	.	.
PDC_01518	Tetrapeptide 27 - Estradiol hemisuccinate conjugate	PEP00807	Tetrapeptide 27	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00309	.	.	17beta-Estradiol hemisuccinate	Investigative	.	.	.	.	.
PDC_01519	"FDFLPENE - O-(N-acetyl-4,7,8,9-tetra-O-acetyl-1-methyl-&alpha;-neuraminosyl)-(23)-O-2,4-di-O-acetyl-6-O-(phenylmethyl)-&beta;-D-galactopyranosyl-(14)-O-[6-deoxy-2,3,4-tris-O-(phenylmethyl)-&alpha;-L-galactopyranosyl-(13)]-2-(acetylamino)-2-deoxy-6-O-(phenylmethyl)-&beta;-D-glucopyranosylamine conjugate"	PEP00278	FDFLPENE	REC99999	Undisclosed	LIN00126	PEG	DRG00324	.	.	"O-(N-acetyl-4,7,8,9-tetra-O-acetyl-1-methyl-&alpha;-neuraminosyl)-(2-3)-O-2,4-di-O-acetyl-6-O-(phenylmethyl)-&beta;-D-galactopyranosyl-(1-4)-O-[6-deoxy-2,3,4-tris-O-(phenylmethyl)-&alpha;-L-galactopyranosyl-(1-3)]-2-(acetylamino)-2-deoxy-6-O-(phenylmethyl)-&beta;-D-glucopyranosylamine"	Investigative	.	.	.	.	.
PDC_01520	"FDFLPENE - O-(N-acetyl-4,7,8,9-tetra-O-acetyl-1-methyl-&alpha;-neuraminosyl)-(23)-O-2,4-di-O-acetyl-6-O-(phenylmethyl)-&beta;-D-galactopyranosyl-(14)-O-[6-deoxy-2,3,4-tris-O-(phenylmethyl)-&alpha;-L-galactopyranosyl-(13)]-2-(acetylamino)-2-deoxy-6-O-(phenylmethyl)-&beta;-D-glucopyranosylamine conjugate"	PEP00278	FDFLPENE	REC99999	Undisclosed	LIN00126	PEG	DRG00324	.	.	"O-(N-acetyl-4,7,8,9-tetra-O-acetyl-1-methyl-&alpha;-neuraminosyl)-(2-3)-O-2,4-di-O-acetyl-6-O-(phenylmethyl)-&beta;-D-galactopyranosyl-(1-4)-O-[6-deoxy-2,3,4-tris-O-(phenylmethyl)-&alpha;-L-galactopyranosyl-(1-3)]-2-(acetylamino)-2-deoxy-6-O-(phenylmethyl)-&beta;-D-glucopyranosylamine"	Investigative	.	.	.	.	.
PDC_01521	"FLPENE - O-(N-acetyl-4,7,8,9-tetra-O-acetyl-1-methyl-&alpha;-neuraminosyl)-(23)-O-2,4-di-O-acetyl-6-O-(phenylmethyl)-&beta;-D-galactopyranosyl-(14)-O-[6-deoxy-2,3,4-tris-O-(phenylmethyl)-&alpha;-L-galactopyranosyl-(13)]-2-(acetylamino)-2-deoxy-6-O-(phenylmethyl)-&beta;-D-glucopyranosylamine conjugate"	PEP00279	FLPENE	REC99999	Undisclosed	LIN00126	PEG	DRG00324	.	.	"O-(N-acetyl-4,7,8,9-tetra-O-acetyl-1-methyl-&alpha;-neuraminosyl)-(2-3)-O-2,4-di-O-acetyl-6-O-(phenylmethyl)-&beta;-D-galactopyranosyl-(1-4)-O-[6-deoxy-2,3,4-tris-O-(phenylmethyl)-&alpha;-L-galactopyranosyl-(1-3)]-2-(acetylamino)-2-deoxy-6-O-(phenylmethyl)-&beta;-D-glucopyranosylamine"	Investigative	.	.	.	.	.
PDC_01522	Tetrapeptide 39 - 6-[[[5-(Dimethylamino)-1-naphthalenyl]sulfonyl]amino]hexanoic acid conjugate 1	PEP00819	Tetrapeptide 39	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00351	.	.	6-[[[5-(Dimethylamino)-1-naphthalenyl]sulfonyl]amino]hexanoic acid	Investigative	.	.	.	.	.
PDC_01523	"Tetrapeptide 39 - 1H-Pyrazole-5-carboxylic acid, 3-amino-1-[(4-methoxyphenyl)methyl]-methyl ester conjugate 1"	PEP00819	Tetrapeptide 39	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00352	.	.	"1H-Pyrazole-5-carboxylic acid, 3-amino-1-[(4-methoxyphenyl)methyl]-methyl ester"	Investigative	.	.	.	.	.
PDC_01524	"Tetrapeptide 39 - 1H-Pyrazole-5-carboxylic acid, 3-amino-1-[(4-methoxyphenyl)methyl]-methyl ester conjugate 2"	PEP00819	Tetrapeptide 39	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00352	.	.	"1H-Pyrazole-5-carboxylic acid, 3-amino-1-[(4-methoxyphenyl)methyl]-methyl ester"	Investigative	.	.	.	.	.
PDC_01525	"Tetrapeptide 39 - 1H-Pyrazole-5-carboxylic acid, 3-amino-1-[(4-methoxyphenyl)methyl]-methyl ester conjugate 3"	PEP00819	Tetrapeptide 39	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00352	.	.	"1H-Pyrazole-5-carboxylic acid, 3-amino-1-[(4-methoxyphenyl)methyl]-methyl ester"	Investigative	.	.	.	.	.
PDC_01526	"Tripeptide 81 - 1H-Pyrazole-5-carboxylic acid, 3-amino-1-[(4-methoxyphenyl)methyl]-methyl ester conjugate 1"	PEP00941	Tripeptide 81	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00352	.	.	"1H-Pyrazole-5-carboxylic acid, 3-amino-1-[(4-methoxyphenyl)methyl]-methyl ester"	Investigative	.	.	.	.	.
PDC_01527	"Tripeptide 81 - 1H-Pyrazole-5-carboxylic acid, 3-amino-1-[(4-methoxyphenyl)methyl]-methyl ester conjugate 2"	PEP00941	Tripeptide 81	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00352	.	.	"1H-Pyrazole-5-carboxylic acid, 3-amino-1-[(4-methoxyphenyl)methyl]-methyl ester"	Investigative	.	.	.	.	.
PDC_01528	AKLVFF - 6-[[[5-(Dimethylamino)-1-naphthalenyl]sulfonyl]amino]hexanoic acid conjugate	PEP00280	AKLVFF	REC99999	Undisclosed	LIN00126	PEG	DRG00351	.	.	6-[[[5-(Dimethylamino)-1-naphthalenyl]sulfonyl]amino]hexanoic acid	Investigative	.	.	.	.	.
PDC_01529	"KKKKKKKK - 1H-Pyrazole-5-carboxylic acid, 3-amino-1-[(4-methoxyphenyl)methyl]-methyl ester conjugate"	PEP00281	KKKKKKKK	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00352	.	.	"1H-Pyrazole-5-carboxylic acid, 3-amino-1-[(4-methoxyphenyl)methyl]-methyl ester"	Investigative	.	.	.	.	.
PDC_01530	Tetrapeptide 39 - 6-[[[5-(Dimethylamino)-1-naphthalenyl]sulfonyl]amino]hexanoic acid conjugate 2	PEP00819	Tetrapeptide 39	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00351	.	.	6-[[[5-(Dimethylamino)-1-naphthalenyl]sulfonyl]amino]hexanoic acid	Investigative	.	.	.	.	.
PDC_01531	LPKTGGGGG - Dansyl chloride conjugate	PEP00282	LPKTGGGGG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00277	.	.	Dansyl chloride	Investigative	.	.	.	.	.
PDC_01532	LPKTGGGWW - Dansyl chloride conjugate	PEP00283	LPKTGGGWW	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00277	.	.	Dansyl chloride	Investigative	.	.	.	.	.
PDC_01533	LPKTGGYRR - Dansyl chloride conjugate	PEP00284	LPKTGGYRR	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00277	.	.	Dansyl chloride	Investigative	.	.	.	.	.
PDC_01534	LPKTGGWRR - Dansyl chloride conjugate	PEP00285	LPKTGGWRR	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00277	.	.	Dansyl chloride	Investigative	.	.	.	.	.
PDC_01535	LPKTGGVRR - Dansyl chloride conjugate	PEP00286	LPKTGGVRR	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00277	.	.	Dansyl chloride	Investigative	.	.	.	.	.
PDC_01536	LPKTGGTRR - Dansyl chloride conjugate	PEP00287	LPKTGGTRR	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00277	.	.	Dansyl chloride	Investigative	.	.	.	.	.
PDC_01537	LPKTGGSRR - Dansyl chloride conjugate	PEP00288	LPKTGGSRR	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00277	.	.	Dansyl chloride	Investigative	.	.	.	.	.
PDC_01538	LPKTGGRRR - Dansyl chloride conjugate	PEP00289	LPKTGGRRR	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00277	.	.	Dansyl chloride	Investigative	.	.	.	.	.
PDC_01539	LPKTGGQRR - Dansyl chloride conjugate	PEP00290	LPKTGGQRR	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00277	.	.	Dansyl chloride	Investigative	.	.	.	.	.
PDC_01540	LPKTGGPRR - Dansyl chloride conjugate	PEP00291	LPKTGGPRR	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00277	.	.	Dansyl chloride	Investigative	.	.	.	.	.
PDC_01541	LPKTGGNRR - Dansyl chloride conjugate	PEP00292	LPKTGGNRR	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00277	.	.	Dansyl chloride	Investigative	.	.	.	.	.
PDC_01542	LPKTGGMRR - Dansyl chloride conjugate	PEP00293	LPKTGGMRR	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00277	.	.	Dansyl chloride	Investigative	.	.	.	.	.
PDC_01543	LPKTGGLRR - Dansyl chloride conjugate	PEP00294	LPKTGGLRR	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00277	.	.	Dansyl chloride	Investigative	.	.	.	.	.
PDC_01544	LPKTGGKRR - Dansyl chloride conjugate	PEP00295	LPKTGGKRR	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00277	.	.	Dansyl chloride	Investigative	.	.	.	.	.
PDC_01545	LPKTGGIRR - Dansyl chloride conjugate	PEP00296	LPKTGGIRR	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00277	.	.	Dansyl chloride	Investigative	.	.	.	.	.
PDC_01546	LPKTGGHRR - Dansyl chloride conjugate	PEP00297	LPKTGGHRR	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00277	.	.	Dansyl chloride	Investigative	.	.	.	.	.
PDC_01547	LPKTGGGRR - Dansyl chloride conjugate	PEP00298	LPKTGGGRR	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00277	.	.	Dansyl chloride	Investigative	.	.	.	.	.
PDC_01548	LPKTGGFRR - Dansyl chloride conjugate	PEP00299	LPKTGGFRR	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00277	.	.	Dansyl chloride	Investigative	.	.	.	.	.
PDC_01549	LPKTGQRR - Dansyl chloride conjugate	PEP00300	LPKTGQRR	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00277	.	.	Dansyl chloride	Investigative	.	.	.	.	.
PDC_01550	LPKTGLRR - Dansyl chloride conjugate	PEP00301	LPKTGLRR	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00277	.	.	Dansyl chloride	Investigative	.	.	.	.	.
PDC_01551	LTVSPWY - Vitamin E succinate conjugate	PEP00302	LTVSPWY	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00287	.	.	Vitamin e succinate	Investigative	.	.	.	.	.
PDC_01552	"NVPGNVPG - O-6-deoxy-2,3,4-tris-O-(phenylmethyl)-&alpha;-L-galactopyranosyl-(13)-O-[6-O-(phenylmethyl)-&beta;-D-galactopyranosyl-(14)]-2-(acetylamino)-2-deoxy-6-O-(phenylmethyl)-&beta;-D-glucopyranosyl azide conjugate 1"	PEP00303	NVPGNVPG	REC99999	Undisclosed	LIN00126	PEG	DRG00353	.	.	"O-6-deoxy-2,3,4-tris-O-(phenylmethyl)-&alpha;-L-galactopyranosyl-(1-3)-O-[6-O-(phenylmethyl)-&beta;-D-galactopyranosyl-(1-4)]-2-(acetylamino)-2-deoxy-6-O-(phenylmethyl)-&beta;-D-glucopyranosyl azide"	Investigative	.	.	.	.	.
PDC_01553	"NVPGNVPG - O-6-deoxy-2,3,4-tris-O-(phenylmethyl)-&alpha;-L-galactopyranosyl-(13)-O-[6-O-(phenylmethyl)-&beta;-D-galactopyranosyl-(14)]-2-(acetylamino)-2-deoxy-6-O-(phenylmethyl)-&beta;-D-glucopyranosyl azide conjugate 2"	PEP00303	NVPGNVPG	REC99999	Undisclosed	LIN00126	PEG	DRG00353	.	.	"O-6-deoxy-2,3,4-tris-O-(phenylmethyl)-&alpha;-L-galactopyranosyl-(1-3)-O-[6-O-(phenylmethyl)-&beta;-D-galactopyranosyl-(1-4)]-2-(acetylamino)-2-deoxy-6-O-(phenylmethyl)-&beta;-D-glucopyranosyl azide"	Investigative	.	.	.	.	.
PDC_01554	FKKKKKKKKK - Fullerene (C60) derivitavie conjugate	PEP00304	FKKKKKKKKK	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00354	.	.	Fullerene (C60) derivitavie 	Investigative	.	.	.	.	.
PDC_01555	FKEEEEGGGS - Fullerene (C60) derivitavie conjugate 1	PEP00305	FKEEEEGGGS	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00354	.	.	Fullerene (C60) derivitavie 	Investigative	.	.	.	.	.
PDC_01556	FKEEEEGGGS - Fullerene (C60) derivitavie conjugate	PEP00305	FKEEEEGGGS	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00354	.	.	Fullerene (C60) derivitavie 	Investigative	.	.	.	.	.
PDC_01557	FKPKKKRKV - Fluorescein isothiocyanate (FITC) AND derivative conjugate 1	PEP00306	FKPKKKRKV	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00355	.	.	Fluorescein isothiocyanate (FITC) AND derivative	Investigative	.	.	.	.	.
PDC_01558	FKPKKKRKV - Fluorescein isothiocyanate (FITC) AND derivative conjugate	PEP00306	FKPKKKRKV	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00355	.	.	Fluorescein isothiocyanate (FITC) AND derivative	Investigative	.	.	.	.	.
PDC_01559	RGDFK - O-&beta;-D-Galactopyranosyl-(13)-O-&beta;-D-galactopyranosyl-(14)-&beta;-D-glucopyranose conjugate	PEP00122	c(RGDfK)	REC00013	Integrin alpha-V; Integrin beta-3 (ITGAV; ITGB3)	LIN00126	PEG	DRG00356	.	.	O-&beta;-D-Galactopyranosyl-(1-3)-O-&beta;-D-galactopyranosyl-(1-4)-&beta;-D-glucopyranose	Investigative	.	.	.	.	.
PDC_01560	ARGDX - O-&beta;-D-Galactopyranosyl-(13)-O-&beta;-D-galactopyranosyl-(14)-&beta;-D-glucopyranose conjugate	PEP00307	ARGDX	REC99999	Undisclosed	LIN00126	PEG	DRG00356	.	.	O-&beta;-D-Galactopyranosyl-(1-3)-O-&beta;-D-galactopyranosyl-(1-4)-&beta;-D-glucopyranose	Investigative	.	.	.	.	.
PDC_01561	"AXGDX - 2,3-Dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonic acid conjugate"	PEP00308	AXGDX	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00201	.	.	"2,3-Dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonic acid"	Investigative	.	.	.	.	.
PDC_01562	"DXAXG - 2,3-Dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonic acid conjugate"	PEP00309	DXAXG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00201	.	.	"2,3-Dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonic acid"	Investigative	.	.	.	.	.
PDC_01563	ANFPI - AZT monophosphate conjugate 1	PEP00310	ANFPI	REC00065	HIV-1 protease	LIN00146	Undisclosed	DRG00307	.	.	Zidovudine monophosphate	Investigative	.	.	.	.	.
PDC_01564	Tetrapeptide 40 - AZT monophosphate conjugate 1	PEP00820	Tetrapeptide 40	REC00065	HIV-1 protease	LIN00146	Undisclosed	DRG00307	.	.	Zidovudine monophosphate	Investigative	.	.	.	.	.
PDC_01565	Tetrapeptide 40 - AZT monophosphate conjugate 2	PEP00820	Tetrapeptide 40	REC00065	HIV-1 protease	LIN00146	Undisclosed	DRG00307	.	.	Zidovudine monophosphate	Investigative	.	.	.	.	.
PDC_01566	Tripeptide 82 - AZT monophosphate conjugate 1	PEP00942	Tripeptide 82	REC00065	HIV-1 protease	LIN00146	Undisclosed	DRG00307	.	.	Zidovudine monophosphate	Investigative	.	.	.	.	.
PDC_01567	Tetrapeptide 40 - Azidothymidine conjugate 1	PEP00820	Tetrapeptide 40	REC00065	HIV-1 protease	LIN00146	Undisclosed	DRG00296	.	.	Zidovudine	Investigative	.	.	.	.	.
PDC_01568	Tripeptide 82 - Azidothymidine conjugate 1	PEP00942	Tripeptide 82	REC00065	HIV-1 protease	LIN00146	Undisclosed	DRG00296	.	.	Zidovudine	Investigative	.	.	.	.	.
PDC_01569	ANFPI - AZT monophosphate conjugate 2	PEP00310	ANFPI	REC00065	HIV-1 protease	LIN00153	Phosphoramidate bond	DRG00307	.	.	Zidovudine monophosphate	Investigative	.	.	.	.	.
PDC_01570	Tetrapeptide 41 - AZT monophosphate conjugate	PEP00821	Tetrapeptide 41	REC00065	HIV-1 protease	LIN00153	Phosphoramidate bond	DRG00307	.	.	Zidovudine monophosphate	Investigative	.	.	.	.	.
PDC_01571	Tetrapeptide 42 - AZT monophosphate conjugate	PEP00822	Tetrapeptide 42	REC00065	HIV-1 protease	LIN00153	Phosphoramidate bond	DRG00307	.	.	Zidovudine monophosphate	Investigative	.	.	.	.	.
PDC_01572	Tripeptide 83 - AZT monophosphate conjugate	PEP00943	Tripeptide 83	REC00065	HIV-1 protease	LIN00153	Phosphoramidate bond	DRG00307	.	.	Zidovudine monophosphate	Investigative	.	.	.	.	.
PDC_01573	Tetrapeptide 40 - AZT monophosphate conjugate 3	PEP00820	Tetrapeptide 40	REC00065	HIV-1 protease	LIN00153	Phosphoramidate bond	DRG00307	.	.	Zidovudine monophosphate	Investigative	.	.	.	.	.
PDC_01574	Tripeptide 82 - AZT monophosphate conjugate 2	PEP00942	Tripeptide 82	REC00065	HIV-1 protease	LIN00153	Phosphoramidate bond	DRG00307	.	.	Zidovudine monophosphate	Investigative	.	.	.	.	.
PDC_01575	Tripeptide 84 - AZT monophosphate conjugate	PEP00944	Tripeptide 84	REC00065	HIV-1 protease	LIN00153	Phosphoramidate bond	DRG00307	.	.	Zidovudine monophosphate	Investigative	.	.	.	.	.
PDC_01576	Dipeptide 36 - AZT monophosphate conjugate	PEP00532	Dipeptide 36	REC00065	HIV-1 protease	LIN00153	Phosphoramidate bond	DRG00307	.	.	Zidovudine monophosphate	Investigative	.	.	.	.	.
PDC_01577	Tetrapeptide 40 - Azidothymidine conjugate 2	PEP00820	Tetrapeptide 40	REC00065	HIV-1 protease	LIN00096	Ester bond	DRG00296	.	.	Zidovudine	Investigative	.	.	.	.	.
PDC_01578	Tetrapeptide 40 - Azidothymidine conjugate 3	PEP00820	Tetrapeptide 40	REC00065	HIV-1 protease	LIN00146	Undisclosed	DRG00296	.	.	Zidovudine	Investigative	.	.	.	.	.
PDC_01579	Tetrapeptide 40 - Azidothymidine conjugate 4	PEP00820	Tetrapeptide 40	REC00065	HIV-1 protease	LIN00096	Ester bond	DRG00296	.	.	Zidovudine	Investigative	.	.	.	.	.
PDC_01580	Tetrapeptide 40 - Azidothymidine conjugate 5	PEP00820	Tetrapeptide 40	REC00065	HIV-1 protease	LIN00146	Undisclosed	DRG00296	.	.	Zidovudine	Investigative	.	.	.	.	.
PDC_01581	Tetrapeptide 40 - Azidothymidine conjugate 6	PEP00820	Tetrapeptide 40	REC00065	HIV-1 protease	LIN00146	Undisclosed	DRG00296	.	.	Zidovudine	Investigative	.	.	.	.	.
PDC_01582	Tetrapeptide 40 - Azidothymidine conjugate 7	PEP00820	Tetrapeptide 40	REC00065	HIV-1 protease	LIN00096	Ester bond	DRG00296	.	.	Zidovudine	Investigative	.	.	.	.	.
PDC_01583	Tetrapeptide 40 - Azidothymidine conjugate 8	PEP00820	Tetrapeptide 40	REC00065	HIV-1 protease	LIN00096	Ester bond	DRG00296	.	.	Zidovudine	Investigative	.	.	.	.	.
PDC_01584	Tetrapeptide 40 - Azidothymidine conjugate 9	PEP00820	Tetrapeptide 40	REC00065	HIV-1 protease	LIN00146	Undisclosed	DRG00296	.	.	Zidovudine	Investigative	.	.	.	.	.
PDC_01585	Tripeptide 84 - Azidothymidine conjugate 1	PEP00944	Tripeptide 84	REC00065	HIV-1 protease	LIN00096	Ester bond	DRG00296	.	.	Zidovudine	Investigative	.	.	.	.	.
PDC_01586	Tripeptide 84 - Azidothymidine conjugate 2	PEP00944	Tripeptide 84	REC00065	HIV-1 protease	LIN00096	Ester bond	DRG00296	.	.	Zidovudine	Investigative	.	.	.	.	.
PDC_01587	Tripeptide 84 - Azidothymidine conjugate 3	PEP00944	Tripeptide 84	REC00065	HIV-1 protease	LIN00096	Ester bond	DRG00296	.	.	Zidovudine	Investigative	.	.	.	.	.
PDC_01588	Tripeptide 82 - Azidothymidine conjugate 2	PEP00942	Tripeptide 82	REC00065	HIV-1 protease	LIN00146	Undisclosed	DRG00296	.	.	Zidovudine	Investigative	.	.	.	.	.
PDC_01589	Tripeptide 82 - Azidothymidine conjugate 3	PEP00942	Tripeptide 82	REC00065	HIV-1 protease	LIN00096	Ester bond	DRG00296	.	.	Zidovudine	Investigative	.	.	.	.	.
PDC_01590	Tripeptide 82 - Azidothymidine conjugate 4	PEP00942	Tripeptide 82	REC00065	HIV-1 protease	LIN00146	Undisclosed	DRG00296	.	.	Zidovudine	Investigative	.	.	.	.	.
PDC_01591	Tripeptide 85 - 9-Aminoacridine conjugate 1	PEP00945	Tripeptide 85	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00314	.	.	9-Aminoacridine	Investigative	.	.	.	.	.
PDC_01592	Tripeptide 85 - 9-Aminoacridine conjugate 2	PEP00945	Tripeptide 85	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00314	.	.	9-Aminoacridine	Investigative	.	.	.	.	.
PDC_01593	"RR - 2H-1-Benzopyran-6-sulfonic acid, 3,4-dihydro-2,2,5,7,8-pentamethyl conjugate 1"	PEP00130	RR	REC00015	Cathepsin B (CTSB)	LIN00146	Undisclosed	DRG00357	.	.	"2H-1-Benzopyran-6-sulfonic acid, 3,4-dihydro-2,2,5,7,8-pentamethyl"	Investigative	.	.	.	.	.
PDC_01594	"RR - 2H-1-Benzopyran-6-sulfonic acid, 3,4-dihydro-2,2,5,7,8-pentamethyl conjugate 2"	PEP00130	RR	REC00015	Cathepsin B (CTSB)	LIN00146	Undisclosed	DRG00357	.	.	"2H-1-Benzopyran-6-sulfonic acid, 3,4-dihydro-2,2,5,7,8-pentamethyl"	Investigative	.	.	.	.	.
PDC_01595	RR - 3-(Benzyloxy)aniline conjugate	PEP00130	RR	REC00015	Cathepsin B (CTSB)	LIN00146	Undisclosed	DRG00321	.	.	3-Benzyloxyaniline	Investigative	.	.	.	.	.
PDC_01596	"Tetrapeptide 43 - 1-(2,4-Dichloro-5-methoxyphenyl)-5-methyl-1H-1,2,4-triazole-3-carboxylic acid conjugate 1"	PEP00823	Tetrapeptide 43	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00283	.	.	"1-(2,4-dichloro-5-methoxyphenyl)-5-methyl-1H-1,2,4-triazole-3-carboxylic acid"	Investigative	.	.	.	.	.
PDC_01597	Tetrapeptide 43 - 1-(1-Methylethyl)-2-(trifluoromethyl)-1H-benzimidazole-5-carboxylic acid conjugate	PEP00823	Tetrapeptide 43	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00358	.	.	1-(1-Methylethyl)-2-(trifluoromethyl)-1H-benzimidazole-5-carboxylic acid	Investigative	.	.	.	.	.
PDC_01598	Tetrapeptide 43 - 2-(1H-Pyrrol-1-yl)-6-benzothiazolecarboxylic acid conjugate	PEP00823	Tetrapeptide 43	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00291	.	.	"2-(1H-pyrrol-1-yl)-1,3-benzothiazole-6-carboxylic acid"	Investigative	.	.	.	.	.
PDC_01599	Tetrapeptide 43 - 2-[(6-Chloro-2-phenyl-1H-benzimidazol-1-yl)oxy]acetic acid conjugate 1	PEP00823	Tetrapeptide 43	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00359	.	.	2-[(6-Chloro-2-phenyl-1H-benzimidazol-1-yl)oxy]acetic acid	Investigative	.	.	.	.	.
PDC_01600	Tetrapeptide 43 - L-Arginyl-L-arginyl-N-[3-(phenylmethoxy)phenyl]-L-leucinamide conjugate	PEP00823	Tetrapeptide 43	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00360	.	.	L-Arginyl-L-arginyl-N-[3-(phenylmethoxy)phenyl]-L-leucinamide	Investigative	.	.	.	.	.
PDC_01601	Tetrapeptide 43 - 2-[(6-Chloro-2-phenyl-1H-benzimidazol-1-yl)oxy]acetic acid conjugate 2	PEP00823	Tetrapeptide 43	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00359	.	.	2-[(6-Chloro-2-phenyl-1H-benzimidazol-1-yl)oxy]acetic acid	Investigative	.	.	.	.	.
PDC_01602	"Tetrapeptide 43 - 3-Nitro-4-(1H-1,2,4-triazol-1-yl)benzoic acid conjugate"	PEP00823	Tetrapeptide 43	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00288	.	.	"3-nitro-4-(1H-1,2,4-triazol-1-yl)benzoic acid"	Investigative	.	.	.	.	.
PDC_01603	"Tetrapeptide 43 - 5-Methyl-1-(4-nitrophenyl)-1H-1,2,4-triazole-3-carboxylic acid conjugate"	PEP00823	Tetrapeptide 43	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00293	.	.	"5-methyl-1-(4-nitrophenyl)-1H-1,2,4-triazole-3-carboxylic acid"	Investigative	.	.	.	.	.
PDC_01604	"Tetrapeptide 43 - 1-(4-Fluorophenyl)-5-methyl-1H-1,2,4-triazole-3-carboxylic acid conjugate"	PEP00823	Tetrapeptide 43	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00297	.	.	"1-(4-fluorophenyl)-5-methyl-1H-1,2,4-triazole-3-carboxylic acid"	Investigative	.	.	.	.	.
PDC_01605	Tetrapeptide 43 - 4-(2-Thioxo-1-imidazolidinyl)benzoic acid conjugate	PEP00823	Tetrapeptide 43	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00361	.	.	4-(2-Thioxo-1-imidazolidinyl)benzoic acid	Investigative	.	.	.	.	.
PDC_01606	"Tetrapeptide 43 - 1-(2,4-Dichlorophenyl)-5-methyl-1H-1,2,4-triazole-3-carboxylic acid conjugate"	PEP00823	Tetrapeptide 43	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00295	.	.	"1-(2,4-dichlorophenyl)-5-methyl-1H-1,2,4-triazole-3-carboxylic acid"	Investigative	.	.	.	.	.
PDC_01607	"Tetrapeptide 43 - 1-(4-Chlorophenyl)-5-methyl-1H-1,2,4-triazole-3-carboxylic acid conjugate"	PEP00823	Tetrapeptide 43	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00284	.	.	"1-(4-chlorophenyl)-5-methyl-1H-1,2,4-triazole-3-carboxylic acid"	Investigative	.	.	.	.	.
PDC_01608	"Tetrapeptide 43 - 1-(2,4-Dichloro-5-methoxyphenyl)-5-methyl-1H-1,2,4-triazole-3-carboxylic acid conjugate 2"	PEP00823	Tetrapeptide 43	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00283	.	.	"1-(2,4-dichloro-5-methoxyphenyl)-5-methyl-1H-1,2,4-triazole-3-carboxylic acid"	Investigative	.	.	.	.	.
PDC_01609	"Tetrapeptide 43 - 5-Chloro-2-phenylimidazo[1,2-a]pyridine-3-carboxylic acid conjugate"	PEP00823	Tetrapeptide 43	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00301	.	.	"5-Chloro-2-phenylimidazo[1,2-a]pyridine-3-carboxylic acid"	Investigative	.	.	.	.	.
PDC_01610	GRRRQRRKKRGGC - 5-O-Phosphonoadenylyl-(25)-adenylyl-(25)-adenosine conjugate	PEP00311	GRRRQRRKKRGGC	REC99999	Undisclosed	LIN00122	Mercaptoacetic acid	DRG00362	.	.	5-O-Phosphonoadenylyl-(2-5)-adenylyl-(2-5)-adenosine	Investigative	.	.	.	.	.
PDC_01611	CGGRKKRRQRRR - 5-O-Phosphonoadenylyl-(25)-adenylyl-(25)-adenosine conjugate	PEP00312	CGGRKKRRQRRR	REC99999	Undisclosed	LIN00122	Mercaptoacetic acid	DRG00362	.	.	5-O-Phosphonoadenylyl-(2-5)-adenylyl-(2-5)-adenosine	Investigative	.	.	.	.	.
PDC_01612	CGGRKKRRQRRR - Adenosine monophosphate conjugate	PEP00312	CGGRKKRRQRRR	REC99999	Undisclosed	LIN00122	Mercaptoacetic acid	DRG00305	.	.	Adenosine Phosphate	Investigative	.	.	.	.	.
PDC_01613	"GGRRKKRRQRRR - 2-Morpholinemethanol, 6-(6-amino-9H-purin-9-yl)-4-(3-azidopropyl)-, 2-phosphinephosphate, (2S,6R) conjugate"	PEP00313	GGRRKKRRQRRR	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00363	.	.	"2-Morpholinemethanol, 6-(6-amino-9H-purin-9-yl)-4-(3-azidopropyl)-, 2-phosphinephosphate, (2S,6R)"	Investigative	.	.	.	.	.
PDC_01614	GKRKKKGKLGKKRPRSRC - Doxorubicin conjugate 1	PEP00314	GKRKKKGKLGKKRPRSRC	REC99999	Undisclosed	LIN00140	4-Maleimidobutyric acid	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_01615	SRRARRSPRHLGSGC - Doxorubicin conjugate 1	PEP00315	SRRARRSPRHLGSGC	REC99999	Undisclosed	LIN00140	4-Maleimidobutyric acid	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_01617	GKRKKKGKLGKKRPRSRC - Doxorubicin conjugate	PEP00314	GKRKKKGKLGKKRPRSRC	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_01618	SRRARRSPRHLGSGC - Doxorubicin conjugate 2	PEP00315	SRRARRSPRHLGSGC	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_01619	SRRARRSPRHLGSGC - Doxorubicin conjugate 3	PEP00315	SRRARRSPRHLGSGC	REC99999	Undisclosed	LIN00140	4-Maleimidobutyric acid	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_01620	CVKRGLKLRHVRPRVTRMDV - Doxorubicin conjugate	PEP00316	CVKRGLKLRHVRPRVTRMDV	REC99999	Undisclosed	LIN00140	4-Maleimidobutyric acid	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_01621	"XRGDF - 2H-Pyrido[3,4-b]indole-2,3-dicarboxylic acid, 1,3,4,9-tetrahydro-1-(4-hydroxy-3,5-dimethoxyphenyl)-, 2-(1,1-dimethylethyl) ester, (3S) conjugate"	PEP00317	XRGDF	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00364	.	.	"2H-Pyrido[3,4-b]indole-2,3-dicarboxylic acid, 1,3,4,9-tetrahydro-1-(4-hydroxy-3,5-dimethoxyphenyl)-, 2-(1,1-dimethylethyl) ester, (3S)"	Investigative	.	.	.	.	.
PDC_01622	"XRGDS - 2H-Pyrido[3,4-b]indole-2,3-dicarboxylic acid, 1,3,4,9-tetrahydro-1-(4-hydroxy-3,5-dimethoxyphenyl)-, 2-(1,1-dimethylethyl) ester, (3S) conjugate 2"	PEP00318	XRGDS	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00364	.	.	"2H-Pyrido[3,4-b]indole-2,3-dicarboxylic acid, 1,3,4,9-tetrahydro-1-(4-hydroxy-3,5-dimethoxyphenyl)-, 2-(1,1-dimethylethyl) ester, (3S)"	Investigative	.	.	.	.	.
PDC_01623	"XRGDS - 2H-Pyrido[3,4-b]indole-2,3-dicarboxylic acid, 1,3,4,9-tetrahydro-1-(4-hydroxy-3,5-dimethoxyphenyl)-, 2-(1,1-dimethylethyl) ester, (3S) conjugate 1"	PEP00318	XRGDS	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00364	.	.	"2H-Pyrido[3,4-b]indole-2,3-dicarboxylic acid, 1,3,4,9-tetrahydro-1-(4-hydroxy-3,5-dimethoxyphenyl)-, 2-(1,1-dimethylethyl) ester, (3S)"	Investigative	.	.	.	.	.
PDC_01624	"XXGDF - 2H-Pyrido[3,4-b]indole-2,3-dicarboxylic acid, 1,3,4,9-tetrahydro-1-(4-hydroxy-3,5-dimethoxyphenyl)-, 2-(1,1-dimethylethyl) ester, (3S) conjugate"	PEP00319	XXGDF	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00364	.	.	"2H-Pyrido[3,4-b]indole-2,3-dicarboxylic acid, 1,3,4,9-tetrahydro-1-(4-hydroxy-3,5-dimethoxyphenyl)-, 2-(1,1-dimethylethyl) ester, (3S)"	Investigative	.	.	.	.	.
PDC_01625	"XXGDV - 2H-Pyrido[3,4-b]indole-2,3-dicarboxylic acid, 1,3,4,9-tetrahydro-1-(4-hydroxy-3,5-dimethoxyphenyl)-, 2-(1,1-dimethylethyl) ester, (3S) conjugate"	PEP00320	XXGDV	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00364	.	.	"2H-Pyrido[3,4-b]indole-2,3-dicarboxylic acid, 1,3,4,9-tetrahydro-1-(4-hydroxy-3,5-dimethoxyphenyl)-, 2-(1,1-dimethylethyl) ester, (3S)"	Investigative	.	.	.	.	.
PDC_01626	"XXGDS - 2H-Pyrido[3,4-b]indole-2,3-dicarboxylic acid, 1,3,4,9-tetrahydro-1-(4-hydroxy-3,5-dimethoxyphenyl)-, 2-(1,1-dimethylethyl) ester, (3S) conjugate"	PEP00321	XXGDS	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00364	.	.	"2H-Pyrido[3,4-b]indole-2,3-dicarboxylic acid, 1,3,4,9-tetrahydro-1-(4-hydroxy-3,5-dimethoxyphenyl)-, 2-(1,1-dimethylethyl) ester, (3S)"	Investigative	.	.	.	.	.
PDC_01627	Alanyl-oligovaline 1 - Phorphirine derivative conjugate 1	PEP00413	Alanyl-oligovaline 1	REC99999	Undisclosed	LIN00141	"1,4-Cyclohexanediamine"	DRG00365	.	.	Phorphirine derivative	Investigative	.	.	.	.	.
PDC_01628	Alanyl-oligovaline 2 - Phorphirine derivative conjugate 1	PEP00414	Alanyl-oligovaline 2	REC99999	Undisclosed	LIN00141	"1,4-Cyclohexanediamine"	DRG00365	.	.	Phorphirine derivative	Investigative	.	.	.	.	.
PDC_01629	Alanyl-oligovaline 3 - Phorphirine derivative conjugate 1	PEP00415	Alanyl-oligovaline 3	REC99999	Undisclosed	LIN00141	"1,4-Cyclohexanediamine"	DRG00365	.	.	Phorphirine derivative	Investigative	.	.	.	.	.
PDC_01630	Alanyl-oligovaline 4 - Phorphirine derivative conjugate 1	PEP00416	Alanyl-oligovaline 4	REC99999	Undisclosed	LIN00141	"1,4-Cyclohexanediamine"	DRG00365	.	.	Phorphirine derivative	Investigative	.	.	.	.	.
PDC_01631	Alanyl-oligovaline 5 - Phorphirine derivative conjugate 1	PEP00417	Alanyl-oligovaline 5	REC99999	Undisclosed	LIN00141	"1,4-Cyclohexanediamine"	DRG00365	.	.	Phorphirine derivative	Investigative	.	.	.	.	.
PDC_01632	Alanyl-oligovaline 5 - Phorphirine derivative conjugate 2	PEP00417	Alanyl-oligovaline 5	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00365	.	.	Phorphirine derivative	Investigative	.	.	.	.	.
PDC_01633	Alanyl-oligovaline 1 - Phorphirine derivative conjugate 2	PEP00413	Alanyl-oligovaline 1	REC99999	Undisclosed	LIN00141	"1,4-Cyclohexanediamine"	DRG00365	.	.	Phorphirine derivative	Investigative	.	.	.	.	.
PDC_01634	Alanyl-oligovaline 2 - Phorphirine derivative conjugate 2	PEP00414	Alanyl-oligovaline 2	REC99999	Undisclosed	LIN00141	"1,4-Cyclohexanediamine"	DRG00365	.	.	Phorphirine derivative	Investigative	.	.	.	.	.
PDC_01635	Alanyl-oligovaline 3 - Phorphirine derivative conjugate 2	PEP00415	Alanyl-oligovaline 3	REC99999	Undisclosed	LIN00141	"1,4-Cyclohexanediamine"	DRG00365	.	.	Phorphirine derivative	Investigative	.	.	.	.	.
PDC_01636	Alanyl-oligovaline 4 - Phorphirine derivative conjugate 2	PEP00416	Alanyl-oligovaline 4	REC99999	Undisclosed	LIN00141	"1,4-Cyclohexanediamine"	DRG00365	.	.	Phorphirine derivative	Investigative	.	.	.	.	.
PDC_01637	Alanyl-oligovaline 6 - Phorphirine derivative conjugate	PEP00418	Alanyl-oligovaline 6	REC99999	Undisclosed	LIN00141	"1,4-Cyclohexanediamine"	DRG00365	.	.	Phorphirine derivative	Investigative	.	.	.	.	.
PDC_01638	Alanyl-oligovaline 7 - Phorphirine derivative conjugate	PEP00419	Alanyl-oligovaline 7	REC99999	Undisclosed	LIN00141	"1,4-Cyclohexanediamine"	DRG00365	.	.	Phorphirine derivative	Investigative	.	.	.	.	.
PDC_01639	Alanyl-oligovaline 5 - Phorphirine derivative conjugate 3	PEP00417	Alanyl-oligovaline 5	REC99999	Undisclosed	LIN00141	"1,4-Cyclohexanediamine"	DRG00365	.	.	Phorphirine derivative	Investigative	.	.	.	.	.
PDC_01640	FQGII - 9-Aminoacridine conjugate 1	PEP00322	FQGII	REC99999	Undisclosed	LIN00142	Ethylendiamine	DRG00314	.	.	9-Aminoacridine	Investigative	.	.	.	.	.
PDC_01641	FQGIIX - 9-Aminoacridine conjugate	PEP00323	FQGIIX	REC99999	Undisclosed	LIN00142	Ethylendiamine	DRG00314	.	.	9-Aminoacridine	Investigative	.	.	.	.	.
PDC_01642	GIIX - 9-Aminoacridine conjugate	PEP00324	GIIX	REC99999	Undisclosed	LIN00142	Ethylendiamine	DRG00314	.	.	9-Aminoacridine	Investigative	.	.	.	.	.
PDC_01643	Tripeptide 86 - 9-Aminoacridine conjugate	PEP00946	Tripeptide 86	REC99999	Undisclosed	LIN00142	Ethylendiamine	DRG00314	.	.	9-Aminoacridine	Investigative	.	.	.	.	.
PDC_01644	FQGII - 9-Aminoacridine conjugate	PEP00322	FQGII	REC99999	Undisclosed	LIN00142	Ethylendiamine	DRG00314	.	.	9-Aminoacridine	Investigative	.	.	.	.	.
PDC_01645	Tripeptide 87 - 9-Aminoacridine conjugate	PEP00947	Tripeptide 87	REC99999	Undisclosed	LIN00142	Ethylendiamine	DRG00314	.	.	9-Aminoacridine	Investigative	.	.	.	.	.
PDC_01646	Dipeptide 37 - 9-Aminoacridine conjugate	PEP00533	Dipeptide 37	REC99999	Undisclosed	LIN00142	Ethylendiamine	DRG00314	.	.	9-Aminoacridine	Investigative	.	.	.	.	.
PDC_01647	XYQWAVGHLM - Paclitaxel conjugate	PEP00325	XYQWAVGHLM	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00012	TAR10017	Microtubule (MT)	Paclitaxel	Investigative	.	.	.	.	.
PDC_01648	EYQWAVGHLM - Paclitaxel conjugate	PEP00326	EYQWAVGHLM	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00012	TAR10017	Microtubule (MT)	Paclitaxel	Investigative	.	.	.	.	.
PDC_01649	GWS - DOTA conjugate 1	PEP00327	GWS	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00279	.	.	Tetraxetan	Investigative	.	.	.	.	.
PDC_01650	GWS - DOTA conjugate 2	PEP00327	GWS	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00279	.	.	Tetraxetan	Investigative	.	.	.	.	.
PDC_01651	EGFLGC - Methotrexate conjugate	PEP00328	EGFLGC	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_01653	XGFLG - Methotrexate conjugate 1	PEP00242	XGFLG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00019	TAR10012	Reduced folate transporter (SLC19A1)	Methotrexate	Investigative	.	.	.	.	.
PDC_01654	GPLGPAG - Doxorubicin conjugate 1	PEP00329	GPLGPAG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_01655	GPLGV - Doxorubicin conjugate 1	PEP00330	GPLGV	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_01656	GPLG - Doxorubicin conjugate 1	PEP00331	GPLG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_01657	GPLGPAG - Doxorubicin conjugate	PEP00329	GPLGPAG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_01658	GPLGV - Doxorubicin conjugate 2	PEP00330	GPLGV	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_01659	GPLG - Doxorubicin conjugate 2	PEP00331	GPLG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_01660	Penetratin fragment - Paclitaxel conjugate	PEP00720	Penetratin fragment	REC99999	Undisclosed	LIN00103	Maleimide	DRG00012	TAR10017	Microtubule (MT)	Paclitaxel	Investigative	.	.	.	.	.
PDC_01663	Penetratin - Paclitaxel conjugate 1	PEP00718	Penetratin	REC99999	Undisclosed	LIN00103	Maleimide	DRG00012	TAR10017	Microtubule (MT)	Paclitaxel	Investigative	.	.	.	.	.
PDC_01664	Penetratin - Paclitaxel conjugate 2	PEP00718	Penetratin	REC99999	Undisclosed	LIN00103	Maleimide	DRG00012	TAR10017	Microtubule (MT)	Paclitaxel	Investigative	.	.	.	.	.
PDC_01666	XASXQSL - Doxorubicin conjugate 1	PEP00332	XASXQSL	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_01667	GRKKRRQRRRPPQ - Porphine derivative conjugate	PEP00051	TAT	REC99999	Undisclosed	LIN00126	PEG	DRG00242	.	.	Porphine derivative	Investigative	.	.	.	.	.
PDC_01668	GPKKKRKV - Porphine derivative conjugate 1	PEP00256	GPKKKRKV	REC99999	Undisclosed	LIN00126	PEG	DRG00242	.	.	Porphine derivative	Investigative	.	.	.	.	.
PDC_01669	PPQ - Porphine derivative conjugate	PEP00764	PPQ	REC99999	Undisclosed	LIN00126	PEG	DRG00242	.	.	Porphine derivative	Investigative	.	.	.	.	.
PDC_01670	GRRRRRRRR - Porphine derivative conjugate	PEP00333	GRRRRRRRR	REC99999	Undisclosed	LIN00126	PEG	DRG00242	.	.	Porphine derivative	Investigative	.	.	.	.	.
PDC_01671	GPKKKRKV - Porphine derivative conjugate 2	PEP00256	GPKKKRKV	REC99999	Undisclosed	LIN00126	PEG	DRG00242	.	.	Porphine derivative	Investigative	.	.	.	.	.
PDC_01672	"CGYGPKKKRKVGG - N-[5-[(6-chloro-2-methoxy-9-acridinyl)amino]pentyl]-4-[(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)methyl]-cyclohexanecarboxamide conjugate"	PEP00334	CGYGPKKKRKVGG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00366	.	.	"N-[5-[(6-chloro-2-methoxy-9-acridinyl)amino]pentyl]-4-[(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)methyl]-cyclohexanecarboxamide"	Investigative	.	.	.	.	.
PDC_01673	"CGYGPKKKRKVGG - N-[5-[[3-[(6-chloro-2-methoxy-9-acridinyl)amino]-1-oxopropyl]amino]pentyl]-4-[(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)methyl]-cyclohexanecarboxamide conjugate"	PEP00334	CGYGPKKKRKVGG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00367	.	.	"N-[5-[[3-[(6-chloro-2-methoxy-9-acridinyl)amino]-1-oxopropyl]amino]pentyl]-4-[(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)methyl]-cyclohexanecarboxamide"	Investigative	.	.	.	.	.
PDC_01674	"CGYGPKKKRKVGG - N-[5-[[12-[(6-chloro-2-methoxy-9-acridinyl)amino]-1-oxododecyl]amino]pentyl]-4-[(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)methyl]-cyclohexanecarboxamide conjugate"	PEP00334	CGYGPKKKRKVGG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00368	.	.	"N-[5-[[12-[(6-chloro-2-methoxy-9-acridinyl)amino]-1-oxododecyl]amino]pentyl]-4-[(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)methyl]-cyclohexanecarboxamide"	Investigative	.	.	.	.	.
PDC_01675	"CGYGPKKKRKVGG - N-[2-[[12-[(6-chloro-2-methoxy-9-acridinyl)amino]-1-oxododecyl]amino]ethyl]-4-[(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)methyl]-cyclohexanecarboxamide conjugate"	PEP00334	CGYGPKKKRKVGG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00369	.	.	"N-[2-[[12-[(6-chloro-2-methoxy-9-acridinyl)amino]-1-oxododecyl]amino]ethyl]-4-[(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)methyl]-cyclohexanecarboxamide"	Investigative	.	.	.	.	.
PDC_01676	Tripeptide 88 - Porphyrin derivative conjugate 1	PEP00948	Tripeptide 88	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00170	.	.	Porphyrin derivative	Investigative	.	.	.	.	.
PDC_01677	Dipeptide 38 - Porphyrin derivative conjugate 1	PEP00534	Dipeptide 38	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00170	.	.	Porphyrin derivative	Investigative	.	.	.	.	.
PDC_01678	Tetrapeptide 44 - Porphyrin derivative conjugate	PEP00824	Tetrapeptide 44	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00170	.	.	Porphyrin derivative	Investigative	.	.	.	.	.
PDC_01679	Tetrapeptide 45 - Porphyrin derivative conjugate	PEP00825	Tetrapeptide 45	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00170	.	.	Porphyrin derivative	Investigative	.	.	.	.	.
PDC_01680	Tripeptide 89 - Porphyrin derivative conjugate	PEP00949	Tripeptide 89	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00170	.	.	Porphyrin derivative	Investigative	.	.	.	.	.
PDC_01681	Tripeptide 88 - Porphyrin derivative conjugate 2	PEP00948	Tripeptide 88	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00170	.	.	Porphyrin derivative	Investigative	.	.	.	.	.
PDC_01682	Dipeptide 38 - Porphyrin derivative conjugate 2	PEP00534	Dipeptide 38	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00170	.	.	Porphyrin derivative	Investigative	.	.	.	.	.
PDC_01683	Tripeptide 88 - Porphyrin derivative conjugate 3	PEP00948	Tripeptide 88	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00170	.	.	Porphyrin derivative	Investigative	.	.	.	.	.
PDC_01684	Dipeptide 39 - Porphyrin derivative conjugate	PEP00535	Dipeptide 39	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00170	.	.	Porphyrin derivative	Investigative	.	.	.	.	.
PDC_01685	Tripeptide 88 - Porphyrin derivative conjugate 4	PEP00948	Tripeptide 88	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00170	.	.	Porphyrin derivative	Investigative	.	.	.	.	.
PDC_01686	"Dipeptide 40 - 3,4-dihydro-2,2,5,7,8-pentamethyl-2H-1-benzopyran-6-sulfonic acid conjugate 1"	PEP00536	Dipeptide 40	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00342	.	.	"3,4-dihydro-2,2,5,7,8-pentamethyl-2H-1-benzopyran-6-sulfonic acid"	Investigative	.	.	.	.	.
PDC_01687	"Dipeptide 40 - 3,4-dihydro-2,2,5,7,8-pentamethyl-2H-1-benzopyran-6-sulfonic acid conjugate"	PEP00536	Dipeptide 40	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00342	.	.	"3,4-dihydro-2,2,5,7,8-pentamethyl-2H-1-benzopyran-6-sulfonic acid"	Investigative	.	.	.	.	.
PDC_01688	"QRPAK - 1H-Imidazol-1-yloxy, 2-[4-(2-ethoxy-2-oxoethoxy)phenyl]-4,5-dihydro-4,4,5,5-tetramethyl-, 3-oxide conjugate"	PEP00335	QRPAK	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00370	.	.	"1H-Imidazol-1-yloxy, 2-[4-(2-ethoxy-2-oxoethoxy)phenyl]-4,5-dihydro-4,4,5,5-tetramethyl-, 3-oxide"	Investigative	.	.	.	.	.
PDC_01689	"GRPAK - 1H-Imidazol-1-yloxy, 2-[4-(2-ethoxy-2-oxoethoxy)phenyl]-4,5-dihydro-4,4,5,5-tetramethyl-, 3-oxide conjugate"	PEP00336	GRPAK	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00370	.	.	"1H-Imidazol-1-yloxy, 2-[4-(2-ethoxy-2-oxoethoxy)phenyl]-4,5-dihydro-4,4,5,5-tetramethyl-, 3-oxide"	Investigative	.	.	.	.	.
PDC_01690	"ARPAK - 1H-Imidazol-1-yloxy, 2-[4-(2-ethoxy-2-oxoethoxy)phenyl]-4,5-dihydro-4,4,5,5-tetramethyl-, 3-oxide conjugate"	PEP00337	ARPAK	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00370	.	.	"1H-Imidazol-1-yloxy, 2-[4-(2-ethoxy-2-oxoethoxy)phenyl]-4,5-dihydro-4,4,5,5-tetramethyl-, 3-oxide"	Investigative	.	.	.	.	.
PDC_01691	QRPAK - P-Tolylsulfonic acid conjugate 1	PEP00335	QRPAK	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00306	.	.	p-Toluenesulfonic acid	Investigative	.	.	.	.	.
PDC_01692	GRPAK - P-Tolylsulfonic acid conjugate 1	PEP00336	GRPAK	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00306	.	.	p-Toluenesulfonic acid	Investigative	.	.	.	.	.
PDC_01693	ARPAK - P-Tolylsulfonic acid conjugate 1	PEP00337	ARPAK	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00306	.	.	p-Toluenesulfonic acid	Investigative	.	.	.	.	.
PDC_01694	QRPAK - P-Tolylsulfonic acid conjugate 2	PEP00335	QRPAK	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00306	.	.	p-Toluenesulfonic acid	Investigative	.	.	.	.	.
PDC_01695	GRPAK - P-Tolylsulfonic acid conjugate	PEP00336	GRPAK	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00306	.	.	p-Toluenesulfonic acid	Investigative	.	.	.	.	.
PDC_01696	QRPAK - P-Tolylsulfonic acid conjugate 3	PEP00335	QRPAK	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00306	.	.	p-Toluenesulfonic acid	Investigative	.	.	.	.	.
PDC_01697	ARPAK - P-Tolylsulfonic acid conjugate2	PEP00337	ARPAK	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00306	.	.	p-Toluenesulfonic acid	Investigative	.	.	.	.	.
PDC_01698	RPAK - P-Tolylsulfonic acid conjugate	PEP00338	RPAK	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00306	.	.	p-Toluenesulfonic acid	Investigative	.	.	.	.	.
PDC_01699	"NAQASAQSAY - 5-(4-Aminophenyl)-10,15,20-triphenylporphyrin conjugate"	PEP00339	NAQASAQSAY	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00281	.	.	"5-(4-Aminophenyl)-10,15,20-triphenyl porphine"	Investigative	.	.	.	.	.
PDC_01700	Oligovalin 1 - ()-Menthol conjugate	PEP00703	Oligovalin 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00099	.	.	()-Menthol	Investigative	.	.	.	.	.
PDC_01701	Oligovalin 2 - ()-Menthol conjugate	PEP00704	Oligovalin 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00099	.	.	()-Menthol	Investigative	.	.	.	.	.
PDC_01702	Oligovalin 3 - ()-Menthol conjugate	PEP00705	Oligovalin 3	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00099	.	.	()-Menthol	Investigative	.	.	.	.	.
PDC_01703	Oligovalin 4 - ()-Menthol conjugate	PEP00706	Oligovalin 4	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00099	.	.	()-Menthol	Investigative	.	.	.	.	.
PDC_01704	Oligovalin 5 - ()-Menthol conjugate	PEP00707	Oligovalin 5	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00099	.	.	()-Menthol	Investigative	.	.	.	.	.
PDC_01705	Oligovalin 6 - ()-Menthol conjugate	PEP00708	Oligovalin 6	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00099	.	.	()-Menthol	Investigative	.	.	.	.	.
PDC_01706	Oligoleucin 1 - Cinchonidine conjugate	PEP00671	Oligoleucin 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00275	.	.	(-)-Cinchonidine	Investigative	.	.	.	.	.
PDC_01707	Oligoleucin 2 - Cinchonidine conjugate	PEP00672	Oligoleucin 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00275	.	.	(-)-Cinchonidine	Investigative	.	.	.	.	.
PDC_01708	Oligoleucin 3 - Cinchonidine conjugate	PEP00673	Oligoleucin 3	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00275	.	.	(-)-Cinchonidine	Investigative	.	.	.	.	.
PDC_01709	Oligoleucin 4 - ()-Menthol conjugate	PEP00674	Oligoleucin 4	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00099	.	.	()-Menthol	Investigative	.	.	.	.	.
PDC_01710	Oligoleucin 5 - ()-Menthol conjugate	PEP00675	Oligoleucin 5	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00099	.	.	()-Menthol	Investigative	.	.	.	.	.
PDC_01711	Oligoleucin 2 - ()-Menthol conjugate	PEP00672	Oligoleucin 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00099	.	.	()-Menthol	Investigative	.	.	.	.	.
PDC_01712	Oligoleucin 6 - ()-Menthol conjugate	PEP00676	Oligoleucin 6	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00099	.	.	()-Menthol	Investigative	.	.	.	.	.
PDC_01713	Oligophenylalanin 1 - Cinchonidine conjugate	PEP00698	Oligophenylalanin 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00275	.	.	(-)-Cinchonidine	Investigative	.	.	.	.	.
PDC_01714	Oligophenylalanin 2 - Cinchonidine conjugate	PEP00699	Oligophenylalanin 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00275	.	.	(-)-Cinchonidine	Investigative	.	.	.	.	.
PDC_01715	Oligophenylalanin 3 - Cinchonidine conjugate	PEP00700	Oligophenylalanin 3	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00275	.	.	(-)-Cinchonidine	Investigative	.	.	.	.	.
PDC_01716	Oligophenylalanin 4 - Cinchonidine conjugate	PEP00701	Oligophenylalanin 4	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00275	.	.	(-)-Cinchonidine	Investigative	.	.	.	.	.
PDC_01717	Oligophenylalanin 5 - Cinchonidine conjugate	PEP00702	Oligophenylalanin 5	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00275	.	.	(-)-Cinchonidine	Investigative	.	.	.	.	.
PDC_01718	XGRKKRRQRRR - Rose bengal (xanthene dye) conjugate	PEP00340	XGRKKRRQRRR	REC99999	Undisclosed	LIN00131	Hexanamide	DRG00316	.	.	"Spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one, 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodo-, dipotassium salt"	Investigative	.	.	.	.	.
PDC_01719	QRKKRRWRRR - Rose bengal (xanthene dye) conjugate	PEP00341	QRKKRRWRRR	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00316	.	.	"Spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one, 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodo-, dipotassium salt"	Investigative	.	.	.	.	.
PDC_01720	QRKKRRHRRR - Rose bengal (xanthene dye) conjugate	PEP00342	QRKKRRHRRR	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00316	.	.	"Spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one, 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodo-, dipotassium salt"	Investigative	.	.	.	.	.
PDC_01721	QRKKRRGRRR - Rose bengal (xanthene dye) conjugate	PEP00343	QRKKRRGRRR	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00316	.	.	"Spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one, 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodo-, dipotassium salt"	Investigative	.	.	.	.	.
PDC_01722	GRKKRRQRRR - Rose bengal (xanthene dye) conjugate	PEP00344	GRKKRRQRRR	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00316	.	.	"Spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one, 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodo-, dipotassium salt"	Investigative	.	.	.	.	.
PDC_01723	HRKKRRQRRR - Rose bengal (xanthene dye) conjugate	PEP00345	HRKKRRQRRR	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00316	.	.	"Spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one, 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodo-, dipotassium salt"	Investigative	.	.	.	.	.
PDC_01724	WRKKRRQRRR - Rose bengal (xanthene dye) conjugate	PEP00346	WRKKRRQRRR	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00316	.	.	"Spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one, 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodo-, dipotassium salt"	Investigative	.	.	.	.	.
PDC_01725	"Tripeptide 90 - 2-[(3,6-Dihydroxy-2,4-dimethoxyphenyl)thio]acetic acid conjugate"	PEP00950	Tripeptide 90	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00371	.	.	"2-[(3,6-Dihydroxy-2,4-dimethoxyphenyl)thio]acetic acid"	Investigative	.	.	.	.	.
PDC_01726	"Tripeptide 91 - 2-[(3,6-Dihydroxy-2,4-dimethoxyphenyl)thio]acetic acid conjugate"	PEP00951	Tripeptide 91	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00371	.	.	"2-[(3,6-Dihydroxy-2,4-dimethoxyphenyl)thio]acetic acid"	Investigative	.	.	.	.	.
PDC_01727	"Tripeptide 92 - 2-[(3,6-Dihydroxy-2,4-dimethoxyphenyl)thio]acetic acid conjugate"	PEP00952	Tripeptide 92	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00371	.	.	"2-[(3,6-Dihydroxy-2,4-dimethoxyphenyl)thio]acetic acid"	Investigative	.	.	.	.	.
PDC_01728	"Tripeptide 93 - 2-[(3,6-Dihydroxy-2,4-dimethoxyphenyl)thio]acetic acid conjugate"	PEP00953	Tripeptide 93	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00371	.	.	"2-[(3,6-Dihydroxy-2,4-dimethoxyphenyl)thio]acetic acid"	Investigative	.	.	.	.	.
PDC_01729	"GAGAG - 3,3,3,4-tetrahexyl-[2,2:5,2:5,2-quaterthiophene]-5-carboxylic acid conjugate"	PEP00347	GAGAG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00372	.	.	"3,3,3,4-tetrahexyl-[2,2:5,2:5,2-quaterthiophene]-5-carboxylic acid"	Investigative	.	.	.	.	.
PDC_01730	"Tripeptide 94 - (3&alpha;,5&beta;,7&alpha;,12&alpha;)-3,7,12-Triaminocholan-24-ol conjugate 1"	PEP00954	Tripeptide 94	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00373	.	.	"(3&alpha;,5&beta;,7&alpha;,12&alpha;)-3,7,12-Triaminocholan-24-ol"	Investigative	.	.	.	.	.
PDC_01731	"Tripeptide 95 - (3&alpha;,5&beta;,7&alpha;,12&alpha;)-3,7,12-Triaminocholan-24-ol conjugate"	PEP00955	Tripeptide 95	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00373	.	.	"(3&alpha;,5&beta;,7&alpha;,12&alpha;)-3,7,12-Triaminocholan-24-ol"	Investigative	.	.	.	.	.
PDC_01732	"Tripeptide 96 - (3&alpha;,5&beta;,7&alpha;,12&alpha;)-3,7,12-Triaminocholan-24-ol conjugate"	PEP00956	Tripeptide 96	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00373	.	.	"(3&alpha;,5&beta;,7&alpha;,12&alpha;)-3,7,12-Triaminocholan-24-ol"	Investigative	.	.	.	.	.
PDC_01733	"Tripeptide 97 - (3&alpha;,5&beta;,7&alpha;,12&alpha;)-3,7,12-Triaminocholan-24-ol conjugate"	PEP00957	Tripeptide 97	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00373	.	.	"(3&alpha;,5&beta;,7&alpha;,12&alpha;)-3,7,12-Triaminocholan-24-ol"	Investigative	.	.	.	.	.
PDC_01734	"Tripeptide 98 - (3&alpha;,5&beta;,7&alpha;,12&alpha;)-3,7,12-Triaminocholan-24-ol conjugate"	PEP00958	Tripeptide 98	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00373	.	.	"(3&alpha;,5&beta;,7&alpha;,12&alpha;)-3,7,12-Triaminocholan-24-ol"	Investigative	.	.	.	.	.
PDC_01735	"Tripeptide 99 - (3&alpha;,5&beta;,7&alpha;,12&alpha;)-3,7,12-Triaminocholan-24-ol conjugate"	PEP00959	Tripeptide 99	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00373	.	.	"(3&alpha;,5&beta;,7&alpha;,12&alpha;)-3,7,12-Triaminocholan-24-ol"	Investigative	.	.	.	.	.
PDC_01736	"Tripeptide 100 - (3&alpha;,5&beta;,7&alpha;,12&alpha;)-3,7,12-Triaminocholan-24-ol conjugate"	PEP00960	Tripeptide 100	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00373	.	.	"(3&alpha;,5&beta;,7&alpha;,12&alpha;)-3,7,12-Triaminocholan-24-ol"	Investigative	.	.	.	.	.
PDC_01737	"Tripeptide 101 - (3&alpha;,5&beta;,7&alpha;,12&alpha;)-3,7,12-Triaminocholan-24-ol conjugate"	PEP00961	Tripeptide 101	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00373	.	.	"(3&alpha;,5&beta;,7&alpha;,12&alpha;)-3,7,12-Triaminocholan-24-ol"	Investigative	.	.	.	.	.
PDC_01738	"Tripeptide 94 - (3&alpha;,5&beta;,7&alpha;,12&alpha;)-3,7,12-Triaminocholan-24-ol conjugate 2"	PEP00954	Tripeptide 94	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00373	.	.	"(3&alpha;,5&beta;,7&alpha;,12&alpha;)-3,7,12-Triaminocholan-24-ol"	Investigative	.	.	.	.	.
PDC_01739	Tripeptide 102 - Prednisolone conjugate	PEP00962	Tripeptide 102	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00303	.	.	Prednisolone	Investigative	.	.	.	.	.
PDC_01740	Dipeptide 41 - Prednisolone conjugate	PEP00537	Dipeptide 41	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00303	.	.	Prednisolone	Investigative	.	.	.	.	.
PDC_01741	Tripeptide 103 - Prednisolone conjugate 1	PEP00963	Tripeptide 103	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00303	.	.	Prednisolone	Investigative	.	.	.	.	.
PDC_01742	Tripeptide 103 - Prednisolone conjugate 2	PEP00963	Tripeptide 103	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00303	.	.	Prednisolone	Investigative	.	.	.	.	.
PDC_01743	Tripeptide 103 - Prednisolone conjugate 3	PEP00963	Tripeptide 103	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00303	.	.	Prednisolone	Investigative	.	.	.	.	.
PDC_01744	Tripeptide 104 - Prednisolone conjugate	PEP00964	Tripeptide 104	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00303	.	.	Prednisolone	Investigative	.	.	.	.	.
PDC_01745	Tripeptide 103 - Prednisolone conjugate 4	PEP00963	Tripeptide 103	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00303	.	.	Prednisolone	Investigative	.	.	.	.	.
PDC_01746	Tripeptide 103 - Prednisolone conjugate 5	PEP00963	Tripeptide 103	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00303	.	.	Prednisolone	Investigative	.	.	.	.	.
PDC_01747	Tripeptide 103 - Prednisolone conjugate 6	PEP00963	Tripeptide 103	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00303	.	.	Prednisolone	Investigative	.	.	.	.	.
PDC_01748	Tripeptide 103 - Prednisolone conjugate 7	PEP00963	Tripeptide 103	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00303	.	.	Prednisolone	Investigative	.	.	.	.	.
PDC_01749	Tripeptide 103 - Prednisolone conjugate 8	PEP00963	Tripeptide 103	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00303	.	.	Prednisolone	Investigative	.	.	.	.	.
PDC_01750	Tripeptide 103 - Prednisolone conjugate 9	PEP00963	Tripeptide 103	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00303	.	.	Prednisolone	Investigative	.	.	.	.	.
PDC_01751	Tripeptide 103 - Prednisolone conjugate 10	PEP00963	Tripeptide 103	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00303	.	.	Prednisolone	Investigative	.	.	.	.	.
PDC_01752	ALEKEVAALEKENAALEKEVAALEKEVAGK - Dansyl chloride conjugate	PEP00348	ALEKEVAALEKENAALEKEVAALEKEVAGK	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00277	.	.	Dansyl chloride	Investigative	.	.	.	.	.
PDC_01753	"ALEKEVAALEKENAALEKEVAALEKEVAGGC - 7-(2-Bromoacetyl)-10-methylbenzo[g]pteridine-2,4(3H,10H)-dione conjugate"	PEP00349	ALEKEVAALEKENAALEKEVAALEKEVAGGC	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00374	.	.	"7-(2-Bromoacetyl)-10-methylbenzo[g]pteridine-2,4(3H,10H)-dione"	Investigative	.	.	.	.	.
PDC_01754	"CGGALEKEVAALEKENAALEKEVAALEKEVA - 7-(2-Bromoacetyl)-10-methylbenzo[g]pteridine-2,4(3H,10H)-dione conjugate"	PEP00350	CGGALEKEVAALEKENAALEKEVAALEKEVA	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00374	.	.	"7-(2-Bromoacetyl)-10-methylbenzo[g]pteridine-2,4(3H,10H)-dione"	Investigative	.	.	.	.	.
PDC_01755	RRLSYSRRRF - 2-pyrrolinodoxorubicin conjugate 1	PEP00351	RRLSYSRRRF	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00278	.	.	2-Pyrrolino-dox	Investigative	.	.	.	.	.
PDC_01756	RRLSYSRRRF - 2-pyrrolinodoxorubicin conjugate 2	PEP00351	RRLSYSRRRF	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00278	.	.	2-Pyrrolino-dox	Investigative	.	.	.	.	.
PDC_01757	RRLSYSRRRF - 2-pyrrolinodoxorubicin conjugate 3	PEP00351	RRLSYSRRRF	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00278	.	.	2-Pyrrolino-dox	Investigative	.	.	.	.	.
PDC_01758	"RRRRRRRRG - Xanthylium, 9-[2-carboxy-6-[[(2,5-dioxo-1-pyrrolidinyl)oxy]carbonyl]phenyl]-3,6-bis(dimethylamino)-, chloride (1:1) conjugate"	PEP00352	RRRRRRRRG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00310	.	.	Rhodamine B	Investigative	.	.	.	.	.
PDC_01759	"RRRRRRRRG - Diaqua[N2,N2-bis[(carboxy-&kappa;O)methyl]-L-lysinato(3-)-&kappa;N2,&kappa;O]-nickelate(1-) conjugate"	PEP00352	RRRRRRRRG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00375	.	.	"Diaqua[N2,N2-bis[(carboxy-&kappa;O)methyl]-L-lysinato(3-)-&kappa;N2,&kappa;O]-nickelate(1-)"	Investigative	.	.	.	.	.
PDC_01760	XXXXXXXXG - Nitrilotriacetic acid conjugate	PEP00353	XXXXXXXXG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00320	.	.	Nitrilotriacetic acid	Investigative	.	.	.	.	.
PDC_01761	RRRRRRRRG - Nitrilotriacetic acid conjugate 1	PEP00352	RRRRRRRRG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00320	.	.	Nitrilotriacetic acid	Investigative	.	.	.	.	.
PDC_01762	RRRRRRRRG - Nitrilotriacetic acid conjugate 2	PEP00352	RRRRRRRRG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00320	.	.	Nitrilotriacetic acid	Investigative	.	.	.	.	.
PDC_01763	Tetrapeptide 46 - Porfirin derivative conjugate 1	PEP00826	Tetrapeptide 46	REC99999	Undisclosed	LIN00128	Butyric acid	DRG00376	.	.	Porfirin derivative	Investigative	.	.	.	.	.
PDC_01765	Tetrapeptide 46 - Porfirin derivative conjugate 2	PEP00826	Tetrapeptide 46	REC99999	Undisclosed	LIN00128	Butyric acid	DRG00376	.	.	Porfirin derivative	Investigative	.	.	.	.	.
PDC_01767	Tetrapeptide 47 - Porfirin derivative conjugate	PEP00827	Tetrapeptide 47	REC99999	Undisclosed	LIN00128	Butyric acid	DRG00376	.	.	Porfirin derivative	Investigative	.	.	.	.	.
PDC_01769	"LRRAXLG - Adenosine 5-(trihydrogen diphosphate), P-anhydride with phosphorothioic acid conjugate"	PEP00354	LRRAXLG	REC99999	Undisclosed	LIN00085	Acetic acid	DRG00377	.	.	"Adenosine 5-(trihydrogen diphosphate), P-anhydride with phosphorothioic acid"	Investigative	.	.	.	.	.
PDC_01770	"LRRAXLG - 3,4-dihydro-2,2,5,7,8-pentamethyl-2H-1-benzopyran-6-sulfonic acid conjugate 1"	PEP00354	LRRAXLG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00342	.	.	"3,4-dihydro-2,2,5,7,8-pentamethyl-2H-1-benzopyran-6-sulfonic acid"	Investigative	.	.	.	.	.
PDC_01771	"LRRAXLG - 3,4-dihydro-2,2,5,7,8-pentamethyl-2H-1-benzopyran-6-sulfonic acid conjugate 2"	PEP00354	LRRAXLG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00342	.	.	"3,4-dihydro-2,2,5,7,8-pentamethyl-2H-1-benzopyran-6-sulfonic acid"	Investigative	.	.	.	.	.
PDC_01773	GAQVWGFSAK - 4-[(3-Methyl-2(3H)-benzothiazolylidene)methyl]quinoline conjugate	PEP00355	GAQVWGFSAK	REC99999	Undisclosed	LIN00143	Decanoic acid	DRG00378	.	.	4-[(3-Methyl-2(3H)-benzothiazolylidene)methyl]quinoline	Investigative	.	.	.	.	.
PDC_01774	KAQSWGKSAK - 4-[(3-Methyl-2(3H)-benzothiazolylidene)methyl]quinoline conjugate	PEP00356	KAQSWGKSAK	REC99999	Undisclosed	LIN00143	Decanoic acid	DRG00378	.	.	4-[(3-Methyl-2(3H)-benzothiazolylidene)methyl]quinoline	Investigative	.	.	.	.	.
PDC_01776	"GLKKG - 3,5,6,7-tetrahydro-6-octyl-1,3,5,7-tetraoxo-benzo[1,2-c:4,5-c]dipyrrole-2(1H)-acetic acid conjugate"	PEP00357	GLKKG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00379	.	.	"3,5,6,7-tetrahydro-6-octyl-1,3,5,7-tetraoxo-benzo[1,2-c:4,5-c]dipyrrole-2(1H)-acetic acid"	Investigative	.	.	.	.	.
PDC_01777	"Tripeptide 105 - 3,5,6,7-tetrahydro-6-octyl-1,3,5,7-tetraoxo-benzo[1,2-c:4,5-c]dipyrrole-2(1H)-acetic acid conjugate"	PEP00965	Tripeptide 105	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00379	.	.	"3,5,6,7-tetrahydro-6-octyl-1,3,5,7-tetraoxo-benzo[1,2-c:4,5-c]dipyrrole-2(1H)-acetic acid"	Investigative	.	.	.	.	.
PDC_01778	"XKKKL - 3,5,6,7-tetrahydro-6-octyl-1,3,5,7-tetraoxo-benzo[1,2-c:4,5-c]dipyrrole-2(1H)-acetic acid conjugate 2"	PEP00358	XKKKL	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00379	.	.	"3,5,6,7-tetrahydro-6-octyl-1,3,5,7-tetraoxo-benzo[1,2-c:4,5-c]dipyrrole-2(1H)-acetic acid"	Investigative	.	.	.	.	.
PDC_01779	"Tetrapeptide 48 - 3,5,6,7-tetrahydro-6-octyl-1,3,5,7-tetraoxo-benzo[1,2-c:4,5-c]dipyrrole-2(1H)-acetic acid conjugate"	PEP00828	Tetrapeptide 48	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00379	.	.	"3,5,6,7-tetrahydro-6-octyl-1,3,5,7-tetraoxo-benzo[1,2-c:4,5-c]dipyrrole-2(1H)-acetic acid"	Investigative	.	.	.	.	.
PDC_01780	"XKKKKL - 3,5,6,7-tetrahydro-6-octyl-1,3,5,7-tetraoxo-benzo[1,2-c:4,5-c]dipyrrole-2(1H)-acetic acid conjugate 2"	PEP00359	XKKKKL	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00379	.	.	"3,5,6,7-tetrahydro-6-octyl-1,3,5,7-tetraoxo-benzo[1,2-c:4,5-c]dipyrrole-2(1H)-acetic acid"	Investigative	.	.	.	.	.
PDC_01781	"XKKKKL - 3,5,6,7-tetrahydro-6-octyl-1,3,5,7-tetraoxo-benzo[1,2-c:4,5-c]dipyrrole-2(1H)-acetic acid conjugate 1"	PEP00359	XKKKKL	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00379	.	.	"3,5,6,7-tetrahydro-6-octyl-1,3,5,7-tetraoxo-benzo[1,2-c:4,5-c]dipyrrole-2(1H)-acetic acid"	Investigative	.	.	.	.	.
PDC_01782	"XKKKL - 3,5,6,7-tetrahydro-6-octyl-1,3,5,7-tetraoxo-benzo[1,2-c:4,5-c]dipyrrole-2(1H)-acetic acid conjugate 1"	PEP00358	XKKKL	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00379	.	.	"3,5,6,7-tetrahydro-6-octyl-1,3,5,7-tetraoxo-benzo[1,2-c:4,5-c]dipyrrole-2(1H)-acetic acid"	Investigative	.	.	.	.	.
PDC_01783	"Tetrapeptide 49 - 3,5,6,7-tetrahydro-6-octyl-1,3,5,7-tetraoxo-benzo[1,2-c:4,5-c]dipyrrole-2(1H)-acetic acid conjugate"	PEP00829	Tetrapeptide 49	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00379	.	.	"3,5,6,7-tetrahydro-6-octyl-1,3,5,7-tetraoxo-benzo[1,2-c:4,5-c]dipyrrole-2(1H)-acetic acid"	Investigative	.	.	.	.	.
PDC_01784	"Dipeptide 38 - 3,5,6,7-tetrahydro-6-octyl-1,3,5,7-tetraoxo-benzo[1,2-c:4,5-c]dipyrrole-2(1H)-acetic acid conjugate"	PEP00534	Dipeptide 38	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00379	.	.	"3,5,6,7-tetrahydro-6-octyl-1,3,5,7-tetraoxo-benzo[1,2-c:4,5-c]dipyrrole-2(1H)-acetic acid"	Investigative	.	.	.	.	.
PDC_01785	XASXQSL - Leurubicin conjugate 1	PEP00332	XASXQSL	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00312	.	.	Leurubicin	Investigative	.	.	.	.	.
PDC_01786	XASXQSL - Leurubicin conjugate 2	PEP00332	XASXQSL	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00312	.	.	Leurubicin	Investigative	.	.	.	.	.
PDC_01787	"FYPAAKG - 1H-Imidazole-2-carboxamide, N-[1-(3-aminopropyl)-5-[[[5-[[[4-[[2-[[[5-[[[5-[[[5-[[[3-[[3-(dimethylamino)propyl]amino]-3-oxopropyl]amino]carbonyl]-1-methyl-1H-pyrrol-3-yl]amino]carbonyl]-1-methyl-1H-pyrrol-3-yl]amino]carbonyl]-1-methyl-1H-pyrrol-3-yl]amino]carbonyl]-1-methyl-1H-imidazol-4-yl]amino]-4-oxobutyl]amino]carbonyl]-1-methyl-1H-pyrrol-3-yl]amino]carbonyl]-1H-pyrrol-3-yl]-1-methyl-4-[[(1-methyl-1H-imidazol-2-yl)carbonyl]amino] conjugate"	PEP00360	FYPAAKG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00325	.	.	"1H-Imidazole-2-carboxamide, N-[1-(3-aminopropyl)-5-[[[5-[[[4-[[2-[[[5-[[[5-[[[5-[[[3-[[3-(dimethylamino)propyl]amino]-3-oxopropyl]amino]carbonyl]-1-methyl-1H-pyrrol-3-yl]amino]carbonyl]-1-methyl-1H-pyrrol-3-yl]amino]carbonyl]-1-methyl-1H-pyrrol-3-yl]amino]carbonyl]-1-methyl-1H-imidazol-4-yl]amino]-4-oxobutyl]amino]carbonyl]-1-methyl-1H-pyrrol-3-yl]amino]carbonyl]-1H-pyrrol-3-yl]-1-methyl-4-[[(1-methyl-1H-imidazol-2-yl)carbonyl]amino]"	Investigative	.	.	.	.	.
PDC_01788	"FYPWMKG - 1H-Imidazole-2-carboxamide, N-[1-(3-aminopropyl)-5-[[[5-[[[4-[[2-[[[5-[[[5-[[[5-[[[3-[[3-(dimethylamino)propyl]amino]-3-oxopropyl]amino]carbonyl]-1-methyl-1H-pyrrol-3-yl]amino]carbonyl]-1-methyl-1H-pyrrol-3-yl]amino]carbonyl]-1-methyl-1H-pyrrol-3-yl]amino]carbonyl]-1-methyl-1H-imidazol-4-yl]amino]-4-oxobutyl]amino]carbonyl]-1-methyl-1H-pyrrol-3-yl]amino]carbonyl]-1H-pyrrol-3-yl]-1-methyl-4-[[(1-methyl-1H-imidazol-2-yl)carbonyl]amino] conjugate"	PEP00361	FYPWMKG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00325	.	.	"1H-Imidazole-2-carboxamide, N-[1-(3-aminopropyl)-5-[[[5-[[[4-[[2-[[[5-[[[5-[[[5-[[[3-[[3-(dimethylamino)propyl]amino]-3-oxopropyl]amino]carbonyl]-1-methyl-1H-pyrrol-3-yl]amino]carbonyl]-1-methyl-1H-pyrrol-3-yl]amino]carbonyl]-1-methyl-1H-pyrrol-3-yl]amino]carbonyl]-1-methyl-1H-imidazol-4-yl]amino]-4-oxobutyl]amino]carbonyl]-1-methyl-1H-pyrrol-3-yl]amino]carbonyl]-1H-pyrrol-3-yl]-1-methyl-4-[[(1-methyl-1H-imidazol-2-yl)carbonyl]amino]"	Investigative	.	.	.	.	.
PDC_01789	XFWSYKLRPG - Protoporphyrin IX conjugate	PEP00362	XFWSYKLRPG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00006	TAR10003	Hematopoietic prostaglandin D synthase (HPGDS)	Protoporphyrin IX	Investigative	.	.	.	.	.
PDC_01790	XHWSYKLRPG - Protoporphyrin IX conjugate	PEP00152	[D-Lys6]-LH-RH	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00146	Undisclosed	DRG00006	TAR10003	Hematopoietic prostaglandin D synthase (HPGDS)	Protoporphyrin IX	Investigative	.	.	.	.	.
PDC_01791	"CKVSVKV - 2-[10,15,20-Tris(4-methylphenyl)-21H,23H-porphin-5-yl]benzenamine conjugate"	PEP00363	CKVSVKV	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00380	.	.	"2-[10,15,20-Tris(4-methylphenyl)-21H,23H-porphin-5-yl]benzenamine"	Investigative	.	.	.	.	.
PDC_01792	"CKVKV - 2-[10,15,20-Tris(4-methylphenyl)-21H,23H-porphin-5-yl]benzenamine conjugate 1"	PEP00364	CKVKV	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00380	.	.	"2-[10,15,20-Tris(4-methylphenyl)-21H,23H-porphin-5-yl]benzenamine"	Investigative	.	.	.	.	.
PDC_01793	"CKVKV - 2-[10,15,20-Tris(4-methylphenyl)-21H,23H-porphin-5-yl]benzenamine conjugate 2"	PEP00364	CKVKV	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00380	.	.	"2-[10,15,20-Tris(4-methylphenyl)-21H,23H-porphin-5-yl]benzenamine"	Investigative	.	.	.	.	.
PDC_01794	XASXQSL - Doxorubicin conjugate 2	PEP00332	XASXQSL	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_01795	Unnatural heptapeptide 1 - Fluorenone-2-carboxylic acid conjugate 1	PEP00999	Unnatural heptapeptide 1	REC99999	Undisclosed	LIN00131	Hexanamide	DRG00313	.	.	9-Fluorenone-2-carboxylic acid	Investigative	.	.	.	.	.
PDC_01796	Unnatural heptapeptide 1 - Fluorenone-2-carboxylic acid conjugate 2	PEP00999	Unnatural heptapeptide 1	REC99999	Undisclosed	LIN00131	Hexanamide	DRG00313	.	.	9-Fluorenone-2-carboxylic acid	Investigative	.	.	.	.	.
PDC_01797	Unnatural heptapeptide 2 - Fluorenone-2-carboxylic acid conjugate	PEP01000	Unnatural heptapeptide 2	REC99999	Undisclosed	LIN00131	Hexanamide	DRG00313	.	.	9-Fluorenone-2-carboxylic acid	Investigative	.	.	.	.	.
PDC_01798	Unnatural heptapeptide 3 - Fluorenone-2-carboxylic acid conjugate	PEP01001	Unnatural heptapeptide 3	REC99999	Undisclosed	LIN00131	Hexanamide	DRG00313	.	.	9-Fluorenone-2-carboxylic acid	Investigative	.	.	.	.	.
PDC_01799	Unnatural heptapeptide 1 - Fluorenone-2-carboxylic acid conjugate 3	PEP00999	Unnatural heptapeptide 1	REC99999	Undisclosed	LIN00131	Hexanamide	DRG00313	.	.	9-Fluorenone-2-carboxylic acid	Investigative	.	.	.	.	.
PDC_01800	Unnatural heptapeptide 4 - Fluorenone-2-carboxylic acid conjugate	PEP01002	Unnatural heptapeptide 4	REC99999	Undisclosed	LIN00131	Hexanamide	DRG00313	.	.	9-Fluorenone-2-carboxylic acid	Investigative	.	.	.	.	.
PDC_01801	Unnatural heptapeptide 1 - 2-Anthraquinonecarboxylic acid conjugate 1	PEP00999	Unnatural heptapeptide 1	REC99999	Undisclosed	LIN00131	Hexanamide	DRG00108	.	.	2-Anthraquinonecarboxylic acid	Investigative	.	.	.	.	.
PDC_01802	Unnatural heptapeptide 1 - 2-Anthraquinonecarboxylic acid conjugate 2	PEP00999	Unnatural heptapeptide 1	REC99999	Undisclosed	LIN00131	Hexanamide	DRG00108	.	.	2-Anthraquinonecarboxylic acid	Investigative	.	.	.	.	.
PDC_01803	Unnatural heptapeptide 2 - 2-Anthraquinonecarboxylic acid conjugate	PEP01000	Unnatural heptapeptide 2	REC99999	Undisclosed	LIN00131	Hexanamide	DRG00108	.	.	2-Anthraquinonecarboxylic acid	Investigative	.	.	.	.	.
PDC_01804	Unnatural heptapeptide 3 - 2-Anthraquinonecarboxylic acid conjugate	PEP01001	Unnatural heptapeptide 3	REC99999	Undisclosed	LIN00131	Hexanamide	DRG00108	.	.	2-Anthraquinonecarboxylic acid	Investigative	.	.	.	.	.
PDC_01805	Unnatural heptapeptide 1 - 2-Anthraquinonecarboxylic acid conjugate 3	PEP00999	Unnatural heptapeptide 1	REC99999	Undisclosed	LIN00131	Hexanamide	DRG00108	.	.	2-Anthraquinonecarboxylic acid	Investigative	.	.	.	.	.
PDC_01806	Unnatural heptapeptide 4 - 9-Acridinecarboxylic acid conjugate 1	PEP01002	Unnatural heptapeptide 4	REC99999	Undisclosed	LIN00131	Hexanamide	DRG00115	.	.	9-Acridinecarboxylic acid	Investigative	.	.	.	.	.
PDC_01807	Unnatural heptapeptide 1 - 9-Acridinecarboxylic acid conjugate 1	PEP00999	Unnatural heptapeptide 1	REC99999	Undisclosed	LIN00131	Hexanamide	DRG00115	.	.	9-Acridinecarboxylic acid	Investigative	.	.	.	.	.
PDC_01808	Unnatural heptapeptide 1 - 9-Acridinecarboxylic acid conjugate 2	PEP00999	Unnatural heptapeptide 1	REC99999	Undisclosed	LIN00131	Hexanamide	DRG00115	.	.	9-Acridinecarboxylic acid	Investigative	.	.	.	.	.
PDC_01809	Unnatural heptapeptide 2 - 9-Acridinecarboxylic acid conjugate	PEP01000	Unnatural heptapeptide 2	REC99999	Undisclosed	LIN00131	Hexanamide	DRG00115	.	.	9-Acridinecarboxylic acid	Investigative	.	.	.	.	.
PDC_01810	Unnatural heptapeptide 3 - 9-Acridinecarboxylic acid conjugate1	PEP01001	Unnatural heptapeptide 3	REC99999	Undisclosed	LIN00131	Hexanamide	DRG00115	.	.	9-Acridinecarboxylic acid	Investigative	.	.	.	.	.
PDC_01811	Unnatural heptapeptide 1 - 9-Acridinecarboxylic acid conjugate 3	PEP00999	Unnatural heptapeptide 1	REC99999	Undisclosed	LIN00131	Hexanamide	DRG00115	.	.	9-Acridinecarboxylic acid	Investigative	.	.	.	.	.
PDC_01812	Unnatural heptapeptide 4 - 9-Acridinecarboxylic acid conjugate 2	PEP01002	Unnatural heptapeptide 4	REC99999	Undisclosed	LIN00131	Hexanamide	DRG00115	.	.	9-Acridinecarboxylic acid	Investigative	.	.	.	.	.
PDC_01813	Unnatural heptapeptide 1 - 9-Acridinecarboxylic acid conjugate 4	PEP00999	Unnatural heptapeptide 1	REC99999	Undisclosed	LIN00131	Hexanamide	DRG00115	.	.	9-Acridinecarboxylic acid	Investigative	.	.	.	.	.
PDC_01814	Unnatural heptapeptide 1 - 9-Acridinecarboxylic acid conjugate 5	PEP00999	Unnatural heptapeptide 1	REC99999	Undisclosed	LIN00131	Hexanamide	DRG00115	.	.	9-Acridinecarboxylic acid	Investigative	.	.	.	.	.
PDC_01815	Unnatural heptapeptide 3 - 9-Acridinecarboxylic acid conjugate 2	PEP01001	Unnatural heptapeptide 3	REC99999	Undisclosed	LIN00131	Hexanamide	DRG00115	.	.	9-Acridinecarboxylic acid	Investigative	.	.	.	.	.
PDC_01816	Unnatural heptapeptide 1 - 9-Acridinecarboxylic acid conjugate 6	PEP00999	Unnatural heptapeptide 1	REC99999	Undisclosed	LIN00131	Hexanamide	DRG00115	.	.	9-Acridinecarboxylic acid	Investigative	.	.	.	.	.
PDC_01817	Unnatural heptapeptide 4 - 9-Acridinecarboxylic acid conjugate 3	PEP01002	Unnatural heptapeptide 4	REC99999	Undisclosed	LIN00131	Hexanamide	DRG00115	.	.	9-Acridinecarboxylic acid	Investigative	.	.	.	.	.
PDC_01818	GSXYSCFWKTCT - Combretastatin A4 conjugate	PEP00365	GSXYSCFWKTCT	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00164	.	.	Combretastatin A4	Investigative	.	.	.	.	.
PDC_01819	GSXYSCFWKTCT - Camptothecin conjugate 1	PEP00365	GSXYSCFWKTCT	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_01820	GSXYSCFWKTCT - Camptothecin conjugate 2	PEP00365	GSXYSCFWKTCT	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_01821	GSXYSCFWKTCT - Camptothecin conjugate 3	PEP00365	GSXYSCFWKTCT	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_01822	GSXYSCFWKTCT - Camptothecin conjugate 4	PEP00365	GSXYSCFWKTCT	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_01823	GSXYSCFWKTCT - Camptothecin conjugate 5	PEP00365	GSXYSCFWKTCT	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_01824	Tetrapeptide 50 - Protoporphyrin IX conjugate	PEP00830	Tetrapeptide 50	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00006	TAR10003	Hematopoietic prostaglandin D synthase (HPGDS)	Protoporphyrin IX	Investigative	.	.	.	.	.
PDC_01825	SV40 nuclear transport signal peptide analog - Protoporphyrin IX conjugate	PEP00769	SV40 nuclear transport signal peptide analog	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00006	TAR10003	Hematopoietic prostaglandin D synthase (HPGDS)	Protoporphyrin IX	Investigative	.	.	.	.	.
PDC_01831	"AGYAG - Ruthenium(2+), bis(2,2-bipyridine-&kappa;N1,&kappa;N1)(dipyrido[3,2-a:2,3-c]phenazine-&kappa;N4,&kappa;N5)-, (OC-6-21) conjugate"	PEP00366	AGYAG	REC99999	Undisclosed	LIN00128	Butyric acid	DRG00381	.	.	"Ruthenium(2+), bis(2,2-bipyridine-&kappa;N1,&kappa;N1)(dipyrido[3,2-a:2,3-c]phenazine-&kappa;N4,&kappa;N5)-, (OC-6-21)"	Investigative	.	.	.	.	.
PDC_01832	"AGKAG - Ruthenium(2+), bis(2,2-bipyridine-&kappa;N1,&kappa;N1)(dipyrido[3,2-a:2,3-c]phenazine-&kappa;N4,&kappa;N5)-, (OC-6-21) conjugate"	PEP00367	AGKAG	REC99999	Undisclosed	LIN00128	Butyric acid	DRG00381	.	.	"Ruthenium(2+), bis(2,2-bipyridine-&kappa;N1,&kappa;N1)(dipyrido[3,2-a:2,3-c]phenazine-&kappa;N4,&kappa;N5)-, (OC-6-21)"	Investigative	.	.	.	.	.
PDC_01833	"AGAAG - Ruthenium(2+), bis(2,2-bipyridine-&kappa;N1,&kappa;N1)(dipyrido[3,2-a:2,3-c]phenazine-&kappa;N4,&kappa;N5)-, (OC-6-21) conjugate"	PEP00368	AGAAG	REC99999	Undisclosed	LIN00128	Butyric acid	DRG00381	.	.	"Ruthenium(2+), bis(2,2-bipyridine-&kappa;N1,&kappa;N1)(dipyrido[3,2-a:2,3-c]phenazine-&kappa;N4,&kappa;N5)-, (OC-6-21)"	Investigative	.	.	.	.	.
PDC_01834	"GAKYKG - Ruthenium(2+), bis(2,2-bipyridine-&kappa;N1,&kappa;N1)(dipyrido[3,2-a:2,3-c]phenazine-&kappa;N4,&kappa;N5)-, (OC-6-21) conjugate"	PEP00369	GAKYKG	REC99999	Undisclosed	LIN00128	Butyric acid	DRG00381	.	.	"Ruthenium(2+), bis(2,2-bipyridine-&kappa;N1,&kappa;N1)(dipyrido[3,2-a:2,3-c]phenazine-&kappa;N4,&kappa;N5)-, (OC-6-21)"	Investigative	.	.	.	.	.
PDC_01835	"ARYRG - Ruthenium(2+), bis(2,2-bipyridine-&kappa;N1,&kappa;N1)(dipyrido[3,2-a:2,3-c]phenazine-&kappa;N4,&kappa;N5)-, (OC-6-21) conjugate"	PEP00370	ARYRG	REC99999	Undisclosed	LIN00128	Butyric acid	DRG00381	.	.	"Ruthenium(2+), bis(2,2-bipyridine-&kappa;N1,&kappa;N1)(dipyrido[3,2-a:2,3-c]phenazine-&kappa;N4,&kappa;N5)-, (OC-6-21)"	Investigative	.	.	.	.	.
PDC_01836	"AKYKG - Ruthenium(2+), bis(2,2-bipyridine-&kappa;N1,&kappa;N1)(dipyrido[3,2-a:2,3-c]phenazine-&kappa;N4,&kappa;N5)-, (OC-6-21) conjugate 1"	PEP00371	AKYKG	REC99999	Undisclosed	LIN00128	Butyric acid	DRG00381	.	.	"Ruthenium(2+), bis(2,2-bipyridine-&kappa;N1,&kappa;N1)(dipyrido[3,2-a:2,3-c]phenazine-&kappa;N4,&kappa;N5)-, (OC-6-21)"	Investigative	.	.	.	.	.
PDC_01837	"AKYKG - Ruthenium(2+), bis(2,2-bipyridine-&kappa;N1,&kappa;N1)(dipyrido[3,2-a:2,3-c]phenazine-&kappa;N4,&kappa;N5)-, (OC-6-21) conjugate 2"	PEP00371	AKYKG	REC99999	Undisclosed	LIN00128	Butyric acid	DRG00381	.	.	"Ruthenium(2+), bis(2,2-bipyridine-&kappa;N1,&kappa;N1)(dipyrido[3,2-a:2,3-c]phenazine-&kappa;N4,&kappa;N5)-, (OC-6-21)"	Investigative	.	.	.	.	.
PDC_01838	"AKSKG - Ruthenium(2+), bis(2,2-bipyridine-&kappa;N1,&kappa;N1)(dipyrido[3,2-a:2,3-c]phenazine-&kappa;N4,&kappa;N5)-, (OC-6-21) conjugate"	PEP00372	AKSKG	REC99999	Undisclosed	LIN00128	Butyric acid	DRG00381	.	.	"Ruthenium(2+), bis(2,2-bipyridine-&kappa;N1,&kappa;N1)(dipyrido[3,2-a:2,3-c]phenazine-&kappa;N4,&kappa;N5)-, (OC-6-21)"	Investigative	.	.	.	.	.
PDC_01839	"AKKKG - Ruthenium(2+), bis(2,2-bipyridine-&kappa;N1,&kappa;N1)(dipyrido[3,2-a:2,3-c]phenazine-&kappa;N4,&kappa;N5)-, (OC-6-21) conjugate"	PEP00373	AKKKG	REC99999	Undisclosed	LIN00128	Butyric acid	DRG00381	.	.	"Ruthenium(2+), bis(2,2-bipyridine-&kappa;N1,&kappa;N1)(dipyrido[3,2-a:2,3-c]phenazine-&kappa;N4,&kappa;N5)-, (OC-6-21)"	Investigative	.	.	.	.	.
PDC_01840	"AKHKG - Ruthenium(2+), bis(2,2-bipyridine-&kappa;N1,&kappa;N1)(dipyrido[3,2-a:2,3-c]phenazine-&kappa;N4,&kappa;N5)-, (OC-6-21) conjugate"	PEP00374	AKHKG	REC99999	Undisclosed	LIN00128	Butyric acid	DRG00381	.	.	"Ruthenium(2+), bis(2,2-bipyridine-&kappa;N1,&kappa;N1)(dipyrido[3,2-a:2,3-c]phenazine-&kappa;N4,&kappa;N5)-, (OC-6-21)"	Investigative	.	.	.	.	.
PDC_01841	"AKEKG - Ruthenium(2+), bis(2,2-bipyridine-&kappa;N1,&kappa;N1)(dipyrido[3,2-a:2,3-c]phenazine-&kappa;N4,&kappa;N5)-, (OC-6-21) conjugate"	PEP00375	AKEKG	REC99999	Undisclosed	LIN00128	Butyric acid	DRG00381	.	.	"Ruthenium(2+), bis(2,2-bipyridine-&kappa;N1,&kappa;N1)(dipyrido[3,2-a:2,3-c]phenazine-&kappa;N4,&kappa;N5)-, (OC-6-21)"	Investigative	.	.	.	.	.
PDC_01842	"AKAKG - Ruthenium(2+), bis(2,2-bipyridine-&kappa;N1,&kappa;N1)(dipyrido[3,2-a:2,3-c]phenazine-&kappa;N4,&kappa;N5)-, (OC-6-21) conjugate"	PEP00376	AKAKG	REC99999	Undisclosed	LIN00128	Butyric acid	DRG00381	.	.	"Ruthenium(2+), bis(2,2-bipyridine-&kappa;N1,&kappa;N1)(dipyrido[3,2-a:2,3-c]phenazine-&kappa;N4,&kappa;N5)-, (OC-6-21)"	Investigative	.	.	.	.	.
PDC_01843	XASXQSL - Doxorubicin conjugate 3	PEP00332	XASXQSL	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_01845	XSSGQSSP - Deacetylvinblastine conjugate	PEP00377	XSSGQSSP	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00184	.	.	Deacetylvinblastine	Investigative	.	.	.	.	.
PDC_01846	XSSGQSP - Deacetylvinblastine conjugate	PEP00378	XSSGQSP	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00184	.	.	Deacetylvinblastine	Investigative	.	.	.	.	.
PDC_01847	XSSGQSG - Deacetylvinblastine conjugate	PEP00379	XSSGQSG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00184	.	.	Deacetylvinblastine	Investigative	.	.	.	.	.
PDC_01848	XSSGQSL - Deacetylvinblastine conjugate	PEP00380	XSSGQSL	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00184	.	.	Deacetylvinblastine	Investigative	.	.	.	.	.
PDC_01849	"Tetrapeptide 51 - 2-[(11aS)-1,3,4,11a-tetrahydro-6-oxo-2H-benzo[b]quinolizin-11(6H)-ylidene]-, (2Z)-acetic acid conjugate"	PEP00831	Tetrapeptide 51	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00382	.	.	"2-[(11aS)-1,3,4,11a-tetrahydro-6-oxo-2H-benzo[b]quinolizin-11(6H)-ylidene]-, (2Z)-acetic acid"	Investigative	.	.	.	.	.
PDC_01850	"Tripeptide 106 - 2-[(11aS)-1,3,4,11a-tetrahydro-6-oxo-2H-benzo[b]quinolizin-11(6H)-ylidene]-, (2Z)-acetic acid conjugate"	PEP00966	Tripeptide 106	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00382	.	.	"2-[(11aS)-1,3,4,11a-tetrahydro-6-oxo-2H-benzo[b]quinolizin-11(6H)-ylidene]-, (2Z)-acetic acid"	Investigative	.	.	.	.	.
PDC_01851	"Dipeptide 42 - 2-[(11aS)-1,3,4,11a-tetrahydro-6-oxo-2H-benzo[b]quinolizin-11(6H)-ylidene]-, (2Z)-acetic acid conjugate"	PEP00538	Dipeptide 42	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00382	.	.	"2-[(11aS)-1,3,4,11a-tetrahydro-6-oxo-2H-benzo[b]quinolizin-11(6H)-ylidene]-, (2Z)-acetic acid"	Investigative	.	.	.	.	.
PDC_01852	"Tripeptide 107 - 2-[(11aS)-1,3,4,11a-tetrahydro-6-oxo-2H-benzo[b]quinolizin-11(6H)-ylidene]-, (2Z)-acetic acid conjugate"	PEP00967	Tripeptide 107	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00382	.	.	"2-[(11aS)-1,3,4,11a-tetrahydro-6-oxo-2H-benzo[b]quinolizin-11(6H)-ylidene]-, (2Z)-acetic acid"	Investigative	.	.	.	.	.
PDC_01853	"Dipeptide 43 - 2-[(11aS)-1,3,4,11a-tetrahydro-6-oxo-2H-benzo[b]quinolizin-11(6H)-ylidene]-, (2Z)-acetic acid conjugate"	PEP00539	Dipeptide 43	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00382	.	.	"2-[(11aS)-1,3,4,11a-tetrahydro-6-oxo-2H-benzo[b]quinolizin-11(6H)-ylidene]-, (2Z)-acetic acid"	Investigative	.	.	.	.	.
PDC_01854	"Dipeptide 44 - 2-[(11aS)-1,3,4,11a-tetrahydro-6-oxo-2H-benzo[b]quinolizin-11(6H)-ylidene]-, (2Z)-acetic acid conjugate"	PEP00540	Dipeptide 44	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00382	.	.	"2-[(11aS)-1,3,4,11a-tetrahydro-6-oxo-2H-benzo[b]quinolizin-11(6H)-ylidene]-, (2Z)-acetic acid"	Investigative	.	.	.	.	.
PDC_01855	"Tetrapeptide 52 - 2-[(3S)-2,3-dihydro-3-methyl-1-oxo-4(1H)-isoquinolinylidene]-, methyl ester, (2Z)-acetic acid conjugate"	PEP00832	Tetrapeptide 52	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00383	.	.	"2-[(3S)-2,3-dihydro-3-methyl-1-oxo-4(1H)-isoquinolinylidene]-, methyl ester, (2Z)-acetic acid"	Investigative	.	.	.	.	.
PDC_01856	"Tripeptide 107 - 2-[(3S)-2,3-dihydro-3-methyl-1-oxo-4(1H)-isoquinolinylidene]-, methyl ester, (2Z)-acetic acid conjugate"	PEP00967	Tripeptide 107	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00383	.	.	"2-[(3S)-2,3-dihydro-3-methyl-1-oxo-4(1H)-isoquinolinylidene]-, methyl ester, (2Z)-acetic acid"	Investigative	.	.	.	.	.
PDC_01857	"Dipeptide 45 - 2-[(3S)-2,3-dihydro-3-methyl-1-oxo-4(1H)-isoquinolinylidene]-, methyl ester, (2Z)-acetic acid conjugate"	PEP00541	Dipeptide 45	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00383	.	.	"2-[(3S)-2,3-dihydro-3-methyl-1-oxo-4(1H)-isoquinolinylidene]-, methyl ester, (2Z)-acetic acid"	Investigative	.	.	.	.	.
PDC_01858	"XKTRTRS - 3,6-Diamino-9(10H)-acridinone conjugate"	PEP00381	XKTRTRS	REC99999	Undisclosed	LIN00144	&szlig;-alanine	DRG00384	.	.	"3,6-Diamino-9(10H)-acridinone"	Investigative	.	.	.	.	.
PDC_01859	"XFRHR - 3,6-Diamino-9(10H)-acridinone conjugate"	PEP00382	XFRHR	REC99999	Undisclosed	LIN00144	&szlig;-alanine	DRG00384	.	.	"3,6-Diamino-9(10H)-acridinone"	Investigative	.	.	.	.	.
PDC_01860	"XKRSR - 3,6-Diamino-9(10H)-acridinone conjugate"	PEP00383	XKRSR	REC99999	Undisclosed	LIN00144	&szlig;-alanine	DRG00384	.	.	"3,6-Diamino-9(10H)-acridinone"	Investigative	.	.	.	.	.
PDC_01861	"XRKKV - 3,6-Diamino-9(10H)-acridinone conjugate"	PEP00384	XRKKV	REC99999	Undisclosed	LIN00144	&szlig;-alanine	DRG00384	.	.	"3,6-Diamino-9(10H)-acridinone"	Investigative	.	.	.	.	.
PDC_01862	XASXQSL - Doxorubicin conjugate 4	PEP00332	XASXQSL	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_01863	XASXQSL - Doxorubicin conjugate 5	PEP00332	XASXQSL	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_01864	XASXQSL - Doxorubicin conjugate 6	PEP00332	XASXQSL	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_01865	XASXQSL - Doxorubicin conjugate 7	PEP00332	XASXQSL	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_01866	XASXQSL - Doxorubicin conjugate 8	PEP00332	XASXQSL	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_01867	"Bombesin receptor ligand peptide 1 - 4-Azido-2,3,5,6-tetrafluorobenzoic acid conjugate"	PEP00469	Bombesin receptor ligand peptide 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00292	.	.	"4-Azido-2,3,5,6-tetrafluorobenzoic acid"	Investigative	.	.	.	.	.
PDC_01868	"Bombesin receptor ligand peptide 2 - 4-Azido-2,3,5,6-tetrafluorobenzoic acid conjugate"	PEP00470	Bombesin receptor ligand peptide 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00292	.	.	"4-Azido-2,3,5,6-tetrafluorobenzoic acid"	Investigative	.	.	.	.	.
PDC_01869	"Bombesin receptor ligand peptide 3 - 4-Azido-2,3,5,6-tetrafluorobenzoic acid conjugate"	PEP00471	Bombesin receptor ligand peptide 3	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00292	.	.	"4-Azido-2,3,5,6-tetrafluorobenzoic acid"	Investigative	.	.	.	.	.
PDC_01870	"Somatostatin receptor ligand peptide 1 - 4-Azido-2,3,5,6-tetrafluorobenzoic acid conjugate"	PEP00766	Somatostatin receptor ligand peptide 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00292	.	.	"4-Azido-2,3,5,6-tetrafluorobenzoic acid"	Investigative	.	.	.	.	.
PDC_01871	"Somatostatin receptor ligand peptide 2 - 4-Azido-2,3,5,6-tetrafluorobenzoic acid conjugate"	PEP00767	Somatostatin receptor ligand peptide 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00292	.	.	"4-Azido-2,3,5,6-tetrafluorobenzoic acid"	Investigative	.	.	.	.	.
PDC_01872	"Tripeptide 90 - 2,6-Dimethoxy-1,4-benzoquinone conjugate"	PEP00950	Tripeptide 90	REC99999	Undisclosed	LIN00085	Acetic acid	DRG00311	.	.	"2,6-Dimethoxyquinone"	Investigative	.	.	.	.	.
PDC_01873	"Tripeptide 91 - 2,6-Dimethoxy-1,4-benzoquinone conjugate"	PEP00951	Tripeptide 91	REC99999	Undisclosed	LIN00085	Acetic acid	DRG00311	.	.	"2,6-Dimethoxyquinone"	Investigative	.	.	.	.	.
PDC_01874	"Tripeptide 108 - 2,6-Dimethoxy-1,4-benzoquinone conjugate"	PEP00968	Tripeptide 108	REC99999	Undisclosed	LIN00085	Acetic acid	DRG00311	.	.	"2,6-Dimethoxyquinone"	Investigative	.	.	.	.	.
PDC_01875	"Tripeptide 93 - 2,6-Dimethoxy-1,4-benzoquinone conjugate"	PEP00953	Tripeptide 93	REC99999	Undisclosed	LIN00085	Acetic acid	DRG00311	.	.	"2,6-Dimethoxyquinone"	Investigative	.	.	.	.	.
PDC_01876	Tripeptide 93 - Chlorambucil conjugate 1	PEP00953	Tripeptide 93	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00002	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Chlorambucil	Investigative	.	.	.	.	.
PDC_01877	Tripeptide 93 - Chlorambucil conjugate 2	PEP00953	Tripeptide 93	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00002	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Chlorambucil	Investigative	.	.	.	.	.
PDC_01878	Dipeptide 46 - Chlorambucil conjugate	PEP00542	Dipeptide 46	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00002	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Chlorambucil	Investigative	.	.	.	.	.
PDC_01879	"Tripeptide 109 - 2,6-Dimethoxy-1,4-benzoquinone conjugate"	PEP00969	Tripeptide 109	REC99999	Undisclosed	LIN00085	Acetic acid	DRG00311	.	.	"2,6-Dimethoxyquinone"	Investigative	.	.	.	.	.
PDC_01880	PASXQSL - Doxorubicin conjugate	PEP00385	PASXQSL	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_01881	KASXQSL - Doxorubicin conjugate	PEP00386	KASXQSL	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_01882	XASYQSL - Doxorubicin conjugate 1	PEP00387	XASYQSL	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_01883	XASYQSL - Doxorubicin conjugate 2	PEP00387	XASYQSL	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_01884	KASYQSL - Doxorubicin conjugate	PEP00388	KASYQSL	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_01885	XASXQSL - Doxorubicin conjugate 9	PEP00332	XASXQSL	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_01886	XASXQSL - Doxorubicin conjugate 10	PEP00332	XASXQSL	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_01887	XASXQSL - Doxorubicin conjugate 11	PEP00332	XASXQSL	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_01888	XYQSSSL - Doxorubicin conjugate	PEP00389	XYQSSSL	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_01889	KYQSSSL - Doxorubicin conjugate	PEP00390	KYQSSSL	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_01890	ANKASYQSSL - Doxorubicin conjugate	PEP00391	ANKASYQSSL	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_01891	ANKASYQSSSL - Doxorubicin conjugate	PEP00392	ANKASYQSSSL	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_01892	ANKASYQSASL - Doxorubicin conjugate	PEP00393	ANKASYQSASL	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_01893	Amphipathic signal-nuclear localization peptide combination - Porfirin derivative conjugate 1	PEP00422	Amphipathic signal-nuclear localization peptide combination	REC99999	Undisclosed	LIN00122	Mercaptoacetic acid	DRG00376	.	.	Porfirin derivative	Investigative	.	.	.	.	.
PDC_01894	Amphipathic signal-nuclear localization peptide combination - Porfirin derivative conjugate 2	PEP00422	Amphipathic signal-nuclear localization peptide combination	REC99999	Undisclosed	LIN00122	Mercaptoacetic acid	DRG00376	.	.	Porfirin derivative	Investigative	.	.	.	.	.
PDC_01895	Partially truncated AP-1-like peptide 1 - Anthraquinone derivative conjugate	PEP00710	Partially truncated AP-1-like peptide 1	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00385	.	.	Anthraquinone derivative	Investigative	.	.	.	.	.
PDC_01896	Partially truncated AP-1-like peptide 2 - Anthraquinone derivative conjugate	PEP00711	Partially truncated AP-1-like peptide 2	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00385	.	.	Anthraquinone derivative	Investigative	.	.	.	.	.
PDC_01897	Partially truncated AP-1-like peptide 3 - Anthraquinone derivative conjugate	PEP00712	Partially truncated AP-1-like peptide 3	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00385	.	.	Anthraquinone derivative	Investigative	.	.	.	.	.
PDC_01898	Partially truncated AP-1-like peptide 4 - Anthraquinone derivative conjugate	PEP00713	Partially truncated AP-1-like peptide 4	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00385	.	.	Anthraquinone derivative	Investigative	.	.	.	.	.
PDC_01899	Partially truncated AP-1-like peptide 5 - Anthraquinone derivative conjugate	PEP00714	Partially truncated AP-1-like peptide 5	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00385	.	.	Anthraquinone derivative	Investigative	.	.	.	.	.
PDC_01900	Partially truncated AP-1-like peptide 6 - Anthraquinone derivative conjugate	PEP00715	Partially truncated AP-1-like peptide 6	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00385	.	.	Anthraquinone derivative	Investigative	.	.	.	.	.
PDC_01901	Partially truncated AP-1-like peptide 7 - Anthraquinone derivative conjugate	PEP00716	Partially truncated AP-1-like peptide 7	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00385	.	.	Anthraquinone derivative	Investigative	.	.	.	.	.
PDC_01902	Partially truncated AP-1-like peptide 8 - Anthraquinone derivative conjugate	PEP00717	Partially truncated AP-1-like peptide 8	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00385	.	.	Anthraquinone derivative	Investigative	.	.	.	.	.
PDC_01903	Oligoglycin 1 - Camptothecin conjugate 1	PEP00667	Oligoglycin 1	REC99999	Undisclosed	LIN00145	Propyl	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_01904	Oligoglycin 2 - Camptothecin conjugate 3	PEP00668	Oligoglycin 2	REC99999	Undisclosed	LIN00145	Propyl	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_01905	Oligoglycin 3 - Camptothecin conjugate 5	PEP00669	Oligoglycin 3	REC99999	Undisclosed	LIN00145	Propyl	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_01906	Oligoglycin 4 - Camptothecin conjugate 7	PEP00670	Oligoglycin 4	REC99999	Undisclosed	LIN00145	Propyl	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_01907	Oligoglycin 1 - Camptothecin conjugate 2	PEP00667	Oligoglycin 1	REC99999	Undisclosed	LIN00145	Propyl	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_01908	Oligoglycin 2 - Camptothecin conjugate 4	PEP00668	Oligoglycin 2	REC99999	Undisclosed	LIN00145	Propyl	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_01909	Oligoglycin 3 - Camptothecin conjugate 6	PEP00669	Oligoglycin 3	REC99999	Undisclosed	LIN00145	Propyl	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_01910	Oligoglycin 4 - Camptothecin conjugate 8	PEP00670	Oligoglycin 4	REC99999	Undisclosed	LIN00145	Propyl	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_01911	Tetrapeptide 53 - Camptothecin conjugate	PEP00833	Tetrapeptide 53	REC99999	Undisclosed	LIN00145	Propyl	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_01912	Tetrapeptide 54 - Irofulven derivative conjugate	PEP00834	Tetrapeptide 54	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00386	.	.	Irofulven derivative	Investigative	.	.	.	.	.
PDC_01913	Tetrapeptide 55 - Irofulven derivative conjugate	PEP00835	Tetrapeptide 55	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00386	.	.	Irofulven derivative	Investigative	.	.	.	.	.
PDC_01914	Tetrapeptide 56 - Irofulven derivative conjugate	PEP00836	Tetrapeptide 56	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00386	.	.	Irofulven derivative	Investigative	.	.	.	.	.
PDC_01915	Tetrapeptide 57 - Irofulven derivative conjugate	PEP00837	Tetrapeptide 57	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00386	.	.	Irofulven derivative	Investigative	.	.	.	.	.
PDC_01916	Tripeptide 110 - 9-(Phenylamino)-4-acridinecarboxylic acid conjugate	PEP00970	Tripeptide 110	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00387	.	.	9-(Phenylamino)-4-acridinecarboxylic acid	Investigative	.	.	.	.	.
PDC_01917	Tripeptide 111 - 9-(Phenylamino)-4-acridinecarboxylic acid conjugate	PEP00971	Tripeptide 111	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00387	.	.	9-(Phenylamino)-4-acridinecarboxylic acid	Investigative	.	.	.	.	.
PDC_01918	Tripeptide 112 - 9-(Phenylamino)-4-acridinecarboxylic acid conjugate	PEP00972	Tripeptide 112	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00387	.	.	9-(Phenylamino)-4-acridinecarboxylic acid	Investigative	.	.	.	.	.
PDC_01919	"Vasoactive intestinal peptide (VIP) fragment - 3H-Indolium, 5-carboxy-2-[7-[1,3-dihydro-3,3-dimethyl-1-(4-sulfobutyl)-2H-indol-2-ylidene]-1,3,5-heptatrien-1-yl]-3,3-dimethyl-1-(4-sulfobutyl)-, inner salt conjugate"	PEP01003	Vasoactive intestinal peptide (VIP) fragment	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00388	.	.	"3H-Indolium, 5-carboxy-2-[7-[1,3-dihydro-3,3-dimethyl-1-(4-sulfobutyl)-2H-indol-2-ylidene]-1,3,5-heptatrien-1-yl]-3,3-dimethyl-1-(4-sulfobutyl)-, inner salt"	Investigative	.	.	.	.	.
PDC_01920	"Model peptide 2 - 3H-Indolium, 5-carboxy-2-[7-[1,3-dihydro-3,3-dimethyl-1-(4-sulfobutyl)-2H-indol-2-ylidene]-1,3,5-heptatrien-1-yl]-3,3-dimethyl-1-(4-sulfobutyl)-, inner salt conjugate"	PEP00637	Model peptide 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00388	.	.	"3H-Indolium, 5-carboxy-2-[7-[1,3-dihydro-3,3-dimethyl-1-(4-sulfobutyl)-2H-indol-2-ylidene]-1,3,5-heptatrien-1-yl]-3,3-dimethyl-1-(4-sulfobutyl)-, inner salt"	Investigative	.	.	.	.	.
PDC_01921	Lysosomally degradable peptide 1 - Tetraphenyl porphyrin (TPP) derivative conjugate 1	PEP00616	Lysosomally degradable peptide 1	REC99999	Undisclosed	LIN00131	Hexanamide	DRG00389	.	.	Tetraphenyl porphyrin (TPP) derivative	Investigative	.	.	.	.	.
PDC_01922	Lysosomally degradable peptide 2 - Tetraphenyl porphyrin (TPP) derivative conjugate	PEP00617	Lysosomally degradable peptide 2	REC99999	Undisclosed	LIN00131	Hexanamide	DRG00389	.	.	Tetraphenyl porphyrin (TPP) derivative	Investigative	.	.	.	.	.
PDC_01923	Lysosomally degradable peptide 1 - Tetraphenyl porphyrin (TPP) derivative conjugate 2	PEP00616	Lysosomally degradable peptide 1	REC99999	Undisclosed	LIN00131	Hexanamide	DRG00389	.	.	Tetraphenyl porphyrin (TPP) derivative	Investigative	.	.	.	.	.
PDC_01924	Lysosomally degradable peptide 3 - Tetraphenyl porphyrin (TPP) derivative conjugate 3	PEP00618	Lysosomally degradable peptide 3	REC99999	Undisclosed	LIN00131	Hexanamide	DRG00389	.	.	Tetraphenyl porphyrin (TPP) derivative	Investigative	.	.	.	.	.
PDC_01925	Lysosomally degradable peptide 4 - Tetraphenyl porphyrin (TPP) derivative conjugate 5	PEP00619	Lysosomally degradable peptide 4	REC99999	Undisclosed	LIN00131	Hexanamide	DRG00389	.	.	Tetraphenyl porphyrin (TPP) derivative	Investigative	.	.	.	.	.
PDC_01926	Lysosomally degradable peptide 3 - Tetraphenyl porphyrin (TPP) derivative conjugate 4	PEP00618	Lysosomally degradable peptide 3	REC99999	Undisclosed	LIN00131	Hexanamide	DRG00389	.	.	Tetraphenyl porphyrin (TPP) derivative	Investigative	.	.	.	.	.
PDC_01927	Lysosomally degradable peptide 4 - Tetraphenyl porphyrin (TPP) derivative conjugate 6	PEP00619	Lysosomally degradable peptide 4	REC99999	Undisclosed	LIN00131	Hexanamide	DRG00389	.	.	Tetraphenyl porphyrin (TPP) derivative	Investigative	.	.	.	.	.
PDC_01928	Tripeptide 113 - Tetraphenyl porphyrin (TPP) derivative conjugate	PEP00973	Tripeptide 113	REC99999	Undisclosed	LIN00131	Hexanamide	DRG00389	.	.	Tetraphenyl porphyrin (TPP) derivative	Investigative	.	.	.	.	.
PDC_01929	Tripeptide 114 - Tetraphenyl porphyrin (TPP) derivative conjugate	PEP00974	Tripeptide 114	REC99999	Undisclosed	LIN00131	Hexanamide	DRG00389	.	.	Tetraphenyl porphyrin (TPP) derivative	Investigative	.	.	.	.	.
PDC_01930	XHWSYKLRPG - Doxorubicin conjugate	PEP00152	[D-Lys6]-LH-RH	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00033	Glutaric acid	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_01931	GCMGAPC - Geranylgeraniol conjugate	PEP00394	GCMGAPC	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00161	.	.	Geranylgeraniol	Investigative	.	.	.	.	.
PDC_01932	GCFGLPC - Geranylgeraniol conjugate	PEP00395	GCFGLPC	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00161	.	.	Geranylgeraniol	Investigative	.	.	.	.	.
PDC_01933	GCAGLPC - Geranylgeraniol conjugate	PEP00396	GCAGLPC	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00161	.	.	Geranylgeraniol	Investigative	.	.	.	.	.
PDC_01934	GCFGLP - Palmitic acid conjugate 1	PEP00397	GCFGLP	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00069	TAR10045	Fatty acid-binding protein 5 (FABP5)	Palmitic acid	Investigative	.	.	.	.	.
PDC_01936	GCFGLP - Palmitic acid conjugate	PEP00397	GCFGLP	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00069	TAR10045	Fatty acid-binding protein 5 (FABP5)	Palmitic acid	Investigative	.	.	.	.	.
PDC_01937	GCAGLP - Palmitic acid conjugate	PEP00398	GCAGLP	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00069	TAR10045	Fatty acid-binding protein 5 (FABP5)	Palmitic acid	Investigative	.	.	.	.	.
PDC_01938	GCFGL - Palmitic acid conjugate 1	PEP00399	GCFGL	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00069	TAR10045	Fatty acid-binding protein 5 (FABP5)	Palmitic acid	Investigative	.	.	.	.	.
PDC_01939	GCAGL - Palmitic acid conjugate 1	PEP00400	GCAGL	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00069	TAR10045	Fatty acid-binding protein 5 (FABP5)	Palmitic acid	Investigative	.	.	.	.	.
PDC_01940	GCMGA - Palmitic acid conjugate	PEP00401	GCMGA	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00069	TAR10045	Fatty acid-binding protein 5 (FABP5)	Palmitic acid	Investigative	.	.	.	.	.
PDC_01941	GCFGL - Palmitic acid conjugate	PEP00399	GCFGL	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00069	TAR10045	Fatty acid-binding protein 5 (FABP5)	Palmitic acid	Investigative	.	.	.	.	.
PDC_01942	GCAGL - Palmitic acid conjugate	PEP00400	GCAGL	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00069	TAR10045	Fatty acid-binding protein 5 (FABP5)	Palmitic acid	Investigative	.	.	.	.	.
PDC_01943	GCMGLP - Palmitic acid conjugate 1	PEP00402	GCMGLP	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00069	TAR10045	Fatty acid-binding protein 5 (FABP5)	Palmitic acid	Investigative	.	.	.	.	.
PDC_01944	GCMGLP - Palmitic acid conjugate	PEP00402	GCMGLP	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00069	TAR10045	Fatty acid-binding protein 5 (FABP5)	Palmitic acid	Investigative	.	.	.	.	.
PDC_01945	GCMGL - Palmitic acid conjugate 1	PEP00403	GCMGL	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00069	TAR10045	Fatty acid-binding protein 5 (FABP5)	Palmitic acid	Investigative	.	.	.	.	.
PDC_01946	GCMGLPC - Geranylgeraniol conjugate	PEP00404	GCMGLPC	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00161	.	.	Geranylgeraniol	Investigative	.	.	.	.	.
PDC_01947	GCMGL - Palmitic acid conjugate	PEP00403	GCMGL	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00069	TAR10045	Fatty acid-binding protein 5 (FABP5)	Palmitic acid	Investigative	.	.	.	.	.
PDC_01948	GGCPC - Palmitic acid conjugate	PEP00405	GGCPC	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00069	TAR10045	Fatty acid-binding protein 5 (FABP5)	Palmitic acid	Investigative	.	.	.	.	.
PDC_01949	Tetrapeptide 58 - Palmitic acid conjugate	PEP00838	Tetrapeptide 58	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00069	TAR10045	Fatty acid-binding protein 5 (FABP5)	Palmitic acid	Investigative	.	.	.	.	.
PDC_01950	Tripeptide 115 - Palmitic acid conjugate	PEP00975	Tripeptide 115	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00069	TAR10045	Fatty acid-binding protein 5 (FABP5)	Palmitic acid	Investigative	.	.	.	.	.
PDC_01951	DGDXG - Methyl 3-(aminocarbonyl)-5-nitrobenzoate conjugate	PEP00406	DGDXG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00390	.	.	Methyl 3-(aminocarbonyl)-5-nitrobenzoate	Investigative	.	.	.	.	.
PDC_01952	"DGEXG - 25,26,27,28-tetrabutoxy-pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(25),3,5,7(28),9,11,13(27),15,17,19(26),21,23-dodecaene-5,11,17,23-tetracarboxylic acid conjugate 1"	PEP00407	DGEXG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00391	.	.	"25,26,27,28-tetrabutoxy-pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(25),3,5,7(28),9,11,13(27),15,17,19(26),21,23-dodecaene-5,11,17,23-tetracarboxylic acid"	Investigative	.	.	.	.	.
PDC_01953	DGEXG - Methyl 3-(aminocarbonyl)-5-nitrobenzoate conjugate	PEP00407	DGEXG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00390	.	.	Methyl 3-(aminocarbonyl)-5-nitrobenzoate	Investigative	.	.	.	.	.
PDC_01954	"DGEXG - 25,26,27,28-tetrabutoxy-pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(25),3,5,7(28),9,11,13(27),15,17,19(26),21,23-dodecaene-5,11,17,23-tetracarboxylic acid conjugate 2"	PEP00407	DGEXG	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00391	.	.	"25,26,27,28-tetrabutoxy-pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(25),3,5,7(28),9,11,13(27),15,17,19(26),21,23-dodecaene-5,11,17,23-tetracarboxylic acid"	Investigative	.	.	.	.	.
PDC_01955	Tripeptide 116 - 4-Carboxybenzenesulfonamide conjugate	PEP00976	Tripeptide 116	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00093	TAR10038	Carbonic anhydrase I (CA-I)	4-Carboxybenzenesulfonamide	Investigative	.	.	.	.	.
PDC_01956	Tetrapeptide 59 - 4-Carboxybenzenesulfonamide conjugate 1	PEP00839	Tetrapeptide 59	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00093	TAR10038	Carbonic anhydrase I (CA-I)	4-Carboxybenzenesulfonamide	Investigative	.	.	.	.	.
PDC_01957	Tetrapeptide 60 - 4-Carboxybenzenesulfonamide conjugate 1	PEP00840	Tetrapeptide 60	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00093	TAR10038	Carbonic anhydrase I (CA-I)	4-Carboxybenzenesulfonamide	Investigative	.	.	.	.	.
PDC_01958	Tetrapeptide 60 - 4-Carboxybenzenesulfonamide conjugate 2	PEP00840	Tetrapeptide 60	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00093	TAR10038	Carbonic anhydrase I (CA-I)	4-Carboxybenzenesulfonamide	Investigative	.	.	.	.	.
PDC_01959	Tetrapeptide 60 - 4-Carboxybenzenesulfonamide conjugate 3	PEP00840	Tetrapeptide 60	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00093	TAR10038	Carbonic anhydrase I (CA-I)	4-Carboxybenzenesulfonamide	Investigative	.	.	.	.	.
PDC_01960	Tetrapeptide 61 - 4-Carboxybenzenesulfonamide conjugate	PEP00841	Tetrapeptide 61	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00093	TAR10038	Carbonic anhydrase I (CA-I)	4-Carboxybenzenesulfonamide	Investigative	.	.	.	.	.
PDC_01961	Tetrapeptide 62 - 4-Carboxybenzenesulfonamide conjugate	PEP00842	Tetrapeptide 62	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00093	TAR10038	Carbonic anhydrase I (CA-I)	4-Carboxybenzenesulfonamide	Investigative	.	.	.	.	.
PDC_01962	Tetrapeptide 63 - 4-Carboxybenzenesulfonamide conjugate	PEP00843	Tetrapeptide 63	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00093	TAR10038	Carbonic anhydrase I (CA-I)	4-Carboxybenzenesulfonamide	Investigative	.	.	.	.	.
PDC_01963	Tetrapeptide 64 - 4-Carboxybenzenesulfonamide conjugate	PEP00844	Tetrapeptide 64	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00093	TAR10038	Carbonic anhydrase I (CA-I)	4-Carboxybenzenesulfonamide	Investigative	.	.	.	.	.
PDC_01964	Tetrapeptide 65 - 4-Carboxybenzenesulfonamide conjugate	PEP00845	Tetrapeptide 65	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00093	TAR10038	Carbonic anhydrase I (CA-I)	4-Carboxybenzenesulfonamide	Investigative	.	.	.	.	.
PDC_01965	Tetrapeptide 66 - 4-Carboxybenzenesulfonamide conjugate 5	PEP00846	Tetrapeptide 66	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00093	TAR10038	Carbonic anhydrase I (CA-I)	4-Carboxybenzenesulfonamide	Investigative	.	.	.	.	.
PDC_01966	Tetrapeptide 66 - 4-Carboxybenzenesulfonamide conjugate 6	PEP00846	Tetrapeptide 66	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00093	TAR10038	Carbonic anhydrase I (CA-I)	4-Carboxybenzenesulfonamide	Investigative	.	.	.	.	.
PDC_01967	Tetrapeptide 67 - 4-Carboxybenzenesulfonamide conjugate	PEP00847	Tetrapeptide 67	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00093	TAR10038	Carbonic anhydrase I (CA-I)	4-Carboxybenzenesulfonamide	Investigative	.	.	.	.	.
PDC_01968	Tetrapeptide 68 - 4-Carboxybenzenesulfonamide conjugate	PEP00848	Tetrapeptide 68	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00093	TAR10038	Carbonic anhydrase I (CA-I)	4-Carboxybenzenesulfonamide	Investigative	.	.	.	.	.
PDC_01969	Tetrapeptide 60 - 4-Carboxybenzenesulfonamide conjugate 4	PEP00840	Tetrapeptide 60	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00093	TAR10038	Carbonic anhydrase I (CA-I)	4-Carboxybenzenesulfonamide	Investigative	.	.	.	.	.
PDC_01970	Tetrapeptide 59 - 4-Carboxybenzenesulfonamide conjugate 2	PEP00839	Tetrapeptide 59	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00093	TAR10038	Carbonic anhydrase I (CA-I)	4-Carboxybenzenesulfonamide	Investigative	.	.	.	.	.
PDC_01971	Tetrapeptide 69 - 4-Carboxybenzenesulfonamide conjugate	PEP00849	Tetrapeptide 69	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00093	TAR10038	Carbonic anhydrase I (CA-I)	4-Carboxybenzenesulfonamide	Investigative	.	.	.	.	.
PDC_01972	Tetrapeptide 70 - 4-Carboxybenzenesulfonamide conjugate	PEP00850	Tetrapeptide 70	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00093	TAR10038	Carbonic anhydrase I (CA-I)	4-Carboxybenzenesulfonamide	Investigative	.	.	.	.	.
PDC_01973	Tetrapeptide 71 - 4-Carboxybenzenesulfonamide conjugate	PEP00851	Tetrapeptide 71	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00093	TAR10038	Carbonic anhydrase I (CA-I)	4-Carboxybenzenesulfonamide	Investigative	.	.	.	.	.
PDC_01974	Tetrapeptide 72 - 4-Carboxybenzenesulfonamide conjugate	PEP00852	Tetrapeptide 72	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00093	TAR10038	Carbonic anhydrase I (CA-I)	4-Carboxybenzenesulfonamide	Investigative	.	.	.	.	.
PDC_01975	Tetrapeptide 73 - 4-Carboxybenzenesulfonamide conjugate	PEP00853	Tetrapeptide 73	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00093	TAR10038	Carbonic anhydrase I (CA-I)	4-Carboxybenzenesulfonamide	Investigative	.	.	.	.	.
PDC_01976	Tetrapeptide 74 - 4-Carboxybenzenesulfonamide conjugate	PEP00854	Tetrapeptide 74	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00093	TAR10038	Carbonic anhydrase I (CA-I)	4-Carboxybenzenesulfonamide	Investigative	.	.	.	.	.
PDC_01977	Tripeptide 117 - 4-Carboxybenzenesulfonamide conjugate 1	PEP00977	Tripeptide 117	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00093	TAR10038	Carbonic anhydrase I (CA-I)	4-Carboxybenzenesulfonamide	Investigative	.	.	.	.	.
PDC_01978	Tripeptide 118 - 4-Carboxybenzenesulfonamide conjugate 1	PEP00978	Tripeptide 118	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00093	TAR10038	Carbonic anhydrase I (CA-I)	4-Carboxybenzenesulfonamide	Investigative	.	.	.	.	.
PDC_01979	Tripeptide 118 - 4-Carboxybenzenesulfonamide conjugate 2	PEP00978	Tripeptide 118	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00093	TAR10038	Carbonic anhydrase I (CA-I)	4-Carboxybenzenesulfonamide	Investigative	.	.	.	.	.
PDC_01980	Tripeptide 118 - 4-Carboxybenzenesulfonamide conjugate 3	PEP00978	Tripeptide 118	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00093	TAR10038	Carbonic anhydrase I (CA-I)	4-Carboxybenzenesulfonamide	Investigative	.	.	.	.	.
PDC_01981	Tripeptide 119 - 4-Carboxybenzenesulfonamide conjugate	PEP00979	Tripeptide 119	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00093	TAR10038	Carbonic anhydrase I (CA-I)	4-Carboxybenzenesulfonamide	Investigative	.	.	.	.	.
PDC_01982	Tripeptide 118 - 4-Carboxybenzenesulfonamide conjugate 4	PEP00978	Tripeptide 118	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00093	TAR10038	Carbonic anhydrase I (CA-I)	4-Carboxybenzenesulfonamide	Investigative	.	.	.	.	.
PDC_01983	Tripeptide 117 - 4-Carboxybenzenesulfonamide conjugate 2	PEP00977	Tripeptide 117	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00093	TAR10038	Carbonic anhydrase I (CA-I)	4-Carboxybenzenesulfonamide	Investigative	.	.	.	.	.
PDC_01984	Tripeptide 120 - 4-Carboxybenzenesulfonamide conjugate	PEP00980	Tripeptide 120	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00093	TAR10038	Carbonic anhydrase I (CA-I)	4-Carboxybenzenesulfonamide	Investigative	.	.	.	.	.
PDC_01985	Tripeptide 121 - 4-Carboxybenzenesulfonamide conjugate	PEP00981	Tripeptide 121	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00093	TAR10038	Carbonic anhydrase I (CA-I)	4-Carboxybenzenesulfonamide	Investigative	.	.	.	.	.
PDC_01986	Tripeptide 122 - 4-Carboxybenzenesulfonamide conjugate	PEP00982	Tripeptide 122	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00093	TAR10038	Carbonic anhydrase I (CA-I)	4-Carboxybenzenesulfonamide	Investigative	.	.	.	.	.
PDC_01987	Tripeptide 117 - 4-Carboxybenzenesulfonamide conjugate 3	PEP00977	Tripeptide 117	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00093	TAR10038	Carbonic anhydrase I (CA-I)	4-Carboxybenzenesulfonamide	Investigative	.	.	.	.	.
PDC_01988	Tripeptide 123 - 4-Carboxybenzenesulfonamide conjugate	PEP00983	Tripeptide 123	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00093	TAR10038	Carbonic anhydrase I (CA-I)	4-Carboxybenzenesulfonamide	Investigative	.	.	.	.	.
PDC_01989	Tripeptide 124 - 4-Carboxybenzenesulfonamide conjugate	PEP00984	Tripeptide 124	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00093	TAR10038	Carbonic anhydrase I (CA-I)	4-Carboxybenzenesulfonamide	Investigative	.	.	.	.	.
PDC_01990	Tripeptide 125 - 4-Carboxybenzenesulfonamide conjugate	PEP00985	Tripeptide 125	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00093	TAR10038	Carbonic anhydrase I (CA-I)	4-Carboxybenzenesulfonamide	Investigative	.	.	.	.	.
PDC_01991	Tripeptide 118 - 4-Carboxybenzenesulfonamide conjugate 5	PEP00978	Tripeptide 118	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00093	TAR10038	Carbonic anhydrase I (CA-I)	4-Carboxybenzenesulfonamide	Investigative	.	.	.	.	.
PDC_01992	Tripeptide 126 - 4-Carboxybenzenesulfonamide conjugate	PEP00986	Tripeptide 126	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00093	TAR10038	Carbonic anhydrase I (CA-I)	4-Carboxybenzenesulfonamide	Investigative	.	.	.	.	.
PDC_01993	Tripeptide 127 - 4-Carboxybenzenesulfonamide conjugate	PEP00987	Tripeptide 127	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00093	TAR10038	Carbonic anhydrase I (CA-I)	4-Carboxybenzenesulfonamide	Investigative	.	.	.	.	.
PDC_01994	Tripeptide 128 - 4-Carboxybenzenesulfonamide conjugate	PEP00988	Tripeptide 128	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00093	TAR10038	Carbonic anhydrase I (CA-I)	4-Carboxybenzenesulfonamide	Investigative	.	.	.	.	.
PDC_01995	Tripeptide 129 - 4-Carboxybenzenesulfonamide conjugate	PEP00989	Tripeptide 129	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00093	TAR10038	Carbonic anhydrase I (CA-I)	4-Carboxybenzenesulfonamide	Investigative	.	.	.	.	.
PDC_01996	Tripeptide 130 - 4-Carboxybenzenesulfonamide conjugate	PEP00990	Tripeptide 130	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00093	TAR10038	Carbonic anhydrase I (CA-I)	4-Carboxybenzenesulfonamide	Investigative	.	.	.	.	.
PDC_01997	Tripeptide 131 - 4-Carboxybenzenesulfonamide conjugate	PEP00991	Tripeptide 131	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00093	TAR10038	Carbonic anhydrase I (CA-I)	4-Carboxybenzenesulfonamide	Investigative	.	.	.	.	.
PDC_01998	Tetrapeptide 53 - Doxorubicin conjugate	PEP00833	Tetrapeptide 53	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_01999	Tuftsin - &Beta;-N-Acetylglucosamine conjugate 2	PEP00178	TKPR	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00102	.	.	&Beta;-N-Acetylglucosamine	Investigative	.	.	.	.	.
PDC_02000	Tuftsin - &Beta;-N-Acetylglucosamine conjugate 3	PEP00178	TKPR	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00102	.	.	&Beta;-N-Acetylglucosamine	Investigative	.	.	.	.	.
PDC_02001	Tuftsin - &Beta;-N-Acetylglucosamine conjugate 1	PEP00993	Tuftsin	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00102	.	.	&Beta;-N-Acetylglucosamine	Investigative	.	.	.	.	.
PDC_02002	Tuftsin - &Beta;-N-Acetylglucosamine conjugate 4	PEP00178	TKPR	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00102	.	.	&Beta;-N-Acetylglucosamine	Investigative	.	.	.	.	.
PDC_02003	TTNYT - 60-Fulleroacetic acid conjugate	PEP00408	TTNYT	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00392	.	.	60-Fulleroacetic acid	Investigative	.	.	.	.	.
PDC_02004	ARHTDYK - Pyridoxine conjugate	PEP00409	ARHTDYK	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00070	TAR10043	Aromatic-L-amino-acid decarboxylase (DDC)	Pyridoxine	Investigative	.	.	.	.	.
PDC_02005	"Diprolyl-oligoalanin 1 - [3S-(3&alpha;,5&alpha;,9&beta;,11a&beta;)]-5-acetyloctahydro-7-oxo-3,6-Methano-1H,3H-pyrrolo[2,1-c][1,4,7]thiadiazonine-9-carboxylic acid conjugate 1"	PEP00543	Diprolyl-oligoalanin 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00393	.	.	"[3S-(3&alpha;,5&alpha;,9&beta;,11a&beta;)]-5-acetyloctahydro-7-oxo-3,6-Methano-1H,3H-pyrrolo[2,1-c][1,4,7]thiadiazonine-9-carboxylic acid"	Investigative	.	.	.	.	.
PDC_02006	"Diprolyl-oligoalanin 2 - [3S-(3&alpha;,5&alpha;,9&beta;,11a&beta;)]-5-acetyloctahydro-7-oxo-3,6-Methano-1H,3H-pyrrolo[2,1-c][1,4,7]thiadiazonine-9-carboxylic acid conjugate 1"	PEP00544	Diprolyl-oligoalanin 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00393	.	.	"[3S-(3&alpha;,5&alpha;,9&beta;,11a&beta;)]-5-acetyloctahydro-7-oxo-3,6-Methano-1H,3H-pyrrolo[2,1-c][1,4,7]thiadiazonine-9-carboxylic acid"	Investigative	.	.	.	.	.
PDC_02007	"Diprolyl-oligoalanin 3 - [3S-(3&alpha;,5&alpha;,9&beta;,11a&beta;)]-5-acetyloctahydro-7-oxo-3,6-Methano-1H,3H-pyrrolo[2,1-c][1,4,7]thiadiazonine-9-carboxylic acid conjugate 1"	PEP00545	Diprolyl-oligoalanin 3	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00393	.	.	"[3S-(3&alpha;,5&alpha;,9&beta;,11a&beta;)]-5-acetyloctahydro-7-oxo-3,6-Methano-1H,3H-pyrrolo[2,1-c][1,4,7]thiadiazonine-9-carboxylic acid"	Investigative	.	.	.	.	.
PDC_02008	"Diprolyl-oligoalanin 4 - [3S-(3&alpha;,5&alpha;,9&beta;,11a&beta;)]-5-acetyloctahydro-7-oxo-3,6-Methano-1H,3H-pyrrolo[2,1-c][1,4,7]thiadiazonine-9-carboxylic acid conjugate"	PEP00546	Diprolyl-oligoalanin 4	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00393	.	.	"[3S-(3&alpha;,5&alpha;,9&beta;,11a&beta;)]-5-acetyloctahydro-7-oxo-3,6-Methano-1H,3H-pyrrolo[2,1-c][1,4,7]thiadiazonine-9-carboxylic acid"	Investigative	.	.	.	.	.
PDC_02009	"Diprolyl-oligoalanin 5 - [3S-(3&alpha;,5&alpha;,9&beta;,11a&beta;)]-5-acetyloctahydro-7-oxo-3,6-Methano-1H,3H-pyrrolo[2,1-c][1,4,7]thiadiazonine-9-carboxylic acid conjugate"	PEP00547	Diprolyl-oligoalanin 5	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00393	.	.	"[3S-(3&alpha;,5&alpha;,9&beta;,11a&beta;)]-5-acetyloctahydro-7-oxo-3,6-Methano-1H,3H-pyrrolo[2,1-c][1,4,7]thiadiazonine-9-carboxylic acid"	Investigative	.	.	.	.	.
PDC_02010	"Diprolyl-oligoalanin 6 - [3S-(3&alpha;,5&alpha;,9&beta;,11a&beta;)]-5-acetyloctahydro-7-oxo-3,6-Methano-1H,3H-pyrrolo[2,1-c][1,4,7]thiadiazonine-9-carboxylic acid conjugate"	PEP00548	Diprolyl-oligoalanin 6	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00393	.	.	"[3S-(3&alpha;,5&alpha;,9&beta;,11a&beta;)]-5-acetyloctahydro-7-oxo-3,6-Methano-1H,3H-pyrrolo[2,1-c][1,4,7]thiadiazonine-9-carboxylic acid"	Investigative	.	.	.	.	.
PDC_02011	"Diprolyl-oligoalanin 1 - [3S-(3&alpha;,5&alpha;,9&beta;,11a&beta;)]-5-acetyloctahydro-7-oxo-3,6-Methano-1H,3H-pyrrolo[2,1-c][1,4,7]thiadiazonine-9-carboxylic acid conjugate"	PEP00543	Diprolyl-oligoalanin 1	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00393	.	.	"[3S-(3&alpha;,5&alpha;,9&beta;,11a&beta;)]-5-acetyloctahydro-7-oxo-3,6-Methano-1H,3H-pyrrolo[2,1-c][1,4,7]thiadiazonine-9-carboxylic acid"	Investigative	.	.	.	.	.
PDC_02012	"Diprolyl-oligoalanin 7 - [3S-(3&alpha;,5&alpha;,9&beta;,11a&beta;)]-5-acetyloctahydro-7-oxo-3,6-Methano-1H,3H-pyrrolo[2,1-c][1,4,7]thiadiazonine-9-carboxylic acid conjugate"	PEP00549	Diprolyl-oligoalanin 7	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00393	.	.	"[3S-(3&alpha;,5&alpha;,9&beta;,11a&beta;)]-5-acetyloctahydro-7-oxo-3,6-Methano-1H,3H-pyrrolo[2,1-c][1,4,7]thiadiazonine-9-carboxylic acid"	Investigative	.	.	.	.	.
PDC_02013	"Diprolyl-oligoalanin 3 - [3S-(3&alpha;,5&alpha;,9&beta;,11a&beta;)]-5-acetyloctahydro-7-oxo-3,6-Methano-1H,3H-pyrrolo[2,1-c][1,4,7]thiadiazonine-9-carboxylic acid conjugate"	PEP00545	Diprolyl-oligoalanin 3	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00393	.	.	"[3S-(3&alpha;,5&alpha;,9&beta;,11a&beta;)]-5-acetyloctahydro-7-oxo-3,6-Methano-1H,3H-pyrrolo[2,1-c][1,4,7]thiadiazonine-9-carboxylic acid"	Investigative	.	.	.	.	.
PDC_02014	"Diprolyl-oligoalanin 2 - [3S-(3&alpha;,5&alpha;,9&beta;,11a&beta;)]-5-acetyloctahydro-7-oxo-3,6-Methano-1H,3H-pyrrolo[2,1-c][1,4,7]thiadiazonine-9-carboxylic acid conjugate"	PEP00544	Diprolyl-oligoalanin 2	REC99999	Undisclosed	LIN00146	Undisclosed	DRG00393	.	.	"[3S-(3&alpha;,5&alpha;,9&beta;,11a&beta;)]-5-acetyloctahydro-7-oxo-3,6-Methano-1H,3H-pyrrolo[2,1-c][1,4,7]thiadiazonine-9-carboxylic acid"	Investigative	.	.	.	.	.
PDC_02015	Piflufolastat F-18	PEP00030	PSMA-617	REC00042	Glutamate carboxypeptidase 2 (FOLH1)	LIN00087	Amide bond	DRG00048	TAR10052	Human Deoxyribonucleic acid (hDNA)	Fluorine-18	Investigative	.	.	.	.	.
PDC_02016	Sinomenine-synovial homing peptide conjugate (L)	PEP01006	Synovial homing peptide (L)	REC99999	Undisclosed	LIN00026	Aminocaproic acid	DRG00394	.	.	Sinomenine	Investigative	.	.	.	.	.
PDC_02017	Sinomenine-synovial homing peptide conjugate (C)	PEP01007	Synovial homing peptide (C)	REC99999	Undisclosed	LIN00026	Aminocaproic acid	DRG00394	.	.	Sinomenine	Investigative	.	.	.	.	.
PDC_02018	MPD1	PEP00063	DEVD	REC00035	Caspase-3 (CASP3)	LIN00087	Amide bond	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_02019	TATE-SS-Ama	PEP00109	3-Tyr-Octreotate	REC00031	Somatostatin receptor type 1 (SSTR1)	LIN00091	Disulfide bond	DRG00395	.	.	Amatoxins	Investigative	.	.	.	.	.
PDC_02020	TATE-VCit-Ama	PEP00109	3-Tyr-Octreotate	REC00031	Somatostatin receptor type 1 (SSTR1)	LIN00005	Val-Cit	DRG00395	.	.	Amatoxins	Investigative	.	.	.	.	.
PDC_02021	TATE-PEG-Ama	PEP00109	3-Tyr-Octreotate	REC00031	Somatostatin receptor type 1 (SSTR1)	LIN00147	PEG<sub>8</sub>	DRG00395	.	.	Amatoxins	Investigative	.	.	.	.	.
PDC_02022	Ac-ECM	PEP01008	CM8	REC99999	Undisclosed	LIN00087	Amide bond	DRG00396	.	.	5-Amino-2-Methyl-N-[(1r)-1-Naphthalen-1-Ylethyl]benzamide	Investigative	.	.	.	.	.
PDC_02023	Ac-EMC	PEP01009	CM7	REC99999	Undisclosed	LIN00087	Amide bond	DRG00396	.	.	5-Amino-2-Methyl-N-[(1r)-1-Naphthalen-1-Ylethyl]benzamide	Investigative	.	.	.	.	.
PDC_02024	Ac-ELRGG	PEP01010	ELRGG	REC99999	Undisclosed	LIN00087	Amide bond	DRG00396	.	.	5-Amino-2-Methyl-N-[(1r)-1-Naphthalen-1-Ylethyl]benzamide	Investigative	.	.	.	.	.
PDC_02025	CPT-Cyclo-GCGPep Conjugate 1	PEP01011	Cyclo-GCGPep1	REC99999	Undisclosed	LIN00148	2-Disulfaneylethyl hydrogen carbonate	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_02026	CPT-Cyclo-GCGPep Conjugate 2	PEP01011	Cyclo-GCGPep1	REC99999	Undisclosed	LIN00149	3-Disulfaneylpropanoic acid	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_02027	CPT-Cyclo-GCGPep Conjugate 3	PEP01011	Cyclo-GCGPep1	REC99999	Undisclosed	LIN00031	"4-yl 6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanoate"	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_02028	BPP-PTX	PEP01012	BPP	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00012	TAR10017	Microtubule (MT)	Paclitaxel	Investigative	.	.	.	.	.
PDC_02029	LLC2B-Mal-DM1	PEP01013	LLC2B	REC99999	Undisclosed	LIN00078	Thiol group (SH) and maleimide	DRG00031	TAR10017	Microtubule (MT)	Mertansine DM1	Investigative	.	.	.	.	.
PDC_02030	LLC2B-SS-DM1	PEP01013	LLC2B	REC99999	Undisclosed	LIN00012	3-Disulfanylpropanoic Acid	DRG00031	TAR10017	Microtubule (MT)	Mertansine DM1	Investigative	.	.	.	.	.
PDC_02031	cCPP-CBT	PEP01014	CWRWRKWRWR	REC99999	Undisclosed	LIN00033	Glutaric acid	DRG00397	TAR10017	Microtubule (MT)	Cabazitaxel	Investigative	.	.	.	.	.
PDC_02032	TP1-cCPP-CBT	PEP01015	TP1-cCPP	REC99999	Undisclosed	LIN00033	Glutaric acid	DRG00397	TAR10017	Microtubule (MT)	Cabazitaxel	Investigative	.	.	.	.	.
PDC_02033	TP2-cCPP-CBT	PEP01016	TP2-cCPP	REC99999	Undisclosed	LIN00033	Glutaric acid	DRG00397	TAR10017	Microtubule (MT)	Cabazitaxel	Investigative	.	.	.	.	.
PDC_02034	R-C12-1	PEP01017	R-C12	REC99999	Undisclosed	LIN00033	Glutaric acid	DRG00398	.	.	D-Glucose	Investigative	.	.	.	.	.
PDC_02035	R-C12-2	PEP01017	R-C12	REC99999	Undisclosed	LIN00033	Glutaric acid	DRG00398	.	.	D-Glucose	Investigative	.	.	.	.	.
PDC_02036	R-C12-3	PEP01017	R-C12	REC99999	Undisclosed	LIN00033	Glutaric acid	DRG00398	.	.	D-Glucose	Investigative	.	.	.	.	.
PDC_02037	R-C12-4	PEP01017	R-C12	REC99999	Undisclosed	LIN00033	Glutaric acid	DRG00398	.	.	D-Glucose	Investigative	.	.	.	.	.
PDC_02038	R-C12-5	PEP01017	R-C12	REC99999	Undisclosed	LIN00033	Glutaric acid	DRG00398	.	.	D-Glucose	Investigative	.	.	.	.	.
PDC_02039	R-C12-6	PEP01017	R-C12	REC99999	Undisclosed	LIN00033	Glutaric acid	DRG00398	.	.	D-Glucose	Investigative	.	.	.	.	.
PDC_02040	R-C12-7	PEP01017	R-C12	REC99999	Undisclosed	LIN00033	Glutaric acid	DRG00398	.	.	D-Glucose	Investigative	.	.	.	.	.
PDC_02041	FA-P3-PTX	PEP00624	Lytic peptides 5	REC99999	Undisclosed	LIN00031	"4-yl 6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanoate"	DRG00012	TAR10017	Microtubule (MT)	Paclitaxel	Investigative	.	.	.	.	.
PDC_02042	FA-P7-PTX	PEP00625	Lytic peptides 6	REC99999	Undisclosed	LIN00031	"4-yl 6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanoate"	DRG00012	TAR10017	Microtubule (MT)	Paclitaxel	Investigative	.	.	.	.	.
PDC_02043	SAL2-Aoa-Thr-OH	PEP01020	Threonine	REC99999	Undisclosed	LIN00019	Aminooxyacetic acid	DRG00189	.	.	N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide	Investigative	.	.	.	.	.
PDC_02044	SAL2-Aoa-Gly-OH	PEP01021	Glycine	REC99999	Undisclosed	LIN00019	Aminooxyacetic acid	DRG00189	.	.	N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide	Investigative	.	.	.	.	.
PDC_02045	Boc-Phe-Pro-AZT	PEP00532	Dipeptide 36	REC00065	HIV-1 protease	LIN00096	Ester bond	DRG00296	.	.	Zidovudine	Investigative	.	.	.	.	.
PDC_02046	Fmoc-Phe-Pro-AZT	PEP00532	Dipeptide 36	REC00065	HIV-1 protease	LIN00096	Ester bond	DRG00296	.	.	Zidovudine	Investigative	.	.	.	.	.
PDC_02047	Z-Phe-Pro-AZT	PEP00532	Dipeptide 36	REC00065	HIV-1 protease	LIN00096	Ester bond	DRG00296	.	.	Zidovudine	Investigative	.	.	.	.	.
PDC_02048	Qnc-Phe-Pro-AZT	PEP00532	Dipeptide 36	REC00065	HIV-1 protease	LIN00096	Ester bond	DRG00296	.	.	Zidovudine	Investigative	.	.	.	.	.
PDC_02049	Boc-Asn-Phe-Pro-AZT	PEP00942	Tripeptide 82	REC00065	HIV-1 protease	LIN00096	Ester bond	DRG00296	.	.	Zidovudine	Investigative	.	.	.	.	.
PDC_02050	Fmoc-Asn-Phe-Pro-AZT	PEP00942	Tripeptide 82	REC00065	HIV-1 protease	LIN00096	Ester bond	DRG00296	.	.	Zidovudine	Investigative	.	.	.	.	.
PDC_02051	Qnc-Asn-Phe-Pro-AZT	PEP00942	Tripeptide 82	REC00065	HIV-1 protease	LIN00096	Ester bond	DRG00296	.	.	Zidovudine	Investigative	.	.	.	.	.
PDC_02052	Boc-Phe-Pro-Ile-AZT	PEP00944	Tripeptide 84	REC00065	HIV-1 protease	LIN00096	Ester bond	DRG00296	.	.	Zidovudine	Investigative	.	.	.	.	.
PDC_02053	NIA-D1	PEP01063	Hydrophilic PD-L1 antagonist D1	REC99999	Undisclosed	LIN00154	Matrix metalloproteinase-2 (MMP-2) peptide substrate (PLGLAG)	DRG00402	.	.	2-(2-Nitro-1H-imidazol-1-yl)acetic acid	Investigative	.	.	.	.	.
PDC_02054	IBF-HYD-GFFpY	PEP01064	GFFpY	REC99999	Undisclosed	LIN00155	4-Hydroxybenzoic acid	DRG00075	TAR10020	Prostaglandin G/H synthase 2 (PTGS2)	Ibuprofen	Investigative	.	.	.	.	.
PDC_02055	FLCpOH-TP10-7-NH<sub>2</sub>	PEP01065	TP10-7-NH<sub>2</sub>	REC99999	Undisclosed	LIN00033	Glutaric acid	DRG00403	TAR10058	Lanosterol 14-alpha demethylase (ERG11)	Fluconazole	Investigative	.	.	.	.	.
PDC_02056	FLCpOH-TP10-NH<sub>2</sub>	PEP01066	TP10-NH<sub>2</sub>	REC99999	Undisclosed	LIN00033	Glutaric acid	DRG00403	TAR10058	Lanosterol 14-alpha demethylase (ERG11)	Fluconazole	Investigative	.	.	.	.	.
PDC_02057	FLCpOH-LFcinB(2-11)-NH<sub>2</sub>	PEP01067	LFcinB(2-11)-NH<sub>2</sub>	REC99999	Undisclosed	LIN00033	Glutaric acid	DRG00403	TAR10058	Lanosterol 14-alpha demethylase (ERG11)	Fluconazole	Investigative	.	.	.	.	.
PDC_02058	"FLCpOH-LFcinB[Nle<sup>1,11</sup>]-NH<sub>2</sub>"	PEP01068	"LFcinB[Nle<sup>1,11</sup>]-NH<sub>2</sub>"	REC99999	Undisclosed	LIN00033	Glutaric acid	DRG00403	TAR10058	Lanosterol 14-alpha demethylase (ERG11)	Fluconazole	Investigative	.	.	.	.	.
PDC_02059	FLCpOH-HLopt2-NH<sub>2</sub>	PEP01069	HLopt2-NH<sub>2</sub>	REC99999	Undisclosed	LIN00033	Glutaric acid	DRG00403	TAR10058	Lanosterol 14-alpha demethylase (ERG11)	Fluconazole	Investigative	.	.	.	.	.
PDC_02060	BTM19-1	PEP01070	Poly-aspartic acid polypeptide	REC99999	Undisclosed	LIN00156	2 Polyethylene glycol and leucine-arginine sequence	DRG00404	.	.	13-Aminomethyl-15-thiomatrin	Investigative	.	.	.	.	.
PDC_02061	BTM19-2	PEP01070	Poly-aspartic acid polypeptide	REC99999	Undisclosed	LIN00157	3 Polyethylene glycol and leucine-arginine sequence	DRG00404	.	.	13-Aminomethyl-15-thiomatrin	Investigative	.	.	.	.	.
PDC_02062	BTM19-3	PEP01070	Poly-aspartic acid polypeptide	REC99999	Undisclosed	LIN00158	4 Polyethylene glycol and leucine-arginine sequence	DRG00404	.	.	13-Aminomethyl-15-thiomatrin	Investigative	.	.	.	.	.
PDC_02063	SynB3PVGLIGPTX	PEP01071	SynB3	REC99999	Undisclosed	LIN00159	PVGLIG	DRG00012	TAR10017	Microtubule (MT)	Paclitaxel	Investigative	.	.	.	.	.
PDC_02064	LTP-1	PEP01072	TTP-CPP	REC99999	Undisclosed	LIN00091	Disulfide bond	DRG00012	TAR10017	Microtubule (MT)	Paclitaxel	Investigative	.	.	.	.	.
PDC_02065	GOXG1	PEP00152	[D-Lys6]-LH-RH	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00160	Boc-aminooxy acetic acid	DRG00013	TAR10009	Ribonucleoside-diphosphate reductase subunit M2 (RRM2)	Gemcitabine	Investigative	.	.	.	.	.
PDC_02066	GOXG2	PEP00152	[D-Lys6]-LH-RH	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00160	Boc-aminooxy acetic acid	DRG00013	TAR10009	Ribonucleoside-diphosphate reductase subunit M2 (RRM2)	Gemcitabine	Investigative	.	.	.	.	.
PDC_02067	GN4OXG	PEP00152	[D-Lys6]-LH-RH	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00160	Boc-aminooxy acetic acid	DRG00013	TAR10009	Ribonucleoside-diphosphate reductase subunit M2 (RRM2)	Gemcitabine	Investigative	.	.	.	.	.
PDC_02068	CRB-FFFK-cyclen	PEP01073	FFFK	REC99999	Undisclosed	LIN00087	Amide bond	DRG00002	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Chlorambucil	Investigative	.	.	.	.	.
PDC_02069	PDC-DOX2	PEP01074	KIGLFRWR	REC99999	Undisclosed	LIN00161	Adipic acid	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_02070	HA@PDC-DOX2	PEP01074	KIGLFRWR	REC99999	Undisclosed	LIN00161	Adipic acid	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_02071	SMAC-FRRG-DOX	PEP01075	SMAC-FRRG	REC99999	Undisclosed	LIN00087	Amide bond	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_02072	R-L-HCPT	PEP01076	R-lycosin-I	REC99999	Undisclosed	LIN00033	Glutaric acid	DRG00405	TAR10008	DNA topoisomerase 1 (TOP1)	10-Hydroxycamptothecin	Investigative	.	.	.	.	.
PDC_02073	diCPTiRGD	PEP01077	iRGD	REC99999	Undisclosed	LIN00039	2-(Disulfanyl)ethyl hydrogen carbonate	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_02074	FDPC-NPs	PEP01074	KIGLFRWR	REC99999	Undisclosed	LIN00003	Succinic Acid	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_02075	DPV1047-E-Dox	PEP01079	DPV1047	REC99999	Undisclosed	LIN00162	"4-(3-((2-Amino-2-carboxyethyl)thio)-2,5-dioxopyrrolidin-1-yl)butanoic acid"	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_02076	DPV10-E-Dox	PEP01080	DPV10	REC99999	Undisclosed	LIN00162	"4-(3-((2-Amino-2-carboxyethyl)thio)-2,5-dioxopyrrolidin-1-yl)butanoic acid"	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_02077	DPV7b-E-Dox	PEP01081	DPV7b	REC99999	Undisclosed	LIN00162	"4-(3-((2-Amino-2-carboxyethyl)thio)-2,5-dioxopyrrolidin-1-yl)butanoic acid"	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_02078	DPV10-TE-Dox	PEP01080	DPV10	REC99999	Undisclosed	LIN00163	S-(carboxymethyl)cysteine	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_02079	DPV7b-TE-Dox	PEP01081	DPV7b	REC99999	Undisclosed	LIN00163	S-(carboxymethyl)cysteine	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_02080	DPV1047-A-Dox	PEP01079	DPV1047	REC99999	Undisclosed	LIN00162	"4-(3-((2-Amino-2-carboxyethyl)thio)-2,5-dioxopyrrolidin-1-yl)butanoic acid"	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_02081	DPV10-A-Dox	PEP01080	DPV10	REC99999	Undisclosed	LIN00162	"4-(3-((2-Amino-2-carboxyethyl)thio)-2,5-dioxopyrrolidin-1-yl)butanoic acid"	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_02082	[C<sup>15</sup>]-NPY-Dauno-MBS	PEP01082	[C<sup>15</sup>]-NPY	REC99999	Undisclosed	LIN00164	"2-(4-(3-mercapto-2,5-dioxopyrrolidin-1-yl)phenyl)acetic acid"	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_02083	[C<sup>15</sup>]-NPY-Dauno-HYD	PEP01082	[C<sup>15</sup>]-NPY	REC99999	Undisclosed	LIN00164	"2-(4-(3-mercapto-2,5-dioxopyrrolidin-1-yl)phenyl)acetic acid"	DRG00010	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Daunorubicin	Investigative	.	.	.	.	.
PDC_02084	[C<sup>15</sup>]-NPY-Doxo-MBS	PEP01082	[C<sup>15</sup>]-NPY	REC99999	Undisclosed	LIN00164	"2-(4-(3-mercapto-2,5-dioxopyrrolidin-1-yl)phenyl)acetic acid"	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_02085	NT4-MON ether	PEP01083	Branched neurotensin (NT4)	REC99999	Undisclosed	LIN00165	Ether bond	DRG00406	TAR10059	Kinesin-like protein KIF11 (KIF11)	Monastrol	Investigative	.	.	.	.	.
PDC_02086	NT4-CA4 ester	PEP01083	Branched neurotensin (NT4)	REC99999	Undisclosed	LIN00096	Ester bond	DRG00407	TAR10017	Microtubule (MT)	Combretastatin A4	Investigative	.	.	.	.	.
PDC_02087	NT4-CA4 ether	PEP01083	Branched neurotensin (NT4)	REC99999	Undisclosed	LIN00165	Ether bond	DRG00407	TAR10017	Microtubule (MT)	Combretastatin A4	Investigative	.	.	.	.	.
PDC_02088	Octreotide doxorubicin conjugate	PEP00105	Octreotide	REC00031	Somatostatin receptor type 1 (SSTR1)	LIN00019	Aminooxyacetic acid	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_02089	NH<sub>2</sub>-GCKSYR-PC4AP-DOX	PEP01084	GCKSYR	REC99999	Undisclosed	LIN00166	PC4AP	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_02090	Ac-NH-GCASYR-PC4AP-DOX	PEP01085	GCASYR	REC99999	Undisclosed	LIN00166	PC4AP	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_02091	NH<sub>2</sub>-GCASYR-PC4AP-DOX	PEP01085	GCASYR	REC99999	Undisclosed	LIN00166	PC4AP	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_02092	Ac-NH-GCKSYR-PC4AP-DOX	PEP01084	GCKSYR	REC99999	Undisclosed	LIN00166	PC4AP	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_02093	NH<sub>2</sub>-GRDWQSCMEYKTHN-PC4AP-DOX	PEP01086	GRDWQSCMEYKTHN	REC99999	Undisclosed	LIN00166	PC4AP	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_02094	NH<sub>2</sub>-GCKSYR-C4AP-DOX	PEP01084	GCKSYR	REC99999	Undisclosed	LIN00167	C4AP	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_02095	Ac-NH-GCASYR-C4AP-DOX	PEP01085	GCASYR	REC99999	Undisclosed	LIN00167	C4AP	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_02096	NH<sub>2</sub>-GCASYR-C4AP-DOX	PEP01085	GCASYR	REC99999	Undisclosed	LIN00167	C4AP	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_02097	Ac-NH-GCKSYR-C4AP-DOX	PEP01084	GCKSYR	REC99999	Undisclosed	LIN00167	C4AP	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_02098	NH<sub>2</sub>-GRDWQSCMEYKTHN-C4AP-DOX	PEP01086	GRDWQSCMEYKTHN	REC99999	Undisclosed	LIN00167	C4AP	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_02099	SN38(10)-CRGDK	PEP01089	CRGDK	REC00001	Neuropilin-1 (NRP1)	LIN00149	3-Disulfaneylpropanoic acid	DRG00018	TAR10008	DNA topoisomerase 1 (TOP1)	7-Ethyl-10-hydroxycamptothecin	Investigative	.	.	.	.	.
PDC_02100	SN38(10)-4-CRGDK	PEP01089	CRGDK	REC00001	Neuropilin-1 (NRP1)	LIN00168	4-(2Disulfaneylethoxy)-4-oxobutanoic acid	DRG00018	TAR10008	DNA topoisomerase 1 (TOP1)	7-Ethyl-10-hydroxycamptothecin	Investigative	.	.	.	.	.
PDC_02101	SN38(10)-5-CRGDK	PEP01089	CRGDK	REC00001	Neuropilin-1 (NRP1)	LIN00169	5-(2-Disulfaneylethoxy)-5-oxopentanoic acid	DRG00018	TAR10008	DNA topoisomerase 1 (TOP1)	7-Ethyl-10-hydroxycamptothecin	Investigative	.	.	.	.	.
PDC_02102	SN38(10)-(Ac)CGVQIRGDK	PEP01088	CGVQIRGDK	REC00001	Neuropilin-1 (NRP1)	LIN00149	3-Disulfaneylpropanoic acid	DRG00018	TAR10008	DNA topoisomerase 1 (TOP1)	7-Ethyl-10-hydroxycamptothecin	Investigative	.	.	.	.	.
PDC_02103	SN38(10)-4-(Ac)CGVQIRGDK	PEP01088	CGVQIRGDK	REC00001	Neuropilin-1 (NRP1)	LIN00168	4-(2Disulfaneylethoxy)-4-oxobutanoic acid	DRG00018	TAR10008	DNA topoisomerase 1 (TOP1)	7-Ethyl-10-hydroxycamptothecin	Investigative	.	.	.	.	.
PDC_02104	SN38(10)-(Ac)CRGDK	PEP01089	CRGDK	REC00001	Neuropilin-1 (NRP1)	LIN00149	3-Disulfaneylpropanoic acid	DRG00018	TAR10008	DNA topoisomerase 1 (TOP1)	7-Ethyl-10-hydroxycamptothecin	Investigative	.	.	.	.	.
PDC_02105	SN38(10)-4-(Ac)CRGDK	PEP01089	CRGDK	REC00001	Neuropilin-1 (NRP1)	LIN00168	4-(2Disulfaneylethoxy)-4-oxobutanoic acid	DRG00018	TAR10008	DNA topoisomerase 1 (TOP1)	7-Ethyl-10-hydroxycamptothecin	Investigative	.	.	.	.	.
PDC_02106	SN38(10)-5-(Ac)CRGDK	PEP01089	CRGDK	REC00001	Neuropilin-1 (NRP1)	LIN00169	5-(2-Disulfaneylethoxy)-5-oxopentanoic acid	DRG00018	TAR10008	DNA topoisomerase 1 (TOP1)	7-Ethyl-10-hydroxycamptothecin	Investigative	.	.	.	.	.
PDC_02107	SN38(10)-CRRGDK	PEP01090	CRRGDK	REC00001	Neuropilin-1 (NRP1)	LIN00149	3-Disulfaneylpropanoic acid	DRG00018	TAR10008	DNA topoisomerase 1 (TOP1)	7-Ethyl-10-hydroxycamptothecin	Investigative	.	.	.	.	.
PDC_02108	SN38(10)-4-CDRGDK	PEP01087	CDRGDK	REC00001	Neuropilin-1 (NRP1)	LIN00168	4-(2Disulfaneylethoxy)-4-oxobutanoic acid	DRG00018	TAR10008	DNA topoisomerase 1 (TOP1)	7-Ethyl-10-hydroxycamptothecin	Investigative	.	.	.	.	.
PDC_02109	SN38(10)-4-(Ac)CDRGDK	PEP01087	CDRGDK	REC00001	Neuropilin-1 (NRP1)	LIN00168	4-(2Disulfaneylethoxy)-4-oxobutanoic acid	DRG00018	TAR10008	DNA topoisomerase 1 (TOP1)	7-Ethyl-10-hydroxycamptothecin	Investigative	.	.	.	.	.
PDC_02110	SN38(10)-(Ac)CDRGDK	PEP01087	CDRGDK	REC00001	Neuropilin-1 (NRP1)	LIN00149	3-Disulfaneylpropanoic acid	DRG00018	TAR10008	DNA topoisomerase 1 (TOP1)	7-Ethyl-10-hydroxycamptothecin	Investigative	.	.	.	.	.
PDC_02111	SN38(20)-4-CRGDK	PEP01089	CRGDK	REC00001	Neuropilin-1 (NRP1)	LIN00168	4-(2Disulfaneylethoxy)-4-oxobutanoic acid	DRG00018	TAR10008	DNA topoisomerase 1 (TOP1)	7-Ethyl-10-hydroxycamptothecin	Investigative	.	.	.	.	.
PDC_02112	SN38(20)-CRGDK	PEP01089	CRGDK	REC00001	Neuropilin-1 (NRP1)	LIN00149	3-Disulfaneylpropanoic acid	DRG00018	TAR10008	DNA topoisomerase 1 (TOP1)	7-Ethyl-10-hydroxycamptothecin	Investigative	.	.	.	.	.
PDC_02113	(MOM)SN38(20)-CRGDK	PEP01089	CRGDK	REC00001	Neuropilin-1 (NRP1)	LIN00149	3-Disulfaneylpropanoic acid	DRG00018	TAR10008	DNA topoisomerase 1 (TOP1)	7-Ethyl-10-hydroxycamptothecin	Investigative	.	.	.	.	.
PDC_02114	(MOM)SN38(20)-(Ac)CRGDK	PEP01089	CRGDK	REC00001	Neuropilin-1 (NRP1)	LIN00149	3-Disulfaneylpropanoic acid	DRG00018	TAR10008	DNA topoisomerase 1 (TOP1)	7-Ethyl-10-hydroxycamptothecin	Investigative	.	.	.	.	.
PDC_02115	(MOM)SN38(20)-(Ac)CGVQIRGDK	PEP01088	CGVQIRGDK	REC00001	Neuropilin-1 (NRP1)	LIN00149	3-Disulfaneylpropanoic acid	DRG00018	TAR10008	DNA topoisomerase 1 (TOP1)	7-Ethyl-10-hydroxycamptothecin	Investigative	.	.	.	.	.
PDC_02116	Pentagastrin-(+)-duocarmycin SA conjugate	PEP01091	Pentagastrin	REC00029	Gastrin-releasing peptide receptor (GRPR)	LIN00087	Amide bond	DRG00045	TAR10016	Human Deoxyribonucleic acid (hDNA)	Duocarmycin Sa	Investigative	.	.	.	.	.
PDC_02117	Peptide 18-4 analog doxorubicin conjugate	PEP01092	Peptide 18-4 analog	REC00009	"Keratin, type II cytoskeletal 1 (KRT1)"	LIN00031	"4-yl 6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanoate"	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_02118	Sal-A6	PEP01093	Peptide A6	REC00024	CD44 antigen (CD44)	LIN00149	3-Disulfaneylpropanoic acid	DRG00408	.	.	Salinomycin	Investigative	.	.	.	.	.
PDC_02119	FB006M-HSA	PEP01094	FB006	REC99999	Undisclosed	LIN00170	2-(2-(2-Aminoethoxy)ethoxy)acetic acid	DRG00409	TAR10061	Human serum albumin	"3-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanoic acid"	Investigative	.	.	.	.	.
PDC_02120	Gefitinib LARLLT conjugate a	PEP00080	D4	REC00005	Pro-epidermal growth factor (EGF)	LIN00003	Succinic Acid	DRG00410	TAR10004	Epidermal growth factor receptor (EGFR)	Gefitinib	Investigative	.	.	.	.	.
PDC_02121	Gefitinib LARLLT conjugate b	PEP00080	D4	REC00005	Pro-epidermal growth factor (EGF)	LIN00033	Glutaric acid	DRG00410	TAR10004	Epidermal growth factor receptor (EGFR)	Gefitinib	Investigative	.	.	.	.	.
PDC_02122	Gefitinib LARLLT conjugate c	PEP00080	D4	REC00005	Pro-epidermal growth factor (EGF)	LIN00161	Adipic acid	DRG00410	TAR10004	Epidermal growth factor receptor (EGFR)	Gefitinib	Investigative	.	.	.	.	.
PDC_02123	Gefitinib LARLLT conjugate d	PEP00080	D4	REC00005	Pro-epidermal growth factor (EGF)	LIN00171	Pimelic acid	DRG00410	TAR10004	Epidermal growth factor receptor (EGFR)	Gefitinib	Investigative	.	.	.	.	.
PDC_02124	Gefitinib LARLLT conjugate e	PEP00080	D4	REC00005	Pro-epidermal growth factor (EGF)	LIN00172	Suberic acid	DRG00410	TAR10004	Epidermal growth factor receptor (EGFR)	Gefitinib	Investigative	.	.	.	.	.
PDC_02125	cyclo[DKP-isoDGR]-PEG<sub>4</sub>-GPLG-PABC-MMAE	PEP01095	cyclo[DKP-isoDGR]	REC00012	Integrin alpha-V (ITGAV)	LIN00173	PEG<sub>4</sub>-GPLG-PABC	DRG00038	TAR10017	Microtubule (MT)	Monomethyl auristatin E	Investigative	.	.	.	.	.
PDC_02126	MLS-HTPP	PEP01096	MLS	REC99999	Undisclosed	LIN00174	"1-Amino-1,5-dioxo-3,9,12,15,18,21,24-heptaoxa-6-azahexacosan-26-oic acid"	DRG00411	.	.	"5-(4-Hydroxy-phenyl)-10,15,20-triphenylporphyrin"	Investigative	.	.	.	.	.
PDC_02127	Peptide 18-4  doxorubicin conjugate 1	PEP00161	Peptide 18-4	REC00009	"Keratin, type II cytoskeletal 1 (KRT1)"	LIN00033	Glutaric acid	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_02128	Peptide 18-4  doxorubicin conjugate 2	PEP00161	Peptide 18-4	REC00009	"Keratin, type II cytoskeletal 1 (KRT1)"	LIN00033	Glutaric acid	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_02129	GPU-201	PEP00122	c(RGDfK)	REC00013	Integrin alpha-V; Integrin beta-3 (ITGAV; ITGB3)	LIN00128	Butyric acid	DRG00412	.	.	Ortho carborane	Investigative	.	.	.	.	.
PDC_02130	BBB1-Lys(BBB1)-(sarcosine)<sub>3</sub>-TATE	PEP00109	3-Tyr-Octreotate	REC00031	Somatostatin receptor type 1 (SSTR1)	LIN00175	(Sarcosine)<sub>3</sub>	DRG00412	.	.	Ortho carborane	Investigative	.	.	.	.	.
PDC_02131	POSS-p18-4-Ce6(PPC)	PEP00161	Peptide 18-4	REC00009	"Keratin, type II cytoskeletal 1 (KRT1)"	LIN00176	POSS	DRG00034	.	.	Chlorin e6	Investigative	.	.	.	.	.
PDC_02132	ANG1009	PEP00162	Angiopep-2	REC00045	Prolow-density lipoprotein receptor-related protein 1; Low-density lipoprotein receptor-related protein 2 (LRP1; LRP2)	LIN00003	Succinic Acid	DRG00413	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Etoposide	Investigative	.	.	.	.	.
PDC_02133	Vancomycin-PEG<sub>3</sub>-TP10	PEP00002	TP10	REC99999	Undisclosed	LIN00069	PEG<sub>3</sub>-Triazole	DRG00097	.	.	Vancomycin	Investigative	.	.	.	.	.
PDC_02134	Vancomycin-PEG<sub>4</sub>-TP10	PEP00002	TP10	REC99999	Undisclosed	LIN00177	PEG<sub>4</sub>-Triazole	DRG00097	.	.	Vancomycin	Investigative	.	.	.	.	.
PDC_02135	FITC-WXEAAYQK(D)FL cyclic peptide conjugate	PEP01097	WXEAAYQK(D)FL cyclic peptide	REC00009	"Keratin, type II cytoskeletal 1 (KRT1)"	LIN00178	&beta;-Alanine	DRG00100	.	.	Fluorescein isothiocyanate	Investigative	.	.	.	.	.
PDC_02136	FITC-WX(D)EAAYQK(D)FL peptide conjugate	PEP01098	WX(D)EAAYQK(D)FL peptide	REC00009	"Keratin, type II cytoskeletal 1 (KRT1)"	LIN00178	&beta;-Alanine	DRG00100	.	.	Fluorescein isothiocyanate	Investigative	.	.	.	.	.
PDC_02137	FITC-WX(D)EAAYQKFL peptide conjugate	PEP01099	WX(D)EAAYQKFL peptide	REC00009	"Keratin, type II cytoskeletal 1 (KRT1)"	LIN00178	&beta;-Alanine	DRG00100	.	.	Fluorescein isothiocyanate	Investigative	.	.	.	.	.
PDC_02138	FITC-WXEAAYQK(D)FL peptide conjugate	PEP01100	WXEAAYQK(D)FL peptide	REC00009	"Keratin, type II cytoskeletal 1 (KRT1)"	LIN00178	&beta;-Alanine	DRG00100	.	.	Fluorescein isothiocyanate	Investigative	.	.	.	.	.
PDC_02139	VivoTag-KK-11	PEP01101	D-aa KK-11	REC99999	Undisclosed	LIN00178	&beta;-Alanine	DRG00414	.	.	Vivotag 680 XL	Investigative	.	.	.	.	.
PDC_02140	FITC-KK-11	PEP01101	D-aa KK-11	REC99999	Undisclosed	LIN00178	&beta;-Alanine	DRG00100	.	.	Fluorescein isothiocyanate	Investigative	.	.	.	.	.
PDC_02141	[D-Lys<sup>6</sup>]-GnRH gemcitabine conjugate	PEP01102	[D-Lys<sup>6</sup>]-GnRH	REC00033	Gonadotropin-releasing hormone receptor (GNRHR)	LIN00033	Glutaric acid	DRG00013	TAR10009	Ribonucleoside-diphosphate reductase subunit M2 (RRM2)	Gemcitabine	Investigative	.	.	.	.	.
PDC_02142	MAHNP-Dox conjugate	PEP01103	AHNP	REC00010	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	LIN00033	Glutaric acid	DRG00011	TAR10002	DNA topoisomerase 2-alpha (TOP2A)	Doxorubicin	Investigative	.	.	.	.	.
PDC_02143	JF-10-81	PEP01104	Potent somatostatin analog (SSA)	REC00032	Somatostatin receptor type 2 (SSTR2)	LIN00179	N-carboxy-N-(2-(methylamino)ethyl)glycine	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.
PDC_02144	JF-10-71	PEP01104	Potent somatostatin analog (SSA)	REC00032	Somatostatin receptor type 2 (SSTR2)	LIN00180	N-(2-aminoethyl)-N-carboxyglycine	DRG00009	TAR10008	DNA topoisomerase 1 (TOP1)	Camptothecin	Investigative	.	.	.	.	.